# BugSigDB 2024-10-18_16:58_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1301	162289	189330	33024	40544	1386
bsdb:1/1/2_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/2/1_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	207244
bsdb:1/2/2_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_DOWN	NA	100883
bsdb:1/4/1_Colorectal-adenoma:Proximal-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1485	836	162289	1301	165779	283168	207244	189330	40544	33024
bsdb:1/4/2_Colorectal-adenoma:Proximal-conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/5/1_Colorectal-adenoma:Distal-conventional-adenoma-cases_vs_controls_DOWN	NA	1485	1350
bsdb:1/6/1_Colorectal-adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	283168	1301	189330	40544	33024
bsdb:1/7/1_Colorectal-adenoma:advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	836	165779	150022	162289	724
bsdb:1/7/2_Colorectal-adenoma:advanced-conventional-adenoma-cases_vs_controls_DOWN	NA	140625	28050
bsdb:2/1/1_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_Head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/2/2_Head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_DOWN	NA	1654
bsdb:3/1/1_Colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	848	836
bsdb:4/1/1_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	469	838	29465	33024
bsdb:4/1/2_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	375288	1263	574697	1678	53246	39948
bsdb:5/1/1_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	46123	1654	642	653683	1380	1678	118747	830	194	1016	43996	82202	84162	893	39948	156973	1730	848	52228	32067	186650	1839	133925	265975	543311	1257	838	32207	970	613	123375	1301	195950	29465
bsdb:5/1/2_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1485	88138	2023	544	1663
bsdb:5/2/1_Chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	1839	289201	1485	186650	642
bsdb:7/1/1_Autism:severely-autistic_vs_non-sibling-control_UP	NA	191303	816	286729	872	258514	375288
bsdb:7/1/2_Autism:severely-autistic_vs_non-sibling-control_DOWN	NA	114627	52784	109326	1678	1485	102106	39948	253238	31983	1578	1243	113286	1263	1301	46255
bsdb:10/1/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:10/2/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1375
bsdb:14/1/1_Halitosis:Oral-Halitosis_vs_Control_UP	NA	194	195950	39948	1257	970	32067	2740	543311	157	1016	416916	838
bsdb:14/1/2_Halitosis:Oral-Halitosis_vs_Control_DOWN	NA	416916	724	437755	265975	838	1301	2740	32067
bsdb:15/1/1_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	33057
bsdb:15/1/2_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	55080	935200	1578	231454	44675
bsdb:16/1/1_Obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	31980	1263	248744	239759	572511
bsdb:16/1/2_Obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	816	283168	109326	574697	209	990721	35832	459786
bsdb:16/2/1_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	583	283168	209	109326	872	574697	239934	1920251
bsdb:16/2/2_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	239759	244127
bsdb:17/1/1_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	848	816	946234	1432051	1505663
bsdb:17/1/2_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	35832	580596	39948	216851	28050	46205	841	292632	40544
bsdb:17/2/1_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	1578	848	816	561	620	375288	1505663	946234
bsdb:17/2/2_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	244127	397864	580596	574697	102106	216851	1407607	28050	437755	846	577310	2740	841	292632
bsdb:18/1/1_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	244127	816	572511	830	1485	189330	1730	216851	1578	459786	1017280	841	1263	292632
bsdb:18/1/2_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239934	239759	283168	375288	838	195950
bsdb:18/2/1_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	1485	841
bsdb:18/2/2_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239934
bsdb:18/3/1_Obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_UP	NA	816
bsdb:18/3/2_Obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	239934	244127
bsdb:19/1/1_Schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	838	83770	848	906	1578	544	33024	904	872
bsdb:19/1/2_Schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	1301	33042	841	572511
bsdb:20/1/1_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	838
bsdb:20/2/1_Non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	1263	816
bsdb:20/2/2_Non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_DOWN	NA	838
bsdb:21/1/1_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	838	102106	841	1301	39948
bsdb:21/1/2_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	816	375288	239759
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	1578	990721	270497	119852	1678
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	189330	816	838	216851
bsdb:23/1/1_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	239759	816	572511	1378	33024	35832
bsdb:23/1/2_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	447020	1678	1485	39948	86331
bsdb:24/1/1_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	331654	816	194	848	1378
bsdb:24/1/2_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	29465	724	836	475	286
bsdb:25/1/1_Psoriasis:Psoriasis-Male_vs_Female_UP	NA	1301	150022	165779	29465	360541	1716	43668	32207	33882	57495	1016	469	36739	171412
bsdb:25/1/2_Psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1578	1743	2701	212791	1696
bsdb:26/1/1_Sex-design:female_vs_male_UP	NA	35832
bsdb:26/2/1_Obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:27/1/1_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	1485	191303	2740	946234	574697	580596	375288
bsdb:27/1/2_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	816	239759	397864	209	283168	872	174708	28138	1331051
bsdb:27/2/1_Obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_UP	NA	172900	256846	1485	28138	244127	459786	946234	1578	2740	574697	375288
bsdb:27/2/2_Obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	209	816	283168	1331051
bsdb:28/1/1_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	119852	84111	1357	244127	100883
bsdb:28/1/2_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	2740	724	1380	1485	216851	1263	416916	1678	102106	40544
bsdb:29/1/1_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	946234	574697	375288	239759
bsdb:29/1/2_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	216851	39948	1263	724	561	620
bsdb:29/2/1_Unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	574697
bsdb:29/2/2_Unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	1263	724	1485
bsdb:30/1/1_Chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	841	61170
bsdb:30/1/2_Chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	816	239759	397864	838	375288
bsdb:30/2/1_Chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	239759	420345
bsdb:30/2/2_Chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	841	61170	39948	84036
bsdb:30/3/1_Chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_UP	NA	420345
bsdb:30/3/2_Chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_DOWN	NA	553372
bsdb:31/1/1_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	207244	1485	100883	1017280
bsdb:31/1/2_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	33042	189330	216851	1378	724	841
bsdb:31/2/1_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	1485	207244
bsdb:31/2/2_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	33042	189330	216851	841
bsdb:31/3/1_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	1485	100883	84111	1017280	286
bsdb:31/3/2_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	189330
bsdb:32/1/2_Anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1263	841	1485
bsdb:34/1/2_Bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_Bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1578	1301
bsdb:34/4/1_Bipolar-disorder:Bipolar-patients-with-high-LDL_vs_low-LDL_DOWN	NA	838
bsdb:34/5/1_Bipolar-disorder:Bipolar-patients-with-high-TRP_vs_low-TRP_UP	NA	1578
bsdb:34/6/1_Bipolar-disorder:Bipolar-patients-with-high-TBARS-level_vs_low-TBARS-level_UP	NA	1730
bsdb:34/7/1_Bipolar-disorder:Bipolar-patients-with-high-MDA-level_vs_low-MDA-level_DOWN	NA	216851
bsdb:34/8/1_Bipolar-disorder:Bipolar-patients-with-high-BMI_vs_low-BMI_UP	NA	1578
bsdb:34/9/1_Bipolar-disorder:Bipolar-patients-with-metabolic-syndrome_vs_no-metabolic-syndrome_UP	NA	1578
bsdb:34/10/2_Bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_DOWN	NA	841
bsdb:34/11/2_Bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:35/1/1_Sjogren-syndrome:PSS_vs_Controls_UP	NA	29465
bsdb:35/1/2_Sjogren-syndrome:PSS_vs_Controls_DOWN	NA	1654	724	482	32207	836	1257
bsdb:36/1/1_Obesity:obese-adolescent_vs_control-adult_UP	NA	1654
bsdb:36/1/2_Obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_Obesity:obese-adult_vs_control-adolescent_UP	NA	1301
bsdb:36/2/2_Obesity:obese-adult_vs_control-adolescent_DOWN	NA	119852
bsdb:36/3/1_Obesity:control-adolescent_vs_control-adult_UP	NA	119852
bsdb:36/3/2_Obesity:control-adolescent_vs_control-adult_DOWN	NA	1301
bsdb:36/4/1_Obesity:obese-adolescent_vs_obese-adult_UP	NA	1654	447020
bsdb:36/5/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	1654	447020	1301
bsdb:36/5/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	119852
bsdb:37/1/1_Colorectal-cancer:CRC-patients_vs_Healthy-controls_UP	NA	165779	194	1730	236752	848	1378	61170	32257	32067	283168	459786	375288	543311	1257	836	123375
bsdb:37/1/2_Colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1243	1301
bsdb:38/1/1_Body-odor-measurement:head-of-teenager_vs_head-of-child_UP	NA	1912216
bsdb:38/1/2_Body-odor-measurement:head-of-teenager_vs_head-of-child_DOWN	NA	55193	1279
bsdb:38/2/1_Body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1912216	55193
bsdb:38/2/2_Body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1279
bsdb:39/1/2_Body-odor-measurement:youth-underarm-after-exercise_vs_youth-underarm-before_DOWN	NA	265
bsdb:39/2/1_Body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:39/3/1_Body-odor-measurement:Children-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/4/1_Body-odor-measurement:Children-Neck-before_vs_after-excercise_UP	NA	1279
bsdb:39/4/2_Body-odor-measurement:Children-Neck-before_vs_after-excercise_DOWN	NA	1912216
bsdb:39/5/1_Body-odor-measurement:teen-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/6/1_Body-odor-measurement:teen-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	1678	84111	283168	375288	239759
bsdb:40/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	292632	1263	35829	33042
bsdb:41/1/1_Psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	2038	528	316625	56688	1578	53572	109262
bsdb:41/1/2_Psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	1163	96	35798
bsdb:42/1/1_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	1301	1350	1279	906	28100	158846
bsdb:42/1/2_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	1678	816	572511	216851	841	207244	102106
bsdb:43/1/1_Behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:43/2/1_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	59735	838
bsdb:44/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	816
bsdb:45/1/1_Obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	572511	1678	33024	174708
bsdb:46/1/1_Obesity:pediatric-obese_vs_controls_DOWN	NA	816	838
bsdb:46/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	838
bsdb:47/1/1_Obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:47/2/2_Obesity:low_vs_hight-moderate-to-vigrous-physical-activity_DOWN	NA	189330	28050	577309
bsdb:48/1/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	816	239759	216851	459786
bsdb:48/2/1_Obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_Obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	816	239759
bsdb:48/3/1_Obesity:high-triglycerides_vs_low-triglycerides_UP	NA	838
bsdb:48/3/2_Obesity:high-triglycerides_vs_low-triglycerides_DOWN	NA	816
bsdb:48/4/1_Obesity:high-total-cholesterol_vs_low-total-cholesterol_DOWN	NA	816
bsdb:48/5/1_Obesity:high-HDL-C_vs_low-HDL-C_UP	NA	816
bsdb:48/6/1_Obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_UP	NA	838
bsdb:48/6/2_Obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_DOWN	NA	816	459786
bsdb:49/1/1_Obesity:Obesity-group_vs_controls_UP	NA	43996	117563	86331	1257	838	123375
bsdb:49/1/2_Obesity:Obesity-group_vs_controls_DOWN	NA	724	2717	1016	47670	1716	1279	40323
bsdb:50/1/1_Colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	836	561	620	1350	1301	1257
bsdb:50/1/2_Colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	816	841	239759	1730	577310
bsdb:51/1/1_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1578	838	150022	48736	1380	404402	1283313	1716	135858	1573535	543311	286	1378	1257	836	46255	117563	1654
bsdb:51/1/2_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	32067	196082	1678	33882	1847725	1573534	40544	28050	1506577	570
bsdb:51/2/1_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	46123	1380	581	838	123375
bsdb:51/2/2_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	574697	1263	1485	33042	150022	437755	459786	872	244127
bsdb:52/1/1_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	838	265	1485	33057
bsdb:52/1/2_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	35832	189330	375288	1301	207244	906	1407607	239759	204475	816	1263
bsdb:52/2/1_Substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	33057	265	838
bsdb:52/2/2_Substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	207244	375288	204475	35832	1301	906	1407607
bsdb:55/1/1_Stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	283168	239759
bsdb:56/1/1_Type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	283	561	570	583	620
bsdb:56/2/1_Gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	507	106589	283	80865	40323
bsdb:56/3/1_Type-II-diabetes-mellitus:Baby-meconium-with-DM-mothers_vs_Healthy-baby-meconium_UP	NA	904	267408	1380	1678	574697	135858	102106	33042	39948	189330	156973	1730	1378	2053	61170	57493	33882	88138	459786	375288	162291	836	838	841	125216	1263	191303
bsdb:57/1/1_Irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_UP	NA	838	1485	79206	1257	507	32008	482
bsdb:57/1/2_Irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_DOWN	NA	1716	1743	1301	13687	286
bsdb:57/2/1_Irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_UP	NA	1716	1678	1380	133925	1386	162291	1578	113286	265975	177971	39948	906	970	92793	80865	194	286	157	838	1279
bsdb:57/2/2_Irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_DOWN	NA	396388	59732	109244	670486	1378	1301	482	724	838	1279
bsdb:58/1/1_High-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1357	117563	1350
bsdb:58/1/2_High-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	40544	375288	816	283
bsdb:58/2/1_High-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	1301	561
bsdb:58/2/2_High-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:60/1/1_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	458839	111142	504481	255204
bsdb:60/1/2_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	92793	338	1847
bsdb:60/2/1_Type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_Type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_Obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	816	838
bsdb:61/3/1_Obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-1-month_DOWN	NA	816	838
bsdb:62/1/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	244127	1678	1649459	596767	2172
bsdb:62/1/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1485	838	1501226	841
bsdb:62/2/1_Cognitive-impairment:Mild-Cognitive-Impairment-PD_vs_Cognitively-Unimpaired-PD-(PD-NC)_UP	NA	1301
bsdb:62/2/2_Cognitive-impairment:Mild-Cognitive-Impairment-PD_vs_Cognitively-Unimpaired-PD-(PD-NC)_DOWN	NA	2152
bsdb:62/3/1_Parkinson's-disease:Mild-Cognitive-Impairment--PD-(PD-MCI)_vs_Control-Subjects_UP	NA	1678	1649459	596767	2172
bsdb:62/3/2_Parkinson's-disease:Mild-Cognitive-Impairment--PD-(PD-MCI)_vs_Control-Subjects_DOWN	NA	1485	838	1501226
bsdb:62/4/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1766253
bsdb:62/6/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	596767	1649459	244127
bsdb:62/6/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1766253	1485	841
bsdb:63/2/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:64/1/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	416916	32067
bsdb:64/4/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	32067
bsdb:64/4/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	482	29465
bsdb:65/1/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	416916	482	1378	538	1654	1016	848	29465	1301	970
bsdb:65/1/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	1730	44259	836	195950	157
bsdb:66/1/1_Neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/2/2_Neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/2/1_Autism:autistic_vs_neurotypical_UP	NA	1578	102106	1716	189330
bsdb:67/2/2_Autism:autistic_vs_neurotypical_DOWN	NA	239759	39948	375288	29465	35832
bsdb:67/3/1_Autism:constipated-autistic_vs_non-constipated-autistic_UP	NA	561	620	1485
bsdb:67/4/1_Autism:constipated-neurotypical_vs_non-constipated-neurotypical_DOWN	NA	204475
bsdb:68/1/1_Obesity:obese_vs_normal-weight_UP	NA	35832	572511	1485	33042	140625	1578	1263	1301
bsdb:68/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	1485	33042	51514	189330	119852	375288
bsdb:68/2/1_Obesity:overweight_vs_normal-weight_UP	NA	816	1578	1301	1485	572511	140625	1263	35832
bsdb:68/2/2_Obesity:overweight_vs_normal-weight_DOWN	NA	51514	119852	375288
bsdb:68/3/1_Obesity:obese-men_vs_normal-weight-men_UP	NA	1578	1301	572511
bsdb:68/3/2_Obesity:obese-men_vs_normal-weight-men_DOWN	NA	1716	51514	1263
bsdb:68/4/1_Obesity:overweight-men_vs_normal-weight-men_UP	NA	816	1578	1301	572511	33042	140625
bsdb:68/4/2_Obesity:overweight-men_vs_normal-weight-men_DOWN	NA	1716	51514	150022	906	1263
bsdb:68/5/1_Obesity:obese-women_vs_normal-weight-women_UP	NA	1301	140625	1263
bsdb:68/5/2_Obesity:obese-women_vs_normal-weight-women_DOWN	NA	51514
bsdb:68/6/1_Obesity:overweight-women_vs_normal-weight-women_UP	NA	1301	1263	140625
bsdb:69/1/1_Sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_Obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:69/3/1_Obesity:male-obese_vs_male-normal-weight_UP	NA	574697	848
bsdb:69/4/1_Obesity:obese_vs_normal-weight_UP	NA	848
bsdb:70/1/1_Obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	39948	816	838
bsdb:70/1/2_Obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	207244	40544	816
bsdb:70/2/2_Obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:71/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1243	909928	2737	830
bsdb:71/2/1_Premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_UP	NA	1386	1279	1350	2737	1578	1243	1485	29465	909928	1678	547	544	551	570	160674	53335	29487	195950
bsdb:71/2/2_Premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/2_Autism:autism_vs_typically-developing-controls_DOWN	NA	1301	29465	561	1654	543311	118747	162289
bsdb:73/1/1_Obesity:obese_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	816
bsdb:73/2/1_Obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/2/2_Obesity:obese-+-metabolic-syndrome_vs_normal-weight_DOWN	NA	816
bsdb:74/1/2_Obesity:obese_vs_non-obese_DOWN	NA	239759	195950
bsdb:74/2/2_Obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	239759
bsdb:74/3/1_Obesity:high-BMI_vs_low-BMI_UP	NA	55079	1678	662	629
bsdb:74/3/2_Obesity:high-BMI_vs_low-BMI_DOWN	NA	239759	195950
bsdb:74/4/1_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	55079
bsdb:74/4/2_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	239759	195950
bsdb:75/1/1_Smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	1016	1257	848	12916	724	482
bsdb:75/1/2_Smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_DOWN	NA	906	29465	52228	1301
bsdb:75/2/1_Smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	1016	848	482	416916
bsdb:75/2/2_Smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	1654	84111	906	29465	34104
bsdb:75/3/1_Smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_UP	NA	1654	1243	469	407217	620	349
bsdb:75/3/2_Smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_DOWN	NA	84111	189330	1730	46123	174708	109326	33042	150022	1378	84036	52784
bsdb:75/4/1_Smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_UP	NA	237	1647	1378	620	40544
bsdb:75/4/2_Smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_DOWN	NA	84111	836	46123	52784	109326	189330	1730	841	84036	194	724	40323
bsdb:76/1/1_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	572511	904
bsdb:76/1/2_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	39948	724	1392389
bsdb:77/1/2_Bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	1350	1301	2740	1375	227979	66831	1485	1716	872	117563	32207	583	100883	1357	191303	2316
bsdb:78/1/2_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	1263	841	33042	1573535	1279	375288	28050	244127	724	283168
bsdb:79/1/1_Obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	33042	189330	1263
bsdb:79/2/1_Obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	100883	1350	61170	1578	265975	1263
bsdb:80/1/1_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	838	904	158846
bsdb:83/1/1_Obesity:before-surgery_vs_after-surgery_UP	NA	207244	33042	216851	209	5782	40637
bsdb:83/1/2_Obesity:before-surgery_vs_after-surgery_DOWN	NA	544	547	590	29465	5140
bsdb:85/1/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/2/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:85/3/1_Cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/4/1_Cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816	102106
bsdb:86/1/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1279	1578
bsdb:86/3/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-28_DOWN	NA	816
bsdb:86/4/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-150_DOWN	NA	816
bsdb:86/7/1_Cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_UP	NA	239934	207244	1485	39948	547	1350	946234	1378	724	1578	1743	32207	1279	1301
bsdb:86/7/2_Cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_DOWN	NA	375288	816	239759
bsdb:87/1/1_Type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	572511	816	29465	1263	1301	547	40544
bsdb:87/2/1_Type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	28050	841	207244	216851
bsdb:88/1/1_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	165779	906	572511
bsdb:88/1/2_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	724	40544	1485
bsdb:89/1/1_Crohn's-disease:CD-patients_vs_Healthy-controls_UP	NA	1654	1678
bsdb:89/1/2_Crohn's-disease:CD-patients_vs_Healthy-controls_DOWN	NA	698776	1730	61170	375288	841	1017280	292632
bsdb:90/1/1_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	469	70774	1301	13687	1716	42255	165695	129337	482	165779	407	29465	1269	1357	357	212791	29580	80865
bsdb:90/2/1_Cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	29465	1350
bsdb:90/2/2_Cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	286	400634	1716	1301	106589	32067	1654	848	13687	42255	2745	157	724	41275	2717	165695
bsdb:91/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1386	1298	1730	216851	40323
bsdb:91/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1743	283	286
bsdb:92/2/1_Non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_UP	NA	838
bsdb:92/3/1_Non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_obese-without-non-alcoholic-fatty-liver-disease_UP	NA	838
bsdb:93/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_Cesarean-section:Antimicrobials-use-during-delivery-(yes)_vs_Antimicrobials-use-during-delivery-(no)_UP	NA	1678
bsdb:93/3/1_Cesarean-section:Maternal-consumption-of-probiotics-(YES)_vs_Maternal-consumption-of-probiotics-(NO)_UP	NA	1578
bsdb:93/4/1_Cesarean-section:Furry-pets-at-home-(YES)_vs_Furry-pets-at-home-(NO)_UP	NA	216851
bsdb:93/4/2_Cesarean-section:Furry-pets-at-home-(YES)_vs_Furry-pets-at-home-(NO)_DOWN	NA	1279
bsdb:95/1/1_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	189330	841
bsdb:95/1/2_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_Obesity:obese_vs_controls_UP	NA	239759	165779	33042	848	543311
bsdb:96/1/2_Obesity:obese_vs_controls_DOWN	NA	816	872	216851	150022	1164882	133925	292632
bsdb:97/2/1_Obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	1678	906
bsdb:97/3/1_Obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	239759	1301
bsdb:97/4/1_Obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_UP	NA	216851
bsdb:97/4/2_Obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1301
bsdb:98/1/1_Chronic-kidney-disease:CKD_vs_controls_UP	NA	469	1386	81	445	68	1664383	286	504481	613	629
bsdb:98/1/2_Chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1705353	911113	1716	1210119	265	13687	40323	1506577
bsdb:99/1/2_Obesity:obese_vs_controls_DOWN	NA	816	239759
bsdb:100/1/1_Obesity:High-BMI_vs_low-BMI_UP	NA	613	838
bsdb:100/2/1_Obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	613	838
bsdb:100/2/2_Obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_Obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:102/1/1_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	838	1263
bsdb:102/1/2_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	572511	239759
bsdb:103/1/1_Unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	572511	1654	1678	553372	1380	84111	644652	133925	1730	207244	841	216851	872
bsdb:103/1/2_Unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	404402	40544	638847
bsdb:103/2/1_Unipolar-depression:depressed-male_vs_Healthy-Controls_UP	NA	1380	816	29465
bsdb:103/2/2_Unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	644652	109326	638847
bsdb:104/1/1_Unipolar-depression:major-depressive-disorder-(visit-1)_vs_healthy-controls_UP	NA	838	570	1301
bsdb:104/2/1_Unipolar-depression:major-depressive-disorder-(visit-2)_vs_healthy-controls_UP	NA	838	1301
bsdb:105/1/1_Bipolar-disorder:Bipolar_vs_Healthy-controls_DOWN	NA	216851
bsdb:106/1/1_Bipolar-disorder:bipolar-disorder-patients_vs_healthy-controls_UP	NA	946234
bsdb:106/2/1_Bipolar-disorder:bipolar-disorder-patients_vs_unaffected-relatives_UP	NA	946234
bsdb:107/1/2_Anorexia-nervosa:Anorexia-patients-at-T1_vs_Healthy-comparison-group-(HCG)_DOWN	NA	207244	216851
bsdb:107/2/1_Anorexia-nervosa:Anorexia-patients-at-T2_vs_Healthy-comparison-group-(HCG)_UP	NA	375288
bsdb:108/1/1_Anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:109/1/1_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_UP	NA	207244	244127	1678	1485
bsdb:109/1/2_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_DOWN	NA	204475	841
bsdb:109/2/1_Anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	207244	1678	1578	1357	1017280	1263	44748	1485
bsdb:109/2/2_Anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816	1485
bsdb:110/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1678	1578
bsdb:111/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	469	990721	100883	1573534	1473205	40323	1505652
bsdb:111/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39948	1506553	216851	40544	904	1508657	1506577
bsdb:112/1/1_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	482	816
bsdb:112/1/2_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	838	375288
bsdb:113/1/1_Unipolar-depression:MDD_vs_controls_DOWN	NA	1678
bsdb:114/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	846	543311	118747	286	1257	1378
bsdb:114/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	216851	33042	572511	189330
bsdb:115/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	1485	1678	459786	1301	970	906	904	838
bsdb:115/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	816	283168	195950
bsdb:115/2/1_Bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	816	283168	195950
bsdb:116/1/1_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	1485	816	29465
bsdb:116/1/2_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	838	1678	1578
bsdb:117/1/1_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	1578	32207
bsdb:117/1/2_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	32067	196082
bsdb:117/2/1_Pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	1578	32207
bsdb:117/2/2_Pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	724	32067	482
bsdb:118/1/1_Cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	1578
bsdb:118/1/2_Cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_Cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	29465	1350
bsdb:118/2/2_Cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_DOWN	NA	1506577	838	216851
bsdb:119/1/1_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/2/1_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:119/3/1_Type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_UP	NA	1678
bsdb:119/3/2_Type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_DOWN	NA	838
bsdb:120/1/1_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	838	1485	1350	816
bsdb:120/1/2_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	816	1678	1578
bsdb:120/2/1_Physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	816	838	1350	1485
bsdb:120/2/2_Physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	1678	1578
bsdb:121/1/1_Gingivitis:gingivitis_vs_healthy-controls_UP	NA	836	195950	157
bsdb:121/1/2_Gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_Breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	237	407
bsdb:122/1/2_Breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13687	914	374
bsdb:123/1/1_Diet:high-fat-diet_vs_low-fat-diet_UP	NA	1357	117563	1486725	109326	1485	33042	1730	216851	946234	119852	100175	1017280	44748	1506577	1505663	61170	32207	447020	102106
bsdb:123/1/2_Diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	544	397864	816	588605
bsdb:124/1/2_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1678	561	1357
bsdb:124/2/1_Diet:body-builders-(high-protein)_vs_control_UP	NA	40544	216851	1485	724	1432051
bsdb:124/2/2_Diet:body-builders-(high-protein)_vs_control_DOWN	NA	1678	577310	1243
bsdb:124/3/1_Diet:distance-runners-(high-carb)_vs_control_UP	NA	40544
bsdb:124/3/2_Diet:distance-runners-(high-carb)_vs_control_DOWN	NA	572511	547	46255	1243
bsdb:125/1/1_Squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1257	848	1283313	1016
bsdb:125/1/2_Squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	32207	724
bsdb:126/1/1_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	724	1386
bsdb:126/1/2_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/2/1_Oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	724	1386
bsdb:126/2/2_Oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/3/1_Oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_UP	NA	724	1301
bsdb:126/3/2_Oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_DOWN	NA	1386
bsdb:127/1/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	1485	61170	40544
bsdb:127/1/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:127/2/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	904	118747	1485	2383	561	61170	570	158846	581	32207	40544
bsdb:127/2/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	447020	102106	216851	52225	283168	265975	838	1279	674963
bsdb:128/1/1_Gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1283313	43996	39948	848	543311	1578	437755	2740	1257	838	84108	1301
bsdb:128/1/2_Gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	469	57739	378210	235572
bsdb:128/2/1_Gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	1301	1257	1378	848	543311	1578	1730	1283313	838	39948	84108	2740	43996	437755
bsdb:128/2/2_Gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	57739	235572
bsdb:128/3/1_Gastric-cancer:gastric-cancer_vs_superficial-gastric_UP	NA	1283313	43996	39948	1730	848	1378	1578	437755	543311	2740	1257	838	84108	1301
bsdb:128/3/2_Gastric-cancer:gastric-cancer_vs_superficial-gastric_DOWN	NA	47420	469	57739	378210	235572
bsdb:129/1/1_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_UP	NA	572511	189330	237	13159	84567	286
bsdb:129/1/2_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_DOWN	NA	447020	572511	102106	100883	724	1578	2093	375288
bsdb:130/1/1_Diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_Diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/5/1_Diet:>-30-years-participants_vs_20-30-years-participants_UP	NA	1578
bsdb:130/6/2_Diet:BMI->25_vs_BMI-<-20_DOWN	NA	1678
bsdb:130/7/1_Diet:BMI-20-25_vs_BMI-<20_DOWN	NA	1678
bsdb:131/1/1_Diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	119852
bsdb:131/2/2_Diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:131/4/1_Diet:Cara-Cara_vs_controls-at-time-7_UP	NA	375288	189330	244127	574697
bsdb:131/5/1_Diet:Bahia_vs_controls-at-time-7_UP	NA	447020	1350	1485	244127
bsdb:132/1/1_Diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_Diet:Meat_vs_mushroom_DOWN	NA	816	375288	33042	207244	40544
bsdb:134/1/1_Diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	1485	872
bsdb:134/2/2_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	239759
bsdb:135/1/1_Diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:136/1/2_Diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_DOWN	NA	1485	1730	459786
bsdb:136/2/1_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84111	1357	1301	1350	1730	102106	1485	1678	572511
bsdb:136/2/2_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	872	39948	216851	1263	84108	29465
bsdb:137/1/1_Colorectal-cancer:CRC_vs_controls_UP	NA	642	848
bsdb:137/1/2_Colorectal-cancer:CRC_vs_controls_DOWN	NA	816	35832	544	413496	189330	1730	841
bsdb:138/1/1_Lung-cancer:lung-cancer_vs_controls_UP	NA	1654	1380	1350	1505663	1573535	1392389	69965	160674
bsdb:138/1/2_Lung-cancer:lung-cancer_vs_controls_DOWN	NA	447020	226	1678	102106	1348911	189330	28050	175304	437755	162289	1257	46205	1508657	40544
bsdb:139/1/2_Head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	1716	32257
bsdb:139/2/1_Squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	46123	1016	1716	32257	482
bsdb:139/3/1_Squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	1716	32257
bsdb:139/4/1_Squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_UP	NA	1654
bsdb:140/1/1_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	2172	239934	84593
bsdb:140/1/2_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	574697
bsdb:140/2/1_Multiple-sclerosis:multiple-sclerosis-patients_vs_controls_UP	NA	84593	2172	239934
bsdb:140/2/2_Multiple-sclerosis:multiple-sclerosis-patients_vs_controls_DOWN	NA	574697
bsdb:140/3/1_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934	2735
bsdb:140/3/2_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/4/1_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934	2172	2735
bsdb:140/4/2_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/5/1_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_UP	NA	838	40544
bsdb:140/5/2_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_DOWN	NA	1266
bsdb:140/6/1_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_UP	NA	838
bsdb:140/6/2_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_DOWN	NA	1266
bsdb:141/1/1_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	165779	39948	162289	543311	43996	838	1301
bsdb:141/1/2_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1578
bsdb:142/1/1_Oral-squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	1578	543311	1257	1279	1301	195950	29465
bsdb:142/1/2_Oral-squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	416916	47670	724	482	32067
bsdb:142/2/1_Oral-squamous-cell-carcinoma:HPV-+_vs_HPV--_UP	NA	1578	1013
bsdb:142/2/2_Oral-squamous-cell-carcinoma:HPV-+_vs_HPV--_DOWN	NA	538	482	32067
bsdb:142/3/1_Oral-squamous-cell-carcinoma:chemotherapy-radiation-and-surgery_vs_surgery_UP	NA	1578
bsdb:142/3/2_Oral-squamous-cell-carcinoma:chemotherapy-radiation-and-surgery_vs_surgery_DOWN	NA	724	416916	32067
bsdb:144/1/1_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	32207	265975	482	1654
bsdb:144/1/2_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	848	475	1257	836	838	29465
bsdb:144/2/2_Air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	194	1016	848	475	1257	836	838	29465
bsdb:144/3/2_Air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_DOWN	NA	32207	848	265975	1654	194	482
bsdb:146/1/1_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	2093	157	194	538	82202	1283313	848	970	39948	1257	44259	2740	43996	543311	1016
bsdb:146/1/2_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	906	1213720	117563	47670	29465	1301	196081	32207	1654
bsdb:147/1/1_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	848	838	543311	1257	39948	43996	970	157	32008
bsdb:147/1/2_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	1301	32207
bsdb:147/2/1_Squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_UP	NA	29465	32067	1654	32207	117563	906	265975	1380	437755
bsdb:147/2/2_Squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_DOWN	NA	848	838	543311	1257	836	39948	2093	44259	43996	538	157	416916
bsdb:148/1/1_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/1/2_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:148/2/1_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/2/2_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:148/3/1_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_NIR-PCOS---NIR(Non-Insulin-Resistance)_UP	NA	816
bsdb:148/3/2_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_NIR-PCOS---NIR(Non-Insulin-Resistance)_DOWN	NA	216851
bsdb:149/1/1_Obesity:Obese-children_vs_Normal-weight-children_UP	NA	158846
bsdb:149/1/2_Obesity:Obese-children_vs_Normal-weight-children_DOWN	NA	207244	61170	459786
bsdb:150/1/1_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	286	416916	216851	1508657	47670	909656	816
bsdb:150/1/2_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_DOWN	NA	713	109326	59735	194	1716	1730	848	724	1506553	32067	475	482	543311	1257	836	838	841	32207	970	157	29465
bsdb:150/2/1_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	547	416916	286
bsdb:150/2/2_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_DOWN	NA	848	838	44259	713	209	1730	841	109326	872	43994
bsdb:152/1/1_Cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330	581	583	1263	22	83770
bsdb:152/1/2_Cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	2745	33024
bsdb:152/2/1_Cervical-cancer:cervical-cancer-patients_vs_healthy-controls_UP	NA	375288	841
bsdb:152/2/2_Cervical-cancer:cervical-cancer-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:153/1/1_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_UP	NA	2747	129337	1357	1301
bsdb:153/1/2_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_DOWN	NA	114627	413496	1350	44249
bsdb:154/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	46913	44249	59732
bsdb:154/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	838	1730	570	32067	33024	86331	613
bsdb:155/1/1_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	29465	970
bsdb:155/1/2_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	1283313	265975	123375	482	724
bsdb:155/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	59735
bsdb:155/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	838
bsdb:156/1/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	838	561	620	570	1578	1301	239759	29465	1678	990721	375288
bsdb:156/1/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	216851	841	28050	1506553
bsdb:156/2/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	1729679	838	561	620	570	1301	1578	239759	1678	29465
bsdb:156/2/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	841	28050	1506553
bsdb:157/1/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	44259	1578	836	838	1301	46123
bsdb:157/1/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	416916	1380	118747	194	43996	1716	44259	848	724	963	47670	32067	482	265975	2740	32207	29465	2717
bsdb:157/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Healthy-controls_UP	NA	816	1016	308865	836	838	1301	830
bsdb:157/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Healthy-controls_DOWN	NA	2147	1654	416916	1380	118747	830	194	2717	43996	1716	39948	44259	724	47670	32067	906	482	265975	2740	1257	32207	970	157	29465
bsdb:158/1/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	816	29465	848	33024
bsdb:158/1/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	579	216851	547	39948	561	620
bsdb:158/2/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	848	570	816
bsdb:158/2/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	39948	547	561	216851	620
bsdb:159/1/1_Gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	713	1016
bsdb:159/2/1_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/2_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	117563
bsdb:160/1/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	346096	1716	836	1654	713	1016	848	416916	47670
bsdb:160/2/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_Head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	32207	724	1716	346096	836	1016
bsdb:161/1/1_Lung-cancer:NSCLC_vs_Healthy-controls_UP	NA	1301	47670
bsdb:161/1/2_Lung-cancer:NSCLC_vs_Healthy-controls_DOWN	NA	838
bsdb:163/1/1_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	1654	1678	872	437755	55506	970	157
bsdb:163/1/2_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	43996	724	482	838	1301	29465
bsdb:163/2/1_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	146	29465
bsdb:163/2/2_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	1213720
bsdb:164/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	838	1301	29465	1654	32067
bsdb:164/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	482	848	724	836	1301
bsdb:165/1/1_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_UP	NA	1283313	1485	872	407	577309
bsdb:165/1/2_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_DOWN	NA	239934	174708	580024	1730	209	1578	1357	1243	248038	133925	265975	577310	1427376	638847	32207	2753
bsdb:166/1/1_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	816	84111	1505663	561	946234	375288	1508657	1769710	620	46255
bsdb:166/1/2_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1506577	102106	580596	1501226	1263	841	33042	292632	28050	2747	39948
bsdb:167/1/1_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	82202
bsdb:167/3/1_Squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	1730
bsdb:168/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_UP	NA	283	47670	482
bsdb:168/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	194	1331051	543311	1481960	196081
bsdb:168/2/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_UP	NA	2093	482
bsdb:168/2/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_DOWN	NA	43996	838
bsdb:168/3/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_UP	NA	59735	118747	82202	836
bsdb:168/3/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_DOWN	NA	1654	194195	113286	196081
bsdb:169/1/1_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	47670	50729
bsdb:169/1/2_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1213720
bsdb:169/3/1_Gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	47670	482	1257
bsdb:169/4/1_Gastric-cancer:yellow-thin-coating-GC-patient_vs_other-coatings_DOWN	NA	5543
bsdb:170/1/1_Lung-cancer:cancerous-site_vs_controls_UP	NA	1301
bsdb:170/1/2_Lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_Lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_UP	NA	1016	237	724	32067	482	970	1301
bsdb:170/2/2_Lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_DOWN	NA	469
bsdb:170/3/1_Sampling-site:cancerous-site-(T)_vs_paired-contralateral-non-cancerous-site-(TN)_UP	NA	39948
bsdb:170/4/1_Lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_UP	NA	1016
bsdb:170/4/2_Lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_DOWN	NA	265	1279	1004300
bsdb:170/5/1_Lung-cancer:contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_vs_control-group-with-no-antibiotics-(No)_UP	NA	482	1279
bsdb:170/5/2_Lung-cancer:contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_vs_control-group-with-no-antibiotics-(No)_DOWN	NA	33042	469	816	1004300
bsdb:170/6/1_Sampling-site:Cancerous-site-with-no-antibiotics-(To)_vs_contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_UP	NA	33024
bsdb:171/1/1_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	1716	848	482	29465
bsdb:171/1/2_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	836	838	32207
bsdb:171/2/1_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_UP	NA	1716	32067	482	838
bsdb:171/2/2_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_DOWN	NA	1301
bsdb:171/3/1_Esophageal-cancer:esophageal-cancer-patients_vs_controls_UP	NA	1716
bsdb:171/3/2_Esophageal-cancer:esophageal-cancer-patients_vs_controls_DOWN	NA	1654	1301	482
bsdb:171/4/1_Colorectal-cancer:colorectal-cancer-patients_vs_controls_UP	NA	1716	482
bsdb:171/4/2_Colorectal-cancer:colorectal-cancer-patients_vs_controls_DOWN	NA	838	1301
bsdb:171/5/1_Gastric-cancer:gastric-cancer-patients_vs_controls_UP	NA	482	1301
bsdb:171/5/2_Gastric-cancer:gastric-cancer-patients_vs_controls_DOWN	NA	838	32207	1301
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	85413	80865	88	86331	32207
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735	1016	848	836
bsdb:172/2/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	86331	970	29465
bsdb:172/2/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	1301
bsdb:172/3/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	85413	80865	47670	88	286	32207
bsdb:172/3/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735
bsdb:172/4/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	86331	838	29465
bsdb:172/4/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	400634
bsdb:173/1/1_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	904	416916	194	135858	82202	413496	547	52228	570	1578	32067	200903	838	970	29465
bsdb:173/1/2_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	239934	239759	207244	244127	1678	35832	572511	41275	580596	1485	33042	189330	84111	946234	204475	158846	906	86331	651554	577310	583	379	44748
bsdb:173/2/1_Pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_UP	NA	283	117563	140625	32067	115543	46205	1200657	1301
bsdb:173/2/2_Pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_DOWN	NA	118966	561	620
bsdb:174/1/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	970	838	1164882	1301	1257	13687	469	1386
bsdb:174/1/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	613	209	1543704	1357
bsdb:174/2/1_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_UP	NA	416916	111142	292480
bsdb:174/2/2_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_DOWN	NA	286
bsdb:174/3/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	469	1386	816	13687	1257	1301	848
bsdb:174/3/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	209	1578
bsdb:175/1/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:175/2/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	1283313	32067
bsdb:175/3/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1716	162289	150022	1279	1654
bsdb:176/1/2_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	216851	1263	28050
bsdb:177/1/1_Colorectal-cancer:colon-cancer-patients_vs_control-group_UP	NA	35832	1485	39948	848	2172	119852	1257
bsdb:177/1/2_Colorectal-cancer:colon-cancer-patients_vs_control-group_DOWN	NA	1301
bsdb:177/2/1_Colorectal-cancer:colon-cancer-patients-(tumor-samples)_vs_control-group_UP	NA	2172	1257	970
bsdb:177/3/1_Colorectal-cancer:colon-cancer-patients-(fecal-samples)_vs_control-group_UP	NA	189330	1257
bsdb:177/3/2_Colorectal-cancer:colon-cancer-patients-(fecal-samples)_vs_control-group_DOWN	NA	841
bsdb:178/1/1_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	2745	22	1350	41275	1663	1763
bsdb:178/1/2_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	106589	445
bsdb:178/2/1_Gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	1350	970	2745	1678	239759	1263	39948	459786	33042	841	906	1279	572511
bsdb:178/2/2_Gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_DOWN	NA	379	158846	22	1763	1578
bsdb:178/3/1_Gastric-cancer:gastric-cancer-tumor-group_vs_normal_UP	NA	92793	1678	572511	33042	39948	1378	204475	117563	70774	1578	149698	407	482	1257	1743	841	42255	1263	22	1301	29465
bsdb:178/3/2_Gastric-cancer:gastric-cancer-tumor-group_vs_normal_DOWN	NA	1716	106589	1654	1279
bsdb:179/1/1_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380	2717
bsdb:179/1/2_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:179/2/1_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380
bsdb:179/2/2_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:181/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-control_UP	NA	239934	572511	946234	283168	459786	375288	29465
bsdb:181/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-control_DOWN	NA	838
bsdb:184/1/1_Prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/1/2_Prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	216851	28050	258514
bsdb:185/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	561	620	1485	29465
bsdb:185/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	816
bsdb:185/2/1_Gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_UP	NA	570
bsdb:185/2/2_Gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_DOWN	NA	239934	620	1578	39948
bsdb:187/1/1_Medroxyprogesterone-acetate:naive-black-participants-(baseline-visit)_vs_depot-medroxyprogesterone-acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_Medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_UP	NA	150022
bsdb:187/2/2_Medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_DOWN	NA	1485	177971
bsdb:187/3/1_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-2)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-2)_UP	NA	1578
bsdb:187/3/2_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-2)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-2)_DOWN	NA	1485	848	1378	838	168808
bsdb:187/4/1_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-3)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-3)_UP	NA	150022
bsdb:187/4/2_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-3)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-3)_DOWN	NA	1375	906	838
bsdb:188/1/1_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846	1654
bsdb:189/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	816	574697	375288	553372	239759	1263
bsdb:190/1/1_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_UP	NA	1485	1350
bsdb:190/1/2_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_DOWN	NA	1578	29465
bsdb:192/1/2_Irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_Irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:194/1/1_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	212791	283	1279	165695	407	106589	586	196013	504481	12916	13687	469
bsdb:194/1/2_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	236752	1357
bsdb:195/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_UP	NA	629	44259
bsdb:195/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	32067	1016
bsdb:195/2/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_UP	NA	44259	157
bsdb:195/2/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_DOWN	NA	482
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	29465	1350	158846	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	39948	724	570	28050	577310	841	1508657	1263	1301
bsdb:197/1/1_Asthma:severe-asthma_vs_non-asthma_UP	NA	239759	207244	816	1016	1432051	1730	216851	946234	5277	283168	459786	375288	4753	5533	1501226	841	1263
bsdb:197/1/2_Asthma:severe-asthma_vs_non-asthma_DOWN	NA	5206	237557	583	5615
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	482	29465	838
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	724	469
bsdb:199/1/2_Ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	44249	2251
bsdb:200/1/2_Postmenopausal:Post-menopausal-patients_vs_Pre-menopausal-patients_UP	NA	1380	816	572511	194	1485	39948	216851	162290	33983	2740	162289	836	285105	72763	184869	165779	419014	1654	437755
bsdb:200/2/1_Endometrial-cancer:Endometrial-cancer_vs_Benign_DOWN	NA	1578
bsdb:200/2/2_Endometrial-cancer:Endometrial-cancer_vs_Benign_UP	NA	1654	28263	194	150022	848	162290	1578	2740	162289	836	838	184869	165779
bsdb:201/1/1_Leukemia:induction_vs_repeat-therapy_UP	NA	816	216851	459786	375288	1263
bsdb:201/1/2_Leukemia:induction_vs_repeat-therapy_DOWN	NA	1654	84111	1350	1573536	1578	292632	29465
bsdb:202/1/1_Autism:children-with-autism-mental-regression-(AMR)_vs_children-with-autism-non-mental-regression-(ANMR)_UP	NA	1350
bsdb:202/2/1_Autism:children-with-autism-non-mental-regression-(ANMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:202/3/1_Autism:children-with-autism-mental-regression-(AMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:204/1/1_Premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_Vulvovaginitis:Women-with-BV_vs_Normal-controls_UP	NA	1380	118747	39948	2701	2050	836	168808
bsdb:207/1/2_Vulvovaginitis:Women-with-BV_vs_Normal-controls_DOWN	NA	1578
bsdb:207/2/1_Vulvovaginitis:Women-with-BV-and-VVC_vs_Normal-controls_UP	NA	838
bsdb:208/1/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	207244	1485	1350	216851	946234	1578	838	1279
bsdb:208/1/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	816	572511	158846	906	1301	29465
bsdb:208/2/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	580596	1485
bsdb:208/2/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	906	68287	222	84111	237	40323	86331	59732	283
bsdb:208/3/1_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/3/2_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:208/4/1_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/4/2_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:209/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	29465	407	544	1279	1716	1301	12916	1743	117563	469	374	80865	1302778	1578	222	65551	28209	40323	114248	724	88	283	28067	504481	1357	547	150247	357
bsdb:209/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	561	816	1485	1678	1350	544	570	158851	620	1279	1716	1301
bsdb:210/1/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	239934	1678	102106	1350	216851	1578	841	1263	13687	292632	40544
bsdb:210/1/2_Food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	239759	816	375288	838	1301	29465
bsdb:210/2/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	292632
bsdb:210/2/2_Food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	816	29465
bsdb:211/1/1_Anemia:gestational-anemia-(GA1-group)_vs_healthy-controls(HC1-group)_UP	NA	244127	265975	543311	191303
bsdb:211/2/1_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls-(HC3-group)_UP	NA	1380	135858	84111
bsdb:211/2/2_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls-(HC3-group)_DOWN	NA	216851	1263	86331	207244	204475	447020
bsdb:212/1/1_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	1654	283168	119852
bsdb:212/1/2_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	216851	28050
bsdb:212/2/1_Diet:Higher-fiber-intake-from-FRUITS/-VEGETABLES_vs_low-fiber-intake-from-FRUITS/-VEGETABLES_DOWN	NA	1654	283168
bsdb:212/3/1_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_UP	NA	33042	216851
bsdb:212/3/2_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_DOWN	NA	816	283168	1263
bsdb:212/4/1_Diet:Higher-fiber-intake-from-GRAINS_vs_low-fiber-intake-from-GRAINS_DOWN	NA	572511
bsdb:213/4/1_Gut-microbiome-measurement:2-month-old-infants_vs_Neonates_UP	NA	29465	1485	1578	838	1678
bsdb:213/5/1_Delivery-method:Vaginally-delivered-neonates_vs_Cesarean-delivered-neonates_UP	NA	816	158846	375288
bsdb:213/5/2_Delivery-method:Vaginally-delivered-neonates_vs_Cesarean-delivered-neonates_DOWN	NA	1301	158851
bsdb:213/6/1_Delivery-method:Vaginally-delivered-2-month-olds_vs_Cesarean-delivered-2-month-olds_UP	NA	816	158846
bsdb:213/6/2_Delivery-method:Vaginally-delivered-2-month-olds_vs_Cesarean-delivered-2-month-olds_DOWN	NA	1485	838
bsdb:214/1/1_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	547	590	158851
bsdb:214/1/2_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	572511	1730	1263
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239934	207244	35832	33042	872	547	216851	946234	204475	44249	375288	577309	33024	836	379	841	29465	561	620	1485
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	904	209879	156454	244127	1678	43668	1696	580596	1485	102106	1716	39948	189330	538	117563	724	570	1578	906	459786	838	1263	1301	40544	191303
bsdb:216/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1380	1350
bsdb:217/3/1_Age:infant-at-18-months_vs_infant-at-6-months_UP	NA	848	583
bsdb:217/3/2_Age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1678
bsdb:218/1/1_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_UP	NA	244127
bsdb:218/1/2_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	28050	158846
bsdb:218/2/1_Hepatocellular-carcinoma:HBV-related-HCC-patients_vs_healthy-controls_UP	NA	244127	33024	838
bsdb:218/3/1_Hepatocellular-carcinoma:non-HBV-non-HCV-patients_vs_HBV-related-HCC-patients_DOWN	NA	32199	28050	33024
bsdb:219/2/1_Diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_UP	NA	28050
bsdb:219/2/2_Diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_DOWN	NA	239759	574697	283168
bsdb:219/3/1_Diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)_DOWN	NA	40544
bsdb:220/1/1_Age:older-age-European-women_vs_younger-age_UP	NA	1663	168808	1716	2745
bsdb:220/1/2_Age:older-age-European-women_vs_younger-age_DOWN	NA	1743
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	547
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	39948	150022	724	149698
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	1350	1506553	1578	1301
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:223/2/1_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_UP	NA	1350	1505663
bsdb:223/2/2_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_DOWN	NA	39948	216851	33024	838
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	1578	1301
bsdb:223/4/1_HIV-infection:homosexual-subjects-with-HIV_vs_heterosexual-subjects-with-HIV_DOWN	NA	1506553	375288	33024	838
bsdb:223/5/1_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_UP	NA	561	1506553	620	1301
bsdb:223/5/2_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:223/6/1_HIV-infection:HAART-untreated_vs_healthy-control_UP	NA	1350	1578
bsdb:224/1/1_Diet:barley-(WGB)_vs_baseline_UP	NA	572511
bsdb:224/1/2_Diet:barley-(WGB)_vs_baseline_DOWN	NA	283168	841	39948
bsdb:224/3/1_Diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_UP	NA	572511
bsdb:224/3/2_Diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_DOWN	NA	816
bsdb:225/1/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	1350
bsdb:225/2/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_DOWN	NA	816
bsdb:226/1/1_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_UP	NA	580596	135858	189330	547	1350	216851	158846	577310	838
bsdb:226/1/2_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_DOWN	NA	33042	397864	39948	816
bsdb:226/2/1_HIV-infection:HAART-treated-HIV-1-patients_vs_HAART-naive-HIV-1-patients_UP	NA	1654	572511	1350	158846	29465
bsdb:226/2/2_HIV-infection:HAART-treated-HIV-1-patients_vs_HAART-naive-HIV-1-patients_DOWN	NA	239759	397864	39948	216851	283168	459786	838	638847
bsdb:227/1/2_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678	239934
bsdb:227/2/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:227/3/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1301
bsdb:227/3/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934
bsdb:227/4/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301	1505657	216851	375288	1505652	1501226	117563	100883
bsdb:227/4/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1654	544	100883	84111	547	1330547	1504576	160674	1485
bsdb:227/5/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	100883	189330	216851	375288	1501226	1301	469
bsdb:227/5/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934	547	1330547	160674	2735
bsdb:227/6/1_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678
bsdb:227/6/2_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_DOWN	NA	32207
bsdb:228/1/1_Diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	841	816	44748
bsdb:229/1/1_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_UP	NA	1678	100883	846	283168	33042	574697	1263	207244	572511	375288	33024	841	816
bsdb:229/1/2_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_DOWN	NA	28050	40544	189330	1485
bsdb:230/1/1_Food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	1243	46255	29465
bsdb:230/1/2_Food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:231/1/1_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	35832	119852	375288	1263	86331
bsdb:231/1/2_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:231/2/1_Diet:Golden-delicious-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	86331	119852	1263	375288	35832
bsdb:231/2/2_Diet:Golden-delicious-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:231/3/1_Diet:Pink-lady-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	86331	119852	1263	375288	35832
bsdb:231/4/1_Diet:Renetta-Canada-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	574697
bsdb:231/4/2_Diet:Renetta-Canada-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	216851	1678
bsdb:231/5/1_Diet:Golden-delicious-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	574697
bsdb:231/5/2_Diet:Golden-delicious-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:231/6/1_Diet:Pink-lady-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	574697
bsdb:231/6/2_Diet:Pink-lady-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	216851
bsdb:231/7/1_Diet:Renatta-canada-apple---at-10-hr_vs_Inulin_DOWN	NA	119852	86331
bsdb:231/7/2_Diet:Renatta-canada-apple---at-10-hr_vs_Inulin_UP	NA	1678
bsdb:231/8/1_Diet:Golden-delicious-apple---at-10-hr_vs_Inulin_DOWN	NA	86331	119852
bsdb:231/8/2_Diet:Golden-delicious-apple---at-10-hr_vs_Inulin_DOWN	NA	1678
bsdb:231/9/1_Diet:Golden-delicious-apple---at-24-hr_vs_Inulin_UP	NA	216851
bsdb:231/10/1_Diet:Pink-Lady-apple---at-10-hr_vs_Inulin_DOWN	NA	86331	119852
bsdb:231/11/1_Diet:Pink-Lady-apple---at-24-hr_vs_Inulin_DOWN	NA	216851
bsdb:231/12/1_Diet:Cellulose---at-10hr_vs_Inulin_UP	NA	35832	119852	375288
bsdb:231/13/1_Diet:Cellulose---at-24hr_vs_Inulin_DOWN	NA	216851
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_UP	NA	165779	848	1257	836
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_DOWN	NA	239759	33042	1730	28050	841	1263
bsdb:233/1/1_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_UP	NA	469	838
bsdb:233/1/2_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_DOWN	NA	816	572511	33042
bsdb:236/1/1_Diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	207244
bsdb:236/1/2_Diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678	572511
bsdb:236/2/1_Diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	204475	1407607	816
bsdb:236/3/1_Diet:replace-both_vs_fat-replacement-(with-walnuts)_UP	NA	204475	1407607	816
bsdb:237/1/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	239934	1283313	544	724	1578	1269	1253	1301	29465	46255	1485
bsdb:237/1/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	35829	35832	574697	52225	1017280	213484	172900
bsdb:237/2/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	1578	29465	1678	239934	724	1269	46255
bsdb:237/2/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_DOWN	NA	213484
bsdb:237/3/1_Chronic-hepatitis-C-virus-infection:No-cirrhosis_vs_healthy-controls_DOWN	NA	52225	946234	906	35829
bsdb:237/3/2_Chronic-hepatitis-C-virus-infection:No-cirrhosis_vs_healthy-controls_UP	NA	1283313	1578	1301	29465	1485
bsdb:238/1/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	40544	1505663	437755	946234	459786	1301
bsdb:238/1/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759	207244	816	572511	547	561	1407607	1505657	375288	1501226	620	574697
bsdb:238/2/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1505663	946234	437755
bsdb:238/2/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1501226	207244	572511	239759
bsdb:238/3/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1301	1505663	437755
bsdb:238/3/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1505657	1501226	1407607	207244	547	239759
bsdb:239/1/1_Egg-allergy:children-with-egg-allergy_vs_healthy-control_UP	NA	1263	1357
bsdb:239/1/2_Egg-allergy:children-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_Egg-allergy:children-with-egg-sensitization_vs_healthy-control_UP	NA	216851	841
bsdb:241/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	475	1357	286	1350	57493	1578
bsdb:242/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1716	482	416916	2717
bsdb:242/2/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	1350	57493	1357	475	286
bsdb:242/2/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	194	2717	32207	416916	215579	1016	482	1716
bsdb:242/3/1_Iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	57493	1111	1279	475	1350	286	1357
bsdb:243/1/1_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12916	1827
bsdb:243/2/1_Gastric-cancer:current-H.pylori-infection-patients_vs_past-H.pylori-infection_UP	NA	838	40544
bsdb:243/3/1_Gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	375288
bsdb:243/4/1_Gastric-cancer:gastritis-cases_vs_normal_UP	NA	244127	189330	561	216851	620	1301	191303
bsdb:243/5/1_Gastric-cancer:subjects-with-metaplasia_vs_normal_UP	NA	39948	189330	1506553	1501226	191303
bsdb:244/1/1_Age:18-62-years_vs_2-12-years_UP	NA	1743	1716	1279	1578	150022	165779
bsdb:244/1/2_Age:18-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	724
bsdb:244/2/1_Atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_Atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	1301	1743
bsdb:244/3/1_Age:13-62-years_vs_2-12-years_UP	NA	1743	1716	1578
bsdb:244/3/2_Age:13-62-years_vs_2-12-years_DOWN	NA	1301	117563	1378	482	724	32207	29465
bsdb:245/1/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	469	1283313	85413	561	1730	1573534	1506553	158846	620
bsdb:245/1/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	1508657	39948	61170	168934	638847	1678	841	577310	547
bsdb:245/2/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	1283313	1505663	33024	158846	469	561	620	40544
bsdb:245/2/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	189330	1508657	207244	1407607	292632	1573535	39948	1263	577310	35832
bsdb:246/1/1_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_UP	NA	1654	1357	158846
bsdb:246/1/2_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_DOWN	NA	158851	1578
bsdb:246/2/1_Asthma:maternal-asthma_vs_no-asthma_UP	NA	816	286
bsdb:246/2/2_Asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906
bsdb:246/4/1_Asthma:maternal-asthma/caucasian-infants_vs_no-asthma_DOWN	NA	1578
bsdb:246/5/1_Asthma:maternal-asthma/female-infants_vs_no-asthma_UP	NA	816	189330
bsdb:246/6/1_Asthma:maternal-asthma/caucasian-infants/allergies_vs_no-asthma_DOWN	NA	1578	906
bsdb:246/7/1_Asthma:maternal-asthma/caucasian-infants/no-allergies_vs_no-asthma_UP	NA	239934
bsdb:246/7/2_Asthma:maternal-asthma/caucasian-infants/no-allergies_vs_no-asthma_DOWN	NA	1654
bsdb:246/8/1_Asthma:overweight-prenatal-asthma-caucasian-mothers_vs_no-asthma_DOWN	NA	1578	906
bsdb:247/1/1_Diet:Placebo_vs_Prebiotic_UP	NA	33042	189330	119852
bsdb:247/1/2_Diet:Placebo_vs_Prebiotic_DOWN	NA	1678
bsdb:247/2/1_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:247/3/1_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_UP	NA	572511	33042	189330
bsdb:247/3/2_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_DOWN	NA	1678
bsdb:247/4/1_Diet:High-dietary-fiber_vs_Low-dietary-fiber_UP	NA	216851
bsdb:247/4/2_Diet:High-dietary-fiber_vs_Low-dietary-fiber_DOWN	NA	1578
bsdb:248/1/1_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	33870
bsdb:248/1/2_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_DOWN	NA	724	28100
bsdb:248/2/1_Human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:248/2/2_Human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	286	28100
bsdb:249/1/1_Hepatitis,-Alcoholic:alcoholics_vs_NAC_UP	NA	374	33882	1843210	1716
bsdb:249/1/2_Hepatitis,-Alcoholic:alcoholics_vs_NAC_DOWN	NA	2053	1839	53387	1678	816	397864	577309	838	239759	237	182709	94008	572511	1263	186650	265	780	114248	12916	47420	215579	29580	70774	642
bsdb:249/2/1_Hepatitis,-Alcoholic:HDC_vs_NAC_UP	NA	469	165779	374	59732	57493	33882	482	20	1883	1060
bsdb:249/2/2_Hepatitis,-Alcoholic:HDC_vs_NAC_DOWN	NA	2053	1839	1678	816	397864	838	237	1301	1485	114248	12916	70774
bsdb:249/3/1_Hepatitis,-Alcoholic:MAH_vs_NAC_UP	NA	469	1654	165779	374	501783	1716	281915	117563	407
bsdb:249/3/2_Hepatitis,-Alcoholic:MAH_vs_NAC_DOWN	NA	1839	53387	838	237	1386	1485	29580	70774
bsdb:249/4/1_Hepatitis,-Alcoholic:SAH_vs_NAC_UP	NA	1654	1651	43668	1716	244698	33882
bsdb:249/4/2_Hepatitis,-Alcoholic:SAH_vs_NAC_DOWN	NA	1839	1678	397864	239759	237
bsdb:250/1/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	482	1213720
bsdb:250/2/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	482
bsdb:251/1/1_Milk-allergic-reaction:cow’s-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_UP	NA	572511	100883	1350	375288	1263
bsdb:251/1/2_Milk-allergic-reaction:cow’s-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_DOWN	NA	590	1301
bsdb:252/1/1_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_UP	NA	46123	100883	946234	117563
bsdb:252/1/2_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_DOWN	NA	102106	33042
bsdb:253/1/1_Asthma:asthma_vs_healthy-control_UP	NA	1279	838
bsdb:253/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_Asthma:asthma-remission_vs_healthy-control_UP	NA	848	838	543311
bsdb:253/2/2_Asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_UP	NA	239759	816	375288
bsdb:254/1/2_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_DOWN	NA	150022	162289	838	184869
bsdb:255/1/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1279
bsdb:255/1/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/2/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1301	543311
bsdb:255/2/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	1375	1378	117563	437755	1257	1279	1301
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	28263	2129	1678
bsdb:256/1/1_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	45402	2745	209	1578	407	1257	970	22	1301	29465
bsdb:256/1/2_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1386	816	1716	216851	848	33024	838	1743	286	13687
bsdb:256/2/1_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	1386	838	1743	286
bsdb:256/2/2_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	216851	2745	33024	22	13687
bsdb:256/3/1_Gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	1386	1716	848	2745	1578	1743	970	22	1301
bsdb:256/3/2_Gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	816	209	286	13687
bsdb:256/9/1_Gastric-cancer:normal-HP+_vs_normal-HP-_UP	NA	149698	1678	1716	1654	407	13687	1301	209
bsdb:256/9/2_Gastric-cancer:normal-HP+_vs_normal-HP-_DOWN	NA	572511	39948	216851	204475	2745	33024	838	841	1263	22
bsdb:256/10/1_Gastric-cancer:peritumor-HP+_vs_peritumor-HP-_UP	NA	1386	1378	209	1301
bsdb:256/10/2_Gastric-cancer:peritumor-HP+_vs_peritumor-HP-_DOWN	NA	33024	841	216851	239759	39948	204475	158846	1386	375288
bsdb:256/11/1_Gastric-cancer:tumor-HP+_vs_tumor-HP-_UP	NA	1279	816	41275	572511	149698	165696	209
bsdb:256/11/2_Gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	469	1263	286	13687	1678
bsdb:257/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934	35832	574697	990721	1485	51514	848	283168	119852	846	375288	1257	836	1263	970	1730
bsdb:257/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	158846	52225
bsdb:258/1/1_Colorectal-cancer:carcinoma_vs_Healthy-Controls_UP	NA	848	836	1485
bsdb:258/1/2_Colorectal-cancer:carcinoma_vs_Healthy-Controls_DOWN	NA	816	1279	1485
bsdb:258/2/1_Colorectal-cancer:Adenoma_vs_Healthy-Controls_UP	NA	1485	286
bsdb:258/2/2_Colorectal-cancer:Adenoma_vs_Healthy-Controls_DOWN	NA	816	1485	283168
bsdb:258/3/1_Colorectal-cancer:Colonic-lesions_vs_Healthy-Controls_UP	NA	286
bsdb:258/3/2_Colorectal-cancer:Colonic-lesions_vs_Healthy-Controls_DOWN	NA	816	1485
bsdb:258/4/1_Colorectal-cancer:Carcinoma_vs_Adenoma_UP	NA	816	1485	848	577310	33024	836
bsdb:258/4/2_Colorectal-cancer:Carcinoma_vs_Adenoma_DOWN	NA	572511	1263	1485
bsdb:260/1/2_Food-allergy:Allergic-Estonian-children._vs_Nonallergic--Estonian-children._DOWN	NA	1678	1578
bsdb:260/2/2_Food-allergy:Allergic-Swedish-children_vs_Non-allergic-Swedish-children._DOWN	NA	1578	1678
bsdb:262/1/1_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_UP	NA	1651	1716	475	1279
bsdb:262/1/2_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_DOWN	NA	1654	32067	836	838	1301
bsdb:262/2/1_Atopic-asthma:oral-wash-specimens_vs_bronchial-brush-specimens_UP	NA	1654	32067	1301
bsdb:262/2/2_Atopic-asthma:oral-wash-specimens_vs_bronchial-brush-specimens_DOWN	NA	1716	475	838	1279
bsdb:262/3/1_Atopic-asthma:induced-sputum-specimens_vs_nasal-brush-specimens_UP	NA	1654	32067	836	838	1301
bsdb:262/3/2_Atopic-asthma:induced-sputum-specimens_vs_nasal-brush-specimens_DOWN	NA	1651	1716	475	1279
bsdb:262/4/1_Atopic-asthma:oral-wash-specimens_vs_nasal-brush-specimens_UP	NA	1654	32067	836	838	1301
bsdb:262/4/2_Atopic-asthma:oral-wash-specimens_vs_nasal-brush-specimens_DOWN	NA	1651	1716	475	1279
bsdb:262/5/1_Atopic-asthma:oral-wash-specimens_vs_induced-sputum-specimens_UP	NA	1654
bsdb:262/5/2_Atopic-asthma:oral-wash-specimens_vs_induced-sputum-specimens_DOWN	NA	1716	838	1279
bsdb:262/6/1_Atopic-asthma:induced-sputum-specimens_vs_bronchial-brush-specimens_UP	NA	32067	1301
bsdb:262/7/1_Atopic-asthma:atopic-asthma-subjects_vs_healthy-controls_UP	NA	1279	1716	47420
bsdb:263/1/1_Crohn's-disease:crohn's-disease_vs_healthy-controls_UP	NA	1654	572511	84111	1573536	1378	1505657	32207	1301
bsdb:263/1/2_Crohn's-disease:crohn's-disease_vs_healthy-controls_DOWN	NA	553372	1485	33042	216851	1407607	204475	28050	86331	459786	1501226	1263	44748	292632	191303
bsdb:263/2/1_Ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1654	264995	1678	84111	1573536	1378	1301
bsdb:263/2/2_Ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	204475	644652	28050	86331	1263	44748
bsdb:263/3/1_Multiple-sclerosis:multiple-sceloris_vs_healthy-controls_UP	NA	1654	264995	1485	84111	1573536	1301	191303
bsdb:263/3/2_Multiple-sclerosis:multiple-sceloris_vs_healthy-controls_DOWN	NA	580596	39948	216851	1407607	204475	28050	100132	292632
bsdb:263/4/1_Rheumatoid-arthritis:arthiritis_vs_healthy-controls_UP	NA	1654	84111	1573536	1378	32207	1301
bsdb:263/4/2_Rheumatoid-arthritis:arthiritis_vs_healthy-controls_DOWN	NA	264995	580596	1485	216851	1407607	204475	28050	1501226	841	44748	292632
bsdb:264/1/1_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	28263	39948	906	162289	1257	838	168808
bsdb:264/1/2_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	56688	1578
bsdb:265/1/1_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	32207	1301	29465	724	150022
bsdb:265/1/2_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_DOWN	NA	357	816	80865	1578	906	1743	286	1279
bsdb:265/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	400634	2129
bsdb:265/2/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	29465
bsdb:266/1/1_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_UP	NA	1301	838	570	216851	841	572511
bsdb:266/1/2_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_DOWN	NA	239934	239759	816	1678	1485	33042	39948	158846	459786	375288	33024	590
bsdb:267/1/1_Atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	1654	109326	194	848	724	32257	482	836	838	165697	157	29465
bsdb:267/1/2_Atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	713	1578	32067	407	1257
bsdb:267/2/1_Atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	1654	416916	1716	2353	848	117563	724	475	970	519427	165697	29465
bsdb:267/2/2_Atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	209	1578	32067	543311	836	838	286	1301
bsdb:267/3/1_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	39948	848	724	32067	2093	838	970
bsdb:267/3/2_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	416916	174708	1716	2353	1578	836	519427	165697	1301
bsdb:267/4/1_Atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_UP	NA	86331	1301
bsdb:267/4/2_Atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	1378
bsdb:267/5/1_Atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline-(corticosteroid-treatment-group)_UP	NA	482	475
bsdb:267/5/2_Atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline-(corticosteroid-treatment-group)_DOWN	NA	848	39948
bsdb:267/6/1_Atopic-asthma:post-placebo-treatment_vs_baseline-(placebo-group)_UP	NA	538
bsdb:267/6/2_Atopic-asthma:post-placebo-treatment_vs_baseline-(placebo-group)_DOWN	NA	469
bsdb:268/1/1_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	1485	102106	1716	168808	29465
bsdb:268/1/2_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	1279	48736
bsdb:269/1/1_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	816
bsdb:269/1/2_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	194	1716	1678	1380	162289	1279	838	165779	836
bsdb:269/1/3_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1380	816	838	848	1716
bsdb:270/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808	906	1253	1696	286
bsdb:270/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	83618	1654	213484	222991
bsdb:270/2/1_Human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	1380	216851
bsdb:270/2/2_Human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_DOWN	NA	28065
bsdb:271/1/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851	253238	44748
bsdb:271/1/2_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	32207
bsdb:271/2/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	1730	216851
bsdb:272/1/1_Pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	475	1301
bsdb:272/1/2_Pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1716	1279
bsdb:273/1/1_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	1678	816	838	239759	189330	216851
bsdb:273/1/2_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	357	507	41275	517
bsdb:274/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1654	1678	39948	2701	1578
bsdb:274/2/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	543311
bsdb:274/2/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	71655	561	1578	162289	620	1301
bsdb:274/3/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	1380	1485	2701	906	543311	177971	168808
bsdb:274/3/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1678	39948	1578	836	1301	2129
bsdb:274/4/2_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	1678	71655	1716	39948	561	404402	1578	620	1301	2129
bsdb:274/5/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	906	133925	838	177971
bsdb:274/5/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1375	165779	1678	2701
bsdb:274/6/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	1678	1485	39948	1578	836	838	168808
bsdb:274/6/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1578
bsdb:274/7/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	1485	2701	906	543311	177971	168808
bsdb:274/7/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1375	165779	1678	39948	162290	2701	404402	836
bsdb:274/8/1_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	165779	1678	2701	1578	437755
bsdb:274/9/1_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_UP	NA	1380	1678	1485	1350	2701	1378	906	437755	543311	1257	838	177971	168808	1279	1301	29465
bsdb:274/9/2_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_DOWN	NA	71655	1485	561	1578	620
bsdb:274/10/1_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	1375	1380	1350	2701	906	437755	836	177971	168808	1301	29465
bsdb:274/10/2_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	1578
bsdb:275/1/1_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_DOWN	NA	841
bsdb:276/2/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	191303	413496
bsdb:276/2/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1508657	1730	207244	84108	135858	904
bsdb:276/3/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	216851	841	29465	904	1472649	830	174708
bsdb:276/3/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1481960
bsdb:277/1/1_Crohn's-disease:crohn's-disease_vs_healthy-control_DOWN	NA	216851	1263	841	239759	1730	46239	206664	836	28138	375288	830
bsdb:278/1/1_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_UP	NA	1578
bsdb:278/1/2_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_DOWN	NA	239759	207244	816	572511	189330	216851	33042	841	375288
bsdb:279/1/2_Acute-myeloid-leukemia:High-Intensity-Chemotherapy_vs_Low-Intensity-Chemotherapy_DOWN	NA	55193
bsdb:279/2/1_Acute-myeloid-leukemia:Patients-with-bacterial-infections-at-T3_vs_Patients-without-bacterial-infections-at-T3_UP	NA	1535326
bsdb:279/3/1_Acute-myeloid-leukemia:Patients-with-bacterial-infections-at-T6_vs_Patients-with-no-bacterial-infections-at-T6_DOWN	NA	5506
bsdb:279/4/1_Antimicrobial-agent:Patients-who-received-Amphotericin-B_vs_Patients-who-did-not-receive-Amphotericin-B_UP	NA	5506
bsdb:280/1/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	165779	168808
bsdb:281/1/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_UP	NA	239934	2086	207244	572511	830	1485	33042	189330	119852	1263
bsdb:281/1/2_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_DOWN	NA	447020	1578	191303
bsdb:281/2/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-of-leukemia-mice_vs_Healthy-Control_UP	NA	1279	1301	48736	1357
bsdb:281/2/2_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-of-leukemia-mice_vs_Healthy-Control_DOWN	NA	1578	1883	848	191303	239934
bsdb:282/1/2_Graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	1506553	572511
bsdb:283/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	84111	1378
bsdb:284/1/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1654	59735	1716	32207	1301	1578
bsdb:284/1/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	848	836
bsdb:285/1/1_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	35832	1678	872	135858	33024
bsdb:285/1/2_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	28050	577309	816	119852
bsdb:285/3/1_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	904	1380	1678	35832	135858	33042	872	189330	1730	158846	906	2172	119852	33024	113286	1263	40544
bsdb:285/3/2_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	577309	816	1263	574697	33042	207244	40544	135858	39948	189330
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	207244	572511	574697	102106	1407607	1263
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	841	1578
bsdb:289/1/1_Health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	59732	119852	841	1263
bsdb:289/1/2_Health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	581	48736	40544
bsdb:290/1/1_Oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	29465	1350	1301	1279	848	838
bsdb:290/1/2_Oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1301	1654
bsdb:290/2/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	838	32067
bsdb:290/2/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1578
bsdb:290/3/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	1654
bsdb:290/4/1_Oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_UP	NA	196081	1279	1578
bsdb:290/4/2_Oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_DOWN	NA	29465	1654	838	32067	906	1301
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	838	724
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	239759	216851	39948
bsdb:292/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling-controls_DOWN	NA	1283313	724	32067	482	265975	838	1301
bsdb:293/1/1_Human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_Human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	1582879	216851	848	873565
bsdb:293/2/1_Human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:295/1/1_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	1654	239759	1678	35832	572511	574697	1485	1348911	33042	39948	1407607	204475	70774	906	745	1257	33024	841	1263	1200657	168808	40544
bsdb:295/1/2_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	209	68	497726
bsdb:297/1/1_Human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1678	1386
bsdb:297/1/2_Human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_DOWN	NA	1578
bsdb:297/2/1_Human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_Human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/2/1_Acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:298/2/2_Acute-myeloid-leukemia:infection_vs_no-infection_DOWN	NA	1301
bsdb:298/3/1_Acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:301/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	39948	906	168808	848
bsdb:301/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1578
bsdb:301/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:301/3/1_Human-papilloma-virus-infection:HR-HPV+_vs_HPV-_UP	NA	168808
bsdb:302/3/1_Asthma:exacerbated-asthma_vs_non-exacerbated-asthma_UP	NA	838	222991	2701
bsdb:302/3/2_Asthma:exacerbated-asthma_vs_non-exacerbated-asthma_DOWN	NA	39948
bsdb:303/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	544	1350	375288	1380	570
bsdb:303/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	447020	165779	1380	1678	572511	1485	102106	33042	189330	570	28050	119852	841	1263
bsdb:304/1/1_Antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	1380	1678	102106
bsdb:305/1/1_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_UP	NA	165779	39948	1582879	848	2050	437755	2093	543311	162289	1257	836	838	168808
bsdb:305/1/2_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_DOWN	NA	1678	1578	177971
bsdb:307/1/1_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/1/2_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	239759	572511	574697	135858	1485	100883	1730	216851	459786
bsdb:307/2/1_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	239759	216851	572511	459786	100883	1730	574697	135858
bsdb:307/2/2_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_DOWN	NA	572511
bsdb:307/3/2_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	135858
bsdb:308/1/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1578
bsdb:308/1/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:308/2/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	28050	816
bsdb:308/2/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	1279	1578	191303
bsdb:308/3/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	119852	1263	1279	191303
bsdb:308/4/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578
bsdb:308/5/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	375288
bsdb:308/5/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	2086	1485	191303
bsdb:308/6/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:309/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	816	574697	1578	375288	59195
bsdb:309/2/1_Cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	357	665874	20	286
bsdb:310/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	816	561
bsdb:310/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	572511	216851	841	1678
bsdb:312/2/1_Antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697	51514	216851	119852	40544
bsdb:314/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1380	168808	906	543311	838
bsdb:314/1/2_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1578
bsdb:316/4/1_Delivery-method:10-day-old-vaginally-delivered-pre-term-neonates_vs_10-day-old-cesarean-delivered-pre-term-neontes_UP	NA	816
bsdb:316/11/1_Antimicrobial-agent:90-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP/postnatal)_vs_90-day-old-pre-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	1678
bsdb:317/1/1_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_UP	NA	239759	207244	1348911	946234	1649459	459786
bsdb:317/1/2_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_DOWN	NA	1766253	580596	135858	1485	33042	39948	404402	28050	577309	1501226
bsdb:317/2/1_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_UP	NA	265975	1654	1380	1164882	86331
bsdb:317/3/1_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_UP	NA	239759	207244	244127	35832	1348911	1432051	946234	61170	1649459	459786	1929305	1508657
bsdb:317/3/2_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	135858	33042	1505657	577309	1501226
bsdb:317/4/1_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_UP	NA	1654	1380	43996	86331
bsdb:317/4/2_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	830	1716	43994
bsdb:318/2/1_Graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	216851	1730
bsdb:319/1/1_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	248744	2093
bsdb:319/1/2_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	209	1501226	100175	174708	191303
bsdb:320/1/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/1/2_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841	1263
bsdb:320/2/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/2/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841
bsdb:320/3/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotic-penicillin_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1678
bsdb:320/4/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33042
bsdb:320/4/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1485	158846	1301
bsdb:320/6/1_Antimicrobial-agent:infants-to-mothers-exposed-to-cephalosporins_vs_infants-to-mothers-unexposed-to-intrapartum-antibiotic_DOWN	NA	1678
bsdb:321/1/1_Antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	816	1357
bsdb:322/1/1_Oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_UP	NA	46123	1357	203697
bsdb:322/1/2_Oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_DOWN	NA	1716	346096	1378	848	22	2745	713
bsdb:322/2/1_Oral-mucositis:oral-mucositis_vs_no-oral-mucositis_UP	NA	1016	1357	146
bsdb:322/3/1_Oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	1279
bsdb:322/3/2_Oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_DOWN	NA	203697
bsdb:322/4/1_Oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	338
bsdb:322/5/1_Oral-mucositis:mucositis-lesions_vs_all-samples_UP	NA	46123	1654	1386	1357	196081	1279	1578	1257	40323	2093
bsdb:322/5/2_Oral-mucositis:mucositis-lesions_vs_all-samples_DOWN	NA	713	416916	724
bsdb:323/1/1_Necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1485	1279
bsdb:323/1/2_Necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	28196	150022	29330	1654	286	59732	283	1301	1716
bsdb:323/3/1_Necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:324/1/1_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	207244	33042	561	1505657	570	1578	620	1301	292632	191303	1357	239759
bsdb:324/1/2_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	1283313	816	1506553	158846	33024	838	841
bsdb:325/1/1_Psoriasis:psoriasis_vs_healthy-controls_UP	NA	572511	1263	216851	1678	33042	86331	189330	990721	1654	102106
bsdb:325/1/2_Psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	574697	35832	283168	375288	838	40544	28050	577309
bsdb:326/1/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_UP	NA	239759	816	1392389	838
bsdb:326/1/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_DOWN	NA	572511	838
bsdb:326/2/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239759	572511	946234	1392389	1263
bsdb:327/1/1_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_UP	NA	1578
bsdb:327/1/2_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_DOWN	NA	561	1301
bsdb:327/2/1_Antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment---week-2_vs_control(no-treatment)---week-2_UP	NA	1350
bsdb:327/3/2_Antimicrobial-agent:infants-received-long-term-(>5days)-antibiotic-treatment---week-1_vs_infants-received-short-term-(<3days)-antibiotic-treatment---week-1_UP	NA	29465
bsdb:328/1/1_Psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	239934	33042	46205	1263
bsdb:328/2/1_Psoriatic-arthritis:skin-psoriasis_vs_healthy-controls_DOWN	NA	375288	100883	33042
bsdb:328/3/1_Psoriatic-arthritis:psoriatic-arthiritis_vs_skin-psoriasis_UP	NA	100883
bsdb:329/1/1_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_Antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/3/1_Antimicrobial-agent:IAP-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:329/4/1_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/4/2_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/5/1_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/6/1_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:330/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724	1257
bsdb:330/3/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	150022
bsdb:330/3/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	207244	572511	580596	33042	189330	1407607	724	1501226	841	1301	292632	1485
bsdb:331/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	816	216851	838	1283313	33024	1506553	375288	577309	1154586
bsdb:333/1/1_Antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/1_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	1618113
bsdb:334/1/2_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:334/2/2_Antimicrobial-agent:infants-exposed-to-antibiotic->7day-(H-group)_vs_infants-exposed-to-antibiotic-<=7day-(L-group)_DOWN	NA	1678
bsdb:336/1/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_UP	NA	816	1578	13687
bsdb:336/1/2_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_DOWN	NA	1485
bsdb:336/4/1_Antimicrobial-agent:piperacillin-tazobactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_UP	NA	816	1350
bsdb:336/4/2_Antimicrobial-agent:piperacillin-tazobactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_DOWN	NA	570
bsdb:336/5/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_piperacillin-tazobactam-group-(postnatal-day-3)_DOWN	NA	1350
bsdb:336/6/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-7)_vs_piperacillin-tazobactam-group-(postnatal-day-7)_DOWN	NA	1485
bsdb:337/1/1_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607	1350
bsdb:337/1/2_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	816	1279	1301	29465
bsdb:337/3/1_Antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1485	29465
bsdb:337/3/2_Antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	239934	239759	816	572511	1485	204475	1506553	29465
bsdb:338/1/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	216851	724	28050	158846	33024
bsdb:338/1/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	39948	119852
bsdb:338/2/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	713	416916	194	848	117563	724	28050	158846	33024	32207	1301	40544	191303	29465
bsdb:338/2/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	447020	239759	244127	1678	35832	990721	1485	102106	1185408	872	1730	1769729	61170	119852	846	838	1263	44748
bsdb:340/1/1_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_UP	NA	469	10	629	100883	561	586	84108	29465
bsdb:340/1/2_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_DOWN	NA	773	189330	2745	1253
bsdb:341/1/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	32207	1301	29465
bsdb:341/2/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	482	838
bsdb:342/1/1_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-asthma-exacerbation_DOWN	NA	724
bsdb:342/2/1_Asthma:Samples-with-any-rhinovirus-infection_vs_Samples-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/2/2_Asthma:Samples-with-any-rhinovirus-infection_vs_Samples-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/3/1_Asthma:Samples-with-rhinovirus-A-(RV-A)_vs_Samples-that-were-RV-A-negative-_UP	NA	724	1301
bsdb:342/3/2_Asthma:Samples-with-rhinovirus-A-(RV-A)_vs_Samples-that-were-RV-A-negative-_DOWN	NA	1279
bsdb:342/5/1_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-exacerbation_UP	NA	475
bsdb:342/5/2_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-exacerbation_DOWN	NA	1651	1716	724	1279
bsdb:342/7/1_Asthma:samples-with-any-rhinovirus-infection_vs_samples-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/7/2_Asthma:samples-with-any-rhinovirus-infection_vs_samples-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/8/1_Asthma:Samples-with-rhinovirus-A_vs_Rhinovirus-negative-samples_UP	NA	724	1301
bsdb:342/8/2_Asthma:Samples-with-rhinovirus-A_vs_Rhinovirus-negative-samples_DOWN	NA	1279
bsdb:343/1/1_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_UP	NA	816	239934	216851
bsdb:343/1/2_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_DOWN	NA	1485
bsdb:344/1/1_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_UP	NA	946234	848	459786
bsdb:344/1/2_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_DOWN	NA	1386	80865	173479	55968	248038	283168	286	970	13687	1301
bsdb:345/1/1_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_UP	NA	2086	816	156973	690621
bsdb:345/1/2_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_DOWN	NA	469	174708	308865	204475	1159323	264147	248038	2093	217063	119852	146	577309
bsdb:345/3/1_Response-to-diet:Offspring-hamsters-Low-protein-diet-(LPD)-group_vs_Offspring-hamsters-Normal-protein-diet-(NPD)-group_UP	NA	222991	2086	1663	1678	517	990721	1485	308865	1578	264147	248038	267929	133925	286	83618	577309
bsdb:345/3/2_Response-to-diet:Offspring-hamsters-Low-protein-diet-(LPD)-group_vs_Offspring-hamsters-Normal-protein-diet-(NPD)-group_DOWN	NA	580596	189330	204475	28050	415014	1263	44748	872	209	29521	146	157
bsdb:345/4/1_Response-to-diet:Offspring-hamsters-niacin--group_vs_Offspring-hamsters-naicin+-group_UP	NA	146	415014
bsdb:345/4/2_Response-to-diet:Offspring-hamsters-niacin--group_vs_Offspring-hamsters-naicin+-group_DOWN	NA	222991	1663	241189	69965	248038	577309	1485
bsdb:346/2/1_Unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	946234
bsdb:346/3/2_Anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	1847725
bsdb:346/4/1_Anxiety-disorder:moderate-anxiety_vs_mild-anxiety_UP	NA	84111
bsdb:346/5/1_Remission:Yes_vs_No_UP	NA	102106	1506553	28050	577310	841
bsdb:346/5/2_Remission:Yes_vs_No_DOWN	NA	1433999	286	561
bsdb:346/6/1_Remission:Yes_vs_No_UP	NA	292632
bsdb:346/6/2_Remission:Yes_vs_No_DOWN	NA	561
bsdb:350/1/1_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_UP	NA	836
bsdb:350/1/2_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_DOWN	NA	33024
bsdb:350/2/1_Obesity:Obesity-with-metabolic-syndrome-(OMS)_vs_Normal-weight-(NW)_UP	NA	135858	102106	33042	196013
bsdb:351/1/1_Obesity:overweight/obesity_vs_normal_UP	NA	1578
bsdb:351/1/2_Obesity:overweight/obesity_vs_normal_DOWN	NA	1678
bsdb:352/1/1_Human-papilloma-virus-infection,Cervical-glandular-intraepithelial-neoplasia:Low-Grade-Squamous-Intraepithelial-Lesion_vs_Atypical-Squamous-Cells-of-Undetermined-Significance_DOWN	NA	4930
bsdb:352/2/1_Human-papilloma-virus-infection,Cervical-glandular-intraepithelial-neoplasia:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:352/4/1_Human-papilloma-virus-infection,Cervical-glandular-intraepithelial-neoplasia:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:354/1/2_Obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:356/1/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_UP	NA	841	239759
bsdb:356/1/2_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	66831	482
bsdb:356/2/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_UP	NA	583
bsdb:356/3/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1378	459786	841	1485
bsdb:356/4/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_UP	NA	1301
bsdb:356/4/2_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_DOWN	NA	816	872	244127
bsdb:356/5/2_Air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_DOWN	NA	580024	838
bsdb:356/6/2_Air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	1578
bsdb:356/7/2_Air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_DOWN	NA	1485
bsdb:357/1/1_Air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	32067
bsdb:357/1/2_Air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	838
bsdb:358/1/1_Cervical-glandular-intraepithelial-neoplasia,Cervical-cancer:CIN2/3-CC_vs_Healthy-controls_UP	NA	1912216	212791	1269	1279	1301	46255	29465	286	1716	149698	2129	13687	2701
bsdb:358/1/2_Cervical-glandular-intraepithelial-neoplasia,Cervical-cancer:CIN2/3-CC_vs_Healthy-controls_DOWN	NA	2701
bsdb:360/1/1_Air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	191303	1485
bsdb:360/1/2_Air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578	119852
bsdb:360/2/2_Air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1485	1578	119852
bsdb:361/1/1_Air-pollution:male-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	239934
bsdb:361/2/1_Air-pollution:female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	816
bsdb:361/3/1_Air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	830	28138	838
bsdb:361/4/1_Air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	239934	816	459786
bsdb:361/4/2_Air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	239759	28050
bsdb:363/1/1_Smoking-behavior:current-smokers_vs_never-smokers_UP	NA	32207	1301	1380	906	1716	346096	109326	195950	44259	2093
bsdb:363/1/2_Smoking-behavior:current-smokers_vs_never-smokers_DOWN	NA	2740	1016	482	2717	47670	1257	43996	848	1283313	836	1164882	32067	265975	1730	194	123375	724	1213720	1378
bsdb:364/1/1_Smoking-behavior:smokers_vs_non-smokers_UP	NA	1654	29465
bsdb:365/1/1_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	33042	119852	1263	1386	1357
bsdb:365/1/2_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	1485	838
bsdb:366/1/1_Non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	1578	588605	841	189330
bsdb:366/1/2_Non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	459786
bsdb:367/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:368/1/1_Smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	1301	32207	1578	419014
bsdb:368/1/2_Smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	538	1257	265975	47
bsdb:369/1/1_Obesity:obese_vs_normal-weight_UP	NA	816	28050	841
bsdb:369/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	84108	838	119852
bsdb:369/2/1_Obesity:after-onset-of-obesity_vs_before-onset-of-obesity_UP	NA	135858	40544
bsdb:369/2/2_Obesity:after-onset-of-obesity_vs_before-onset-of-obesity_DOWN	NA	1263
bsdb:370/1/1_Air-pollution:Spring/Summer-individuals_vs_Winter-individuals_DOWN	NA	1378	117563	724	2745	1301
bsdb:372/1/1_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:372/1/2_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	816	1485
bsdb:373/1/1_Obesity:overweight-children_vs_normal-weight-children_UP	NA	33042
bsdb:373/1/2_Obesity:overweight-children_vs_normal-weight-children_DOWN	NA	239759
bsdb:373/2/1_Obesity:Overweight-children_vs_Adults_UP	NA	1506553	1573535	135858
bsdb:373/2/2_Obesity:Overweight-children_vs_Adults_DOWN	NA	28050
bsdb:373/3/1_Obesity:normal-weight-children_vs_Adults_UP	NA	40840	28050
bsdb:373/3/2_Obesity:normal-weight-children_vs_Adults_DOWN	NA	1283313
bsdb:374/1/1_Cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_UP	NA	114627	1643951	953
bsdb:374/1/2_Cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_DOWN	NA	53246	497
bsdb:374/2/1_Cervical-cancer:cervical-cancer_vs_normal-control_UP	NA	114627	1643951	953
bsdb:374/2/2_Cervical-cancer:cervical-cancer_vs_normal-control_DOWN	NA	1578	1279	1263978
bsdb:375/1/1_Obesity:obese_vs_normal-weight_UP	NA	1578
bsdb:375/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	838
bsdb:376/1/1_Antimicrobial-agent:patients-that-took-amoxiclav_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/2/1_Antimicrobial-agent:patients-that-took-levofloxacin_vs_before-antibiotic-exposure_UP	NA	816	33042
bsdb:376/2/2_Antimicrobial-agent:patients-that-took-levofloxacin_vs_before-antibiotic-exposure_DOWN	NA	572511
bsdb:378/1/1_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	1357	47670	40323
bsdb:378/1/2_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	207244	572511	1505663	946234	1378	1392389	1506553	459786	1508657	1769710
bsdb:378/2/1_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	40323	838
bsdb:378/2/2_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	572511	946234	1506553	1769710
bsdb:379/1/1_Obesity:non-obese_vs_obese_UP	NA	1678	1578
bsdb:379/2/1_Obesity:obese_vs_non-obese_UP	NA	1378	117563
bsdb:379/2/2_Obesity:obese_vs_non-obese_UP	NA	419014	156454
bsdb:381/1/1_Response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_UP	NA	1350
bsdb:381/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_DOWN	NA	46205	292632
bsdb:381/2/1_Response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_UP	NA	84111	1508657	1506553	572511	46205	1505663
bsdb:381/2/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_DOWN	NA	1578	1350
bsdb:382/1/1_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	1375
bsdb:382/1/2_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_DOWN	NA	1578
bsdb:382/2/1_Chlamydophila-infectious-disease,Human-papilloma-virus-infection:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	810
bsdb:382/2/2_Chlamydophila-infectious-disease,Human-papilloma-virus-infection:patient-with-chlamydia-infection_vs_HPV-positive-women_DOWN	NA	1578
bsdb:383/1/1_Food-allergy:child-with-food-sensitization_vs_no-food-sensitization_DOWN	NA	724	39948	189330	1485
bsdb:383/2/1_Food-allergy:child-with-food-allergy_vs_no-food-allergy_DOWN	NA	544	119852	1357	189330
bsdb:384/1/1_Schizophrenia:FSCZ_vs_healthy-controls_UP	NA	561	620	29465	1350
bsdb:384/1/2_Schizophrenia:FSCZ_vs_healthy-controls_DOWN	NA	848	906	713
bsdb:384/2/1_Schizophrenia:TSCZ_vs_healthy-controls_UP	NA	561	1350	1578	620	1301	29465
bsdb:384/2/2_Schizophrenia:TSCZ_vs_healthy-controls_DOWN	NA	713	906
bsdb:384/3/1_Schizophrenia:TSCZ_vs_FSCZ_UP	NA	561	848	906	1350	1578	620	1301
bsdb:384/3/2_Schizophrenia:TSCZ_vs_FSCZ_DOWN	NA	29465
bsdb:385/1/1_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_UP	NA	416916	1283313	482	836
bsdb:385/1/2_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_DOWN	NA	1654	1380	150203	561	165695
bsdb:386/1/1_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	33042
bsdb:387/1/1_Antimicrobial-agent:after-ciprofloxacin-exposure_vs_before-ciprofloxacin-exposure_UP	NA	816
bsdb:387/1/2_Antimicrobial-agent:after-ciprofloxacin-exposure_vs_before-ciprofloxacin-exposure_DOWN	NA	239759	216851
bsdb:387/2/1_Antimicrobial-agent:after-clindamycin-exposure_vs_Before-clindamycin-exposure_DOWN	NA	33042	189330	28050	841	1263
bsdb:388/1/1_Oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_UP	NA	2747	44259	848	543311	1257	1301	195950	157
bsdb:388/1/2_Oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_DOWN	NA	1663	41275	872	33882	248038	44249
bsdb:389/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301
bsdb:389/1/2_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:389/2/1_Schizophrenia:mania_vs_healthy-controls_UP	NA	1301	215579
bsdb:389/2/2_Schizophrenia:mania_vs_healthy-controls_DOWN	NA	838
bsdb:390/1/1_Schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	258514	1654	244127	35832	946234	1505657	1508657	191303
bsdb:390/1/2_Schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	1774107	1432051	1392389
bsdb:390/2/1_Schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	1654	264995	244127	1380	35832	2383	1485	283	946234	61170	1505657	420345	375288	838	123375	191303
bsdb:390/2/2_Schizophrenia:scizophrenia-during-remission_vs_healthy-controls_DOWN	NA	580596	1774107	1432051	1392389	577309	3025755
bsdb:390/3/1_Schizophrenia:acute-schizphrenia_vs_symptomatic-remission_DOWN	NA	1485
bsdb:391/1/1_Neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_UP	NA	561	620	265975	1486725	156454	946234	1301
bsdb:391/1/2_Neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_DOWN	NA	40544	1407607	33042	1501226	572511	841	216851	838
bsdb:392/1/1_Milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	239759	816	1266
bsdb:392/2/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	816	239759
bsdb:392/3/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	239759	816
bsdb:392/3/2_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_UP	NA	1883
bsdb:392/4/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_UP	NA	28050	1578	119852	1263
bsdb:392/4/2_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_DOWN	NA	239759	816	39948
bsdb:393/1/1_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:393/2/2_Milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_DOWN	NA	816
bsdb:394/1/1_Asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	838	29465
bsdb:396/1/1_Atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/2_Atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	47670	106589
bsdb:396/2/1_Atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_UP	NA	469	1716	838
bsdb:396/2/2_Atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_DOWN	NA	1279
bsdb:396/3/1_Atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-only_vs_baseline_UP	NA	469	1716	838
bsdb:396/3/2_Atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-only_vs_baseline_DOWN	NA	1279
bsdb:397/1/1_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	1279	1827	1651	114248
bsdb:397/1/2_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	357	1380	32067	131079	836	838	32207	1301	29465	117563
bsdb:398/1/1_Atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	32207	1301	29465	1578	1678
bsdb:399/1/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	1016	848	724	482	195950	157	538	47670	43994	2717	283	44259	1743	1716	836	1481960
bsdb:399/2/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	561	1578	620	1301	244127	46205	1508657
bsdb:399/2/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	239934	816	84108
bsdb:400/1/1_Asthma:asthma_vs_healthy-control_UP	NA	1485	1350	561	1730	1578
bsdb:400/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	39948	216851	841
bsdb:400/2/1_Allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	447020
bsdb:400/2/2_Allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	39948	189330
bsdb:401/1/1_Asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	830	543311
bsdb:401/2/1_Allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	475	482	724	848	836
bsdb:401/2/2_Allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	830	416916	437755
bsdb:402/2/1_Atopic-eczema:Mothers-whose-infants-developed-IgE-associated-eczema_vs_mothers-whose-infants-remained-non-allergic_UP	NA	1301
bsdb:403/1/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	841	551
bsdb:403/1/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547
bsdb:403/2/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:403/3/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/3/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	216851	28050
bsdb:403/5/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/5/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	1301	194
bsdb:403/6/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	216851	1678	547
bsdb:403/7/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547	570	1301	29465
bsdb:403/9/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	40544	1485	102106	35832
bsdb:403/10/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:404/1/1_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263	375288	216851	292632	140625	158846	207244	239759
bsdb:404/1/2_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	561	620
bsdb:404/2/1_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263
bsdb:404/2/2_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	191303	100883
bsdb:404/3/1_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	588605
bsdb:404/3/2_Atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	244127	574697	102106	33042	61170	577309
bsdb:405/1/1_Asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465	1301
bsdb:405/1/2_Asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	841	239759	946234	216851	1678	572511	375288	207244	1263	39948	838
bsdb:405/2/1_Asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/2/2_Asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	239759	1678	39948	216851	841	1263	572511	375288	1301	838	946234	239934
bsdb:405/3/1_Asthma:child-with-asthma-at-5-years-old-among-mothers-without-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465	838	1301	1263	239934
bsdb:405/3/2_Asthma:child-with-asthma-at-5-years-old-among-mothers-without-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	216851	1678	572511	207244	239759	946234
bsdb:406/1/1_Lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_UP	NA	150203	963	13687
bsdb:406/1/2_Lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_DOWN	NA	469	59732	283	1301
bsdb:407/1/1_Peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_UP	NA	1380	1730	1164882	906	265975	1257	838	123375	29465	356797
bsdb:407/1/2_Peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	416916	194	1716	538	44259	2701	1378	940557	52228	43994	1508421	482	113286	32207	1301	157	843
bsdb:408/2/1_Asthma:asthma-at-1-year_vs_healthy-controls_UP	NA	32207
bsdb:409/1/1_Milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	216851	1263
bsdb:409/1/2_Milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_DOWN	NA	1678	561
bsdb:409/2/1_Milk-allergic-reaction:post-EHCF-with-LGG_vs_pre-EHCF-with-LGG_UP	NA	572511	841	33042
bsdb:409/3/1_Lactobacillus-rhamnosus-GG:Post-EHCF-with-LGG_vs_Post-EHCF-treatment_UP	NA	841	264995
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	165779	194	150022	162289
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301	848	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	561	620
bsdb:411/2/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301
bsdb:412/1/1_HIV-infection,Methamphetamine-dependence:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	1654	75984	909928	34104
bsdb:412/2/1_Methamphetamine-dependence:Methamphetamine-users_vs_non-users_UP	NA	1161127	724	1730	29465	37914	1301	543311	150022	1716	848	162289	836	1257	165779	86331
bsdb:412/2/2_Methamphetamine-dependence:Methamphetamine-users_vs_non-users_DOWN	NA	580596	216851	1283313
bsdb:412/3/1_Methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_UP	NA	165779	1716	37914	1730	150022	848	86331	1161127	162289	1257	836
bsdb:412/3/2_Methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_DOWN	NA	216851	1485	1578	1313210	83770
bsdb:412/4/1_Methamphetamine-dependence:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_UP	NA	34104
bsdb:412/4/2_Methamphetamine-dependence:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_DOWN	NA	846
bsdb:412/5/1_Methamphetamine-dependence:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_UP	NA	1485
bsdb:412/5/2_Methamphetamine-dependence:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_DOWN	NA	397864	117563	168808	34104	292632
bsdb:413/1/1_Obsessive-compulsive-disorder:OCD_vs_healthy-controls_DOWN	NA	119852	283168	207244
bsdb:414/1/1_Epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	1678	39948
bsdb:414/1/2_Epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	561
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	265975	437755
bsdb:415/2/1_HIV-infection,Oral-candidiasis:HIV-positive-women-with-oral-candidiasis_vs_Age-matched-HIV-uninfected-womenn_UP	NA	29465
bsdb:415/3/1_Age:HIV-uninfected-women-who-are-50-years-of-age-or-older_vs_HIV-uninfected-women-who-are-less-than-35-years-of-age_UP	NA	265975	437755
bsdb:415/4/1_Coinfection,Age:aging-HIV-infected-women-with-coinfections_vs_young-HIV-infected-group-without-coinfection_UP	NA	119852
bsdb:417/1/1_HIV-infection,Diabetes-mellitus:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	165779	150022	168808	447020
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872	158846
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:418/2/1_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872	158846
bsdb:418/2/2_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:419/1/1_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	1508657
bsdb:420/1/1_HIV-infection:Probiotic-group-after-8-weeks-of-intervention_vs_baseline-probiotic-group_UP	NA	1678
bsdb:420/1/2_HIV-infection:Probiotic-group-after-8-weeks-of-intervention_vs_baseline-probiotic-group_DOWN	NA	816
bsdb:420/2/1_HIV-infection:Probiotic-intervention-group-(after-8-weeks)_vs_Non-probiotic-intervention-group-(after-8-weeks)_UP	NA	1578
bsdb:421/1/1_HIV-infection:Vertically-HIV-infected-children_vs_HIV-uninfected-siblings-or-children-born-to-HIV-infected-mothers_UP	NA	239934	100883	561	848	838
bsdb:421/1/2_HIV-infection:Vertically-HIV-infected-children_vs_HIV-uninfected-siblings-or-children-born-to-HIV-infected-mothers_DOWN	NA	244127	207244	51514	1357	189330	33042	28050	216851	1678
bsdb:422/1/1_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_UP	NA	838	906	970	1485	32067	53335
bsdb:422/1/2_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_DOWN	NA	816	51514	216851	724	475961	48463	1263
bsdb:423/1/2_Amyotrophic-lateral-sclerosis:Amyotrophic-lateral-sclerosis---ALS-patients_vs_Healthy-controls_DOWN	NA	158846
bsdb:424/1/1_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_UP	NA	239934	906	283168
bsdb:424/1/2_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_DOWN	NA	207244	216851	292632
bsdb:424/3/1_Pancreatic-carcinoma:BO-PC_vs_NBO-PC_DOWN	NA	572511
bsdb:424/3/2_Pancreatic-carcinoma:BO-PC_vs_NBO-PC_UP	NA	838
bsdb:424/4/1_Pancreatic-carcinoma:NBO-PC_vs_Healthy-control_DOWN	NA	216851
bsdb:424/4/2_Pancreatic-carcinoma:NBO-PC_vs_Healthy-control_UP	NA	239934
bsdb:426/1/1_Autoimmune-Hepatitis:autoimmune-hepatits-cases_vs_healthy-controls_UP	NA	570	1578	1301	29465
bsdb:426/1/2_Autoimmune-Hepatitis:autoimmune-hepatits-cases_vs_healthy-controls_DOWN	NA	33042	119852	375288
bsdb:427/1/1_Diet:omnivores_vs_vegetarians_DOWN	NA	28050
bsdb:427/1/2_Diet:omnivores_vs_vegetarians_UP	NA	1263
bsdb:427/2/1_Diet:omnivores_vs_vegans_DOWN	NA	841	28050	838
bsdb:427/2/2_Diet:omnivores_vs_vegans_UP	NA	1263	119852
bsdb:427/3/1_Diet:vegetarians_vs_vegans_UP	NA	119852
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	375288
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	100883
bsdb:429/1/1_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_UP	NA	1301
bsdb:429/1/2_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:431/1/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	222	283	1079922	162290	2745	1357	1243	68	149698	407	1839	265	33024	1522432	286	207599	152161	84036	270
bsdb:431/3/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	168808	177971	29465	906	46913	2701
bsdb:431/4/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	906	1257	177971	168808
bsdb:431/5/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	216851	1847725	162289	165779	39948	838	2701	1243	404402	150022	1279	1350
bsdb:431/6/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_DOWN	NA	836	1567	1506577	73029
bsdb:431/7/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_UP	NA	501783	1578	231454
bsdb:431/8/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	168808	1578	286	177971
bsdb:431/9/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_UP	NA	581
bsdb:431/9/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	39948	838	40544	1257	286
bsdb:432/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2093
bsdb:432/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	2077
bsdb:433/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_UP	NA	2701
bsdb:433/1/2_Cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_DOWN	NA	1578
bsdb:433/2/1_Cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	1301	162289	150022	165779	838
bsdb:433/2/2_Cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	1578
bsdb:434/1/1_Human-papilloma-virus-infection:HPV-+_vs_healthy-control_UP	NA	906
bsdb:434/3/1_Cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	838	177971
bsdb:434/4/1_Cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	1386	168808	12916	848	182709	836	165779
bsdb:434/5/1_Human-papilloma-virus-infection:HPV+_vs_Healthy-control_UP	NA	838	1386	168808	906	1301	165779
bsdb:434/5/2_Human-papilloma-virus-infection:HPV+_vs_Healthy-control_DOWN	NA	1380
bsdb:435/1/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_UP	NA	28100	13687	165779	838	836	39948	162289
bsdb:435/1/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_DOWN	NA	1578
bsdb:435/3/1_Human-papilloma-virus-infection:HPV+-persistent_vs_HPV+-transient_UP	NA	13687	28100
bsdb:435/3/2_Human-papilloma-virus-infection:HPV+-persistent_vs_HPV+-transient_DOWN	NA	1578
bsdb:435/4/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls_UP	NA	28228	283168	39948	838	165779	13687	28100
bsdb:435/4/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls_DOWN	NA	1578	1386
bsdb:437/1/1_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_UP	NA	78156	1578
bsdb:437/1/2_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_DOWN	NA	333750
bsdb:438/1/2_Antimicrobial-agent:Antibiotic-treated-(week-4)_vs_Untreated-controls-(week-4)_DOWN	NA	1678	1578
bsdb:438/3/1_Antimicrobial-agent:Week-8-(treated)_vs_Week-4-(treated)_UP	NA	1678
bsdb:439/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:441/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301	32207	29465	1505663	1654
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1766253	207244	189330	216851	1407607	1505657	570	1501226	191303	1485
bsdb:441/2/1_Influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_DOWN	NA	572511	1501226	102106	1678	1766253	1407607	207244	189330
bsdb:441/2/2_Influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_UP	NA	1350	838	150022	162289
bsdb:441/3/1_COVID-19:COVID-19-patients_vs_H1N1-patients_UP	NA	1766253	207244	1678	572511	102106	189330	1407607	32207	1263	1301	1485
bsdb:441/3/2_COVID-19:COVID-19-patients_vs_H1N1-patients_DOWN	NA	838	1582879	239934	1161127	836
bsdb:441/4/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301
bsdb:442/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	5598	5498	5453	41254	95729	5644
bsdb:443/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	816	29465
bsdb:443/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1678
bsdb:443/2/1_Irritable-bowel-syndrome:IBS-C_vs_Health-Control_UP	NA	816	1578	29465
bsdb:443/3/1_Irritable-bowel-syndrome:IBS-D_vs_Health-Control_UP	NA	816
bsdb:443/3/2_Irritable-bowel-syndrome:IBS-D_vs_Health-Control_DOWN	NA	1578
bsdb:443/5/1_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome,-constipation-predominant-(IBS-C)_vs_Irritable-Bowel-Syndrome,-diarrhea-predominant-(IBS-D)_UP	NA	1578
bsdb:443/5/2_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome,-constipation-predominant-(IBS-C)_vs_Irritable-Bowel-Syndrome,-diarrhea-predominant-(IBS-D)_DOWN	NA	816
bsdb:444/1/2_Physical-activity:Inactive-patients_vs_Active-patients_DOWN	NA	83770	40840
bsdb:444/2/2_Body-mass-index:Overweight-patients_vs_Normal-weight-patients_DOWN	NA	133925	86331	165779	1730	1485	40840	83770
bsdb:444/3/1_Body-mass-index:Obese-patients_vs_Normal-weight-patients_UP	NA	1263
bsdb:444/3/2_Body-mass-index:Obese-patients_vs_Normal-weight-patients_DOWN	NA	447020	1485	83770
bsdb:444/4/1_Body-mass-index,Physical-activity:Normal-weight/inactive-patients_vs_Normal-weight/active-patients_DOWN	NA	40840	83770
bsdb:444/4/2_Body-mass-index,Physical-activity:Normal-weight/inactive-patients_vs_Normal-weight/active-patients_UP	NA	638847
bsdb:444/5/1_Body-mass-index,Physical-activity:Overweight/Obese/active-patients_vs_Normal-weight/active-patients_UP	NA	638847
bsdb:444/5/2_Body-mass-index,Physical-activity:Overweight/Obese/active-patients_vs_Normal-weight/active-patients_DOWN	NA	162289	40840	83770
bsdb:444/6/2_Body-mass-index,Physical-activity:Overweight/Obese/inactive-patients_vs_Normal-weight/active-patients_DOWN	NA	83770
bsdb:444/7/1_Body-mass-index,Physical-activity:Overweight/Obese/inactive-patients_vs_Overweight/Obese/active-patients_DOWN	NA	40840	83770
bsdb:447/1/1_Gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	724
bsdb:447/1/2_Gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	239759	33024
bsdb:447/2/1_Gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	1678	970
bsdb:447/2/2_Gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	1164882	32067	1243
bsdb:448/1/1_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	286	1386
bsdb:448/1/2_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:448/1/5_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	1386	286
bsdb:448/1/6_Influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:452/1/1_Gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	244127	33042	189330	577309	838	1263
bsdb:452/1/2_Gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_DOWN	NA	29465
bsdb:453/1/1_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	1716	194	150022	2050	165779	1582879	836	838	1161127	236752	66831	162290	1279	1380	990721	39948	577310	1649459	1392389
bsdb:453/1/2_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	1578	1505657	189330	572511	32207	216851	561	2039302	292632	1301	29465	841	1407607	1766253	570
bsdb:453/2/1_COVID-19:SARS-CoV-2-recovered-individuals_vs_SARS-CoV-2-infected-patients_DOWN	NA	194	1716	2050	1686313	1582879	1161127	236752	66831	1279	162290	1847725	150022	40544	162289	836	1380	255204	508459	1769710	191303	31983	165779	36739	872
bsdb:453/2/2_COVID-19:SARS-CoV-2-recovered-individuals_vs_SARS-CoV-2-infected-patients_UP	NA	1357	207244	1926663	216851	561	1505657	135858	570	292632	117563	572511	1766253
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	207244	1926663
bsdb:453/3/2_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	248744	1470349	35832	577309	39948	40544	1263
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	283	399320	2753	158846	588605	1505657	570	577309	171413	1870884	583	848	1505663	1573535	1769710	2129	1766253
bsdb:453/4/2_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_DOWN	NA	171412	53456	447020	72763	1269	1357	944321	1926663	156973	168808	36739	1501226	547	1505652	1213720	1273095	1696	1912216	255204
bsdb:454/1/1_Colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_UP	NA	1654	239759	209879	816	1678	39948	1350	848	1378	117563	86331	459786	543311	1257	33024	286	841	1263	1279	1301	172900	1485	258514	194	1730	404402	836	838
bsdb:454/1/2_Colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_DOWN	NA	118966	207244	816	572511	580596	33042	39948	189330	216851	204475	61170	570	841	1485
bsdb:454/3/1_Colorectal-cancer:Proximal-cancer_vs_Distal-(and-rectal)-cancer_UP	NA	572511	216851	29465	1485
bsdb:454/3/2_Colorectal-cancer:Proximal-cancer_vs_Distal-(and-rectal)-cancer_DOWN	NA	2745	22
bsdb:455/1/1_Pregnancy:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_UP	NA	816	848	157
bsdb:455/1/2_Pregnancy:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_DOWN	NA	59735	1378	724	1301	217201
bsdb:455/2/1_Gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	816	194	44259	1434006	195950	157
bsdb:455/3/1_Gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	32067
bsdb:455/4/1_Pregnancy:pregnant-women_vs_non-pregnant-women_UP	NA	59735	194	265975	1257
bsdb:456/1/1_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	207244	816	35832	572511	1485	33042	216851	28050	248744	283168	577310	33024	46205	841	1263	13687	40544
bsdb:456/1/2_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1654	239934	244127	1678	544	102106	84111	1350	570	1578	906	375288	160674	1301	292632	46255
bsdb:457/1/1_Periodontitis:Individuals-diagnosed-with-Periodontitis-group_vs_Healthy-controls-group_UP	NA	40544
bsdb:458/1/1_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	469	570	48736	13687
bsdb:458/1/2_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_DOWN	NA	1654	724	482	838	1301	29465
bsdb:459/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	1283313	165779	38501	580596	194	1016	59732	150022	237	1378	57493	1269	475	162289	836	838	32207	970	29465	662
bsdb:459/1/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	432330	397456
bsdb:462/1/1_Type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	165440	4930
bsdb:462/1/2_Type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	4855	42658	1124675
bsdb:462/2/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	4970	5314	1851509	5605	148959
bsdb:462/2/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1500560	42658	1891946
bsdb:462/3/1_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_DOWN	NA	4970	5314	1851509	42658
bsdb:462/3/2_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_UP	NA	4930	1500560
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1331051	2717	43996	1716	44259	848	1378	724	86331	265975	543311	1257	836	123375	1301
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	194	117563	32067	906	970	146	195950
bsdb:464/2/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1331051	724	543311	836
bsdb:464/2/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	82202	32067	906	970
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	239759	816	35832	572511	1485	102106	33042	39948	189330	216851	724	61170	1392389	570	28050	283168	375288	577310	46205	841	1263	13687	40544	191303
bsdb:464/3/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	239934	1678	1350	1301	32207	2745	207244	265975	29465	123375	1380	946234	1082930	1378	117563
bsdb:465/1/1_Diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	572511	561	1506553	906
bsdb:465/1/2_Diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_DOWN	NA	816	216851
bsdb:466/1/1_Chewing-tobacco-behavior:smokeless-tobacco-users_vs_age-matched-controls_UP	NA	43996	1434006
bsdb:466/2/1_Smoking-behavior:Smokers-who-were-using-either-bidis-or-cigarettes_vs_age-matched-controls_UP	NA	848	177971
bsdb:466/3/1_Smoking-behavior:Smokers_vs_Smokeless-tobacco-users_DOWN	NA	848	194
bsdb:467/1/1_HER2-Positive-Breast-Carcinoma:Her2-positive-tumor_vs_Her2-negative-tumor_UP	NA	904
bsdb:467/1/2_HER2-Positive-Breast-Carcinoma:Her2-positive-tumor_vs_Her2-negative-tumor_DOWN	NA	872	1263
bsdb:467/2/1_Age-at-menarche:later-age-at-menarche-(≥12)_vs_early-age-at-menarche-(≤11)_UP	NA	561
bsdb:467/2/2_Age-at-menarche:later-age-at-menarche-(≥12)_vs_early-age-at-menarche-(≤11)_DOWN	NA	2172	1263
bsdb:467/3/1_Estrogen-receptor-status:ER-_vs_ER+_DOWN	NA	724	29465
bsdb:467/5/1_Breast-cancer:Grade-High-(III)_vs_Grade-Low-(I/II)_UP	NA	84111
bsdb:467/5/2_Breast-cancer:Grade-High-(III)_vs_Grade-Low-(I/II)_DOWN	NA	207244
bsdb:467/6/1_Breast-cancer-stage:Stage-High-(III)_vs_Stage-Low-(I/II)_UP	NA	1485	29465	724
bsdb:467/6/2_Breast-cancer-stage:Stage-High-(III)_vs_Stage-Low-(I/II)_DOWN	NA	904	135858
bsdb:467/7/1_Age:Age-≤50_vs_Age-50+_UP	NA	1485	1357
bsdb:467/8/1_Parous:Nulliparous_vs_Parous_DOWN	NA	135858
bsdb:467/9/1_Body-mass-index:BMI≥25_vs_BMI<25_UP	NA	239934
bsdb:468/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	2701	1283313	1301	2129
bsdb:468/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	168808	838	39948	906	2701	397864
bsdb:470/1/1_Colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:470/1/2_Colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:472/1/2_Gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_DOWN	NA	140625
bsdb:473/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	848	724	32067
bsdb:476/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	343821	41949	32207	1505663
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	102106	216851	119852	1263
bsdb:477/1/1_COVID-19:Severe-COVID-19-patients_vs_COVID-19-negative-controls_UP	NA	1283313	43996	1164882	265975	838
bsdb:477/2/1_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_UP	NA	157
bsdb:477/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	838
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	2801844	2050	265975	32207	84108
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465
bsdb:478/2/1_COVID-19:COVID-19-patients_vs_Flu-patients_DOWN	NA	2801844	265975	32207	84108
bsdb:478/3/1_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	29465
bsdb:478/3/2_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	265975	2801844	32207	2050
bsdb:478/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	76833	1678	118747	1707	1716	84162	44259	57499	1164882	86331	543311	1743	2529408	970	1301	1654	32207	265975	186188	2801844	2717	184869	2050
bsdb:478/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	906	29465	46123
bsdb:478/5/1_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	1301	1654	32207	265975	186188	2801844	2717	184869
bsdb:478/5/2_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	906	29465
bsdb:479/1/1_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_DOWN	NA	469	642	1663	59735	1678	32008	830	1485	1298	44259	397456	43994	33882	745	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/1/2_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_UP	NA	547	561	570	1506553	1847725	1269	133925	44249	53335	1827	590	196081	613	40323
bsdb:479/2/1_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1663	118747	32008	1298	397456	43994	57493	1357	948104	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/2/2_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_UP	NA	2330	407	34104
bsdb:479/3/1_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_DOWN	NA	469	642	59735	1678	118747	830	1485	44259	2330	407	745
bsdb:479/3/2_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_UP	NA	547	561	570	57493	1506553	1357	1847725	1269	948104	133925	44249	53335	1827	590	196081	613	40323	286
bsdb:479/4/1_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_DOWN	NA	469	642	239759	207244	637	1663	59735	1678	38501	572511	1696	41275	32008	1715793	75	59732	1485	106589	189330	66831	44259	1573535	53457	149698	407	33882	1763	909928	1839	283168	375288	265	84567	335058	48736	841	42255	1508657	1263	1835	1193515	13687	1506577	338
bsdb:479/4/2_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_UP	NA	1357	590	196081	613
bsdb:480/1/1_Endometriosis:Vaginal-Fluid_vs_Control-group_UP	NA	1378	1301
bsdb:480/1/2_Endometriosis:Vaginal-Fluid_vs_Control-group_DOWN	NA	1375	1380
bsdb:480/2/1_Endometriosis:Eutopic-Endometrium-Samples_vs_Control-group_UP	NA	1678
bsdb:480/2/2_Endometriosis:Eutopic-Endometrium-Samples_vs_Control-group_DOWN	NA	59753	1380	194	42054	2050
bsdb:480/3/1_Endometriosis:endometriotic-lesion-samples_vs_Controls-group_UP	NA	1375	1279	13687	111142	286	1350
bsdb:480/3/2_Endometriosis:endometriotic-lesion-samples_vs_Controls-group_DOWN	NA	838	1380	1033	2050	194	66831
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	84111	100883
bsdb:481/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_UP	NA	100883
bsdb:481/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	80865
bsdb:482/1/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	29465	482	1301	838
bsdb:482/1/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	1279	561
bsdb:482/2/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	375288
bsdb:483/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients,-pneumonia-patients,-uninfected-controls_DOWN	NA	572511	216851	1730	841	33042
bsdb:483/3/1_COVID-19:Pneumonia-controls_vs_Uninfected-controls,-COVID-19-patients_DOWN	NA	100883
bsdb:485/1/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	4930	1350
bsdb:485/1/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	207244	838	375288	33024	84111
bsdb:485/2/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1350	544	4930	724
bsdb:485/2/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	577310	644652
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	84111	547	1350	666060	1263	620	46255	1485
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	207244	194	28050	906	52225	133925	841	83770
bsdb:486/2/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	469	1350	33969	620	46255	1578
bsdb:486/2/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	207244	1485	33042	39948	189330	547	216851	28050	906	52225	133925	841	1263	970	292632	83770
bsdb:486/3/1_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_UP	NA	816	1350	620	1380	33969
bsdb:486/3/2_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	580596	194	1485	33042	39948	189330	547	216851	28050	906	133925	841	83770
bsdb:487/2/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_DOWN	NA	207244	33042	1407607	2039302	119852	841
bsdb:487/2/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_UP	NA	102106	1350	1578	1301	1501226	1253	544
bsdb:487/3/1_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_DOWN	NA	1766253	239759	207244	816	397864	580596	574697	1980681	33042	216851	1506553	28050	2039302	283168	459786	375288	577309	838	841	1263	40544
bsdb:487/3/2_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_UP	NA	102106	1350	1578	1301	191303	1501226	1253	572511	620	1678	1485	1505657
bsdb:488/1/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	1283313	1678	216851	1263
bsdb:488/1/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1301
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_UP	NA	1663	909928	2737	84108	1269	1827	57493	1883	33926	1763	86331	1935176	404402	1434004	724	1926667	1696	1350	1716	66831	44249	1386	1935461	577310
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_DOWN	NA	35829	244127	544	102106	1348911	872	1432051	216851	1686313	946234	1407607	117563	2330	1243	2093	265975	2740	1017280	638847	588605	590	292632	662	1653174	1980689	2005359	1738645	1649459	574697	1508657	1506577	207244	570
bsdb:489/2/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_UP	NA	1663	84108	2737	33882	44249	1269	1827	57493	1883	33926	1763	642	86331	404402	1434004	724	1926667	1279	1716	1696	1935461	577310
bsdb:489/2/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_DOWN	NA	1375	59753	544	102106	100883	1348911	413496	872	216851	1686313	946234	117563	1937007	28050	1357	1980689	1161127	133925	590	970	292632	40544	662	33024	574697	547	561	1649459	1508657	207244
bsdb:489/3/1_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_UP	NA	59753	1375	40544	51196	100883	133925	909928	1357	1795789	1935176	904	1931105	970	1573535	241189	119977	906	35832	561	662	66831	547
bsdb:489/3/2_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_DOWN	NA	583	1653174	1432051	33882	2005359	244127	1738645	2740	1407607	1017280	44249	642	588605	35829	1243	1905344	2093	1378	469	1200657	1506577	580596
bsdb:490/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	29465	1578
bsdb:490/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1485
bsdb:491/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	2740
bsdb:492/1/1_Type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_DOWN	NA	207244	572511	283	33042	724	28050	33024	841	40544	191303
bsdb:492/1/2_Type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_UP	NA	904	574697	547	561	140625	2172	157	46255
bsdb:492/2/1_Diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_DOWN	NA	82373	2152	1678	572511	118747	830	1485	283	872	551	216851	724	28050	1578	52225	841	32207	1301	40544	191303
bsdb:492/2/2_Diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_UP	NA	904	239934	239759	508459	547	1350	561	158846	846	375288	620
bsdb:492/3/1_Diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_DOWN	NA	82373	2152	1678	872	551	724	570	140625	2172	52225	1301	157	46255
bsdb:492/3/2_Diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_UP	NA	239934	239759	508459	1350	33024	620
bsdb:494/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	239934	1678	375288	216851
bsdb:494/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	189330	848	1301
bsdb:495/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1283313	906	838
bsdb:495/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	816	577309
bsdb:495/2/1_Prediabetes-syndrome:Individuals-with-Prediabetes-(PreDM)_vs_Healthy-controls_UP	NA	906	724
bsdb:495/2/2_Prediabetes-syndrome:Individuals-with-Prediabetes-(PreDM)_vs_Healthy-controls_DOWN	NA	209
bsdb:496/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	1654	174708	165779	1380	1678	118747	1485	1716	84111	1350	561	209	1578	437755	265975	583	32207	196081	177971	1301	29465
bsdb:496/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	239759	207244	32008	574697	1485	283	33042	106589	189330	216851	61170	28050	482	283168	119852	375288	838	48736	841	1263	40544	172900	629
bsdb:496/2/1_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_UP	NA	561	1678	1485	1301	375288	29465	40544	848
bsdb:496/2/2_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_DOWN	NA	1654	416916	572511	118747	32008	1485	106589	189330	1730	724	209	1243	437755	265975	119852	33024	638847	48736	177971	40323
bsdb:497/1/1_Acute-myeloid-leukemia:Febrile-neutropenia_vs_Pretreatment_UP	NA	1350
bsdb:497/1/2_Acute-myeloid-leukemia:Febrile-neutropenia_vs_Pretreatment_DOWN	NA	561
bsdb:497/3/1_Acute-myeloid-leukemia:Bone-marrow-recovery_vs_Pre-treatment_UP	NA	1350
bsdb:497/3/2_Acute-myeloid-leukemia:Bone-marrow-recovery_vs_Pre-treatment_DOWN	NA	561
bsdb:498/1/1_COVID-19:Symptomatic,-mild-to-moderate-COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	1582879
bsdb:498/2/2_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_DOWN	NA	469	40323
bsdb:499/1/1_Irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_DOWN	NA	239759	216851	283168	375288	195950
bsdb:499/1/2_Irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_UP	NA	572511	39948	189330	248744	100175	1263
bsdb:499/2/1_Irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	239759	283168	375288	195950
bsdb:499/2/2_Irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_UP	NA	244127	109326	55079	189330	28050	248744	100175	2740	44748
bsdb:499/3/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	283168	375288	195950
bsdb:499/3/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	830	189330	28050	2740	841
bsdb:499/4/1_Irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_DOWN	NA	1678	239759	283168	375288	195950
bsdb:499/4/2_Irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_UP	NA	55079	100175	39948	2740	109326	572511	248744	189330	28050	841
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_COVID-19-negative-patients-with-pneumonia_UP	NA	469	28453
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_COVID-19-negative-patients-with-pneumonia_DOWN	NA	1654	1380	194	1016	43996	1378	117563	32067	906	437755	482	265975	836	838	970	1301	195950	29465
bsdb:501/1/1_Endometriosis:One-(1)-Stage-III-Endometriosis-patient_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions-as-well-as-women-with-Stage-I-or-Stage-II-endometriosis_UP	NA	35829	222	1193324	174708	244127	816	580596	100883	33042	946234	1578	375288	1743	168808	1279	191303
bsdb:502/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	194
bsdb:502/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	816	29465	838
bsdb:502/2/2_Irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	816	838
bsdb:502/3/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	816	838
bsdb:502/4/1_Irritable-bowel-syndrome:IBS-M_vs_Healthy-Control_UP	NA	194
bsdb:503/1/1_Amoxicillin:Amoxicillin-exposed_vs_Control(Unexposed-to-Amoxicillin)_UP	NA	848
bsdb:503/2/1_Amoxicillin:Amoxicillin-exposed_vs_Control(Unexposed-to-Amoxicillin)_UP	NA	848
bsdb:504/4/1_Neoplasm:TPBC-tumor-tissue_vs_TPBC-normal-tissue_UP	NA	1301
bsdb:504/5/2_Ethnic-group:BNH_vs_WNH_DOWN	NA	20
bsdb:504/6/1_Ethnic-group:BNH_vs_WNH_UP	NA	29465	28100
bsdb:504/6/2_Ethnic-group:BNH_vs_WNH_DOWN	NA	1578	20
bsdb:505/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1678
bsdb:506/1/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1678
bsdb:507/1/1_Antimicrobial-agent:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	724	841	29465
bsdb:507/2/1_Antimicrobial-agent:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_UP	NA	1578
bsdb:507/2/2_Antimicrobial-agent:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	841
bsdb:508/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	1678	561	119852	375288	33024
bsdb:508/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	848
bsdb:509/1/1_Smoking-behavior:Smoking_vs_Non-smoking_UP	NA	1283313	1281902	120831	1357	84567	162291	836	583	475230	292632	82802
bsdb:509/1/2_Smoking-behavior:Smoking_vs_Non-smoking_DOWN	NA	43668	55080	238749	547	28231	579	1578	68287	57494	33024	48736	160674
bsdb:509/2/1_Smoking-behavior:Smoking_vs_Non-smoking_UP	NA	1283313	120831	1434010	1357	69965	248744	346096	84567	162291	836	583	354349	475230	292632	82802
bsdb:509/2/2_Smoking-behavior:Smoking_vs_Non-smoking_DOWN	NA	43668	55080	1774107	1716	238749	547	28231	227979	579	1578	68287	248038	57494	745	157932	160674	1649510
bsdb:510/2/1_Rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	1678	52225
bsdb:511/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465	194	117563	32257	44259
bsdb:511/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	482	1716	713	437755	416916	157	286
bsdb:511/2/1_COVID-19:COVID-19-patients-(severe/critical)_vs_COVID-19-patients-(mild/moderate)_DOWN	NA	157	416916	970	44259	2740
bsdb:511/3/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	117563	29465	194	162289
bsdb:511/3/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	437755	157
bsdb:511/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	1301	46255	1350	32207	1578	1654	117563
bsdb:511/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	572511	33042	102106
bsdb:511/5/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	1301	165779	162289	194	1380
bsdb:511/5/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	572511	33042	207244	482
bsdb:512/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls-and-healthcare-workers_UP	NA	469	1269	475	286	32207
bsdb:512/2/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	150247	469	286
bsdb:512/3/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_UP	NA	150247
bsdb:512/4/1_Viral-load:low-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_UP	NA	1716	482	286
bsdb:512/5/1_Viral-load:mid-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_UP	NA	1716	482
bsdb:512/5/2_Viral-load:mid-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_DOWN	NA	1301
bsdb:512/7/1_Viral-load:high-Ct-CoV+-patients_vs_low-and-mid-Ct-CoV+-patients_UP	NA	1301
bsdb:512/7/2_Viral-load:high-Ct-CoV+-patients_vs_low-and-mid-Ct-CoV+-patients_DOWN	NA	1716	1912216	482	286
bsdb:513/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	613	29465
bsdb:513/2/1_COVID-19:COVID-19-positive-patients-with-breathing-assistance_vs_COVID-19-positive-patients-without-breathing-assistance_UP	NA	547	838	29465	1301	32207	613
bsdb:513/3/1_COVID-19:COVID-19-positive-patients-with-antibiotic-use_vs_COVID-19-positive-patients-without-antibiotic-use_UP	NA	150022	613
bsdb:514/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions_UP	NA	1301
bsdb:516/1/1_Endometriosis:Mice-who-were-injected-with-endometrial-tissues_vs_Healthy-mice_UP	NA	1678	577310
bsdb:516/2/2_Endometriosis:Mice-who-were-injected-with-endometrial-tissues_vs_Healthy-mice_DOWN	NA	1283313
bsdb:518/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1654	572511	180162	1716	189330	84111	1350	117563	1578	1357	1763	1742993	1508657	1301	1485
bsdb:518/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	28050	283168	577310	1508657
bsdb:519/1/1_Endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	816
bsdb:520/2/1_Endometriosis:patients-with-rASRM-stages-3---4_vs_patients-with-rASRM-stages-1---2_DOWN	NA	724	482	836	1301
bsdb:520/2/2_Endometriosis:patients-with-rASRM-stages-3---4_vs_patients-with-rASRM-stages-1---2_UP	NA	12916	165779	39948	404402	1578	162289	28100	838	1743	13687	1301	184869
bsdb:521/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_DOWN	NA	1654	1743	32207
bsdb:521/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_UP	NA	469	212791	286	1301
bsdb:522/1/1_Endometriosis:Endometriosis-patients_vs_Controls-Subject-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	2737	1663	165695	80865	156973	265	22	469	1350	55968	44249	286	81
bsdb:522/1/2_Endometriosis:Endometriosis-patients_vs_Controls-Subject-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	1375	1578	838	2050	39948	906	543311	119852	1663	469	953	33877	40544
bsdb:523/1/1_Endometriosis:Endo-mice_vs_Non-endo-mice_DOWN	NA	207244	816	572511	1432051	1573534	644652	1578	841	1506577
bsdb:523/1/2_Endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	239934	174708	544	375288	577310	28138
bsdb:524/1/1_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_UP	NA	1654	102106	84111	1407607	1649459	1506553
bsdb:524/1/2_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_DOWN	NA	239759	816	397864	872	283168	375288	577309	577310	1481960	1505652
bsdb:524/2/1_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_UP	NA	1654	102106	84111	1649459	1506553
bsdb:524/2/2_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_DOWN	NA	239759	816	397864	283168	375288	1481960	1505652
bsdb:525/1/1_Endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	1578
bsdb:525/2/1_Endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	419014	40323	29465
bsdb:525/2/2_Endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	906	177971	168808
bsdb:525/3/1_Endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	419014
bsdb:526/1/1_Adenomyosis,Endometriosis:Endometriosis/-adenomyosis-patients-(AMEM)_vs_Endometriosis-patients-(EM)-and-Patients-without-endometriosis(Control-CT)_UP	NA	1380	194	1582879	216851
bsdb:526/3/1_Adenomyosis,Endometriosis:Endometriosis/-adenomyosis-patients-(AMEM)_vs_Adenomysis-patients_UP	NA	1380	194	1582879	216851
bsdb:527/1/1_Endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_DOWN	NA	447020	28050	577309	191303
bsdb:527/1/2_Endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	119852	816	375288	33042
bsdb:527/2/2_Endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	28050	119852
bsdb:529/1/1_Rheumatoid-arthritis,Osteoarthritis:arthritis-patient_vs_healthy-controls_UP	NA	848	47670	32067	117563	1654	1301	32207	724	29465	836	482	838
bsdb:529/1/2_Rheumatoid-arthritis,Osteoarthritis:arthritis-patient_vs_healthy-controls_DOWN	NA	469	59732	286	212791	40323	13687	343873	816	283	13159
bsdb:529/2/1_Rheumatoid-arthritis,Osteoarthritis:rheumatoid-arthritis_vs_Osteoarthritis_UP	NA	713	416916	848	29465	838	724	482
bsdb:529/2/2_Rheumatoid-arthritis,Osteoarthritis:rheumatoid-arthritis_vs_Osteoarthritis_DOWN	NA	1301	1654	47670	32207	117563	1263	265975	46123
bsdb:530/1/1_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_UP	NA	1678	1578	1654	32207	1380	906
bsdb:530/1/2_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_DOWN	NA	2717	1350	32257	47670	482	416916	724	1378
bsdb:530/2/1_Smoking-status-measurement:Former-Smokers_vs_Never-Smokers_UP	NA	1678	32207
bsdb:530/2/2_Smoking-status-measurement:Former-Smokers_vs_Never-Smokers_DOWN	NA	2717	1350	47670	32257	838	1380	724	416916	482	1378
bsdb:530/3/1_Smoking-status-measurement:Current-Smokers_vs_Former-Smokers_UP	NA	1654	1380	1678	32207	906	1578
bsdb:530/3/2_Smoking-status-measurement:Current-Smokers_vs_Former-Smokers_DOWN	NA	416916	1350	1378	47670	482	724	32257	2717
bsdb:531/1/1_Rheumatoid-arthritis:Pre---High-risk-Patients_vs_Healthy-controls_UP	NA	1378
bsdb:531/1/2_Rheumatoid-arthritis:Pre---High-risk-Patients_vs_Healthy-controls_DOWN	NA	44259	724	482	836	146
bsdb:531/2/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Healthy-controls_UP	NA	1654	157	970	838	906	1380
bsdb:531/2/2_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Healthy-controls_DOWN	NA	44259	724	482	836	146
bsdb:531/3/1_Rheumatoid-arthritis:Pre---High-risk-Patients_vs_Rheumatoid-Arthritis_UP	NA	1378
bsdb:531/3/2_Rheumatoid-arthritis:Pre---High-risk-Patients_vs_Rheumatoid-Arthritis_DOWN	NA	1654	906	838	970	157	1380
bsdb:532/1/1_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_UP	NA	1654	84111	551	1730	1301	191303
bsdb:532/1/2_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	216851
bsdb:533/1/1_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_UP	NA	239934	561	1678	29465	1301	1485	613	206664	547	84108	48463	33951	207244	872	44000
bsdb:533/1/2_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_DOWN	NA	830	1696	283168	46205	375288	33042	748770	40544	28050	841	570	203804	572511	816
bsdb:533/2/1_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_UP	NA	44000	29465	1301	33951	207244
bsdb:533/2/2_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_DOWN	NA	572511	28050	830	841
bsdb:534/1/1_Exercise:obese-subjects_vs_lean-subjects_UP	NA	816	102106
bsdb:534/1/2_Exercise:obese-subjects_vs_lean-subjects_DOWN	NA	216851	28050
bsdb:534/2/1_Exercise:obese-subjects_vs_lean-subjects_DOWN	NA	189330	102106
bsdb:534/2/2_Exercise:obese-subjects_vs_lean-subjects_UP	NA	216851	28050
bsdb:535/1/1_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	904	830	28050
bsdb:535/1/2_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	165779	420345	1578	906	5073	583
bsdb:535/2/1_Antimicrobial-agent:Antibiotic-treated-subjects-in-day-hospital_vs_Antibiotic-untreated-subjects-in-day-hospital_UP	NA	1578	86331	437755	162289	172900	46255
bsdb:535/2/2_Antimicrobial-agent:Antibiotic-treated-subjects-in-day-hospital_vs_Antibiotic-untreated-subjects-in-day-hospital_DOWN	NA	572511	216851
bsdb:536/1/2_Azithromycin:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_UP	NA	946234
bsdb:537/1/1_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1678	561
bsdb:537/1/2_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	216851
bsdb:537/2/1_Parkinson's-disease:the-trend-over-Parkinson's-disease-progression_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1578
bsdb:537/3/1_Parkinson's-disease:patients-with-MSA(multiple-system-atrophy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1301	1678	74107
bsdb:537/3/2_Parkinson's-disease:patients-with-MSA(multiple-system-atrophy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	216851	841
bsdb:537/4/1_Parkinson's-disease:patients-with-PSP(progressive-supranuclear-palsy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	119852
bsdb:537/4/2_Parkinson's-disease:patients-with-PSP(progressive-supranuclear-palsy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	1301	838	216851
bsdb:537/6/1_Parkinson's-disease:patients-with-early-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-disease_UP	NA	239934	119852
bsdb:537/6/2_Parkinson's-disease:patients-with-early-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-disease_DOWN	NA	216851	841
bsdb:537/7/1_Parkinson's-disease:patients-with-mid-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1678	375288
bsdb:537/7/2_Parkinson's-disease:patients-with-mid-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	216851
bsdb:537/8/1_Parkinson's-disease:patients-with-advanced-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	561	1578	375288	1678
bsdb:537/8/2_Parkinson's-disease:patients-with-advanced-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	216851	841
bsdb:538/1/1_Antimicrobial-agent:ciprofloxacin-treated_vs_baseline-of-the-ciprofloxacin-treated_DOWN	NA	216851	119852	1263
bsdb:538/1/2_Antimicrobial-agent:ciprofloxacin-treated_vs_baseline-of-the-ciprofloxacin-treated_UP	NA	572511	1485	1730	841
bsdb:538/2/2_Antimicrobial-agent:Nitrofurantoin-treated_vs_Baseline-of-the-Nitrofurantoin-treated_UP	NA	216851
bsdb:538/6/1_Antimicrobial-agent,Urinary-tract-infection:Ciprofloxacin-treated-group-(timepoint-2)_vs_control-group-(timepoint-2)_UP	NA	239759	119852	375288	841	1263
bsdb:538/7/1_Antimicrobial-agent,Urinary-tract-infection:nitrofurantoin-treated-group-(timepoint-2)_vs_controls-(timepoint-2)_UP	NA	239759	216851
bsdb:540/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	838	1301	29465
bsdb:540/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	482
bsdb:540/2/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	1654	1380	906	838	1301	29465
bsdb:540/2/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	59735	848	1378	724	47670	482	195950
bsdb:542/1/1_Hidradenitis-suppurativa:Hidradenitis-suppurativa-patients_vs_Healthy-controls_UP	NA	1654	39948	1582879	150022	162289	836	13687
bsdb:542/1/2_Hidradenitis-suppurativa:Hidradenitis-suppurativa-patients_vs_Healthy-controls_DOWN	NA	283	1743	162289
bsdb:542/2/1_Hidradenitis-suppurativa:Lesional-skin-of-Hidradenitis-suppurativa-patients_vs_Non-lesional-skin-of-Hidradenitis-suppurativa-patients_UP	NA	1654	194	39948	162289	836
bsdb:542/2/2_Hidradenitis-suppurativa:Lesional-skin-of-Hidradenitis-suppurativa-patients_vs_Non-lesional-skin-of-Hidradenitis-suppurativa-patients_DOWN	NA	469	201096	92793	238749	1269	475	265	1743	286	529883
bsdb:543/1/1_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_DOWN	NA	342658	459786	1501226	44748
bsdb:543/1/2_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_UP	NA	1485
bsdb:545/1/1_Antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1350
bsdb:545/1/2_Antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1470349	1729679	1501226
bsdb:545/2/1_Antimicrobial-agent:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1501226	1937008
bsdb:545/2/2_Antimicrobial-agent:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1470349
bsdb:545/3/2_Antimicrobial-agent:40-week-old-(old)-mice-10-days-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1501226	1729679
bsdb:545/4/1_Antimicrobial-agent:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1729679	1918540	1501226
bsdb:545/4/2_Antimicrobial-agent:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_UP	NA	1937008
bsdb:546/1/2_COVID-19:COVID-19-cases_vs_Non-infected-controls_DOWN	NA	848	724	482	1301	838
bsdb:547/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	561	946234	1505657
bsdb:547/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	35832	580596	189330	216851	1407607	1392389	1501226	841	1263
bsdb:548/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	2745	117563	32067	1301
bsdb:548/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	482	838	1283313	848	724
bsdb:549/1/1_Keratoconjunctivitis:Atopic-keratoconjunctivitis-(AKC)_vs_Healthy-controls_UP	NA	286	1279	724
bsdb:549/1/2_Keratoconjunctivitis:Atopic-keratoconjunctivitis-(AKC)_vs_Healthy-controls_DOWN	NA	48736	1678	583
bsdb:550/1/1_Juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_UP	NA	123375	86331
bsdb:550/1/2_Juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_DOWN	NA	724	1386	133925
bsdb:550/2/1_Temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_DOWN	NA	724	265975	1380	1386	508215
bsdb:550/2/2_Temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_UP	NA	538	724	1283313
bsdb:551/1/1_High-fat-diet:High-fat-diet-(HFD:200-Inul-)_vs_High-fat-diet-(HFD:-50-cell)_UP	NA	1678
bsdb:551/1/2_High-fat-diet:High-fat-diet-(HFD:200-Inul-)_vs_High-fat-diet-(HFD:-50-cell)_DOWN	NA	816	1485	51514	1350	1578	1357	1301
bsdb:551/2/1_High-fat-diet:High-fat-diet-(HFD:200-Inul-)_vs_Chow_UP	NA	1678	1357	174708
bsdb:551/2/2_High-fat-diet:High-fat-diet-(HFD:200-Inul-)_vs_Chow_DOWN	NA	1578	191303	49082	207244	1263	135858
bsdb:552/1/1_Gestational-age:Week-36_vs_Week-24_UP	NA	475	1301	1279	1350	1716	1378
bsdb:552/1/2_Gestational-age:Week-36_vs_Week-24_UP	NA	1578
bsdb:552/2/1_Gestational-age:Birth_vs_36_UP	NA	1716	1350	1378	475	1279	1301
bsdb:552/2/2_Gestational-age:Birth_vs_36_DOWN	NA	1578
bsdb:553/2/2_Spontaneous-abortion:First-trimester-miscarriage_vs_Viable-control-pregnancy_UP	NA	1301	162289	2129	39948
bsdb:554/1/1_Parkinson's-disease:patients-with-parkinson's-disease_vs_Healthy-Controls(HC)_UP	NA	838
bsdb:554/1/2_Parkinson's-disease:patients-with-parkinson's-disease_vs_Healthy-Controls(HC)_DOWN	NA	1578
bsdb:554/2/8_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_UP	NA	239934	239759	33042	28050	2172	375288	33024	841	1263
bsdb:554/2/9_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_DOWN	NA	1578	1301
bsdb:555/1/1_Rheumatoid-arthritis:Rheumatoid-arthritis-patient_vs_Healthy-controls_UP	NA	572511	84111	1573535	286	1301	32207
bsdb:555/1/2_Rheumatoid-arthritis:Rheumatoid-arthritis-patient_vs_Healthy-controls_DOWN	NA	1506553	841	41949	2093	162290	1274351
bsdb:556/1/1_Dry-eye-syndrome:Dry-Eye_vs_Normal-Control-(NC)_UP	NA	1301	1186	184869	508215	724	65551	39948	57495	838	216851	357
bsdb:556/1/2_Dry-eye-syndrome:Dry-Eye_vs_Normal-Control-(NC)_DOWN	NA	286	209	434	374	40323	37914	57739	191	261933	263370	295418	561	67575
bsdb:557/1/1_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	713	1654	1283313	165779	207244	816	572511	150022	946234	1940255	1434006	2701	1164882	1578	1847725	32067	906	2050	482	265975	459786	543311	1257	33024	286	1501226	841	508215	1508657	970	1301	40544
bsdb:557/1/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	39948	1350	848	375288	970	157	1506577	29465
bsdb:557/2/1_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_UP	NA	1654	207244	1678	572511	194	848	1847725	32067	482	33024	1501226	841	508215	970	40544	29465
bsdb:557/2/2_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_DOWN	NA	1654	816	102106	39948	1407607	2701	117563	1578	459786	375288	508215	1263	157	29465
bsdb:557/3/1_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	904	1375	216851	906	1263	177971	1578	816	194
bsdb:557/3/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	713	416916	1283313	816	194	1016	43996	39948	150022	848	117563	1164882	1578	1847725	32067	482	375288	836	838	1508657	970	1213720	1301	195950	29465
bsdb:557/4/1_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_UP	NA	904	216851	906	162289	292632	29465
bsdb:557/4/2_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_DOWN	NA	1766253	165779	1380	816	39948	236752	946234	375288	162289	1257	836	838	286	1508657	168808	1470353
bsdb:557/5/1_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	577309	838	286	508215	40544	1508657	216851	194	848	29465	1578	33024
bsdb:557/5/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	713	1654	1766253	1283313	419014	165779	156454	816	194	1016	1716	39948	84111	1434006	1407607	28050	1357	32067	1980693	265975	375288	543311	841	1263	1301	292632	157
bsdb:557/6/1_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_UP	NA	1678	580596	1434006	28050	52225	459786	543311	286	1508657	970	157	32067	816	848	29465
bsdb:557/6/2_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_DOWN	NA	904	1654	239759	1283313	1016	1716	216851	1407607	1378	117563	1164882	265975	375288	162289	1257	838	841	1506577	848
bsdb:558/1/1_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	1678	40544
bsdb:558/1/2_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	207244	572511	574697	216851	283168
bsdb:558/1/3_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	40323
bsdb:558/2/2_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	375288	283168
bsdb:561/1/1_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._UP	NA	157920	407	1827	234	5475	1678	1573	2701	1578	196082
bsdb:561/1/2_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._DOWN	NA	32199	511434	1518147
bsdb:562/1/1_Health-study-participation:healthy-adult-vagina-50%-up_vs_NA_NA	NA	1578
bsdb:562/2/1_Health-study-participation:healthy-adult-skin-50%-up_vs_none_NA	NA	1279	1912216	1716	1301	1269	150022	475	32207
bsdb:562/3/1_Health-study-participation:feces-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	447020	2048137	239934	239759	2569097	207244	816	397864	1678	35832	572511	574697	1485	102106	33042	189330	561	1730	216851	946234	1407607	204475	644652	1505657	28050	2172004	2316020	283168	459786	375288	577310	33024	909656	838	841	1263	1905344	1301
bsdb:562/4/1_Health-study-participation:nasal-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1912216	1279	1716	55193
bsdb:562/5/1_Health-study-participation:oral-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1301	32207	1654	29465	838	848	1378	482	724	836	194	2529408	1016	32067	1716	47670	416916	195950	1283313	117563	265976	1164882	543311	970	157	46123	32257	86331	1213720	123375	2717	906	538	1257
bsdb:562/6/1_Health-study-participation:milk-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1301
bsdb:562/7/1_Health-study-participation:healthy-adult-vagina-70%-up_vs_NA_NA	NA	1578
bsdb:562/8/1_Health-study-participation:healthy-adult-skin-70%-up_vs_none_NA	NA	1716	1912216	55193	1279	1301
bsdb:562/9/1_Health-study-participation:feces-from-healthy-adult_vs_none---70%-prevalence-threshold_NA	NA	447020	2048137	239759	2569097	207244	816	1678	572511	1485	102106	33042	189330	1730	216851	946234	1407607	204475	28050	2316020	283168	459786	375288	909656	841	1263	1301	1905344
bsdb:562/10/1_Health-study-participation:feces-from-healthy-adult_vs_none---0%-prevalence-threshold_NA	NA	46123	2147	222	904	1912215	12916	469	76833	1654	1653174	447020	240233	1375	642	2048137	416916	186829	239934	507	2321111	239759	2675234	133193	114627	222991	209879	1283313	419014	2823232	2749846	2707015	13334	2569097	165779	52784	264995	156454	1924093	653683	207244	2039240	244127	55079	69278	2801844	28263	35823	5052	1903434	1380	1386	816	397864	697279	1678	35832	572511	517	85413	43668	29521	55080	1696	41275	2755	234	32008	580596	574697	830	1276290	1158982	1535326	1291539	1470349	1016	2717	2747	135858	75	158483	698776	157920	180162	28209	810	990721	59732	1573	508459	501783	1870884	1485	102106	283	2767879	100883	1348911	33042	2678534	1716	1937664	413496	69578	2675230	80865	2767880	79603	36739	82800	893	898	872	46913	39948	1472649	189330	75654	156973	635	84111	1279384	538	1432051	308865	423604	59734	212791	1472762	106591	5758	547	2719313	1350	2782229	171412	551	1647	561	1730	41201	33986	1582879	66831	216851	2005359	1573536	1573534	2767327	44259	1914234	150022	237	946234	1649295	1434006	1335631	2767881	1407607	848	2701	1378	113	204475	129337	1860	154116	1193503	13075	89583	441	1742989	2053	644652	117563	366614	724	568	1892380	31983	209	1445609	963	1573535	61170	2815774	1649459	243627	1609627	70774	89092	1937007	1934947	1505657	1392389	157226	428711	2782231	257820	32257	570	579	136099	1330547	186475	1649	57499	1506553	28050	2719231	2759736	2767842	1578	1357	420345	2767353	2767884	2767885	47670	1847725	41707	2172004	83654	110932	5658	2767893	171	32067	55968	1243	2767886	2767887	1676651	2742598	2767888	1637	2767889	745364	400634	68	69965	1637257	55193	2803850	2837505	86795	248744	149698	1926659	2316020	158846	906	65551	1649468	33969	68287	2055876	2172	1080709	2316	316612	1484898	2282523	33882	44471	29404	116071	57479	52225	2100764	2050	88138	158848	86331	2039302	475	581	212742	248038	1918540	1774128	1763	670516	1073531	1866885	2093	2767358	53460	53	909928	482	57494	1817	1839	2013	165696	283168	46254	90243	133925	265975	125287	1158	459786	219181	44249	1849828	1763521	375288	1849822	265	577309	196082	577310	745	361607	318147	2767890	2740557	122277	1253	84567	106146	2743582	1913599	2740	162289	1257	2675229	33024	909656	657	28100	447792	332100	162291	190323	702	1330546	142577	838	2800373	206375	1743	203133	583	586	1742993	2055880	53246	1504576	1017280	1742991	2755140	286	1847	113286	83618	1221880	497	2678886	638847	2260	34037	48736	160674	67575	379	75309	1827	780	28138	588605	1960084	841	2730923	120961	125216	2837508	32207	1565532	295418	42255	1263	1905344	4930	1835	45669	404432	263377	590	60919	1266	196081	2529408	2767891	970	1769710	265976	613	519427	22	177971	1649298	71	204447	84108	168808	84565	648800	413435	123375	28453	165695	13687	165697	2132	1569	1279	152053	40323	1213720	1301	1883	292632	674963	2303321	1129	2753	195950	82986	114248	203470	1505652	1418588	51668	99479	192992	141948	270	492233	1505663	111782	2847313	157	2038	1069494	2060	191303	1918598	1506577	2129	2737	184869	34072	29465	662	172900	1013	2817139	85043	2692118	338	629	158876	541
bsdb:562/11/1_Health-study-participation:feces-from-healthy-adult_vs_none---30%-prevalence-threshold_NA	NA	216851	816	841	572511	2316020	189330	1730	909656	1407607	375288	239759	207244	33042	102106	2048137	2569097	1263	1678	28050	1301	204475	1905344	459786	1485	283168	946234	447020	838	397864	644652	33024	2172004	561	35832	239934	574697	577310	1505657	1578	1505663	84108	2719313	1348911	84111	39948	29465	1472762	1392389	724	1924093	1573535	2172	61170	577309	2847313	191303	1918598	1654
bsdb:563/1/1_Chlamydia-trachomatis:Controls-aged->-10-years_vs_Controls-aged-<-=-0-years_UP	NA	1716	253183	265	1743
bsdb:563/1/2_Chlamydia-trachomatis:Controls-aged->-10-years_vs_Controls-aged-<-=-0-years_DOWN	NA	43668	57493	1269	1279	1301
bsdb:563/2/1_Chlamydia-trachomatis:Controls-aged->-10-years-with-samples-collected-in-the-wet-season_vs_Controls-aged->-10-years-with-samples-collected-in-the-dry-season_UP	NA	1386	432330
bsdb:563/3/1_Chlamydia-trachomatis:Cases-with-conjunctival-scarring-(C-=-0)-alone,-with-samples-collected-in-the-dry-season_vs_Cases-with-conjunctival-scarring-(C->-0)-alone,-with-samples-collected-in-the-dry-season_UP	NA	13075
bsdb:563/3/2_Chlamydia-trachomatis:Cases-with-conjunctival-scarring-(C-=-0)-alone,-with-samples-collected-in-the-dry-season_vs_Cases-with-conjunctival-scarring-(C->-0)-alone,-with-samples-collected-in-the-dry-season_DOWN	NA	1716	1301
bsdb:563/4/1_Chlamydia-trachomatis:Cases-aged-=-10-years-with-clinical-signs-of-conjunctival-scarring-sampled-during-the-dry-season_vs_Cases-aged->-10-years-with-clinical-signs-of-conjunctival-scarring-sampled-during-the-dry-season_UP	NA	13075
bsdb:563/4/2_Chlamydia-trachomatis:Cases-aged-=-10-years-with-clinical-signs-of-conjunctival-scarring-sampled-during-the-dry-season_vs_Cases-aged->-10-years-with-clinical-signs-of-conjunctival-scarring-sampled-during-the-dry-season_DOWN	NA	1716	1301
bsdb:563/6/1_Chlamydia-trachomatis:Cases-with-conjunctival-scarring-(C>0)-and-trachomatous-trichiasis-(TT),with-samples-collected-in-the-dry-season_vs_Cases-with-conjunctival-scarring-(C>0)-alone,-with-samples-collected-in-the-dry-season_UP	NA	1716	57493
bsdb:563/6/2_Chlamydia-trachomatis:Cases-with-conjunctival-scarring-(C>0)-and-trachomatous-trichiasis-(TT),with-samples-collected-in-the-dry-season_vs_Cases-with-conjunctival-scarring-(C>0)-alone,-with-samples-collected-in-the-dry-season_DOWN	NA	253183	265
bsdb:565/1/1_Arthritis:dogs-with-hip-or-elbow-arthritis_vs_healthy-dogs_DOWN	NA	13334	375288	2740	33024	86331
bsdb:565/1/2_Arthritis:dogs-with-hip-or-elbow-arthritis_vs_healthy-dogs_UP	NA	158846
bsdb:566/1/1_Juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_DOWN	NA	724	84111
bsdb:566/1/2_Juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_UP	NA	35832	39948	596767	1578	459786	543311
bsdb:566/2/1_Juvenile-idiopathic-arthritis:JIA-patients-in-remission_vs_JIA-patients-with-active-disease_DOWN	NA	40544
bsdb:566/2/2_Juvenile-idiopathic-arthritis:JIA-patients-in-remission_vs_JIA-patients-with-active-disease_UP	NA	577310	283168
bsdb:567/1/1_Colorectal-adenoma:Advanced-colorectal-adenoma-group-(A-CRA)_vs_Healthy-control-group-(HC)_UP	NA	816	1301	1350
bsdb:567/1/2_Colorectal-adenoma:Advanced-colorectal-adenoma-group-(A-CRA)_vs_Healthy-control-group-(HC)_DOWN	NA	1730	841	1485
bsdb:568/1/1_Parkinson's-disease:NPD-group:-patients-suffering-with-suffering-with-with-PD-for-less-than-1-year-and-before-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/1/2_Parkinson's-disease:NPD-group:-patients-suffering-with-suffering-with-with-PD-for-less-than-1-year-and-before-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	577309	1263	1301
bsdb:568/2/1_Parkinson's-disease:NPD-group:-patients-suffering-with-PD-for-less-than-1-year-and-5-days-after-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/3/1_Parkinson's-disease:NPD-group:-patients-suffering-with-PD-for-less-than-1-year-and-14-days-after-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/3/2_Parkinson's-disease:NPD-group:-patients-suffering-with-PD-for-less-than-1-year-and-14-days-after-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	1263
bsdb:570/1/1_Rheumatoid-arthritis:female-with-early-RA_vs_female-healthy-control_DOWN	NA	102106	1730	1243
bsdb:571/1/1_Osteoarthritis,-knee:Knee-osteroarthritis_vs_Normal-Vitamin-D-status_DOWN	NA	52784
bsdb:571/1/2_Osteoarthritis,-knee:Knee-osteroarthritis_vs_Normal-Vitamin-D-status_UP	NA	1392389	543311	2740	1743	1335483
bsdb:571/2/1_Osteoarthritis,-knee:Knee-osteroarthritis-with-vit-D-deficiency_vs_Vitamin-D-deficiency_DOWN	NA	1283313	283168	265975	838
bsdb:571/2/2_Osteoarthritis,-knee:Knee-osteroarthritis-with-vit-D-deficiency_vs_Vitamin-D-deficiency_UP	NA	574697	1331051	80865	644652	375288	33024
bsdb:572/1/1_Arthritis:New-onset-rheumatoid-arthritis---NORA_vs_Healthy-controls_UP	NA	135858	838	29465
bsdb:572/1/2_Arthritis:New-onset-rheumatoid-arthritis---NORA_vs_Healthy-controls_DOWN	NA	816	572511	33024
bsdb:574/1/1_Antimicrobial-agent:azithromycin-lactulose-treated-(day-18)_vs_azithromycin-lactulose-treated-(day-0)_DOWN	NA	547	838
bsdb:574/1/2_Antimicrobial-agent:azithromycin-lactulose-treated-(day-18)_vs_azithromycin-lactulose-treated-(day-0)_UP	NA	207244	1350	1578	841	1263
bsdb:574/2/1_Antimicrobial-agent:azithromycin-treated-(day-18)_vs_azithromycin-treated-(day-0)_DOWN	NA	547
bsdb:574/2/2_Antimicrobial-agent:azithromycin-treated-(day-18)_vs_azithromycin-treated-(day-0)_UP	NA	447020	28050
bsdb:574/3/1_Antimicrobial-agent:azithromycin-treated-(day-60)_vs_azithromycin-treated-(day-0)_DOWN	NA	547	283168	577309	838	40544
bsdb:574/3/2_Antimicrobial-agent:azithromycin-treated-(day-60)_vs_azithromycin-treated-(day-0)_UP	NA	447020	114627	1301	29465
bsdb:574/4/1_Antimicrobial-agent:azithromycin-lactulose-treated-(0-18)_vs_azithromycin-treated-(0-18)_UP	NA	207244
bsdb:574/4/2_Antimicrobial-agent:azithromycin-lactulose-treated-(0-18)_vs_azithromycin-treated-(0-18)_UP	NA	1301
bsdb:574/5/1_Antimicrobial-agent:azithromycin-lactulose-treated-(0-60)_vs_azithromycin-treated-(0-60)_UP	NA	156973
bsdb:574/5/2_Antimicrobial-agent:azithromycin-lactulose-treated-(0-60)_vs_azithromycin-treated-(0-60)_DOWN	NA	114627	1301
bsdb:574/6/1_Antimicrobial-agent:azithromycin-lactulose-at-day-18_vs_azithromycin-treated-at-day-18_UP	NA	207244	572511	574697	100883	1647	906
bsdb:574/7/1_Antimicrobial-agent:azithromycin-lactulose-at-day-60_vs_azithromycin-treated-at-day-60_UP	NA	156973
bsdb:574/7/2_Antimicrobial-agent:azithromycin-lactulose-at-day-60_vs_azithromycin-treated-at-day-60_DOWN	NA	114627	1301
bsdb:575/1/1_Antimicrobial-agent:perinatal-antibiotics_vs_Control-group_UP	NA	1485	216851	838
bsdb:575/1/2_Antimicrobial-agent:perinatal-antibiotics_vs_Control-group_DOWN	NA	816
bsdb:576/1/1_Colorectal-cancer:patients-with-adenocarcinoma_vs_controls-with-no-cancer_DOWN	NA	33042
bsdb:577/2/3_Asthma:Female-participants-with-asthma_vs_Female-normal-controls_UP	NA	1578
bsdb:579/1/2_Major-depressive-disorder:Middle-aged-HC-(aged-30-59-years)_vs_Young-Healthy-Controls(aged-18-29-years)_DOWN	NA	102106	117563	158846	1301	29465
bsdb:579/2/1_Major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Young-MDD-(aged-18-29-years)_UP	NA	207244	84111	644652	191303
bsdb:579/2/2_Major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Young-MDD-(aged-18-29-years)_DOWN	NA	158846	33024	838
bsdb:579/3/1_Major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Middle-aged-HC-(aged-30-59-years)_UP	NA	109326	40544	459786	33024	33042	816	216851
bsdb:579/3/2_Major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Middle-aged-HC-(aged-30-59-years)_DOWN	NA	207244	29465	1301	84111	841	1730	1654
bsdb:580/1/1_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_DOWN	NA	194	1016	848	482	265975	838	195950
bsdb:580/1/2_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_UP	NA	1678	1578	32207	1301	29465
bsdb:580/2/1_Smoking-behavior,Nicotine-dependence:HIV+-smokers_vs_HIV+-non-smokers_DOWN	NA	1283313	59735	194	848	43994	482	838
bsdb:580/2/2_Smoking-behavior,Nicotine-dependence:HIV+-smokers_vs_HIV+-non-smokers_UP	NA	1380	1678	1578	1301	29465
bsdb:580/3/1_Abnormality-on-pulmonary-function-testing:HIV+-patients-with-reduced-DLCO_vs_HIV+-patients-with-normal-DLCO_UP	NA	1578	1301	29465
bsdb:580/3/2_Abnormality-on-pulmonary-function-testing:HIV+-patients-with-reduced-DLCO_vs_HIV+-patients-with-normal-DLCO_DOWN	NA	1283313	1016	848	1164882	543311	838	1213720	482
bsdb:581/1/1_Epilepsy:Drug-resistant-epilepsy_vs_Drug-sensitive-epilepsy_DOWN	NA	816	397864
bsdb:581/1/2_Epilepsy:Drug-resistant-epilepsy_vs_Drug-sensitive-epilepsy_UP	NA	841	33024	2172	848	33042	482	239934	204475	1263	577309	100883	80865	189330	61170	1380
bsdb:582/1/1_Colorectal-cancer:CRC-patients_vs_healthy-controls_UP	NA	848	543311	1279
bsdb:582/1/2_Colorectal-cancer:CRC-patients_vs_healthy-controls_DOWN	NA	572511	1485	33042	1301
bsdb:582/2/1_Colorectal-cancer:CRC-patients_vs_adenoma-patients_UP	NA	543311	1279
bsdb:582/2/2_Colorectal-cancer:CRC-patients_vs_adenoma-patients_DOWN	NA	189330	33042	572511	447020
bsdb:583/1/1_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_UP	NA	838	848	32207	32257	29465	437755	1301	724
bsdb:583/1/2_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_DOWN	NA	906	29465
bsdb:584/1/1_Colorectal-adenoma:cra-patients_vs_normal-participants_UP	NA	613	620	590	53335	581	158851	561
bsdb:585/1/1_Colorectal-cancer:CRC-tumor-biopsy_vs_Healthy-tumor-adjacent-biopsy_UP	NA	848	32067	543311	1257	1301
bsdb:585/1/2_Colorectal-cancer:CRC-tumor-biopsy_vs_Healthy-tumor-adjacent-biopsy_DOWN	NA	189330	216851	375288
bsdb:585/2/1_Colorectal-cancer:Fecal-samples_vs_Tumor-biopsy_UP	NA	841	572511	1678
bsdb:585/2/2_Colorectal-cancer:Fecal-samples_vs_Tumor-biopsy_DOWN	NA	848	1301	838	1279
bsdb:587/1/1_Nicotine-dependence,Smoking-behavior:Current-Smokers_vs_Never-smokers_UP	NA	135858
bsdb:587/2/1_Nicotine-dependence,Smoking-behavior:Current-Smokers_vs_Never-smokers_UP	NA	84108	135858	102106	52225
bsdb:588/1/1_Colorectal-cancer:colorectal-cancer-patients_vs_healthy-subjects_UP	NA	46123	469	33870	776	1243	131079	2172	32207	100132	674963	574899
bsdb:588/1/2_Colorectal-cancer:colorectal-cancer-patients_vs_healthy-subjects_DOWN	NA	119852
bsdb:588/2/1_Intestinal-polyp:polyps-patients_vs_healthy-subjects_UP	NA	244127	52225
bsdb:588/2/2_Intestinal-polyp:polyps-patients_vs_healthy-subjects_DOWN	NA	194	1350	286	978
bsdb:588/3/1_Intestinal-polyp:cancer-patients_vs_polyps-patients_UP	NA	1654	194	1350	84108	638847	33870	2172	1257	46123	776	574899	1243	46255
bsdb:588/3/2_Intestinal-polyp:cancer-patients_vs_polyps-patients_DOWN	NA	642	100132	119852	52225	34104
bsdb:589/1/1_Colorectal-cancer:Colorectal-Cancer-patients-(CRC)_vs_Healthy-controls_UP	NA	33024	65402
bsdb:590/1/1_HIV-infection:Recently-HIV-1-infected-individuals_vs_HIV-1-negative-individuals_DOWN	NA	189330
bsdb:590/1/2_HIV-infection:Recently-HIV-1-infected-individuals_vs_HIV-1-negative-individuals_UP	NA	29465
bsdb:591/1/1_HIV-infection:HIV+-individuals_vs_HIV–-individuals_UP	NA	572511	118747	580596	544	1716	872	1350	561	1730	848	117563	158846	906	52225	86331	543311	1257	33024	838	113286	1279	191303
bsdb:591/1/2_HIV-infection:HIV+-individuals_vs_HIV–-individuals_DOWN	NA	447020	357	207244	816	1678	830	1485	33042	189330	216851	61170	140625	28050	119852	841	1263	168808	1301
bsdb:591/2/1_HIV-infection:MSM-(men-who-have-sex-with-men)_vs_non-MSM_UP	NA	416916	2152	118747	830	135858	102106	872	39948	1350	561	1730	906	52225	86331	265975	2740	33024	838	84108	83770	40544	172900
bsdb:591/2/2_HIV-infection:MSM-(men-who-have-sex-with-men)_vs_non-MSM_DOWN	NA	447020	239934	239759	816	1678	35832	572511	580596	1485	33042	216851	61170	2172	283168	375288	577309	836	1263	1301
bsdb:592/1/1_HIV-infection:HIV-Patients_vs_Healthy-controls_UP	NA	265975	123375	1578	1926663	133925	580024	86331	2082587	83770	906	1473205	84108	1573535	102106	135858	838	158846	39948
bsdb:592/1/2_HIV-infection:HIV-Patients_vs_Healthy-controls_DOWN	NA	816	207244	2039302	239759	1407607	547	117563	724
bsdb:593/1/1_Polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_UP	NA	33042	848	1506553	1506577
bsdb:593/1/2_Polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_DOWN	NA	239759	574697	283	33042	1892380	61170	283168	1508657	123375	292632
bsdb:594/1/1_Periodontitis:HIV+_vs_HIV–_UP	NA	416916	32257	482	32207	46123
bsdb:594/1/2_Periodontitis:HIV+_vs_HIV–_DOWN	NA	82202	195950	32067	970	157	838
bsdb:595/1/1_Colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_UP	NA	816	35832	872	848	32067	543311	1257	836	1017280	970	482
bsdb:595/1/2_Colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_DOWN	NA	469	194	1730	1263
bsdb:595/2/1_Colorectal-carcinoma:CRC-patients_vs_Adenoma-patients_UP	NA	848	133925	543311	1257	836
bsdb:595/2/2_Colorectal-carcinoma:CRC-patients_vs_Adenoma-patients_DOWN	NA	1730
bsdb:595/3/1_Colorectal-carcinoma:Adenoma-patients_vs_Neoplasia-free_DOWN	NA	1263
bsdb:595/4/1_Colorectal-carcinoma:CRC_vs_Neoplasia-free-control_UP	NA	872	848	543311	1257	1017280	836	194
bsdb:595/4/2_Colorectal-carcinoma:CRC_vs_Neoplasia-free-control_DOWN	NA	35832	2316	1263	1730
bsdb:596/1/1_HIV-infection:HIV-infected-men_vs_HIV-uninfected-men_DOWN	NA	1678	212791	1847	149698	551	110932	12916	53387	469	1386	34072	99479	89966	28065
bsdb:596/1/2_HIV-infection:HIV-infected-men_vs_HIV-uninfected-men_UP	NA	29465	402649
bsdb:598/1/1_HIV-infection:HIV-seroconverted_vs_HIV-seronegative_UP	NA	39948	2050	1257
bsdb:598/1/2_HIV-infection:HIV-seroconverted_vs_HIV-seronegative_DOWN	NA	838	1161127
bsdb:600/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	469	239759	92793	580596	1485	872	570	577309	13687	497726
bsdb:600/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	1578	504481
bsdb:601/2/1_Parkinson's-disease:Participants-with-idiopathic-Parkinson's-Disease_vs_Healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239759	547	644652	117563	61170	1578	1301	46123
bsdb:603/1/1_Colorectal-cancer:CRC-patients_vs_Non-disease-controls_DOWN	NA	292632	158846
bsdb:603/1/2_Colorectal-cancer:CRC-patients_vs_Non-disease-controls_UP	NA	1263	29465	906	2753
bsdb:604/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-free-of-neurological-disease_UP	NA	1678	1716	1578	836	838
bsdb:604/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-free-of-neurological-disease_DOWN	NA	1766253	572511	580596	216851	1407607	28050	119852	841
bsdb:604/2/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-control-free-of-neurological-disease._UP	NA	836	838	1716	572511	1678	1578
bsdb:604/2/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-control-free-of-neurological-disease._DOWN	NA	216851	1766253	841	580596	1407607	28050
bsdb:605/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-without-Parkinson's-disease_UP	NA	375288	239934	574697	29465	283168	248038	35832	1350	1578
bsdb:605/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-without-Parkinson's-disease_DOWN	NA	216851	838
bsdb:605/2/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-with-tremor-subtypes_vs_Participants-with-Parkinson's-Disease-with-non-tremor-subtypes_UP	NA	239934
bsdb:605/2/2_Parkinson's-disease:Participants-with-Parkinson's-Disease-with-tremor-subtypes_vs_Participants-with-Parkinson's-Disease-with-non-tremor-subtypes_DOWN	NA	106589	872	237	86331	1743	40544
bsdb:607/1/1_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_UP	NA	239934	244127	35832	990721	1578	1301	904
bsdb:607/1/2_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_DOWN	NA	191303
bsdb:608/1/1_Health-study-participation:healthy-child-oral-50%-up_vs_none_NA	NA	1301	32207	29465	838	1378	482	724
bsdb:608/2/1_Health-study-participation:healthy-child-stool-50%-up_vs_none_NA	NA	1301	1678	561	29465	816	1350	1485	2316020
bsdb:609/1/1_Colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_UP	NA	239934	207244	1716	84111	1350	1578	906	375288	577310	543311	1257	836	970	40544	547
bsdb:609/1/2_Colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_DOWN	NA	52784	553372	572511	580596	102106	216851	1407607	848	204475	1501226	841	1506577	28050
bsdb:610/1/1_Irritable-bowel-syndrome:constipated-IBS_vs_Healthy-Control_DOWN	NA	1678	1730	841
bsdb:610/1/3_Irritable-bowel-syndrome:constipated-IBS_vs_Healthy-Control_DOWN	NA	1578	1678
bsdb:611/1/1_Colorectal-cancer:Colorectal-Cancer-patients_vs_healthy-controls_UP	NA	239934	848	256846	543311	836
bsdb:611/1/2_Colorectal-cancer:Colorectal-Cancer-patients_vs_healthy-controls_DOWN	NA	1678	572511	216851	28050	158846	577310	33024	46205	1501226	648800	292632
bsdb:612/1/1_Colorectal-cancer:CRC-cases_vs_control-subjects_DOWN	NA	33042
bsdb:613/1/1_Colorectal-cancer:CRC-patients_vs_healthy-individuals_DOWN	NA	713	207244	544	1485	33042	189330	551	216851	724	28050	32067	482	265975	33024	838	841	970	1301	40544	29465
bsdb:614/1/1_Colorectal-cancer:CRC_vs_Healthy-Controls_UP	NA	838	102106	283168	1257	1164882
bsdb:614/1/2_Colorectal-cancer:CRC_vs_Healthy-Controls_DOWN	NA	413496	44748
bsdb:615/1/1_Rheumatoid-arthritis:rheumatoid-arthritis_vs_healthy-controls_UP	NA	2701
bsdb:617/1/1_Microbiome:Neonatal-samples-taken-at-delivery_vs_Maternal-samples-taken-at-delivery._UP	NA	1716	1743	13687	2701	838	1578
bsdb:617/1/2_Microbiome:Neonatal-samples-taken-at-delivery_vs_Maternal-samples-taken-at-delivery._DOWN	NA	1716	1654	836	1283313	482	724	29465	1301	165779	1279	1743	1263	119852	375288	216851	838	816	2701	1578
bsdb:617/2/1_Microbiome:Infant-samples-taken-at-6-weeks-postpartum_vs_Maternal-samples-taken-at-6--weeks-postpartum_UP	NA	1716	29465	1301	162289	150022	1743	165779	1279	1678	1485	570	561	816
bsdb:617/2/2_Microbiome:Infant-samples-taken-at-6-weeks-postpartum_vs_Maternal-samples-taken-at-6--weeks-postpartum_DOWN	NA	1716	1016	1654	848	1283313	836	482	724	29465	1301	1279	1743	1263	119852	375288	841	216851	816	906	2701	1380	1578
bsdb:618/1/1_Dementia:Severe-dementia_vs_Control,-mild,-and-moderate-dementia_UP	NA	244127	1432051	1649459	459786	1769710	84036
bsdb:618/2/1_Dementia:Patients-with-dementia_vs_Controls-without-cognitive-impairments_UP	NA	1506553
bsdb:618/2/2_Dementia:Patients-with-dementia_vs_Controls-without-cognitive-impairments_DOWN	NA	1766253
bsdb:618/3/1_Dementia:moderate-dementia_vs_control,-mild,-and-severe-dementia_UP	NA	1578	1508657
bsdb:618/4/1_Dementia:mild-dementia_vs_control,-moderate,-and-severe-dementia_UP	NA	216851	1407607
bsdb:620/1/1_Colorectal-cancer:Invasive-cancer-group_vs_Early-cancer-group_UP	NA	848
bsdb:621/1/1_Colorectal-cancer:Aspirin_vs_Placebo_UP	NA	838
bsdb:621/1/2_Colorectal-cancer:Aspirin_vs_Placebo_DOWN	NA	29465
bsdb:621/2/1_Colorectal-cancer:Aspirin_vs_Placebo_UP	NA	239934	838	216851
bsdb:621/2/2_Colorectal-cancer:Aspirin_vs_Placebo_DOWN	NA	816	189330	375288	1263
bsdb:622/1/1_Colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_DOWN	NA	1654	1678	572511	1485	189330	1730	1578	841
bsdb:622/1/2_Colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_UP	NA	33042	1350	848	1301
bsdb:623/1/1_Colorectal-cancer:Patients-with-CRC-recurrence_vs_Patients-without-CRC-recurrence_UP	NA	848	543311	1486725	1257	838
bsdb:623/1/2_Colorectal-cancer:Patients-with-CRC-recurrence_vs_Patients-without-CRC-recurrence_DOWN	NA	40323	29465
bsdb:625/1/1_Socioeconomic-status:Increasing-socioeconomic-status_vs_lower-socioeconomic-status_UP	NA	207244	1730	216851
bsdb:625/1/2_Socioeconomic-status:Increasing-socioeconomic-status_vs_lower-socioeconomic-status_DOWN	NA	816
bsdb:628/1/1_Socioeconomic-status:Low-SES_vs_High-SES_UP	NA	838
bsdb:628/1/2_Socioeconomic-status:Low-SES_vs_High-SES_DOWN	NA	816
bsdb:632/1/1_Gut-microbiome-measurement:Infants-(median-age = 6.6-months)_vs_Neonates-(median-age = 1.2-months)_UP	NA	239934	1678	572511	1485	33042	1730	1578	1357	838	841	1263	1279	375288	216851	189330	158846	577309	162289	1350	2383	816	156973	29465
bsdb:632/1/2_Gut-microbiome-measurement:Infants-(median-age = 6.6-months)_vs_Neonates-(median-age = 1.2-months)_DOWN	NA	239934	1678	572511	1485	33042	1730	1578	1357	838	841	1263	1279	906	184869	119852	1301
bsdb:633/1/1_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_UP	NA	848	1357	1257	838	1378	22	543311	39948
bsdb:633/1/2_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_DOWN	NA	12916	469	41275	82976	75	2782229	237	29580	84567	1743	286	497	34037	28453	13687	40323	2755
bsdb:633/2/1_Colorectal-cancer:cancerous-tissues_vs_adjacent-non-cancerous-tissues_UP	NA	816	1357	848	838	1301
bsdb:633/2/2_Colorectal-cancer:cancerous-tissues_vs_adjacent-non-cancerous-tissues_DOWN	NA	286
bsdb:633/3/1_Sigmoid-neoplasm:Distal-Colorectal-Cancer_vs_Proximal-Colon-Cancer_UP	NA	848	32067
bsdb:633/3/2_Sigmoid-neoplasm:Distal-Colorectal-Cancer_vs_Proximal-Colon-Cancer_DOWN	NA	1257	838	970
bsdb:634/1/2_Smoking-behavior:smokers_vs_non-smokers_DOWN	NA	970
bsdb:635/1/1_Smoking-behavior:Less-than-High-school-diploma_vs_College-graduate-or-more_DOWN	NA	1283313
bsdb:635/1/2_Smoking-behavior:Less-than-High-school-diploma_vs_College-graduate-or-more_UP	NA	836	194	838	29465	44259	196081	1301
bsdb:635/2/1_Smoking-behavior:Some-college-or-associate's-degree_vs_College-graduate-or-more_DOWN	NA	1716
bsdb:635/2/2_Smoking-behavior:Some-college-or-associate's-degree_vs_College-graduate-or-more_UP	NA	196081	1578	1283313	29465
bsdb:635/3/1_Smoking-behavior:Alternative-smokers_vs_Cigarette-smokers_DOWN	NA	156454	286	1301	419014	1654	1213720
bsdb:635/3/2_Smoking-behavior:Alternative-smokers_vs_Cigarette-smokers_UP	NA	848	482	34104	836	59735	47670	2717	1378	1283313
bsdb:635/4/1_Smoking-behavior:Former-smokers_vs_Cigarette-smokers_DOWN	NA	29465	1578	1283313	194	838	286
bsdb:635/4/2_Smoking-behavior:Former-smokers_vs_Cigarette-smokers_UP	NA	482	59735	47670	724	2740	1016
bsdb:635/5/1_Smoking-behavior:Never-smokers_vs_Cigarette-smokers_DOWN	NA	906	1213720	838	194	32067	29465
bsdb:635/5/2_Smoking-behavior:Never-smokers_vs_Cigarette-smokers_UP	NA	482	59735	1301	836	1378	1357	724	47670	1678	713
bsdb:635/6/1_Smoking-behavior:Secondhand-smokers_vs_Cigarette-smokers_DOWN	NA	29465	32067	1578	508215	1301	156454	1654
bsdb:635/6/2_Smoking-behavior:Secondhand-smokers_vs_Cigarette-smokers_UP	NA	59735	1257	1378	1283313	482	838
bsdb:635/7/1_Smoking-behavior:Asian_vs_Non-Hispanic-white_UP	NA	1283313
bsdb:635/8/1_Smoking-behavior:Hispanic_vs_Non-Hispanic-white_UP	NA	838	836	194	44259	157	848	1283313	29465
bsdb:635/9/1_Smoking-behavior:Non-Hispanic-black_vs_Non-Hispanic-white_DOWN	NA	29465	2717	34104
bsdb:635/9/2_Smoking-behavior:Non-Hispanic-black_vs_Non-Hispanic-white_UP	NA	838	194	1380	1578	156454	1678	44259	1283313	2147	836
bsdb:635/10/1_Smoking-behavior:Females_vs_Males_DOWN	NA	713	157	836
bsdb:635/11/1_Smoking-behavior:age-group-35-64_vs_age-group-20-29_DOWN	NA	836	286	1283313	1380	32067	848	713
bsdb:635/11/2_Smoking-behavior:age-group-35-64_vs_age-group-20-29_UP	NA	1301	1578	32067
bsdb:635/12/1_Smoking-behavior:age-group-65-and-over_vs_age-group-20-29_DOWN	NA	1283313	838	44259	32067	157	836	29465	43996	39948	1257	724	59735
bsdb:635/12/2_Smoking-behavior:age-group-65-and-over_vs_age-group-20-29_UP	NA	1578	1301	508215	1357	1016	1678	196081	156454
bsdb:636/1/1_Smoking-behavior:Tobacco-smokers_vs_Non-Smokers_UP	NA	836
bsdb:636/2/2_Smoking-behavior:E-cigarette-smokers_vs_Non-Smokers_DOWN	NA	482	1716
bsdb:636/3/1_Smoking-behavior:E-cigarette-smokers_vs_Tobacco-smokers_DOWN	NA	482
bsdb:636/5/1_Smoking-behavior:Tobacco-smokers_vs_Quitting-smokers_UP	NA	836
bsdb:636/5/2_Smoking-behavior:Tobacco-smokers_vs_Quitting-smokers_DOWN	NA	1716
bsdb:636/6/2_Smoking-behavior:E-cigarette-smokers_vs_Quitting-smokers_DOWN	NA	1716
bsdb:637/1/1_Colorectal-cancer:CRC_vs_Healthy-Individuals_UP	NA	165779	207244	43668	374	501783	1378	1269	482	53335	286	497	1301	292636
bsdb:637/1/2_Colorectal-cancer:CRC_vs_Healthy-Individuals_DOWN	NA	29465	1654	838	848	68
bsdb:637/2/1_Colorectal-adenoma:CRA_vs_Healthy-Individuals_UP	NA	1234	1301	1378	173479	204475	374	43668	338
bsdb:637/2/2_Colorectal-adenoma:CRA_vs_Healthy-Individuals_DOWN	NA	1654	2054427	416916	1283313	156454	109326	150247	2152	1380	830	194	1016	1716	39948	238749	1279384	1730	1434006	848	1164882	32067	68	2093	482	265975	543311	2740	1257	28100	836	838	1743	123375	1213720	195950	157	29465	338
bsdb:637/3/1_Colorectal-cancer:CRC_vs_CRA_DOWN	NA	836	238749	482	838	28100	283	123375	165779	1016	1257	848	416916	28219	543311	501783	194	1730	225842
bsdb:637/3/2_Colorectal-cancer:CRC_vs_CRA_UP	NA	572511	173479	204475	158846	1301	338
bsdb:638/1/1_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_UP	NA	1654	1678	102106	1716	84111	216851	158846	906	482	838	32207	40544
bsdb:638/1/2_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_DOWN	NA	830	544	1485	547	1730	848	570	283168	375288	841	194	1350
bsdb:639/1/1_Socioeconomic-status:underdeveloped-cities-vs-developed-cities_vs_NA_UP	NA	816	375288	1263
bsdb:639/1/2_Socioeconomic-status:underdeveloped-cities-vs-developed-cities_vs_NA_DOWN	NA	838	1263
bsdb:640/1/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_UP	NA	1301	32207	32067
bsdb:640/1/2_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_DOWN	NA	1016	416916	836	848
bsdb:641/1/1_Arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_DOWN	NA	29465	1283313	117563
bsdb:641/1/2_Arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_UP	NA	1301	970
bsdb:642/2/2_Socioeconomic-status:Orang-Asli-Children-(low-SES,-household-income<RM500)_vs_Chinese-Children-(High-SES,-household-income->RM500)_DOWN	NA	239759
bsdb:643/1/1_Colorectal-cancer:yCRC_vs_yControl_UP	NA	1654	946234	848	283168	29465
bsdb:643/1/2_Colorectal-cancer:yCRC_vs_yControl_DOWN	NA	1766253	207244	572511	580596	1485	39948	561	724	570	158846	577310	1501226	620
bsdb:643/2/1_Colorectal-cancer:oCRC_vs_oControls_DOWN	NA	1766253	207244	35832	572511	580596	1485	102106	33042	216851	1407607	28050	2039302	577310	33024	1501226	841	1263	292632
bsdb:643/2/2_Colorectal-cancer:oCRC_vs_oControls_UP	NA	41275	84111	1505663	561	848	1378	724	1649459	1506553	543311	1257	620	1301
bsdb:644/2/1_Colorectal-cancer:colorectal-cancer-(adenocarcinoma)_vs_healthy-controls_UP	NA	119852
bsdb:644/3/1_Colorectal-cancer:colorectal-cancer_vs_colorectal-adenoma_UP	NA	119852
bsdb:644/5/2_Colorectal-cancer:adenocarcinoma-mucosae_vs_adenoma-adjacent_UP	NA	119852
bsdb:644/9/1_Colorectal-cancer:carcinoma-adjacent-tissue_vs_colorectal-adenoma-tissue_UP	NA	119852
bsdb:645/1/1_Maternal-milk:MOM-(Mother's-own-milk)_vs_DM-(Donor's-Milk)_UP	NA	816	1678	1350
bsdb:645/1/2_Maternal-milk:MOM-(Mother's-own-milk)_vs_DM-(Donor's-Milk)_DOWN	NA	1279
bsdb:646/1/1_Colorectal-adenoma:Adenoma_vs_Non-Adenoma_UP	NA	35832	86331	40544
bsdb:646/1/2_Colorectal-adenoma:Adenoma_vs_Non-Adenoma_DOWN	NA	1485	724	29465
bsdb:647/1/1_Ethnic-group:Black-Women_vs_White-Women_UP	NA	816
bsdb:648/1/1_Ethnic-group,Gut-microbiome-measurement:Gut-microbiome-of-African-American-children-(AA)_vs_Gut-microbiome-of-European-American-children-(EA)_UP	NA	244127	872	248744	846	838	1473205	84108
bsdb:648/2/1_Ethnic-group:Oral-microbiota-of-African-American-children-(AA)_vs_Oral-microbiota-of-European-American-children-(EA)_UP	NA	1301
bsdb:648/2/2_Ethnic-group:Oral-microbiota-of-African-American-children-(AA)_vs_Oral-microbiota-of-European-American-children-(EA)_DOWN	NA	830	1016	848	724	838
bsdb:648/3/1_Socioeconomic-status:Household-income-(EA-&-AA)-<-$50,000._vs_Household-income-(EA-&-AA)-=>$50,000._UP	NA	33024
bsdb:648/3/2_Socioeconomic-status:Household-income-(EA-&-AA)-<-$50,000._vs_Household-income-(EA-&-AA)-=>$50,000._DOWN	NA	1573534
bsdb:648/4/1_Socioeconomic-status:Low--income-in-European-American-households--<-$50,000._vs_High-income-in-European-American-households-=>$50,000._UP	NA	1301
bsdb:648/5/1_Obesity:Obese-EA-children_vs_Non-obese-EA-children_UP	NA	416916	538
bsdb:648/6/1_Obesity:Obese-African-American--children_vs_Non-obese-African-American-children_UP	NA	570	906
bsdb:649/1/1_Huntington-disease:R6/2_vs_Wild-type_UP	NA	816	100883	1578	375288
bsdb:649/1/2_Huntington-disease:R6/2_vs_Wild-type_DOWN	NA	447020	872
bsdb:650/1/1_Gut-microbiome-measurement:Children-of-high-SES_vs_Children-of-low-SES_UP	NA	1263	1407607	572511	207244	1730	1678
bsdb:650/1/2_Gut-microbiome-measurement:Children-of-high-SES_vs_Children-of-low-SES_DOWN	NA	216851	86331	838	580024	2082587
bsdb:651/1/1_Colorectal-cancer:CRC-patients-(swp)_vs_Healthy-volunteers-(swc)_DOWN	NA	207244	135858	216851	572511	2701	1678	28050
bsdb:651/1/2_Colorectal-cancer:CRC-patients-(swp)_vs_Healthy-volunteers-(swc)_UP	NA	43996	848	1378	570	86331	1257	836	970	44259
bsdb:651/2/1_Colorectal-cancer:cancerous-tissue-(cat)_vs_paracancerous-tissue-(pa10t)_DOWN	NA	1386	577309	33024	375288	216851	407	50709
bsdb:651/3/1_Colorectal-cancer:cancerous-tissue-(cat)_vs_paracancerous-tissue-(pa2t)_DOWN	NA	528
bsdb:651/4/1_Colorectal-cancer:CRC-patients-(stp)_vs_Healthy-volunteers-(stc)_UP	NA	165779	244127	102106	1730	86331	84108	577309	872	836	1257
bsdb:652/1/1_Colorectal-cancer:Intramucosal-CRC_vs_Healthy_DOWN	NA	158846	165695
bsdb:652/1/2_Colorectal-cancer:Intramucosal-CRC_vs_Healthy_UP	NA	713	848	543311	1257	1654
bsdb:652/2/1_Colorectal-cancer:Intramucosal-CRC_vs_CRA-(colorectal-adenoma)_UP	NA	574697	102106	52225	283
bsdb:652/2/2_Colorectal-cancer:Intramucosal-CRC_vs_CRA-(colorectal-adenoma)_DOWN	NA	158846	29465
bsdb:652/3/1_Colorectal-adenoma:CRA-(colorectal-adenoma)_vs_Healthy_UP	NA	140625	574697	590	283
bsdb:652/3/2_Colorectal-adenoma:CRA-(colorectal-adenoma)_vs_Healthy_DOWN	NA	1380	543311	848
bsdb:653/1/1_Colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_UP	NA	39948	848	1378	543311	1257	123375	1301
bsdb:653/1/2_Colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_DOWN	NA	1654	724	29465
bsdb:653/2/1_Colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_UP	NA	724	543311	838	1283313	1164882	482	1301
bsdb:653/3/1_Colorectal-cancer:Individuals-with-polyps_vs_Healthy-Controls_UP	NA	543311	1301	32067
bsdb:654/1/1_Ethnic-group:Asian-Pacific_vs_Caucasians_UP	NA	29465
bsdb:654/1/2_Ethnic-group:Asian-Pacific_vs_Caucasians_DOWN	NA	283168
bsdb:654/2/1_Ethnic-group:Hispanic_vs_Caucasians_UP	NA	283168	29465
bsdb:654/3/1_Ethnic-group:African-Americans_vs_Caucasians_UP	NA	29465	283168
bsdb:654/4/1_Ethnic-group:Asian-Pacific_vs_Caucasians_UP	NA	29465
bsdb:654/4/2_Ethnic-group:Asian-Pacific_vs_Caucasians_DOWN	NA	283168
bsdb:654/5/1_Ethnic-group:Hispanics_vs_Caucasians_UP	NA	29465
bsdb:654/5/2_Ethnic-group:Hispanics_vs_Caucasians_DOWN	NA	283168
bsdb:654/6/1_Ethnic-group:African-Americans_vs_Caucasians_UP	NA	29465	283168
bsdb:655/1/1_Ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_UP	NA	836
bsdb:655/1/2_Ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_DOWN	NA	117563	32207
bsdb:656/1/1_Socioeconomic-status:Children-living-in-slum-(Low-SES)_vs_Private-school-children-(High-SES)_UP	NA	1730
bsdb:658/1/1_Colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_UP	NA	577309
bsdb:658/1/2_Colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_DOWN	NA	904	239759	35832	848	1506553
bsdb:660/1/1_Smoking-behavior:Smokers_vs_Never-smokers_UP	NA	1654	1380	118747	194	906	437755	265975	838	29465
bsdb:660/1/2_Smoking-behavior:Smokers_vs_Never-smokers_DOWN	NA	416916	2717	538	724	32257	47670	475	482	2740
bsdb:661/1/2_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Healthy-Control-(HC)_DOWN	NA	572511	1678	1407607	375288	841	1501226
bsdb:661/2/1_Meningeal-tuberculosis:Pulmonary-tuberculosis-(PTB)_vs_Healthy-Control-(HC)_UP	NA	816
bsdb:661/2/2_Meningeal-tuberculosis:Pulmonary-tuberculosis-(PTB)_vs_Healthy-Control-(HC)_DOWN	NA	572511	1407607	189330	1501226	33042
bsdb:661/3/2_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Pulmonary-tuberculosis-(PTB)_DOWN	NA	572511	816
bsdb:662/1/1_Socioeconomic-status:Low-SES-(high-land-region)_vs_High-SES-(low-land-region)_UP	NA	1578
bsdb:663/1/1_Ethnic-group:Malay_vs_Chinese_UP	NA	838
bsdb:663/1/2_Ethnic-group:Malay_vs_Chinese_DOWN	NA	816
bsdb:663/2/1_Ethnic-group:India_vs_Chinese_UP	NA	838
bsdb:663/2/2_Ethnic-group:India_vs_Chinese_DOWN	NA	816
bsdb:663/3/1_Ethnic-group:Jakun_vs_Chinese_UP	NA	838
bsdb:663/3/2_Ethnic-group:Jakun_vs_Chinese_DOWN	NA	816
bsdb:666/1/1_Socioeconomic-status:Low-income-country-(Malawi)_vs_High-Income-country-(Finland)_UP	NA	1678
bsdb:667/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	216851	162289	33024	32207	1263
bsdb:667/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	2701
bsdb:669/1/1_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_UP	NA	203861	52784	82978	830	194	1485	33870	978	1350	52228	140625	1243	52225	581	346096	866	1266	84108	83768	83770	157	299568	46255
bsdb:669/1/2_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_DOWN	NA	244127	342658	228923	158846	44261	84034	113286	292637	76632	848	84111	35832	158483	230666	544	547	579	41707	149698	69474	146805	590	620	40544	34069	266808
bsdb:669/2/1_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_DOWN	NA	561	620
bsdb:670/1/1_Ethnic-group,Socioeconomic-status:Bangladesh-Children-(Household-income-<-$61)_vs_US-children_UP	NA	830
bsdb:671/1/1_Seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_UP	NA	838	1485	216851
bsdb:671/1/2_Seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_DOWN	NA	547	1485	482	1263
bsdb:672/2/1_Spontaneous-preterm-birth:Lower-SES-(D10)_vs_Higher-SES-(D10)_UP	NA	1678
bsdb:672/3/1_Spontaneous-preterm-birth:Lower-SES-(4M)_vs_Higher-SES-(4M)_UP	NA	906
bsdb:672/5/1_Spontaneous-preterm-birth:Maori-(4M)_vs_Asian-(4M)_DOWN	NA	32207	1279
bsdb:672/6/1_Spontaneous-preterm-birth:Pacifica-(4M)_vs_Asian-(4M)_DOWN	NA	1279
bsdb:672/7/1_Spontaneous-preterm-birth:University-(4M)_vs_No-University-(4M)_DOWN	NA	84111
bsdb:672/9/1_Spontaneous-preterm-birth:Breastmilk-feeding-(4M)_vs_Only-formula-(4M)_UP	NA	906
bsdb:672/12/1_Spontaneous-preterm-birth:Yes-maternal-probiotics_vs_No-maternal-probiotics_UP	NA	1678	1578
bsdb:672/13/1_Spontaneous-preterm-birth:Yes-infant-probiotics_vs_No-infant-probiotics_UP	NA	1578
bsdb:672/14/1_Spontaneous-preterm-birth:Yes-Antibiotics_vs_No-Antibiotics_UP	NA	1485
bsdb:672/16/1_Spontaneous-preterm-birth:Breast-Milk-(D10)_vs_Only-Formula-(D10)_UP	NA	1678
bsdb:672/17/1_Spontaneous-preterm-birth:Breast-Milk-(4M)_vs_Mixed-Feeding-(4M)_UP	NA	35832
bsdb:672/18/1_Spontaneous-preterm-birth:Only-Formula-(D10)_vs_Mixed-Feeding-(D10)_UP	NA	1678
bsdb:672/19/1_Spontaneous-preterm-birth:Yes-Antibiotics-(4M)_vs_No-Antibiotics-(4M)_UP	NA	1506553	1505657
bsdb:672/21/1_Spontaneous-preterm-birth:Yes-Infant-Antibiotics-(D10)_vs_No-Infant-Antibiotics-(D10)_UP	NA	1678
bsdb:672/22/1_Spontaneous-preterm-birth:Vaginal-delivery-(D10)_vs_Caesarean-section-(D10)_UP	NA	816
bsdb:672/23/1_Spontaneous-preterm-birth:Twins-(4M)_vs_Singletons-(4M)_UP	NA	1508657
bsdb:673/1/2_Ethnic-group:Colombia-data_vs_USA-data_DOWN	NA	816
bsdb:674/1/1_Socioeconomic-status:High-SES_vs_Low-SES_UP	NA	80865	1485	375288	283168	1263
bsdb:674/1/2_Socioeconomic-status:High-SES_vs_Low-SES_DOWN	NA	135858	118747	86331	838	1730	189330	447020
bsdb:675/1/1_Socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_UP	NA	61170	119852
bsdb:675/1/2_Socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_DOWN	NA	838
bsdb:676/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	140625	620
bsdb:676/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	1263
bsdb:677/1/1_Survival-time:Short-term-surviviors_vs_Long-term-survivors_UP	NA	194	724	1578	1506577	29465
bsdb:677/1/2_Survival-time:Short-term-surviviors_vs_Long-term-survivors_DOWN	NA	39948	836
bsdb:678/1/1_Smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_UP	NA	1380	1678	194	39948	212791	906	2093	346096	838	157
bsdb:678/1/2_Smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_DOWN	NA	836	1016	1378	2737	1257	848	32067	47670	538	482	2717	713	416916	724
bsdb:678/2/1_Smoking-behavior:Dokha-Smokers_vs_Nonsmokers_UP	NA	1678
bsdb:678/2/2_Smoking-behavior:Dokha-Smokers_vs_Nonsmokers_DOWN	NA	47670	836
bsdb:678/4/1_Smoking-behavior:Mutiple-Smokers_vs_Nonsmokers_UP	NA	194	212791	2093	346096	157
bsdb:678/4/2_Smoking-behavior:Mutiple-Smokers_vs_Nonsmokers_DOWN	NA	713	538	1378	724	47670	482	2737
bsdb:678/5/1_Cotinine-measurement:Cotinine-positive_vs_Cotinine-negative_DOWN	NA	416916	1016	2717	538	848	1378	724	47670	482	2740	1257	836	32207
bsdb:678/5/2_Cotinine-measurement:Cotinine-positive_vs_Cotinine-negative_UP	NA	1678	194	893	44259	906	2093	346096	157	577309
bsdb:678/8/1_Smoking-behavior:CIigarettes_vs_Shisha_DOWN	NA	713	830	1016
bsdb:678/8/2_Smoking-behavior:CIigarettes_vs_Shisha_UP	NA	346096	157	2093
bsdb:678/9/1_Smoking-behavior:Dokha_vs_Shisha_DOWN	NA	713
bsdb:679/2/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	375288
bsdb:680/1/1_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_UP	NA	158846	29465
bsdb:680/1/2_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_DOWN	NA	572511
bsdb:681/1/1_Colorectal-cancer:Colorectal-cancer_vs_Healthy-Controls(HC)_UP	NA	1578	32207
bsdb:681/3/1_Colorectal-cancer:Old-(≥-65-yrs)_vs_Young_UP	NA	1301
bsdb:681/3/2_Colorectal-cancer:Old-(≥-65-yrs)_vs_Young_DOWN	NA	836	32207
bsdb:681/4/1_Colorectal-cancer:Current-Smokers_vs_Non-Smokers_UP	NA	29465
bsdb:681/4/2_Colorectal-cancer:Current-Smokers_vs_Non-Smokers_DOWN	NA	482
bsdb:682/1/1_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_UP	NA	1663	2747	1243	374	64001	1357	286
bsdb:682/1/2_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_DOWN	NA	222	357	1696	41275	33882	1269	528	44249	1743	379	28453	165695	1716
bsdb:682/3/1_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_UP	NA	82373	2747	1350	88138	129337	1678	1743	31983
bsdb:682/3/2_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_DOWN	NA	838	841	1263	572511	1279	53457	544	283168	407	1298	357	28453
bsdb:683/1/1_Colorectal-adenoma:adenoma-group_vs_non-adenoma-group_UP	NA	574697	135858	40544
bsdb:683/1/2_Colorectal-adenoma:adenoma-group_vs_non-adenoma-group_DOWN	NA	207244	1678	1573534
bsdb:683/3/1_Colorectal-adenoma:adenoma-group_vs_non-adenoma-group_DOWN	NA	1678
bsdb:683/3/2_Colorectal-adenoma:adenoma-group_vs_non-adenoma-group_UP	NA	40544
bsdb:683/4/1_Colorectal-adenoma:adenoma-group-post-polypectomy_vs_adenoma-group-pre-polypectomy_UP	NA	1485
bsdb:683/5/1_Colorectal-adenoma:control-group-post-endoscopy_vs_control-group-pre-endoscopy_UP	NA	872	39948	1301	172900	1485
bsdb:685/1/1_Colorectal-cancer:CRC_vs_Control_UP	NA	848	816	572511
bsdb:686/1/1_Colorectal-cancer:Colorectal-cancer-(CRC)_vs_Healthy-controls_DOWN	NA	292632
bsdb:687/1/1_Colorectal-adenocarcinoma:colorectal-cancer-patients_vs_healthy-controls_UP	NA	816	1678	620	561
bsdb:687/1/2_Colorectal-adenocarcinoma:colorectal-cancer-patients_vs_healthy-controls_DOWN	NA	102106	100883	216851	1501226	1301	1766253
bsdb:687/2/1_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-KRAS-mutation_vs_colorectal-cancer-patients-without-KRAS-mutation_UP	NA	580596	1738645	216851	342658	1892380	1506553	158846	165696	33024	841	2569097	33042
bsdb:687/2/2_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-KRAS-mutation_vs_colorectal-cancer-patients-without-KRAS-mutation_DOWN	NA	1678
bsdb:687/4/1_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-APC-mutation_vs_colorectal-cancer-patients-without-APC-mutation_UP	NA	1654
bsdb:687/5/1_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-PIK3CA-mutation_vs_colorectal-cancer-patients-without-PIK3CA-mutation_DOWN	NA	1654
bsdb:687/5/2_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-PIK3CA-mutation_vs_colorectal-cancer-patients-without-PIK3CA-mutation_UP	NA	239759	1578	906	48736
bsdb:688/2/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	216851	1263	33024	162289	32207
bsdb:688/2/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	2701
bsdb:689/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders-(Progressive-disease)_DOWN	NA	162289	1380	194	1654	1578
bsdb:690/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	1485	1578	84036
bsdb:690/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	35832	375288	40544
bsdb:691/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	35832	561	39948	33024
bsdb:691/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	84111	133925	29465	1301	838
bsdb:692/1/1_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_vs_colorectal-cancer-patients-who-didn't-take-prebiotics-(preoperative-fecal-sample)_DOWN	NA	816	1350
bsdb:692/1/2_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_vs_colorectal-cancer-patients-who-didn't-take-prebiotics-(preoperative-fecal-sample)_UP	NA	1678
bsdb:692/2/1_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-non-prebiotic-(postoperative)_vs_colorectal-cancer-patients-non-prebiotic-(preoperative)_DOWN	NA	816
bsdb:692/2/2_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-non-prebiotic-(postoperative)_vs_colorectal-cancer-patients-non-prebiotic-(preoperative)_UP	NA	1386	1350	1357	1301
bsdb:692/3/1_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(postoperative-fecal-sample)_vs_colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_UP	NA	1386	1678	1350
bsdb:692/3/2_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(postoperative-fecal-sample)_vs_colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_DOWN	NA	816
bsdb:693/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	146918	292632	1578	1678	1263	239934	39948	196081
bsdb:693/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	773	517	191303	10
bsdb:694/1/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1470349	1578	577310	841	1331051
bsdb:694/1/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	1331051	191303	1506577
bsdb:694/2/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1470349	583	577310
bsdb:694/2/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	1279	1331051	191303	1506577
bsdb:694/3/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)-+-PD-1_vs_control_UP	NA	239759	1470349	1508657
bsdb:694/3/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)-+-PD-1_vs_control_DOWN	NA	1331051
bsdb:694/4/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_control_UP	NA	816	1649459	375288
bsdb:694/4/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_control_DOWN	NA	2086	1678	572511	33042	872	580024	1506577
bsdb:694/5/1_Colorectal-cancer:PD-1-group_vs_control_UP	NA	447020	2086	1505663	1649459
bsdb:694/5/2_Colorectal-cancer:PD-1-group_vs_control_DOWN	NA	459786
bsdb:694/6/1_Colorectal-cancer:low-dose-300-mg/kg-GQD-+-PD-1-group_vs_control_UP	NA	239759	816	1470349	1508657
bsdb:694/6/2_Colorectal-cancer:low-dose-300-mg/kg-GQD-+-PD-1-group_vs_control_DOWN	NA	244127	1678
bsdb:695/1/1_Antimicrobial-agent:Coli_vs_control_UP	NA	816	1508657	375288
bsdb:695/1/2_Antimicrobial-agent:Coli_vs_control_DOWN	NA	872	577310
bsdb:695/2/1_Antimicrobial-agent:Vanc_vs_control_UP	NA	239934	1578	375288	577310	841
bsdb:695/2/2_Antimicrobial-agent:Vanc_vs_control_DOWN	NA	872
bsdb:695/3/1_Antimicrobial-agent:Vanc_vs_Coli_UP	NA	239934	1578	375288	577310	841	1508657
bsdb:695/3/2_Antimicrobial-agent:Vanc_vs_Coli_DOWN	NA	816	1508657	872
bsdb:695/5/1_Antimicrobial-agent:Vanc_vs_control_UP	NA	816	375288
bsdb:695/6/1_Antimicrobial-agent:Vanc_vs_coli_UP	NA	375288
bsdb:696/1/1_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_CGT-group---colorectal-cancer-patients-perioperative-placebo_UP	NA	379	1350
bsdb:696/1/2_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_CGT-group---colorectal-cancer-patients-perioperative-placebo_DOWN	NA	848	1378	1257	653683
bsdb:696/2/1_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_HGT-Group---Healthy-controls_UP	NA	379	1350
bsdb:696/2/2_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_HGT-Group---Healthy-controls_DOWN	NA	848	1378	1257	653683
bsdb:696/3/1_Nutraceutical:CGT--colorectal-cancer-patients-that-received-perioperative-placebo_vs_HGT--Healthy-controls_UP	NA	848	1378	1257	653683
bsdb:696/3/2_Nutraceutical:CGT--colorectal-cancer-patients-that-received-perioperative-placebo_vs_HGT--Healthy-controls_DOWN	NA	286
bsdb:697/1/1_Hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_UP	NA	83770	1506577
bsdb:697/1/2_Hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_DOWN	NA	239934
bsdb:697/2/1_Hepatocellular-carcinoma:Disease-control-with-Immune-checkpoint-inhibitors_vs_Non-Disease-control-with-Immune-checkpoint-inhibitors_UP	NA	904	1283313	1678	572511	33042	28050	906	674963	1506577
bsdb:697/2/2_Hepatocellular-carcinoma:Disease-control-with-Immune-checkpoint-inhibitors_vs_Non-Disease-control-with-Immune-checkpoint-inhibitors_DOWN	NA	216851
bsdb:697/3/1_Hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_DOWN	NA	1283313
bsdb:698/1/1_Crohn's-disease:Patients-with-Crohn's-disease_vs_Healthy-controls_UP	NA	46123	561	113286
bsdb:698/1/2_Crohn's-disease:Patients-with-Crohn's-disease_vs_Healthy-controls_DOWN	NA	580596	52225	724	172900
bsdb:698/2/1_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_UP	NA	117563	1257	55506	1016	561	29580	194	1654	84111	1716
bsdb:698/2/2_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	239759	574697	872	61170	140625	158846	52225	846	838	638847	2753	172900
bsdb:698/3/1_Crohn's-disease:Patients-with-Crohn's-disease_vs_Patients-with-ulcerative-colitis_UP	NA	872	113286	84108
bsdb:698/3/2_Crohn's-disease:Patients-with-Crohn's-disease_vs_Patients-with-ulcerative-colitis_DOWN	NA	580596	437755	1279	1016	724	29580	2717	47670	22	1716
bsdb:699/1/1_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	447020	239934	1263	244127	397864	1870884	2172	84108	195950
bsdb:699/1/2_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_UP	NA	836	1301	1506553	1870884	1257	165779	29465	848	538	724
bsdb:700/1/1_Ulcerative-colitis:children-with-ulcerative-colitis_vs_healthy-controls_DOWN	NA	256846
bsdb:701/1/1_Crohn's-disease:CD_vs_Non-IBD_UP	NA	713	180162	1485	1350	561	1164882
bsdb:701/1/2_Crohn's-disease:CD_vs_Non-IBD_DOWN	NA	239759	33042	216851	204475	838	841	286
bsdb:701/2/1_Ulcerative-colitis:UC_vs_NON-IBD-controls_UP	NA	1678	572511	544	1578	29465
bsdb:701/2/2_Ulcerative-colitis:UC_vs_NON-IBD-controls_DOWN	NA	29521	209	283168	239759	204475	286	33042	838
bsdb:701/3/1_Crohn's-disease:CD_vs_UC_UP	NA	180162	1485	561	581	1257
bsdb:701/3/2_Crohn's-disease:CD_vs_UC_DOWN	NA	84111	580596	28050	204475	544	841	1678	572511	216851
bsdb:702/1/1_Rheumatoid-arthritis:Active-(RA)-Rheumatoid-Arthritis_vs_Rheumatoid-Arthritis-(RA)-Remission_UP	NA	1654	1716	838	1301	29465
bsdb:702/1/2_Rheumatoid-arthritis:Active-(RA)-Rheumatoid-Arthritis_vs_Rheumatoid-Arthritis-(RA)-Remission_DOWN	NA	1380	848	265975	838	970
bsdb:702/2/1_Rheumatoid-arthritis:Prednisolone_vs_No-prednisolone_UP	NA	32257	1016	1301	2717	970
bsdb:702/2/2_Rheumatoid-arthritis:Prednisolone_vs_No-prednisolone_DOWN	NA	1380	39948	1434006	848	86331	838	157
bsdb:702/3/1_Rheumatoid-arthritis:Former-Smokers_vs_Never-Smokers_UP	NA	1654	416916	59735	1016	2717	1716	1378	724	47670	482
bsdb:702/3/2_Rheumatoid-arthritis:Former-Smokers_vs_Never-Smokers_DOWN	NA	76833	2717	32067	482
bsdb:702/4/1_Rheumatoid-arthritis:Current-Smokers_vs_Never-Smokers_UP	NA	848	1434006	346096	1654	157	195950	970	2093	86331	838
bsdb:702/4/2_Rheumatoid-arthritis:Current-Smokers_vs_Never-Smokers_DOWN	NA	32067	76833	482	2717
bsdb:702/5/1_Rheumatoid-arthritis:Current-Smokers_vs_Former-Smokers_UP	NA	848	1434006	346096	1654	157	195950	970	2093	86331	838
bsdb:702/5/2_Rheumatoid-arthritis:Current-Smokers_vs_Former-Smokers_DOWN	NA	482	1716	724	1016	416916	47670	2717	1378	1654	59735
bsdb:703/1/1_Rheumatoid-arthritis:All-Matched-(AM)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	848
bsdb:703/2/1_Rheumatoid-arthritis:Periodontally-diseased-(PD)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1654	848	543311
bsdb:704/1/2_Arthritis:Rheumatoid-Arthritis_vs_Healthy-Non-RA-Controls_UP	NA	32067
bsdb:705/1/1_Arthritis:Rheumatoid-Arthritis-(RA)_vs_Osteoarthritis-(OA)_DOWN	NA	43996	836	970
bsdb:706/1/2_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	1578
bsdb:707/1/1_Rheumatoid-arthritis:NORA---[New-Onset-Rheumatoid-Arthritis]-Patient_vs_Healthy-controls_UP	NA	156454	909656	32067	838	970	482	836
bsdb:707/1/2_Rheumatoid-arthritis:NORA---[New-Onset-Rheumatoid-Arthritis]-Patient_vs_Healthy-controls_DOWN	NA	1716	52225	1301	32067
bsdb:707/2/1_Rheumatoid-arthritis:NORA---[New-Onset-Rheumatoid-Arthritis]-Patient_vs_CRA---[Chronic-Established--Rheumatoid-Arthritis]_UP	NA	836	970	838	157	195950
bsdb:707/2/2_Rheumatoid-arthritis:NORA---[New-Onset-Rheumatoid-Arthritis]-Patient_vs_CRA---[Chronic-Established--Rheumatoid-Arthritis]_DOWN	NA	52225	838
bsdb:707/3/1_Rheumatoid-arthritis:All-[RA]---Rheumatoid-Arthritis-Patients_vs_Healthy-Controls_UP	NA	156454	838	970
bsdb:707/3/2_Rheumatoid-arthritis:All-[RA]---Rheumatoid-Arthritis-Patients_vs_Healthy-Controls_DOWN	NA	1716	32067	1016
bsdb:708/1/1_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_UP	NA	157	836	838
bsdb:708/1/2_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	1301	195950
bsdb:708/2/1_Periodontitis:periodontal-disease-patients_vs_rheumatoid-arthritis-patients_UP	NA	1301
bsdb:708/2/2_Periodontitis:periodontal-disease-patients_vs_rheumatoid-arthritis-patients_DOWN	NA	838	157	195950	836
bsdb:709/1/1_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1016	157	1578	39948	44259	1434006	118747
bsdb:709/1/2_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	1654	43996	47670	265975	1213720	29465
bsdb:710/2/2_Psoriasis:Psoriasis_vs_periodntitis_DOWN	NA	848
bsdb:710/3/1_Periodontitis:Periodontitis-patients_vs_orally-healthy-individuals_UP	NA	32207
bsdb:711/1/1_Systemic-lupus-erythematosus:SLE_vs_HC_UP	NA	1649459	570	579	1506553	886360	13687	1301	3025755
bsdb:711/1/2_Systemic-lupus-erythematosus:SLE_vs_HC_DOWN	NA	1766253	239934	39948	189330	216851	1407607	283168	292632
bsdb:712/1/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_healthy-controls_UP	NA	893	872	43994	906	52225	437755	133925
bsdb:713/1/1_Arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_DOWN	NA	1654	1716	32067
bsdb:713/1/2_Arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_UP	NA	1301	32067	724	32257
bsdb:714/1/1_Response-to-ketogenic-diet:Overweight/Obese-Men-on-Ketogenic-Diet-(KD)_vs_Overweight/Obese-Men-on-Baseline-Diet-(BD)_UP	NA	1573534	946234	848	1505657	1392389	158846	1980693	577310	3025755
bsdb:714/1/2_Response-to-ketogenic-diet:Overweight/Obese-Men-on-Ketogenic-Diet-(KD)_vs_Overweight/Obese-Men-on-Baseline-Diet-(BD)_DOWN	NA	1766253	207244	1678	39948	1301
bsdb:714/2/1_Response-to-ketogenic-diet:Mice-fed-on-Ketogenic-Diet-(KD)_vs_Mice-fed-on-High-fat-Diet-(HFD)_UP	NA	1427378	580596	580024	1392389	248038	1470349
bsdb:714/2/2_Response-to-ketogenic-diet:Mice-fed-on-Ketogenic-Diet-(KD)_vs_Mice-fed-on-High-fat-Diet-(HFD)_DOWN	NA	1678	1937008	1578	248744	1508657
bsdb:714/3/1_Response-to-ketogenic-diet:Mice-fed-High-fat-Diet-+-Ketone-Ester-(HFD-KE)_vs_Mice-fed-on-High-fat-Diet-(HFD-control)_UP	NA	1427378	816	216851	375288	838
bsdb:714/3/2_Response-to-ketogenic-diet:Mice-fed-High-fat-Diet-+-Ketone-Ester-(HFD-KE)_vs_Mice-fed-on-High-fat-Diet-(HFD-control)_DOWN	NA	1678	102106	1350	1578	1301	191303
bsdb:715/1/1_Acute-respiratory-distress-syndrome:Mortality_vs_Hyper-inflammatory-subphenotype-and-ventilation-free-days(VFDs)_DOWN	NA	838
bsdb:715/2/1_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype-and-mortality_UP	NA	838	1301	29465	32207	117563
bsdb:715/2/2_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype-and-mortality_DOWN	NA	1279
bsdb:715/3/1_Acute-respiratory-failure:Hyper-inflammatory-subphenotype_vs_VFD-(Ventilator-free-days)-and-mortality_UP	NA	848	1279
bsdb:715/4/1_Acute-respiratory-failure:Hyper-inflammatory-subphenotype_vs_VFD-(Ventilator-free-days)-and-mortality_UP	NA	1578
bsdb:715/5/1_Acute-respiratory-failure:Mortality_vs_Hyper-inflammatory-subphenotype-and-ventilation-free-days(VFDs)_UP	NA	838	1301	29465	482
bsdb:715/6/1_Acute-respiratory-failure:Mortality_vs_Hyper-inflammatory-subphenotype-and-ventilation-free-days(VFDs)_UP	NA	1716
bsdb:715/6/2_Acute-respiratory-failure:Mortality_vs_Hyper-inflammatory-subphenotype-and-ventilation-free-days(VFDs)_DOWN	NA	838	724
bsdb:715/7/1_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype-and-mortality_UP	NA	1279
bsdb:715/7/2_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype-and-mortality_DOWN	NA	724	32207	1378	1301	838
bsdb:715/8/1_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype-and-mortality_DOWN	NA	117563	482	838	32207	1301	29465
bsdb:715/9/1_Acute-respiratory-failure:Mortality_vs_Hyper-inflammatory-subphenotype-and-ventilation-free-days(VFDs)_DOWN	NA	838
bsdb:715/10/1_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype-and-mortality_DOWN	NA	724	838
bsdb:716/2/1_Parkinson's-disease:PD-duration-more-than-5-years_vs_PD-duration-less-than-5-years_UP	NA	416916	248038
bsdb:716/2/2_Parkinson's-disease:PD-duration-more-than-5-years_vs_PD-duration-less-than-5-years_DOWN	NA	28100
bsdb:716/3/1_Parkinson's-disease:Early-onset-PD_vs_Late-onset-PD_UP	NA	66831	216851	724	1357	40544	1485
bsdb:716/3/2_Parkinson's-disease:Early-onset-PD_vs_Late-onset-PD_DOWN	NA	244127	283
bsdb:716/4/1_Parkinson's-disease:Tremor-dominant-PD_vs_Non-tremor-dominant-PD_UP	NA	244127
bsdb:716/4/2_Parkinson's-disease:Tremor-dominant-PD_vs_Non-tremor-dominant-PD_DOWN	NA	841
bsdb:717/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-baseline_vs_Healthy-controls-at-baseline_UP	NA	239759	1678	1501226
bsdb:717/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-baseline_vs_Healthy-controls-at-baseline_DOWN	NA	572511	574697	838	39948
bsdb:717/2/1_Parkinson's-disease:Progressed-PD-patients-at-follow-up_vs_Stable-PD-patients-at-follow-up_UP	NA	1678	2152
bsdb:717/2/2_Parkinson's-disease:Progressed-PD-patients-at-follow-up_vs_Stable-PD-patients-at-follow-up_DOWN	NA	838	33024	33042	872
bsdb:717/3/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-time-of-follow-up_vs_Healthy-controls-at-time-of-follow-up_UP	NA	1678	1501226
bsdb:717/3/2_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-time-of-follow-up_vs_Healthy-controls-at-time-of-follow-up_DOWN	NA	816	838	841	1263	39948
bsdb:717/4/1_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-baseline_vs_Tremor-dominant-phenotype-(TD)-at-baseline_DOWN	NA	2152	1678	1485	1432051	1357	838
bsdb:717/4/2_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-baseline_vs_Tremor-dominant-phenotype-(TD)-at-baseline_UP	NA	816	830	204475
bsdb:717/5/1_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-follow-up_vs_Tremor-dominant-phenotype-(TD)-at-follow-up_DOWN	NA	397864	1357	2152
bsdb:717/5/2_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-follow-up_vs_Tremor-dominant-phenotype-(TD)-at-follow-up_UP	NA	239934
bsdb:717/6/1_Parkinson's-disease:Progressed-PD-patients-at-baseline_vs_Stable-PD-patients-at-baseline_UP	NA	1301
bsdb:717/6/2_Parkinson's-disease:Progressed-PD-patients-at-baseline_vs_Stable-PD-patients-at-baseline_DOWN	NA	838	33024	33042	872
bsdb:718/1/1_Polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_UP	NA	174708	572511	33042	841
bsdb:718/1/2_Polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_DOWN	NA	239759	51514
bsdb:719/3/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	244127	946234	133925	577310	838
bsdb:719/3/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	816	574697	1578	133925	841	1263	40544
bsdb:719/4/1_REM-sleep-behavior-disorder:idiopathic-rapid-eye-movement-sleep-behavior-disorder_vs_Healthy-Controls_UP	NA	244127	946234	644652
bsdb:719/4/2_REM-sleep-behavior-disorder:idiopathic-rapid-eye-movement-sleep-behavior-disorder_vs_Healthy-Controls_DOWN	NA	816	574697	135858	33042	906	52225	133925	838	40544	2316
bsdb:720/1/1_Chlamydia-trachomatis-infectious-disease:Chlamydia-trachomatis_vs_Healthy-Controls_UP	NA	1375	419014	1380	572511	1485	39948	561	216851	906	841	168808	1301	2129	1678
bsdb:720/2/1_Vulvovaginal-candidiasis:Vulvovaginal-candidiasis_vs_Healthy-Controls_DOWN	NA	1578
bsdb:720/2/2_Vulvovaginal-candidiasis:Vulvovaginal-candidiasis_vs_Healthy-Controls_UP	NA	419014	1380	572511	39948	561	216851	150022	2701	906	1257	838	841	1301	29465	338
bsdb:720/3/1_Bacterial-vaginosis:bacterial-vaginosis_vs_Healthy-Controls_DOWN	NA	1578
bsdb:720/3/2_Bacterial-vaginosis:bacterial-vaginosis_vs_Healthy-Controls_UP	NA	1375	1380	1485	39948	2701	1378	906	2050	1257	838	841	168808	2129
bsdb:721/1/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-6-weeks_vs_HIV-unexposed-infants-(HUU)-at-6-weeks_UP	NA	397864	572511	84111	283168	168808
bsdb:721/1/2_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-6-weeks_vs_HIV-unexposed-infants-(HUU)-at-6-weeks_DOWN	NA	135858	547	158846
bsdb:721/2/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_HIV-unexposed-infants-(HUU)-at-28-weeks_UP	NA	570	1357	158846	577310
bsdb:721/2/2_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_HIV-unexposed-infants-(HUU)-at-28-weeks_DOWN	NA	1380	2701	1378	2050	543311	168808
bsdb:721/3/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-62-weeks_vs_HIV-unexposed-infants-(HUU)-at-62-weeks_DOWN	NA	583
bsdb:721/4/1_HIV-mother-to-child-transmission:HIV-infected-mothers-at-delivery_vs_Healthy-controls-at-delivery_UP	NA	904	165779	816	35832	572511	1716	946234	848	117563	570	2093	1279	40544	158846	543311
bsdb:721/4/2_HIV-mother-to-child-transmission:HIV-infected-mothers-at-delivery_vs_Healthy-controls-at-delivery_DOWN	NA	2152	423604	216851	724
bsdb:721/5/1_HIV-mother-to-child-transmission:HIV-infected--mothers-at-62-weeks_vs_Healthy-controls-at-62-weeks_UP	NA	904	207244	572511	102106	189330	216851	946234	158846	375288	292632	168934	61170
bsdb:721/5/2_HIV-mother-to-child-transmission:HIV-infected--mothers-at-62-weeks_vs_Healthy-controls-at-62-weeks_DOWN	NA	469	423604	1378	838	1279	29465
bsdb:721/6/2_HIV-mother-to-child-transmission:HIV-infected-mothers_vs_Healthy-controls_UP	NA	165779	1663	1380	1386	38501	1696	59732	1716	1350	33986	216851	150022	2701	963	89966	1357	149698	407	1269	186650	475	482	1839	162289	838	1743	46205	1847	295418	42255	1279
bsdb:721/7/1_HIV-mother-to-child-transmission:Exclusively-breastfed-HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_Exclusively-breastfed-HIV-unexposed-infants-(HUU)-at-28-weeks_UP	NA	2383
bsdb:721/7/2_HIV-mother-to-child-transmission:Exclusively-breastfed-HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_Exclusively-breastfed-HIV-unexposed-infants-(HUU)-at-28-weeks_DOWN	NA	168808
bsdb:721/8/1_HIV-mother-to-child-transmission:Not-exclusively-breastfed-HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_Not-exclusively-breastfed-HIV-unexposed-infants-(HUU)-at-28-weeks_UP	NA	2383	570	745
bsdb:721/8/2_HIV-mother-to-child-transmission:Not-exclusively-breastfed-HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_Not-exclusively-breastfed-HIV-unexposed-infants-(HUU)-at-28-weeks_DOWN	NA	2701	2050	239759	135858	39948	150022	1378	2740	1257	123375	168808
bsdb:722/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	574697	1432051	61170	596767	1392389	283168	577310	292632
bsdb:722/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	209879	816	1485	102106	1573535	1506577
bsdb:723/1/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	1380	1562	117563	841	577309
bsdb:723/3/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Healthy-Controls_UP	NA	35832	283168	577309
bsdb:723/3/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Healthy-Controls_DOWN	NA	109326	117563	1654	1380	165779
bsdb:723/4/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_vs_Healthy-Controls_UP	NA	1350	2383
bsdb:723/4/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_vs_Healthy-Controls_DOWN	NA	572511	1485	51514	841	577309
bsdb:723/5/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_UP	NA	28050	102106	841
bsdb:723/5/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_DOWN	NA	1350
bsdb:724/1/1_Parkinson's-disease:Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-mild-cognitive-impairment_UP	NA	1263	572511
bsdb:724/2/1_Parkinson's-disease:Parkinson's-disease-patients-with-mild-cognitive-impairment_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-normal-cognition_UP	NA	239759	570	397864	574697	244127	283168
bsdb:724/3/1_Parkinson's-disease:Parkinson's-disease-patients-with-mild-cognitive-impairment-and-Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses_DOWN	NA	29465
bsdb:725/1/1_Eczema:Atopic-dermatitis-case-group_vs_Healthy-controls_DOWN	NA	1378	724	1301	29465
bsdb:725/1/2_Eczema:Atopic-dermatitis-case-group_vs_Healthy-controls_UP	NA	57495	407	1298
bsdb:725/2/1_Eczema:Females-(cases)_vs_Females-(controls)_DOWN	NA	57495	407
bsdb:725/3/1_Eczema:Males-(case)_vs_Males-(control)_DOWN	NA	1298	57495
bsdb:725/3/2_Eczema:Males-(case)_vs_Males-(control)_UP	NA	1301	1378	29465	724
bsdb:725/4/1_Eczema:AD-cases-with-no-reported-cream-usage_vs_Normal-control_DOWN	NA	57495	407
bsdb:725/4/2_Eczema:AD-cases-with-no-reported-cream-usage_vs_Normal-control_UP	NA	1301	1378	29465	724
bsdb:726/1/1_Aging:Group-2_vs_Group-1-(18–35-years-old)_UP	NA	713	816	561	1578
bsdb:726/2/1_Aging:Group-3_vs_Group-1-(18–35-years-old)_UP	NA	713	1578	816	561
bsdb:726/3/1_Aging:Group-4_vs_Group-1-(18–35-years-old)_UP	NA	713	816	1578	561
bsdb:727/1/1_Tobacco-smoke-exposure-measurement:Current-cigarette-smokers_vs_Never-smokers_DOWN	NA	713	59735	1678	2717	1378	724	1164882	1357	47670	482	836	1301
bsdb:727/1/2_Tobacco-smoke-exposure-measurement:Current-cigarette-smokers_vs_Never-smokers_UP	NA	1283313	156454	194	1434006	1578	32067	906	838	286	32207	157	29465
bsdb:727/3/1_Tobacco-smoke-exposure-measurement:participants-who-only-smoked-hookah_vs_Never-Smokers_DOWN	NA	836	32067	34104	848
bsdb:728/1/1_Diarrhea:Diarrhea-Group_vs_Controls-(No-Diarrhea-Group)_DOWN	NA	207244	816	1678	572511	100883	189330	1730	216851	1407607	459786	1501226	1508657	1263	33042
bsdb:728/1/2_Diarrhea:Diarrhea-Group_vs_Controls-(No-Diarrhea-Group)_UP	NA	1350	561	1506553
bsdb:728/2/1_Diarrhea:Antibiotic-excluded-Diarrhea-Group_vs_Antibiotic-excluded-Controls-(No-Diarrhea-Group)_DOWN	NA	1730	33042	207244	1501226	189330	216851	1263	1407607	1678	459786	1508657	816	204475	100883
bsdb:728/2/2_Diarrhea:Antibiotic-excluded-Diarrhea-Group_vs_Antibiotic-excluded-Controls-(No-Diarrhea-Group)_UP	NA	1506553	561	3025755	572511	1301
bsdb:728/3/1_Diarrhea:2000-mg/day-MMF-Dosage-No-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_DOWN	NA	1501226	33042	1407607	189330	1505657	1730	1301	207244
bsdb:728/3/2_Diarrhea:2000-mg/day-MMF-Dosage-No-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_UP	NA	1263	1508657	572511	816	1678	216851	1506553	204475
bsdb:728/4/1_Diarrhea:1000-mg/day-MMF-Dosage-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_DOWN	NA	816	1730	459786	189330	1263	207244	216851	1501226	1407607	1508657	204475	33042	3025755	572511	1505657
bsdb:728/4/2_Diarrhea:1000-mg/day-MMF-Dosage-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_UP	NA	1350	561	1301	1506553	100883
bsdb:728/5/1_Diarrhea:2000-mg/day-MMF-Dosage-Diarrhea-Group_vs_2000-mg/day-MMF-Dosage-No-Diarrhea-Group_DOWN	NA	1730	33042	207244	1263	216851	1501226	1508657	189330	459786	1678	1407607	572511	816	204475	100883	3025755
bsdb:728/5/2_Diarrhea:2000-mg/day-MMF-Dosage-Diarrhea-Group_vs_2000-mg/day-MMF-Dosage-No-Diarrhea-Group_UP	NA	1350	1506553	1301	1505657
bsdb:728/6/1_Diarrhea:Diarrheal-specimens_vs_Pre-Diarrheal-specimens_DOWN	NA	204475	1263	1730	207244	3025755	100883	459786	1508657	1678	33042	561	816	189330
bsdb:728/6/2_Diarrhea:Diarrheal-specimens_vs_Pre-Diarrheal-specimens_UP	NA	1301	1506553
bsdb:728/7/1_Diarrhea:First-Diarrheal-Specimens-in-the-Diarrhea-group_vs_First-Diarrheal-Specimens-Time-Matched-Fecal-Specimens-from-the-No-Diarrhea-Group_DOWN	NA	1730	33042	207244	1501226	216851	1407607	189330	1263	572511	459786	1508657	1678	816	100883	204475	3025755	1301
bsdb:728/7/2_Diarrhea:First-Diarrheal-Specimens-in-the-Diarrhea-group_vs_First-Diarrheal-Specimens-Time-Matched-Fecal-Specimens-from-the-No-Diarrhea-Group_UP	NA	1350	561	1506553	1505657
bsdb:729/1/1_Schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_UP	NA	239934	1283313	1678	35832	135858	872	848	1573535	158846	52225	1501226	1473205	84108	1301	83770	40544
bsdb:729/1/2_Schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_DOWN	NA	207244	580596	544	33042	1432051	216851	1407607	204475	570	577310	841	1263	191303
bsdb:729/2/1_Schizophrenia:Schizophrenia_vs_healthy-control_UP	NA	904	1654	239934	1283313	1380	35832	135858	102106	1716	872	189330	724	2745	1573535	158846	906	133925	543311	1082930	33024	838	1501226	1473205	1301	83770	40544
bsdb:729/2/2_Schizophrenia:Schizophrenia_vs_healthy-control_DOWN	NA	580596	33042	216851	1407607	204475	841
bsdb:730/1/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	1766253	397864	572511	580596	102106	33042	189330	216851	1686313	1407607	1573535	248744	577310	841	1263	84108	40544
bsdb:730/1/2_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_UP	NA	52784	2383	990721	156973	84111	1350	946234	1505657	1578	459786	1769710	3025755
bsdb:730/2/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	572511	216851	1766253	102106	189330	841	1407607	1573535	1263
bsdb:730/2/2_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_UP	NA	84111
bsdb:731/1/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	1506553	841
bsdb:731/2/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	1980681	841
bsdb:731/4/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	580596
bsdb:732/1/1_Obesity:Obese-individuals_vs_Individuals-with-a-healthy-body-mass-index_DOWN	NA	508459	1263	244127	119852	84111	572511	239934
bsdb:732/1/2_Obesity:Obese-individuals_vs_Individuals-with-a-healthy-body-mass-index_UP	NA	904	906	135858	838	1301
bsdb:732/2/1_Age:Later-age_vs_Early-age_UP	NA	574697	724	33024	283168	216851	570	838	577309	28050	140625	872
bsdb:732/2/2_Age:Later-age_vs_Early-age_DOWN	NA	100883	816	904	40544	61170	1678	102106	119852	906	572511	375288	189330	244127	447020	1730
bsdb:732/4/1_Ethnic-group:LAB_vs_USB-(US-born)_DOWN	NA	604195	5635	264095
bsdb:732/4/2_Ethnic-group:LAB_vs_USB-(US-born)_UP	NA	5410
bsdb:732/6/2_Age:Later-age_vs_Early-age_UP	NA	5475
bsdb:733/1/1_Sampling-site:duodenal-microbiota_vs_biliary-microbiota_UP	NA	1301
bsdb:735/1/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	482	713	416916	724
bsdb:735/1/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	216851	375288	841	33042	572511	1263	1730	1678	1485
bsdb:735/2/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	1263	189330
bsdb:735/3/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	1578	1730	1263	1485	84111	189330	1301	33042	1678	572511
bsdb:735/3/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	816	416916	469	1279	482	508215	1716	836
bsdb:736/1/1_Alzheimer's-disease:Alzheimer’s-disease-patients_vs_healthy-controls_UP	NA	239934	1678	1716	1350	1730	1578	292632	2735
bsdb:736/1/2_Alzheimer's-disease:Alzheimer’s-disease-patients_vs_healthy-controls_DOWN	NA	207244	580596	33042	39948	216851	1407607	204475	838	1501226	841	29465
bsdb:737/1/1_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	1378	117563	724	482	836	838	1301	848
bsdb:737/1/2_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	1654	848	1301	29465	838
bsdb:737/2/1_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	848	1378	117563	724	482	836	838	1301
bsdb:737/2/2_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	1654	29465
bsdb:737/3/1_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	482	265975	836	838	508215	1301	29465	848	1378
bsdb:737/3/2_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	1654	848	265975	838	2038	1301
bsdb:737/4/1_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	1654	848	1378	482	836	838	1301	29465
bsdb:737/4/2_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	265975	2038	1301	838
bsdb:738/1/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	158846
bsdb:738/2/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_UP	NA	146	244127
bsdb:738/2/2_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	189330	1301	3025755
bsdb:738/3/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_UP	NA	1263
bsdb:738/4/1_Gut-microbiome-measurement:Lysine-acetylome-aliquot-of-human-gut_vs_Metaproteome-aliquot-of-human-gut_UP	NA	1407607	283168	1506553	580596
bsdb:738/4/2_Gut-microbiome-measurement:Lysine-acetylome-aliquot-of-human-gut_vs_Metaproteome-aliquot-of-human-gut_DOWN	NA	816	830	577310	102106	204475	9605
bsdb:739/1/1_Treatment:Bacillus-clausii-UBBC-07-group-after-intervention/treatment_vs_Placebo-group-before-intervention/treatment_UP	NA	216851	1578	1678
bsdb:740/1/1_Alzheimer's-disease:Alzheimer’s-disease_vs_healthy-controls_DOWN	NA	572511	1263
bsdb:740/2/1_Alzheimer's-disease:aMCI-patients_vs_healthy-controls_DOWN	NA	572511
bsdb:740/2/2_Alzheimer's-disease:aMCI-patients_vs_healthy-controls_UP	NA	816
bsdb:740/3/2_Alzheimer's-disease:aMCI-patients_vs_Alzheimers-patients-in-dementia-stage_UP	NA	1263	816
bsdb:741/2/1_Parkinson's-disease:Parkinson's-Disease-patients-without-constipation-and-Parkinson's-Disease-patients-with-constipation_vs_Healthy-Controls_DOWN	NA	28050	1407607
bsdb:741/3/1_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Healthy-Controls-and-Parkinson's-Disease-patients-without-constipation_UP	NA	102106	1649459
bsdb:741/4/1_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Parkinson's-Disease-patients-without-constipation_DOWN	NA	1573535	158846
bsdb:741/4/2_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Parkinson's-Disease-patients-without-constipation_UP	NA	244127	1649459	1301
bsdb:742/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_UP	NA	239759	244127	35832	574697	830	872	846	196081	292632	133925
bsdb:742/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_DOWN	NA	816	1279384
bsdb:743/1/1_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_UP	NA	239934	816	119852
bsdb:743/1/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_DOWN	NA	572511	33042	189330	841
bsdb:743/2/1_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_UP	NA	48736
bsdb:743/2/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_DOWN	NA	189330	216851
bsdb:744/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-controls._UP	NA	239934	1350	1649459
bsdb:745/1/1_Fasting:Adults-after-fasting_vs_Adults-before-fasting_UP	NA	239934	174708	816	580596	39948	1730	216851	906	841
bsdb:745/1/2_Fasting:Adults-after-fasting_vs_Adults-before-fasting_DOWN	NA	1350	561
bsdb:746/1/1_Parkinson's-disease:Parkinson's-Disease-subjects._vs_Healthy-controls._UP	NA	1654
bsdb:750/1/1_Sex-design:Females_vs_Males_DOWN	NA	59735	195950
bsdb:750/1/2_Sex-design:Females_vs_Males_UP	NA	157	2093	1716
bsdb:750/2/1_Aging:Elderly_vs_Adults_UP	NA	838	146	157
bsdb:750/2/2_Aging:Elderly_vs_Adults_DOWN	NA	46123	1654	416916	156454	194	43996	39948	538	1378	117563	724	32257	1164882	47670	32067	906	86331	32207	970	1213720	1301	29465
bsdb:750/3/1_Gingival-bleeding:Participants-with-gingival-bleeding_vs_Participants-without-gingivitis-bleeding_UP	NA	1016	838
bsdb:750/3/2_Gingival-bleeding:Participants-with-gingival-bleeding_vs_Participants-without-gingivitis-bleeding_DOWN	NA	1283313	1378	117563	724	47670	32067	906	482	1301	29465
bsdb:750/4/1_Oral-ulcer:Participants-with-oral-ulcers_vs_Participants-without-oral-ulcers_UP	NA	1016	838
bsdb:750/4/2_Oral-ulcer:Participants-with-oral-ulcers_vs_Participants-without-oral-ulcers_DOWN	NA	1378	117563	724	32067	906	482	1301	29465
bsdb:750/5/1_Dentures:Participants-with-dentures_vs_Participants-without-dentures_UP	NA	482	1301	113286
bsdb:750/5/2_Dentures:Participants-with-dentures_vs_Participants-without-dentures_DOWN	NA	194
bsdb:750/6/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	838
bsdb:750/6/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	1357	1716	1378	1016	1301
bsdb:750/7/1_Coffee-consumption:Coffee-drinkers_vs_Non-coffee-drinkers_UP	NA	47670	117563	724	29465	1301
bsdb:750/7/2_Coffee-consumption:Coffee-drinkers_vs_Non-coffee-drinkers_DOWN	NA	838
bsdb:750/8/1_Tea-consumption-measurement:Tea-drinkers_vs_Non-tea-drinkers_DOWN	NA	1016
bsdb:751/1/1_Alcohol-drinking:Moderate-drinkers_vs_Non-drinkers_UP	NA	1301	838	59735	1716	848	32067	416916	2717	538	32257	482
bsdb:751/2/1_Alcohol-drinking:Heavy-drinkers_vs_Non-drinkers_UP	NA	1654	416916	59735	1164882	32067	482	1301	195950
bsdb:751/3/1_Alcohol-drinking:Wine-drinkers_vs_Non-drinkers_UP	NA	416916	1716	538
bsdb:751/3/2_Alcohol-drinking:Wine-drinkers_vs_Non-drinkers_DOWN	NA	2740	838	86331
bsdb:751/4/1_Alcohol-drinking:Beer-drinkers_vs_Non-drinkers_UP	NA	416916	196082
bsdb:751/4/2_Alcohol-drinking:Beer-drinkers_vs_Non-drinkers_DOWN	NA	265975	836	838	1213720
bsdb:751/5/1_Alcohol-drinking:Liquor-drinkers_vs_Non-drinkers_DOWN	NA	838
bsdb:751/5/2_Alcohol-drinking:Liquor-drinkers_vs_Non-drinkers_DOWN	NA	86331	265975	196082	838	1213720
bsdb:752/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	713	1651	118747	59732	1647	848	1378	82980	908284	613	40544
bsdb:752/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	46123	1654	1016	1716	44259	117563	32067	86331	53370	970	1279	1301	195950	469
bsdb:753/1/1_Smoking-behavior:Smokers_vs_Nonsmokers_UP	NA	970	157
bsdb:753/1/2_Smoking-behavior:Smokers_vs_Nonsmokers_DOWN	NA	1016	2717
bsdb:753/2/1_Smoking-behavior:Smokers_vs_Nonsmokers_UP	NA	1380	39948
bsdb:753/2/2_Smoking-behavior:Smokers_vs_Nonsmokers_DOWN	NA	43996	1378	117563	724	1257
bsdb:754/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	816	1716	893	1730	44259	1434006	848	1378	117563	47670	86331	543311	32207	1301	195950	29465	43996	32067	157
bsdb:754/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	416916	194	2717	724	838	1434006	482	836	970	157
bsdb:756/1/1_Smoking-behavior:Smokers-(S)_vs_Controls-(C)_DOWN	NA	46123	416916	292480	1386	59735	28219	1378	117563	32257	86331	437755	482	196079	265975	162289	1257	67572	75309	42255	1279	265570	933
bsdb:756/1/2_Smoking-behavior:Smokers-(S)_vs_Controls-(C)_UP	NA	222	110934	507	28263	1663	1016	308865	848	32636	110932	33882	838	48736	13687	40323	195950	34072	84567	46466
bsdb:756/2/1_Smoking-behavior,Alcohol-drinking:Smokers/Drinkers-(SD)_vs_Controls-(C)_DOWN	NA	46123	416916	28263	1663	1386	59735	28219	237	848	46466	32257	110932	33882	86331	437755	482	196079	265975	84567	1257	67572	48736	75309	42255	13687	1279	265570	195950	933	34072
bsdb:756/2/2_Smoking-behavior,Alcohol-drinking:Smokers/Drinkers-(SD)_vs_Controls-(C)_UP	NA	222	110934	507	1016	1378	117563	32636	196079	162289	838	40323
bsdb:758/1/1_Nasopharyngeal-squamous-cell-carcinoma:Nasopharyngeal-carcinoma-patients-at-baseline_vs_Healthy-controls-at-Baseline_UP	NA	32067	482	286
bsdb:758/1/2_Nasopharyngeal-squamous-cell-carcinoma:Nasopharyngeal-carcinoma-patients-at-baseline_vs_Healthy-controls-at-Baseline_DOWN	NA	1301
bsdb:758/2/1_Nasopharyngeal-squamous-cell-carcinoma:Nasopharyngeal-carcinoma-patients-after-treatment_vs_Nasopharyngeal-carcinoma-patients-at-baseline_UP	NA	1301	29465
bsdb:758/2/2_Nasopharyngeal-squamous-cell-carcinoma:Nasopharyngeal-carcinoma-patients-after-treatment_vs_Nasopharyngeal-carcinoma-patients-at-baseline_DOWN	NA	482	838
bsdb:759/1/1_Dry-eye-syndrome:Dry-Eye_vs_control_DOWN	NA	1716	237	848	724	149698	33882	219181	32207	13687	270	29465
bsdb:759/2/1_Dry-eye-syndrome:OGVHD_vs_control_DOWN	NA	2747	501783	1637	33882	286
bsdb:759/2/2_Dry-eye-syndrome:OGVHD_vs_control_UP	NA	1386
bsdb:759/3/1_Dry-eye-syndrome:ADDE_vs_control_UP	NA	1696	212791
bsdb:759/3/2_Dry-eye-syndrome:ADDE_vs_control_DOWN	NA	2747	286
bsdb:760/1/1_Colorectal-cancer:Probio-group_vs_Placebo-control-group_UP	NA	32207	42255	283168	239759	191303	1485	572511	420345	2740	244127	724
bsdb:760/1/2_Colorectal-cancer:Probio-group_vs_Placebo-control-group_DOWN	NA	46123	713	239934	580596	227979	28050	581	375288	651554	577309	497	1263
bsdb:760/2/1_Colorectal-cancer:Probio-group_vs_CRC-[colorectal-cancer]--Patients-Pre-treatment-group_UP	NA	239759	118966	244127	572511	204475	724	420345	283168	2740	32207	42255	191303
bsdb:760/2/2_Colorectal-cancer:Probio-group_vs_CRC-[colorectal-cancer]--Patients-Pre-treatment-group_DOWN	NA	447020	1578	162290	207244	830	33042	841	33024	172900	872
bsdb:760/3/1_Colorectal-cancer:Placebo-group_vs_CRC-[colorectal-cancer]-Patients-Pre-treatment-group_UP	NA	46123	713	239934	580596	227979	28050	581	375288	651554	497
bsdb:760/3/2_Colorectal-cancer:Placebo-group_vs_CRC-[colorectal-cancer]-Patients-Pre-treatment-group_DOWN	NA	447020	207244	830	33042	872	162290	1578	33024	172900
bsdb:761/1/1_Breast-cancer:Breast-Health-Condition_vs_Control_UP	NA	1161127	543311	836	838	196081	195950
bsdb:761/2/1_Breast-cancer:Breast-Health-Condition_vs_Control_UP	NA	59735	86331	836	838	196081	195950
bsdb:761/3/1_Breast-cancer:Breast-cancer_vs_Non-malignant_UP	NA	1161127
bsdb:762/1/2_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	286
bsdb:762/2/2_Dry-eye-syndrome:MGD_vs_Non-MGD_DOWN	NA	1283313	141948
bsdb:763/1/2_Age-at-assessment:Old_vs_Young_DOWN	NA	336809
bsdb:764/1/1_Type-II-diabetes-mellitus:diabetic_vs_healthy-controls_UP	NA	469	1375	357	1663	76890	191	1696	32008	1562	2745	2742	1269	13159	57494	28100	67575	1060	1835	235888	343873
bsdb:764/1/2_Type-II-diabetes-mellitus:diabetic_vs_healthy-controls_DOWN	NA	165696	1279
bsdb:765/1/1_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_UP	NA	419014	212791	216851	158846	119852	292632
bsdb:765/1/2_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_DOWN	NA	236752	906
bsdb:766/1/1_Stevens-Johnson-syndrome:Stevens-Johnson-Syndrome_vs_healthy-controls_UP	NA	816	216851	51366	239934	838	33042	1301	1578	848	1678	572511	1386	33024	577309	469	1263	158846	283168	1279	53246	551	286	102106	2172	29465	141948	841	191303
bsdb:766/1/2_Stevens-Johnson-syndrome:Stevens-Johnson-Syndrome_vs_healthy-controls_DOWN	NA	22	655352	1485	76008	104267	40222	180162	28196	662
bsdb:767/1/1_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_UP	NA	816	102106	283168	375288	577309	838
bsdb:767/1/2_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_DOWN	NA	580596	216851	577310	838	841
bsdb:767/2/1_Alzheimer's-disease:Mild-Cognitive-Impairment-group_vs_Non-demented-Controls_UP	NA	1774107	39948	1573535	375288	838	40544	1485
bsdb:767/2/2_Alzheimer's-disease:Mild-Cognitive-Impairment-group_vs_Non-demented-Controls_DOWN	NA	580596	577310	841	39948
bsdb:771/1/2_Health-study-participation:Bejing-healthy-volunteers_vs_Guangzhou-healthy-volunteers_DOWN	NA	336809
bsdb:772/3/2_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T1(end-of-baseline-feeding)_DOWN	NA	1678
bsdb:772/4/1_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T2-(end-of-intervention)_UP	NA	216851
bsdb:772/4/2_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T2-(end-of-intervention)_DOWN	NA	1678	906	29465
bsdb:773/2/1_Gut-microbiome-measurement:Blood-fed-mosquito---2-days-post-blood-meal-(triplicates)_vs_Sugar-fed-mosquito---3-day-old,sugar-(triplicates)_UP	NA	547	308865
bsdb:773/2/2_Gut-microbiome-measurement:Blood-fed-mosquito---2-days-post-blood-meal-(triplicates)_vs_Sugar-fed-mosquito---3-day-old,sugar-(triplicates)_DOWN	NA	160674
bsdb:774/1/1_Irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_DOWN	NA	1766253	653683	207244	1678	572511	580596	33042	1716	189330	216851	1407607	724	28050	2039302	838	841	1263	292632	83770	40544	29465
bsdb:774/1/2_Irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_UP	NA	239934	397864	990721	80865	872	1472649	1432051	1730	1573534	150022	946234	1918511	1649459	596767	1392389	1980693	459786	119852	375288	1508657	2918511
bsdb:774/2/1_Irritable-bowel-syndrome:IBS-D-(IBS-Diarrhea)_vs_Non-IBS2-(Non-irritable-bowel-syndrome-2)_DOWN	NA	222	239934	239759	207244	397864	1678	574697	830	194	33042	73029	872	216851	1686313	596767	283168	846	577310	162289	836	838	1263	40544	184869	29465	172900
bsdb:774/2/2_Irritable-bowel-syndrome:IBS-D-(IBS-Diarrhea)_vs_Non-IBS2-(Non-irritable-bowel-syndrome-2)_UP	NA	46123	189330	946234	724	292632	41275
bsdb:774/3/1_Irritable-bowel-syndrome:IBS-U-(IBS-Unclassified)_vs_Non-IBS3-(Non-irritable-bowel-syndrome-3)_DOWN	NA	1766253	207244	1678	572511	194	135858	102106	189330	216851	1686313	150022	1407607	1378	1573535	162289	838	1263	292632	40544	191303	184869	1350
bsdb:774/3/2_Irritable-bowel-syndrome:IBS-U-(IBS-Unclassified)_vs_Non-IBS3-(Non-irritable-bowel-syndrome-3)_UP	NA	286	40840
bsdb:774/4/1_Depressive-disorder:IBS-patients-with-depression-in-all-three-subtypes-(IBS-D,-IBS-C-and-IBS-U)_vs_IBS-patients-without-depression_DOWN	NA	1678	574697	40544
bsdb:774/4/2_Depressive-disorder:IBS-patients-with-depression-in-all-three-subtypes-(IBS-D,-IBS-C-and-IBS-U)_vs_IBS-patients-without-depression_UP	NA	583
bsdb:775/1/1_Breast-cancer:Breast-cancer-(BC)_vs_Healthy-controls-(HC)_UP	NA	1654	572511	84111	1573534
bsdb:776/1/1_Overactive-bladder:Overactive-Bladder-(OAB)-patients_vs_Asymptomatic-controls_UP	NA	1279	168808	583	31983	1378	2093	1375
bsdb:776/1/2_Overactive-bladder:Overactive-Bladder-(OAB)-patients_vs_Asymptomatic-controls_DOWN	NA	165779	194	39948	1350	150022	848	428711	1578	1357	165696	838	638847	2129
bsdb:776/2/1_Anxiety:Overactive-Bladder-(OAB)-with-anxiety_vs_Overactive-Bladder-(OAB)-without-anxiety_UP	NA	76833	29330	162290	31983	47251	836	168808
bsdb:776/2/2_Anxiety:Overactive-Bladder-(OAB)-with-anxiety_vs_Overactive-Bladder-(OAB)-without-anxiety_DOWN	NA	357	32008	102106	205841	2172	497
bsdb:776/3/1_Depressive-disorder:Overactive-Bladder-(OAB)-with-depression_vs_Overactive-Bladder-(OAB)-without-depression_DOWN	NA	1485	76833	84567
bsdb:777/2/2_Crohn's-disease:Crohn's-disease-(CD)_vs_healthy-controls_UP	NA	29465	1506553
bsdb:777/3/1_Crohn's-disease:Crohn's-disease-(CD)_vs_ulcerative-colitis-(UC)_UP	NA	191303
bsdb:777/3/2_Crohn's-disease:Crohn's-disease-(CD)_vs_ulcerative-colitis-(UC)_DOWN	NA	239934	653683	574697	848	1892380	158846	33024	40544
bsdb:778/1/1_Gastric-cancer:Gastric-cancer-(GC)_vs_Superficial-gastritis_UP	NA	642	194	39948	209	1578	838	1827	886360	504481	1301
bsdb:778/1/2_Gastric-cancer:Gastric-cancer-(GC)_vs_Superficial-gastritis_DOWN	NA	1654	1283313	1663	374	41275	194	848	724	32067	482	28100	836	838	508215	29465
bsdb:778/2/1_Gastric-cancer:tumor-tissues-of-gastric-cancer-patients_vs_non-tumor-tissues-of-gastric-cancer-patients_DOWN	NA	68287	374
bsdb:778/2/2_Gastric-cancer:tumor-tissues-of-gastric-cancer-patients_vs_non-tumor-tissues-of-gastric-cancer-patients_UP	NA	848
bsdb:780/1/1_Exercise:Meditation-group_vs_Control-group_UP	NA	216851	158846	838	816
bsdb:780/1/2_Exercise:Meditation-group_vs_Control-group_DOWN	NA	1678	102106	39948	906	841
bsdb:782/1/1_COVID-19:Pharyngeal-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	32008	194	561	848	724	1269	482	970	195950	157
bsdb:782/1/2_COVID-19:Pharyngeal-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	1654	508215	1301
bsdb:782/2/1_COVID-19:Sputum-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	1016	1301
bsdb:782/2/2_COVID-19:Sputum-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	80865	724	482	836	195950	157
bsdb:782/3/1_COVID-19:Feces-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	2745	286
bsdb:782/3/2_COVID-19:Feces-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	207244	1678	84111	2719313	216851	946234	1506553	28050	375288	841
bsdb:784/1/2_Gut-microbiome-measurement:Severe-COVID-19_vs_Moderate-COVID-19_DOWN	NA	459786
bsdb:785/1/1_Ulcerative-colitis:Ulcerative-colitis-patient_vs_Healthy-control-individual_UP	NA	375288
bsdb:785/3/2_Ulcerative-colitis:Patients-with-moderate-to-severe-ulcerative-colitis_vs_Patients-with-mild-ulcerative-colitis_DOWN	NA	239759
bsdb:785/4/2_Ulcerative-colitis:Patients-with-moderate-to-severe-ulcerative-colitis_vs_Patients-with-remission-ulcerative-colitis-(symptoms-of-UC-are-reduced-or-inapparent)_DOWN	NA	239759	40544
bsdb:785/5/2_Pancolitis,Distal-colitis:patients-with-left-sided-or-extensive-ulcerative-colitis_vs_patients-with-proctitis-ulcerative-colitis_DOWN	NA	838	44748
bsdb:786/1/1_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls---based-on-GA--map_UP	NA	189330
bsdb:786/1/2_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls---based-on-GA--map_DOWN	NA	841	29465
bsdb:786/2/1_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-Controls---based-on-LUMI--Seq-data_UP	NA	1301	1432051	1924105
bsdb:786/3/1_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D_vs_Healthy-Controls---based-on-LUMI--Seq-data_UP	NA	189330	191303
bsdb:786/3/2_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D_vs_Healthy-Controls---based-on-LUMI--Seq-data_DOWN	NA	2039240
bsdb:786/4/1_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D-Patients_vs_Pre--Type-2-Diabetes-individuals_UP	NA	189330	191303
bsdb:786/4/2_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D-Patients_vs_Pre--Type-2-Diabetes-individuals_DOWN	NA	1432051	1924105	1301
bsdb:788/2/1_Ruminative-stress-response:Jersey-cows-under-heat-stress-condition_vs_Jersey-cows-under-normal-condition_UP	NA	1386	1485	1279
bsdb:788/2/2_Ruminative-stress-response:Jersey-cows-under-heat-stress-condition_vs_Jersey-cows-under-normal-condition_DOWN	NA	286	1883	118966
bsdb:789/1/1_Breast-cancer:Prediagnostic-(PD)_vs_Healthy-(H)_UP	NA	196013	848	53335	1501226	13687	1279
bsdb:789/1/2_Breast-cancer:Prediagnostic-(PD)_vs_Healthy-(H)_DOWN	NA	1716
bsdb:789/2/1_Breast-cancer:Adjacent-normal-(AN)_vs_Healthy-(H)_UP	NA	165779	1716	75654	570	583	1494958
bsdb:789/2/2_Breast-cancer:Adjacent-normal-(AN)_vs_Healthy-(H)_DOWN	NA	1663	816	374	2755	1912216	1357	657	42255	1263	613	2737
bsdb:789/3/1_Breast-cancer:Tumor-(T)_vs_Healthy-(H)_UP	NA	165779	1494958	1827
bsdb:789/3/2_Breast-cancer:Tumor-(T)_vs_Healthy-(H)_DOWN	NA	469	1663	816	35832	1357	1847725	657	295418	613	270	2737
bsdb:791/1/1_Spontaneous-preterm-birth:Preterm-Birth_vs_Full-term-Birth_UP	NA	1213720
bsdb:792/1/1_Root:Test-group-(Roots)_vs_Control-group-(Leaves)_UP	NA	149698	4855	164535
bsdb:792/1/2_Root:Test-group-(Roots)_vs_Control-group-(Leaves)_DOWN	NA	29580	286	5598	253308	5498	40657
bsdb:793/1/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	270497	119852
bsdb:793/1/2_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_DOWN	NA	1485	2172	172900
bsdb:793/2/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	990721
bsdb:793/2/2_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_DOWN	NA	151037	397864	135858	1485	2172	119852	1263
bsdb:793/3/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	135858	102106
bsdb:793/3/2_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_DOWN	NA	239759	2172	1263
bsdb:794/1/1_Colorectal-cancer:EOCRC-(Early-onset-Colorectal-cancer)-patients_vs_Healthy-controls_UP	NA	848	158846	543311	1257	836
bsdb:794/3/1_Colorectal-cancer:LOCRC-(Late-onset-colorectal-cancer)_vs_Healthy-controls_UP	NA	239759	375288	33024
bsdb:795/1/2_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._DOWN	NA	165779
bsdb:795/2/1_Streptococcus-pneumoniae:Smokers_vs_non--smokers_UP	NA	1386	32008
bsdb:795/4/1_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._UP	NA	1016	195950
bsdb:795/4/2_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._DOWN	NA	32067
bsdb:795/5/1_Streptococcus-pneumoniae:Smokers_vs_Non--smokers_UP	NA	1386	32008
bsdb:795/5/2_Streptococcus-pneumoniae:Smokers_vs_Non--smokers_DOWN	NA	482	195950	157
bsdb:795/6/1_Streptococcus-pneumoniae:Contact-with-children_vs_No-Contact-with-Children_UP	NA	29465
bsdb:795/6/2_Streptococcus-pneumoniae:Contact-with-children_vs_No-Contact-with-Children_DOWN	NA	838	482
bsdb:796/1/1_Aging:Group-4--oldest-age-group-(66-to-80-years-old.-elderly-people)_vs_Group-1--youngest-age-group-(18-to-35-years-old)_UP	NA	570	1578	561
bsdb:796/1/2_Aging:Group-4--oldest-age-group-(66-to-80-years-old.-elderly-people)_vs_Group-1--youngest-age-group-(18-to-35-years-old)_DOWN	NA	577309	86331
bsdb:796/2/1_Aging:Group-2,-3-and-4---older-age-groups-(36-to-50-years-old;-51-to-65-years-old-and-66-to-80-years-old.)_vs_Group-1--youngest-age-group-(18-to-35-years-old)_UP	NA	713	816	561	1578
bsdb:797/1/1_Smoking-status-measurement:Active-smokers_vs_Never-smokers_DOWN	NA	848	724	407	1301
bsdb:797/1/2_Smoking-status-measurement:Active-smokers_vs_Never-smokers_UP	NA	335058	40323
bsdb:797/2/2_Smoking-status-measurement:former-smokers_vs_Never-smokers_UP	NA	47670	32067
bsdb:797/3/1_Smoking-status-measurement:active-smokers_vs_former-smokers_DOWN	NA	848	482
bsdb:797/3/2_Smoking-status-measurement:active-smokers_vs_former-smokers_UP	NA	838	1213720
bsdb:797/4/1_Smoking-status-measurement:Never-smokers_vs_Active-smokers-&-former-smokers_UP	NA	1730	724	47670	906	407	86331	838	29465
bsdb:797/5/1_Smoking-status-measurement:Active-smokers_vs_never-smokers-&-former-smokers_DOWN	NA	80865
bsdb:798/1/1_Urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_UP	NA	165779	1716	39948	906	836	838	48736	1653174	162289	194	848	212791
bsdb:798/1/2_Urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_DOWN	NA	469	239759	1582879	2701	1578	168808	1301
bsdb:799/1/1_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_UP	NA	416916	2801844	1386	2717	1716	1730	44259	848	1378	1840214	32067	2742598	475	543311	838	1743	508215	970	1301	195950
bsdb:799/1/2_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_DOWN	NA	46123	2147	713	1654	1283313	156454	1380	59735	194	1331051	1016	39948	1434006	117563	724	1164882	47670	482	265975	2740	1257	836	71	123375	1213720	34104	195950	157	29465
bsdb:799/2/1_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-(without-COPD)_vs_HIV-negative-individuals-(without-COPD)_UP	NA	713	1654	1283313	2060094	1380	1386	830	194	1331051	1016	43996	1716	1730	1378	117563	724	1164882	475	265975	1913599	836	1743	970	123375	1213720	34104	157	29465
bsdb:799/2/2_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-(without-COPD)_vs_HIV-negative-individuals-(without-COPD)_DOWN	NA	46123	416916	2801844	44259	1434006	848	47670	32067	482	543311	1257	838	508215	1301
bsdb:800/1/1_Health-study-participation:pandemic-group-with-covariates-controlled-for_vs_pre-pandemic-group-with-covariates-controlled-for_DOWN	NA	724
bsdb:801/1/1_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_UP	NA	2801844	1678	1716	561	724	570	44249	286	497	195950
bsdb:801/1/2_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_DOWN	NA	543311	2093	970	39948	32067	86331	1380	416916	123375	133925	43996	47670	76833	194	1164882	1257	1283313	1485	898	848	157	838
bsdb:802/1/1_Cachexia:cachexia-induced-mice_vs_Healthy-controls_UP	NA	248744	49082	1301	1485	1926677
bsdb:802/1/2_Cachexia:cachexia-induced-mice_vs_Healthy-controls_DOWN	NA	1501226	1357	191303	1678	1263	1980681
bsdb:803/1/1_Colorectal-cancer:Egyptian-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	57493
bsdb:803/1/2_Colorectal-cancer:Egyptian-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	33986	1269	482
bsdb:803/2/1_Colorectal-cancer:African-American-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	2701	117563	1060
bsdb:803/2/2_Colorectal-cancer:African-American-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	374
bsdb:803/3/1_Colorectal-cancer:European-American-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	149698
bsdb:803/3/2_Colorectal-cancer:European-American-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	28231
bsdb:803/4/1_Population:Tumor-samples-of-European-American_vs_KeNyaN,-African-American-and-Egyptians-patients_UP	NA	2086	2353	2093	1301
bsdb:803/5/1_Population:Tumor-samples-of-kenyans_vs_Egyptian,-African-American-and-European-American-Patients_UP	NA	59507	171673	838
bsdb:803/6/1_Population:Tumor-samples-of-African-Americans_vs_Egyptian,-Kenyan-and-European-American-patients_UP	NA	1716	212791	66831	1578	1357	32067	162289	286	1060
bsdb:803/7/1_Population:Tumor-samples-of-Egyptians_vs_African-American,-Kenya-and-European-American-patients_UP	NA	469	374	963	70774	68	65551	1269	44249	28100	583	13687	1279
bsdb:804/1/1_Response-to-transplant:CON-FMT:-receiving-control-microbiota-FMT-mice_vs_SD-FMT-AND-SD+MEL-FMT_UP	NA	248038	1508657	1918598
bsdb:804/2/1_Response-to-transplant:SD-FMT:-receiving-Sleep-deprivation--FMT-mice_vs_CON-FMT:(-receiving-control-microbiota-FMT-mice)-and-SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota--FMT-mice)_UP	NA	1283313	577310	1918598
bsdb:804/2/2_Response-to-transplant:SD-FMT:-receiving-Sleep-deprivation--FMT-mice_vs_CON-FMT:(-receiving-control-microbiota-FMT-mice)-and-SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota--FMT-mice)_DOWN	NA	1263
bsdb:804/3/1_Response-to-transplant:SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota-FMT-mice)_vs_CON-FMT-and-SD-FMT_UP	NA	239759	1331051	1263	2086	1730
bsdb:805/4/2_Childhood-trauma-measurement:Individuals-who-experienced-life-threatening-childhood-trauma_vs_Individuals-who-did-not-experience-life-threatening-childhood-trauma_DOWN	NA	256846
bsdb:806/1/1_Mood-disorder:bipolar-disorder-(BD)_vs_healthy-controls-(HCs)_UP	NA	816	102106	84111	848	1506553	1578	286	1301	292632	3025755	1485
bsdb:806/2/1_Mood-disorder:Major-depressive-disorder-(MDD)_vs_healthy-controls-(HCs)_UP	NA	816	544	848
bsdb:806/2/2_Mood-disorder:Major-depressive-disorder-(MDD)_vs_healthy-controls-(HCs)_DOWN	NA	816
bsdb:806/3/1_Mood-disorder:Major-depressive-disorder-(MDD)_vs_bipolar-disorder-(BD)_UP	NA	816	1678	572511	84111	216851	1301	3025755
bsdb:806/3/2_Mood-disorder:Major-depressive-disorder-(MDD)_vs_bipolar-disorder-(BD)_DOWN	NA	207244	816	572511	580596	39948	1350	216851	1506553	33024	286	1501226	1301
bsdb:807/1/1_Microbiome-measurement:Nasopharyngeal-swab-samples-from-workplaces_vs_Indoor-dust-samples_UP	NA	1716	1279
bsdb:808/1/1_Response-to-diet:mice-on-ketogenic-diet_vs_mice-on-American-diet_UP	NA	35832	28138	1508657
bsdb:808/1/2_Response-to-diet:mice-on-ketogenic-diet_vs_mice-on-American-diet_DOWN	NA	375288
bsdb:809/1/1_Retinopathy:diabetes-mellitus-(DM)_vs_healthy-controls-(HC)_UP	NA	724	906	375288	29465
bsdb:809/3/1_Retinopathy:diabetes-retinopathy-(DR)_vs_healthy-controls-(HC)_UP	NA	904	1730	46255
bsdb:811/1/1_Psoriasis:Psoriasis-patients_vs_Healthy-controls_UP	NA	135858	39948
bsdb:811/1/2_Psoriasis:Psoriasis-patients_vs_Healthy-controls_DOWN	NA	264995	572511	990721	28050	1263
bsdb:812/1/1_Urinary-tract-infection:rUTI-History,-UTI-(-)_vs_No-UTI-History_UP	NA	1375	1578
bsdb:812/1/2_Urinary-tract-infection:rUTI-History,-UTI-(-)_vs_No-UTI-History_UP	NA	816	84111	561	1378	570	1301	2129
bsdb:812/2/1_Hormone-replacement-therapy:EHT+-Group-(Premenopausal-women-in-the-'No-UTI-History-and-rUTI-History(-UTI(−)-cohorts'-who-used-estrogen-hormone-therapy-(EHT))_vs_EHT--Group-(Premenopausal-women-in-the-'No-UTI-History-and-rUTI-History(-UTI(−)-cohorts'-who-did-not-use-estrogen-hormone-therapy-(EHT))_UP	NA	1578
bsdb:813/1/1_Body-weight:Aging_vs_Adult_UP	NA	51514	40544	35832
bsdb:813/2/1_Body-fat-percentage:high-body-fat-percentage_vs_low-body-fat-percentage_UP	NA	191303
bsdb:813/3/1_Body-weight:Higher-weight_vs_Less-weight_DOWN	NA	1678	1485	40544
bsdb:814/1/1_Diet-measurement:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._UP	NA	1350	570	906
bsdb:814/1/2_Diet-measurement:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._DOWN	NA	1649459	265975	1481960	1505652
bsdb:814/2/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with-increased-GIT-2.0-score_vs_Not-Applicable_UP	NA	1350	570	1578	165695
bsdb:814/2/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with-increased-GIT-2.0-score_vs_Not-Applicable_DOWN	NA	135858	33042	1918450	1937008	2172	838	1501226	292632	191303	1506577
bsdb:814/3/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with-more-severe-diarrhoea_vs_NA_UP	NA	1350	29465	1578	165695
bsdb:814/3/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with-more-severe-diarrhoea_vs_NA_DOWN	NA	447020	244127	1678	33042	61170	1505657	2172	838	1501226	1508657	1263	1470353	292632	191303	1506577	1485
bsdb:814/4/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with--worsened-social-functioning_vs_NA_UP	NA	84111	1350	1649459	1506553	1578	1357	906	165695
bsdb:814/4/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with--worsened-social-functioning_vs_NA_DOWN	NA	33042	2172	1501226	1263	292632	191303
bsdb:815/1/1_Ulcerative-proctosigmoiditis:Infants-diagnosed-with-food-protein-induced-allergic-proctocolitis-(FPIAP)_vs_Infants-diagnosed-without-food-protein-induced-allergic-proctocolitis-(FPIAP)_UP	NA	572511
bsdb:815/1/2_Ulcerative-proctosigmoiditis:Infants-diagnosed-with-food-protein-induced-allergic-proctocolitis-(FPIAP)_vs_Infants-diagnosed-without-food-protein-induced-allergic-proctocolitis-(FPIAP)_DOWN	NA	1578
bsdb:816/2/1_Diarrhea:post-cholecystectomy-diarrhea-(PCD)_vs_post-cholecystectomy-non-diarrhea-(PCND)_DOWN	NA	1678	1357	1266	160674	544
bsdb:816/2/2_Diarrhea:post-cholecystectomy-diarrhea-(PCD)_vs_post-cholecystectomy-non-diarrhea-(PCND)_UP	NA	838	40544
bsdb:817/1/2_Granulomatosis-with-Polyangiitis:Kidneys-with-calcification_vs_Healthy/Healthy-with-no-visible-granuloma_DOWN	NA	150247	57495	1269	265
bsdb:817/2/2_Granulomatosis-with-Polyangiitis:Sick-with-Kidney-calcification_vs_Systemic-Granulomatosis-(SG)-affected_DOWN	NA	265	1562565
bsdb:817/3/2_Granulomatosis-with-Polyangiitis:Sick_vs_Healthy/Healthy-with-no-visible-granuloma_DOWN	NA	1386	442430	65551	265	1301
bsdb:820/1/2_Antimicrobial-agent,Amoxicillin:mouse--after-antibiotic-treatment_vs_mouse-before-antibiotic-treatment_UP	NA	5052	5498	83174
bsdb:820/2/2_Antimicrobial-agent,Amoxicillin:Mouse-after-antibiotic-treatment_vs_Mouse-before-antibiotic--treatment_UP	NA	1350
bsdb:821/1/1_Temperature:Warm-Gut_vs_Cool-Gut_UP	NA	239934	244127	100883	375288	168934
bsdb:821/1/2_Temperature:Warm-Gut_vs_Cool-Gut_DOWN	NA	544	150247	653683	1501226	469	29580
bsdb:822/1/1_Azithromycin:Azithromycin(AZM)-at-48-weeks_vs_Placebo-at-48-Weeks_UP	NA	47670	475	32207	157
bsdb:822/2/1_Azithromycin:AZM-at-72-weeks_vs_Placebo-at-72-weeks_UP	NA	47670	157
bsdb:822/3/1_Azithromycin:AZM-at-48-weeks---Azithromycin-arm-only_vs_AZM-at-baseline---Azithromycin-arm-only_UP	NA	47670	475	157	265975
bsdb:822/4/1_Azithromycin:Placebo-at-72-Weeks---Arm-Only_vs_Placebo-at-48-Weeks---Arm-Only_UP	NA	475
bsdb:822/5/1_Azithromycin:Placebo-at-72-weeks_vs_Placebo-at-baseline_UP	NA	475
bsdb:823/1/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-Groups_vs_Healthy-controls_UP	NA	1279	13687
bsdb:823/1/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-Groups_vs_Healthy-controls_DOWN	NA	1716
bsdb:824/1/1_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_UP	NA	404402	1578
bsdb:824/1/2_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	1654	1766253	239759	2060094	207244	2801844	830	1331051	848	2740	40544
bsdb:824/2/1_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_UP	NA	59735	1678	570	1578	1481960
bsdb:824/2/2_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	1283313	830	1331051	43996	100883	189330	1573534	848	209	1573535	86795	482	577310	1257	836	196081
bsdb:825/1/1_Urolithiasis:urinary-stone-disease-patients_vs_healthy-controls_UP	NA	1654	239759	209879	1283313	244127	816	1678	572511	574697	135858	1980681	102106	1348911	1716	872	39948	848	596767	1392389	1506553	1578	248744	158846	906	52225	86331	2039302	283168	459786	375288	577310	838	1263	1301	40544	157	191303	29465
bsdb:825/2/1_Urolithiasis:urinary-stone-disease-patients_vs_healthy-controls_UP	NA	469	1654	165779	1380	816	572511	374	1696	59732	1716	308865	66831	236752	237	1407607	848	162290	31983	57493	1578	1847725	407	1161127	133925	2740	162289	836	838	286	1263	13687	1301	292632	29465	43947	401469	332102	149698	1931224	508215
bsdb:826/2/1_Colorectal-cancer:CRC-(participants-diagnosed-with-colorectal-cancer)_vs_Healthy-controls_UP	NA	33024
bsdb:826/4/2_Colorectal-adenoma:HRA-(high-risk-adenoma)_vs_Healthy-controls_DOWN	NA	577310
bsdb:826/5/1_Colorectal-cancer:CRC-(participants-diagnosed-with-colorectal-cancer)_vs_Healthy-controls_UP	NA	904
bsdb:826/7/1_Time:Colorectal-cancer-diagnosed-during-17-year-follow-up/post-screening_vs_Colorectal-cancer-diagnosed-at-time-of-screening_UP	NA	1678
bsdb:827/1/1_Disease-progression-measurement:Advanced-cholangiocarcinoma_vs_Early-cholangiocarcinoma_UP	NA	194	544	32067
bsdb:827/2/1_Disease-progression-measurement:Advanced-pancreatic-ductal-adenocarcinoma_vs_Early-pancreatic-ductal-adenocarcinoma_UP	NA	28100	13687
bsdb:827/2/2_Disease-progression-measurement:Advanced-pancreatic-ductal-adenocarcinoma_vs_Early-pancreatic-ductal-adenocarcinoma_DOWN	NA	547	1649459	1763
bsdb:827/3/1_Disease-progression-measurement:Intraductal-papillary-mucinous-carcinoma-(IPMC)_vs_intraductal-papillary-mucinous-neoplasm-(IPMN)_UP	NA	1654	1283313	35832	39948	84111	970	1301
bsdb:827/4/1_Disease-prognosis-measurement:Good-prognosis-in-bile-duct-lesion-cases_vs_Poor-prognosis-in-bile-duct-lesion-cases_UP	NA	848	1301	29465
bsdb:827/4/2_Disease-prognosis-measurement:Good-prognosis-in-bile-duct-lesion-cases_vs_Poor-prognosis-in-bile-duct-lesion-cases_DOWN	NA	816	1716	1350	724	1649459	1847725	475	1279
bsdb:827/5/1_Disease-prognosis-measurement:Good-prognosis-in-pancreatic-lesion-cases_vs_Poor-prognosis-in-pancreatic-lesion-cases_UP	NA	816	1350	160674	1279	1301
bsdb:827/5/2_Disease-prognosis-measurement:Good-prognosis-in-pancreatic-lesion-cases_vs_Poor-prognosis-in-pancreatic-lesion-cases_DOWN	NA	469	570	265	970	29465
bsdb:828/2/1_COVID-19,Pneumonia:COVID-19-patients-with-severe-pneumonia_vs_COVID-19-patients-with-mild-pneumonia_UP	NA	125287
bsdb:828/3/1_COVID-19,Respiratory-failure-requiring-assisted-ventilation:Intubated_vs_Non-intubated_UP	NA	1350	125287
bsdb:829/1/1_Breastfeeding-duration:Low-Total-Time-Breastfeeding_vs_Medium-Total-Time-Breastfeeding_DOWN	NA	110934	1678	84567	40323	212744
bsdb:829/2/1_Breastfeeding-duration:High-Total-Time-Breastfeeding_vs_Medium-Total-Time-Breastfeeding_DOWN	NA	110934	1678	84567	40323	212744
bsdb:829/3/1_Breastfeeding-duration:Low-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_UP	NA	1678	1269
bsdb:829/3/2_Breastfeeding-duration:Low-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_DOWN	NA	84567	50709	222
bsdb:829/4/1_Breastfeeding-duration:High-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_UP	NA	1678
bsdb:829/4/2_Breastfeeding-duration:High-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_DOWN	NA	1269	84567	50709	222
bsdb:830/6/1_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	1716
bsdb:831/1/1_COVID-19:COVID-19-Patients_vs_Non-Covid-19-Patients---pneumonia-patients_UP	NA	816	1017280	1905344
bsdb:831/1/2_COVID-19:COVID-19-Patients_vs_Non-Covid-19-Patients---pneumonia-patients_DOWN	NA	1686313	150022	836	1716	40544	165779	909928
bsdb:831/2/1_COVID-19:COVID-19-patients---Ventilated_vs_COVID-19-patients---Non-Ventilated_UP	NA	194	1263	1485
bsdb:831/2/2_COVID-19:COVID-19-patients---Ventilated_vs_COVID-19-patients---Non-Ventilated_DOWN	NA	1301	216851	841
bsdb:832/1/1_Atrial-fibrillation:Individuals-with-Prevalent-Atrial-Fibrillation-(AF)_vs_Individuals-without-Prevalent-Atrial-Fibrillation-(AF)_UP	NA	1432051	1472762	547	579
bsdb:832/1/2_Atrial-fibrillation:Individuals-with-Prevalent-Atrial-Fibrillation-(AF)_vs_Individuals-without-Prevalent-Atrial-Fibrillation-(AF)_DOWN	NA	816	1678	1573535	375288	191303
bsdb:832/2/1_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_Individuals-without-Incident-Atrial-Fibrillation-(AF)_UP	NA	1678	1472762	1357	52225	1769710
bsdb:832/2/2_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_Individuals-without-Incident-Atrial-Fibrillation-(AF)_DOWN	NA	1649459	1506577	1635148
bsdb:832/3/1_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_NA_DOWN	NA	239759	397864	1350	283168	577309	60919
bsdb:832/3/2_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_NA_UP	NA	1485	102106	1472762	123375
bsdb:833/1/1_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome_vs_Healthy-controls_UP	NA	1654
bsdb:835/1/1_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_UP	NA	41275	2053
bsdb:835/1/2_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_DOWN	NA	174708	48736	191303
bsdb:835/2/1_Response-to-vaccine:High-IgA-mothers-at-Baseline_vs_Low-IgA-mothers-at-Baseline_UP	NA	848	713	416916	111142	2801844	359336	2039302	482	1213720	40544	1505652
bsdb:835/2/2_Response-to-vaccine:High-IgA-mothers-at-Baseline_vs_Low-IgA-mothers-at-Baseline_DOWN	NA	469	41275
bsdb:835/3/1_Response-to-vaccine:High-IgA-mothers-at-one-week-post-second-dose_vs_Low-IgA-mothers-at-one-week-post-second-dose_UP	NA	904	1678	1716	189330	1730	204456	1573535	55968	75687	1060	292632	662
bsdb:835/3/2_Response-to-vaccine:High-IgA-mothers-at-one-week-post-second-dose_vs_Low-IgA-mothers-at-one-week-post-second-dose_DOWN	NA	41275
bsdb:835/4/1_Response-to-vaccine:Mothers-at-one-week-post-first-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	713	150247	1386	59735	41275	75654	59734	212791	237	29580	33882	586	1742993	22	13687	2053	28453
bsdb:835/4/2_Response-to-vaccine:Mothers-at-one-week-post-first-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_DOWN	NA	174708	1407607	375288	48736	191303
bsdb:835/5/1_Response-to-vaccine:Mothers-at-one-week-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	469	713	41275	204456	2053	570	32067	158846	481445	75687	528	162289	613	57739	1730	2321113	56358
bsdb:835/5/2_Response-to-vaccine:Mothers-at-one-week-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_DOWN	NA	1730	239934	507	174708	816	359336	1980681	1937008	216851	162027	2745	1649	1578	375288	577310	1567	48736	1501226	40544	157	191303
bsdb:835/6/1_Response-to-vaccine:Mothers-at-one-month-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	12916	2040	1380	41275	225842	2053	1164882	186650	475	165696	1253	2321113	613	204447	13687	114248
bsdb:835/6/2_Response-to-vaccine:Mothers-at-one-month-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_DOWN	NA	1375	239934	507	239759	174708	165779	816	958	359336	39948	1937008	1350	33986	216851	1573534	1522056	162027	2745	1573535	570	1506553	47670	33882	2039302	459786	577310	1567	48736	1501226	841	1263	1200657	157	191303
bsdb:836/1/1_Food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_UP	NA	469	286	1696
bsdb:836/1/2_Food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_DOWN	NA	239934	239759	1283313	1678	1485	158846	33024	838	1501226	841	1263	29465	204475	572511	459786	1380	848	397864	577309	191303	66831	499551	336260	1017280	580596	43773	53457	423604	906	580024	1184396	283168	2172	2740	1860
bsdb:837/1/1_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Men-with-coronary-heart-disease-(CHD)_DOWN	NA	28050	838	841
bsdb:837/1/2_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Men-with-coronary-heart-disease-(CHD)_UP	NA	397864	1678	35832	375288
bsdb:837/2/1_Cardiovascular-disease:Women-without-cardiovascular-disease_vs_Men-without-cardiovascular-disease_DOWN	NA	102106
bsdb:837/2/2_Cardiovascular-disease:Women-without-cardiovascular-disease_vs_Men-without-cardiovascular-disease_UP	NA	239934
bsdb:837/3/1_Cardiovascular-disease:Men-with-coronary-heart-disease-(CHD)_vs_Men-without-cardiovascular-disease_UP	NA	239934	561	724	1578	33024	841	620	1301	292632	29465
bsdb:837/3/2_Cardiovascular-disease:Men-with-coronary-heart-disease-(CHD)_vs_Men-without-cardiovascular-disease_DOWN	NA	239759	816	397864	572511	574697	1348911	283168	375288	577309	577310	1263	40544	3025755
bsdb:837/4/1_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Women-without-cardiovascular-disease_UP	NA	35832	102106	561	1578	33024	620	1301	29465
bsdb:837/4/2_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Women-without-cardiovascular-disease_DOWN	NA	572511	574697	283168	577310	1263
bsdb:839/1/3_Epilepsy:pre-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	102106	1378
bsdb:839/2/1_Epilepsy:post-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	574697	102106	1730	459786	375288
bsdb:839/3/1_Response-to-oxcarbazepine:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_UP	NA	459786	172900
bsdb:839/3/2_Response-to-oxcarbazepine:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_DOWN	NA	1378	1501226	1301
bsdb:839/4/1_Epilepsy:pre-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	216851	375288	158846	1301	1501226	102106
bsdb:839/5/1_Epilepsy:post-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	375288	207244	459786	158846
bsdb:839/6/1_Response-to-oxcarbazepine:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_UP	NA	572511	158846	459786	1301	1501226	102106	207244
bsdb:840/1/2_Microbiome-measurement:2015-sampling-period_vs_2013-sampling-period_DOWN	NA	1187078
bsdb:840/12/1_Microbiome-measurement:2015-sampling-period-(Complete-microbiome)_vs_2013-sampling-period-(Complete-microbiome)_DOWN	NA	1298
bsdb:841/1/1_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_UP	NA	76831	651554	1257
bsdb:841/1/2_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_DOWN	NA	816	375288
bsdb:841/2/1_Breastfeeding-duration:Calves-without-dam-on-day-65_vs_Calves-with-dam-on-day-65_UP	NA	816	1578
bsdb:841/2/2_Breastfeeding-duration:Calves-without-dam-on-day-65_vs_Calves-with-dam-on-day-65_DOWN	NA	157
bsdb:841/3/1_Breastfeeding-duration:Calves-without-dam-on-day-95_vs_Calves-with-dam-on-day-95_UP	NA	157
bsdb:842/1/1_Food-allergy:Food-Allergy_vs_Control-group_UP	NA	816
bsdb:842/2/1_Dermatitis:Atopic-dermatitis_vs_Control-group_UP	NA	375288
bsdb:842/3/1_Food-allergy,Dermatitis:Atopic-dermatitis-and-Food-Allergy-(ADFA)_vs_Control-group_UP	NA	816	375288
bsdb:842/4/1_Food-allergy,Dermatitis:Infants-with-Allergy-Symptoms_vs_Control-group_UP	NA	1378
bsdb:844/1/1_Response-to-metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_UP	NA	1506553
bsdb:844/3/1_Population:Denmark-(normoglycaemic-controls-and-T2D-patients)_vs_Indians-(normoglycaemic-controls-and-T2D-patients)_UP	NA	447020	239934	239759	52784	244127	1935176	816	397864	35832	374	574697	990721	1348911	872	1432051	216851	946234	61170	1649459	1506553	28050	1935200	3028852	1980693	283168	459786	119852	846	375288	577309	577310	2740	33024	1017280	1827	1508657	1635148	292632	40544	2895461
bsdb:844/3/2_Population:Denmark-(normoglycaemic-controls-and-T2D-patients)_vs_Indians-(normoglycaemic-controls-and-T2D-patients)_DOWN	NA	222	1654	1766253	1283313	156454	207244	1678	135858	102106	189330	1407607	117563	1573535	404402	257820	1578	248744	906	52225	133925	265975	2082587	1501226	1473205	613	123375	1505652	46255
bsdb:844/4/1_Metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_DOWN	NA	216851
bsdb:844/5/1_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_DOWN	NA	653683	580596	39948	216851	1578	1501226	841	292632
bsdb:844/5/2_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	816	189330	1506553	906	459786
bsdb:844/6/1_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_DOWN	NA	653683	580596	292632
bsdb:844/6/2_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	1506553
bsdb:844/7/1_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	1506553
bsdb:845/1/1_Smoking-status-measurement:Current-smokers_vs_Never-smokers_UP	NA	1654	419014	1380	1678	118747	84162	39948	44259	1434006	1578	906	52225	2093	508215	1213720	157	29465
bsdb:845/1/2_Smoking-status-measurement:Current-smokers_vs_Never-smokers_DOWN	NA	46123	416916	1283313	59735	1016	2717	43996	848	724	32257	47670	32067	482	219181	2740	1257	836
bsdb:846/1/1_Diet:Base-Diet---B_vs_Home-Made-Diet---H_UP	NA	816	848	1263	174708	13334	572511	135858	1485	102106	100883	561	209	28050	1578	158846	2740	841	84108
bsdb:846/1/2_Diet:Base-Diet---B_vs_Home-Made-Diet---H_DOWN	NA	1730	577309	447020	572511	580596	100883	33042	189330	1350	2383	216851	119852	375288	33024	838	1301	40544	191303
bsdb:846/2/1_Diet:Complete-diet---K_vs_Commercial-moist-complete-diet---W_UP	NA	447020	580596	1485	189330	1350	1578	375288	838	1301
bsdb:846/2/2_Diet:Complete-diet---K_vs_Commercial-moist-complete-diet---W_DOWN	NA	816	1730	577309	1263	174708	13334	572511	135858	102106	100883	33042	2383	561	216851	848	209	28050	158846	119852	2740	33024	841	84108	40544	191303
bsdb:847/1/1_Obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_UP	NA	46123	135858	102106	100883	84108	123375
bsdb:847/1/2_Obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_DOWN	NA	239759	244127	397864	194	1485	1582879	596767	459786	577310	162289	836	1501226	44748	292632	191303
bsdb:848/1/1_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_UP	NA	397864	1470349	283	1348911	33042	872	1472762	848	158846	283168	375288	577309	1481960	2740	33024	1508657	172900
bsdb:848/1/2_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_DOWN	NA	1375	207244	1716	1506553	1578	1637	475961	248744	407	33882	838	286	48736	1263	399320	1279	3025755	157	1506577
bsdb:849/1/1_Age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_UP	NA	816	1578	29465
bsdb:849/1/2_Age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_DOWN	NA	1485	216851
bsdb:849/2/1_Cytokine:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_UP	NA	816	375288
bsdb:849/2/2_Cytokine:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_DOWN	NA	838
bsdb:849/3/1_Diet:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_UP	NA	816	1485	1578
bsdb:849/4/1_HbA1c-measurement:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_UP	NA	33024
bsdb:849/4/2_HbA1c-measurement:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_DOWN	NA	1485
bsdb:850/10/1_Breastfeeding-duration,Transport:weaning+short-transportation_vs_suckling-calves-(control)_UP	NA	75984
bsdb:850/10/2_Breastfeeding-duration,Transport:weaning+short-transportation_vs_suckling-calves-(control)_DOWN	NA	475
bsdb:851/1/1_Crohn's-disease:non-inflamed-crohn's-disease_vs_non-inflammatory-bowel-disease-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	33042	459786
bsdb:851/2/1_Ulcerative-colitis:non-inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_UP	NA	1654	2742	286
bsdb:851/2/2_Ulcerative-colitis:non-inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	239759	816	189330	459786	375288	33024	838
bsdb:851/3/1_Ulcerative-colitis:inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_UP	NA	286
bsdb:851/3/2_Ulcerative-colitis:inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	239759	375288
bsdb:852/1/1_Acne:Acne-group_vs_Healthy-group_UP	NA	1716	40323
bsdb:852/1/2_Acne:Acne-group_vs_Healthy-group_DOWN	NA	1654	37914	150022	32067	437755	836	838
bsdb:852/2/1_Acne:Acne-group_vs_Healthy-group_DOWN	NA	1716	836
bsdb:852/3/1_Acne:Acne-group_vs_Healthy-group_UP	NA	2570834
bsdb:854/1/1_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Normal-Control-(NC)_UP	NA	469	1485	1716
bsdb:854/1/2_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Normal-Control-(NC)_DOWN	NA	1386
bsdb:854/2/1_Dry-eye-syndrome:Non-Sjogrens-Syndrome-Dry-Eye-(NSSDE)_vs_Normal-Control-(NC)_UP	NA	469	1485
bsdb:854/2/2_Dry-eye-syndrome:Non-Sjogrens-Syndrome-Dry-Eye-(NSSDE)_vs_Normal-Control-(NC)_DOWN	NA	1386
bsdb:854/3/2_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Non-Sjogrens-Syndrome-Dry-Eye-(NSSDE)_DOWN	NA	1485
bsdb:855/1/1_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_UP	NA	547	1350	1582879	236752	2701	724	47670	83614	1370	1817	543311	1632780	286	1060	84108	165695	34104	1883	2060	349
bsdb:855/1/2_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_DOWN	NA	12916	469	642	111142	1283313	1663	414371	1386	59735	1678	43668	1696	10	59732	1716	1912216	80865	82800	37914	1433999	59734	212791	2053	117563	366614	2745	53457	570	57493	57499	1578	1847725	32067	68	149698	407	33882	1269	1763	44249	265	28100	985001	1085622	83618	1855416	32207	613	22	204447	40323
bsdb:855/2/1_Dry-eye-syndrome:Sjogren's-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_UP	NA	59735	547	1350	1582879	724	1578	47670	1370	543311	1632780	28100	286	1060	590	165695	1883	2060
bsdb:855/2/2_Dry-eye-syndrome:Sjogren's-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_DOWN	NA	12916	111142	1283313	165779	1663	43668	1696	10	59732	1716	1912216	80865	82800	37914	1433999	212791	33986	1378	2053	117563	366614	2745	57499	1847725	32067	83614	68	149698	407	33882	1269	1763	265	985001	1085622	1855416	32207	613	22	204447	40323	662	46255	349
bsdb:855/3/1_Dry-eye-syndrome:Non-Sjogren's-Syndrome-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_UP	NA	59735	547	1350	1582879	236752	2701	47670	83614	1370	33882	1817	543311	28100	286	1060	32207	613	165695	34104	1883	292632	2060	349
bsdb:855/3/2_Dry-eye-syndrome:Non-Sjogren's-Syndrome-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_DOWN	NA	12916	469	642	111142	1283313	150247	1386	1678	43668	1696	41275	10	59732	1716	1912216	80865	82800	37914	1433999	59734	212791	2053	366614	724	2745	53457	570	57493	57499	1847725	32067	68	451512	149698	407	1269	1763	44249	265	985001	1085622	83618	1855416	22	204447	84108	40323
bsdb:856/2/1_Dry-eye-syndrome:Diabetic-children-with-Dry-Eye-Disease-(DM-DE)_vs_Normal-healthy-(NDM)-children_UP	NA	547	662
bsdb:857/1/1_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_UP	NA	904	469	1350	158846	906	583	1301
bsdb:857/1/2_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_DOWN	NA	572511	216851	1263
bsdb:858/1/1_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_UP	NA	1924093	644652
bsdb:858/1/2_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_DOWN	NA	577310
bsdb:862/1/1_Bronchiectasis:Severe-bronchiectasis_vs_Less-severe-bronchiectasis_UP	NA	286	40323
bsdb:862/1/2_Bronchiectasis:Severe-bronchiectasis_vs_Less-severe-bronchiectasis_DOWN	NA	1654	1380	118747	194	1016	848	117563	32257	32067	906	437755	482	265975	346096	836	838	970	1279	1301	29465	32207
bsdb:862/2/1_Bronchiectasis:Frequent-exacerbating-stable-patients_vs_Non-frequent-exacerbating-stable-patients_UP	NA	286
bsdb:862/2/2_Bronchiectasis:Frequent-exacerbating-stable-patients_vs_Non-frequent-exacerbating-stable-patients_DOWN	NA	1654	416916	1380	194	1016	1716	848	117563	32257	1578	32067	906	475	482	265975	346096	836	838	970	1279	40323	1301	29465	32207
bsdb:862/3/1_Bronchiectasis:Exacerbation-samples_vs_Stable-samples_UP	NA	538	117563
bsdb:862/3/2_Bronchiectasis:Exacerbation-samples_vs_Stable-samples_DOWN	NA	357	194	59732	848	724	32067	906	482	838	286	1301	29465	32207
bsdb:863/1/1_Eczema,Urticaria:Atopic-dermatitis-(eczema)_vs_Chronic-urticaria-(hives)_UP	NA	1501226	40544
bsdb:863/1/2_Eczema,Urticaria:Atopic-dermatitis-(eczema)_vs_Chronic-urticaria-(hives)_DOWN	NA	838
bsdb:863/2/1_Eczema,Allergic-rhinitis:Atopic-dermatitis-(eczema)_vs_Allergic-rhinitis_UP	NA	1501226	40544
bsdb:863/2/2_Eczema,Allergic-rhinitis:Atopic-dermatitis-(eczema)_vs_Allergic-rhinitis_DOWN	NA	1380
bsdb:864/1/1_Diet:Post-fed-group-at-1230-h_vs_Pre-fed-group-at-1100-h_UP	NA	150247	28196	12960	1386	180162	544	551	129337	47420	227979	1578	1357	1243	58050	265	1257	657	838	583	2800384	623282	497	67572	119541	165812	1569	1279	1301	285105	270	160795	2737	84406	629
bsdb:864/2/1_Diet:Post-fed-group-at-1400-h_vs_Pre-fed-group-at-1100-h_UP	NA	657	28196	265	67572	1279	1578	497	180162	1301	1386	1357	129337	270	47420	544	285105	838	583	150247	1257	2737	1243	227979	551	629	58050	623282	84406	1569	160795	12960	2800384	119541	165812
bsdb:864/3/1_Diet:Post-fed-group-at-1600-h_vs_Pre-fed-group-at-1100-h_UP	NA	629	551	227979	1243	2737	1257	150247	583	838	285105	544	47420	270	129337	1357	1386	1301	180162	497	1578	1279	67572	265	28196	657	58050	623282	84406	1569	160795	12960	2800384	119541	165812
bsdb:864/4/1_Diet:Post-fed-group-at-2000-h_vs_Pre-fed-group-at-1100-h_UP	NA	150247	28196	12960	1386	180162	544	551	129337	47420	227979	1578	1357	1243	58050	265	1257	657	838	583	2800384	623282	497	67572	119541	165812	1569	1279	285105	270	160795	2737	84406	629
bsdb:864/4/2_Diet:Post-fed-group-at-2000-h_vs_Pre-fed-group-at-1100-h_DOWN	NA	1301
bsdb:865/1/1_Colorectal-cancer-cell-line:azoxymethane/dextran-sodiumsulfate-(AOM/DSS)-group-at-week-10-(AD10-group)_vs_control-group-at-week-10-(C10-group)_DOWN	NA	239759	1485	872	283168
bsdb:865/1/2_Colorectal-cancer-cell-line:azoxymethane/dextran-sodiumsulfate-(AOM/DSS)-group-at-week-10-(AD10-group)_vs_control-group-at-week-10-(C10-group)_UP	NA	816	1730	209	1392389	375288	1301
bsdb:866/1/1_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_UP	NA	816	1263
bsdb:866/1/2_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_DOWN	NA	572511	2676048	2678884
bsdb:866/2/1_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_UP	NA	1283313
bsdb:867/1/1_Breast-cancer:Breast-cancer-patients_vs_Healthy-controls_UP	NA	904	1649459	1506577
bsdb:867/1/2_Breast-cancer:Breast-cancer-patients_vs_Healthy-controls_DOWN	NA	52784	2840511	39948	1501226
bsdb:868/1/1_Ulcerative-colitis:Ulcerative-colitis_vs_Healthy-controls_UP	NA	830	158483	216851	724	28050	1980693	133925	1257	838
bsdb:868/1/2_Ulcerative-colitis:Ulcerative-colitis_vs_Healthy-controls_DOWN	NA	41275	574697	1348911	1912216	1432051	1649292	1407607	1357	1243	629
bsdb:869/1/1_Ulcerative-colitis:quiescent-ulcerative-colitis-patients_vs_healthy-controls_UP	NA	1678
bsdb:869/2/1_Disease-progression-measurement:relapsed-ulcerative-colitis-group_vs_sustained-remission-of-ulcerative-colitis-group_UP	NA	1678	216851
bsdb:869/2/2_Disease-progression-measurement:relapsed-ulcerative-colitis-group_vs_sustained-remission-of-ulcerative-colitis-group_DOWN	NA	838
bsdb:870/1/1_Postmenopausal-osteoporosis:Postmenopausal-osteoporosis-(PMOP)-patients_vs_Healthy-controls_UP	NA	1578
bsdb:872/1/1_NA:spinal-cord-injury-patient_vs_typically-healthy-control-group_UP	NA	84111
bsdb:872/1/2_NA:spinal-cord-injury-patient_vs_typically-healthy-control-group_DOWN	NA	1766253	572511	102106	189330	216851	1407607	1573535	841	1263
bsdb:875/1/2_Acne:Acne-vulgaris-group_vs_Healthy-control-group_DOWN	NA	1375	114627	1386	35832	572511	580596	2747	212791	1407607	204475	117563	1357	400634	182709	846	44249	577309	1263
bsdb:876/1/1_Male-homosexuality:Men-with->3-sexual-partners_vs_Men-with-0-3-sexual-partners_DOWN	NA	459786
bsdb:876/8/1_Male-homosexuality:Westernized_vs_MSM_UP	NA	12967
bsdb:876/8/2_Male-homosexuality:Westernized_vs_MSM_DOWN	NA	572511	123375
bsdb:876/9/1_Male-homosexuality:MSM_vs_Non-MSM_UP	NA	838
bsdb:876/10/1_Male-homosexuality:MSM_vs_Non-MSM_UP	NA	838
bsdb:876/10/2_Male-homosexuality:MSM_vs_Non-MSM_DOWN	NA	204475	577310
bsdb:876/11/1_Male-homosexuality:Non-Westernized_vs_MSM_UP	NA	574697
bsdb:876/11/2_Male-homosexuality:Non-Westernized_vs_MSM_DOWN	NA	1243	572511	970
bsdb:876/12/2_Male-homosexuality:Westernized_vs_MSM_DOWN	NA	816
bsdb:876/13/1_Male-homosexuality:Non-Westernized_vs_MSM_UP	NA	816
bsdb:876/14/2_Male-homosexuality:China-(Urban)_vs_MSM_DOWN	NA	816
bsdb:878/1/1_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_UP	NA	416916
bsdb:878/1/2_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_DOWN	NA	547	469
bsdb:878/2/1_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_UP	NA	848
bsdb:878/2/2_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_DOWN	NA	216851	816
bsdb:879/1/1_Oral-ulcer:Covid-19-with-oral-lesions_vs_Covid-19-patients-without-oral-lesions_UP	NA	1279
bsdb:879/2/1_Illness-severity-status:Severe-COVID-patients_vs_Non-severe-COVID-patients_UP	NA	838
bsdb:879/3/1_Antimicrobial-agent:Antibiotics-use_vs_No-antibiotics-use_UP	NA	1578	482	838	1279
bsdb:879/4/1_Oxygen:Oxygen-therapy_vs_No-oxygen-therapy_UP	NA	1578	29465
bsdb:879/5/1_Illness-severity-status:ICU-patients_vs_Non-ICU-patients_UP	NA	1578	29465
bsdb:879/5/2_Illness-severity-status:ICU-patients_vs_Non-ICU-patients_DOWN	NA	724
bsdb:879/6/1_Diet:Covid-19-patients-on-enteral-diet_vs_Non-enteral-diet_UP	NA	2717	117563	724	1578	32067	836	32207	1301	29465
bsdb:881/2/1_Clinical-treatment:Individuals-using-psychotropic-medication_vs_Individuals-not-using-psychotropic-medication_UP	NA	1263
bsdb:881/2/2_Clinical-treatment:Individuals-using-psychotropic-medication_vs_Individuals-not-using-psychotropic-medication_DOWN	NA	239934
bsdb:885/1/1_COVID-19:Moderate-severity_vs_Mild-severity_UP	NA	2039240	189330
bsdb:885/1/2_COVID-19:Moderate-severity_vs_Mild-severity_DOWN	NA	1980693	1485	33042	1263
bsdb:885/2/1_COVID-19:Severe/Critical-severity_vs_Mild-severity_UP	NA	2039240	189330
bsdb:885/2/2_COVID-19:Severe/Critical-severity_vs_Mild-severity_DOWN	NA	1980693	1485	33042	1263
bsdb:885/3/1_COVID-19:Severe/Critical-severity_vs_Moderate-severity_UP	NA	2039240
bsdb:885/3/2_COVID-19:Severe/Critical-severity_vs_Moderate-severity_DOWN	NA	1980693	1485	33042	1263
bsdb:886/1/1_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	1375	1386	1485	1716	51514	832	375288	577309	838	1279	1301	82802	46255
bsdb:886/1/2_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	1578	838
bsdb:886/2/1_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	544	2093	841
bsdb:886/2/2_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	904
bsdb:886/3/1_Ascariasis:Low-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	82373	119852	375288	838
bsdb:886/3/2_Ascariasis:Low-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	39948
bsdb:886/4/1_Ascariasis:High-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	82373	119852	375288	838
bsdb:886/4/2_Ascariasis:High-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	39948
bsdb:889/1/1_Cervix-erosion:Short-Cervix-Length_vs_Control_UP	NA	41275	286	83618	1279	1443919
bsdb:889/1/2_Cervix-erosion:Short-Cervix-Length_vs_Control_DOWN	NA	265	836	2050
bsdb:890/1/1_Premature-birth:Preterm-birth-(PTB)_vs_Term-birth-(TB)_UP	NA	1016	29465
bsdb:890/1/2_Premature-birth:Preterm-birth-(PTB)_vs_Term-birth-(TB)_DOWN	NA	1716	1654	1164882	194	1283313	836	43996	32067	29465	482	1301	32207	1378	724
bsdb:893/1/1_Prostate-carcinoma:Prostate-Cancer-(PCa),--Cohort-1-(Discovery-Cohort)_vs_Benign-prostatic-hyperplasia-(BPH),--Cohort-1-(Discovery-Cohort)_UP	NA	374
bsdb:893/1/2_Prostate-carcinoma:Prostate-Cancer-(PCa),--Cohort-1-(Discovery-Cohort)_vs_Benign-prostatic-hyperplasia-(BPH),--Cohort-1-(Discovery-Cohort)_UP	NA	2040	165779	43668	1696	10	59732	283	1716	59734	57493	68	186650	265	286	83618	1060	265976	1279	40323
bsdb:894/1/1_Seasonal-gut-microbiome-measurement:Day-180_vs_Day-0_UP	NA	174708	43996	150022	1573535	702	174951	46255
bsdb:894/1/2_Seasonal-gut-microbiome-measurement:Day-180_vs_Day-0_DOWN	NA	3025755	35832	1573534	1506553	33024
bsdb:896/1/1_Health-study-participation:Day-7-participants_vs_Day-1-participants_UP	NA	43994	1301	29465	547
bsdb:896/3/1_Health-study-participation:Day-14_vs_Day-7_UP	NA	207244	244127	191303
bsdb:896/3/2_Health-study-participation:Day-14_vs_Day-7_DOWN	NA	547	551	75984	1301	29465	233191	43994	724
bsdb:896/4/1_Health-study-participation:Indian-participants_vs_Chinese-participants_UP	NA	1647
bsdb:896/7/1_Health-study-participation:Female-participants_vs_Male-participants_UP	NA	28453
bsdb:896/7/2_Health-study-participation:Female-participants_vs_Male-participants_DOWN	NA	233191	1578	265975
bsdb:897/1/1_Neonatal-death:Unsuccessful-breeders_vs_Successful-breeders_UP	NA	286	570	1330546	53416
bsdb:897/1/2_Neonatal-death:Unsuccessful-breeders_vs_Successful-breeders_DOWN	NA	1918540
bsdb:898/1/1_Bladder-carcinoma:Bladder-cancer_vs_Non-neoplastic-(controls)_UP	NA	469	165779	292480	507002	129337	508215	42255	28453
bsdb:898/1/2_Bladder-carcinoma:Bladder-cancer_vs_Non-neoplastic-(controls)_DOWN	NA	583	125216	613
bsdb:898/2/1_Disease-recurrence:Higher-risk-of-recurrence-(HER)_vs_Lower-risk-of-recurrence-(LER)_UP	NA	642	816	216851	1378	963	1111
bsdb:898/3/1_Disease-progression-measurement:Higher-risk-of-progression-(HEP)_vs_Lower-risk-of-progression-(LEP)_UP	NA	816	86795	1111
bsdb:901/1/1_Allergic-asthma:Allergic-asthma_vs_Healthy-control_UP	NA	1678	84111	1301	5475
bsdb:901/1/2_Allergic-asthma:Allergic-asthma_vs_Healthy-control_DOWN	NA	906	816	1348911	239759	904
bsdb:901/2/1_Allergic-rhinitis:Allergic-rhinitis_vs_Healthy-control_UP	NA	561	1378	189330	265975
bsdb:901/2/2_Allergic-rhinitis:Allergic-rhinitis_vs_Healthy-control_DOWN	NA	906	816	1348911	239759	904
bsdb:902/1/1_SAPHO-syndrome:SAPHO-syndrome-Patients_vs_Healthy-control-group_UP	NA	1378
bsdb:902/1/2_SAPHO-syndrome:SAPHO-syndrome-Patients_vs_Healthy-control-group_DOWN	NA	1508657
bsdb:903/1/1_Hypercholesterolemia:hypercholesterolemic-(cases)_vs_normocholesterolemic-individuals-(controls)_DOWN	NA	216851	970	172900
bsdb:903/1/2_Hypercholesterolemia:hypercholesterolemic-(cases)_vs_normocholesterolemic-individuals-(controls)_UP	NA	2316	508215
bsdb:904/1/1_Response-to-allogeneic-hematopoietic-stem-cell-transplant:Engraftment-(Patients-After-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_vs_Preconditioning-(Patients-Before-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_UP	NA	1350	1578	1243	2093	1279
bsdb:904/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:Engraftment-(Patients-After-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_vs_Preconditioning-(Patients-Before-Allogeneic-Hematopoietic-Stem-Cell-Transplantation)_DOWN	NA	1654	1378	1164882	32067	1301
bsdb:905/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_UP	NA	239934	1678	1578	375288	838
bsdb:905/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_DOWN	NA	572511	33042	216851	841
bsdb:905/2/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_UP	NA	1678	375288	838	1578	239934
bsdb:905/2/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_DOWN	NA	572511	33042	216851	841
bsdb:906/1/1_Developmental-stage:Mature-hen-magnum-sample_vs_Immature-hen-magnum-sample-(23-weeks-old)_UP	NA	237	158846
bsdb:906/1/2_Developmental-stage:Mature-hen-magnum-sample_vs_Immature-hen-magnum-sample-(23-weeks-old)_DOWN	NA	374
bsdb:907/1/1_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Advanced-Adenoma-Patients_UP	NA	1765964	504090	1330545	543311
bsdb:907/1/2_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Advanced-Adenoma-Patients_DOWN	NA	572511	1485	1263	841	1407607	724	28050	1501226	189330	459786	1980693	1730	1935176	990721	2005359	2023266	1392389	1935927	207244	1935200	61170	906	35829	1715798	1164882	1940255	244127	191303	588605	1213720
bsdb:908/1/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_Healthy-Controls_UP	NA	46123	469	1654	1380	990721	1485	102106	100883	1348911	1716	84111	1350	1730	204475	117563	1578	32067	581	482	133925	577309	1257	286	638847	32207	1263	196081	177971	123375	1279	1301
bsdb:908/1/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_Healthy-Controls_DOWN	NA	838	216851	841	33024	1263	33042	39948	239759	459786	577310	553372	724	580596	846	84108	189330	1407607	1573535	1485	397864	1501226	207244	574697	283168	904	209879
bsdb:910/1/1_Parkinson's-disease:Wild-type-(WT)-mice-with-fecal-microbes-from-Parkinson’s-disease-patients-(PD)_vs_Wild-type-(WT)-mice-with-fecal-microbes-from-healthy-controls-(HC)_UP	NA	1350	113286
bsdb:910/1/2_Parkinson's-disease:Wild-type-(WT)-mice-with-fecal-microbes-from-Parkinson’s-disease-patients-(PD)_vs_Wild-type-(WT)-mice-with-fecal-microbes-from-healthy-controls-(HC)_DOWN	NA	574697	841
bsdb:910/2/1_Parkinson's-disease:ASO-mice-with-fecal-microbes-from-Parkinson’s-disease-patients-(PD)_vs_ASO-mice-with-fecal-microbes-from-healthy-controls-(HC)_UP	NA	816	35832	1350	583	113286
bsdb:910/2/2_Parkinson's-disease:ASO-mice-with-fecal-microbes-from-Parkinson’s-disease-patients-(PD)_vs_ASO-mice-with-fecal-microbes-from-healthy-controls-(HC)_DOWN	NA	580596	1485	841
bsdb:911/1/1_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-2.3years-(mean-age--1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)-exposure-in-4.7years-(mean-age)_UP	NA	2039240	1678	574697	715222	1980681	102106	423604	46238	946234	1505657	1392389	133925	119852	33024	84108	123375	83770	35829
bsdb:911/1/2_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-2.3years-(mean-age--1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)-exposure-in-4.7years-(mean-age)_DOWN	NA	419014	189330	216851	832	848	1378	117563	459786	1960084	1506577	3025755
bsdb:911/2/1_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)--exposure-in-4.7years-old(mean-age)_UP	NA	419014	574697	189330	216851	832	848	117563	459786	1960084	1506577
bsdb:911/2/2_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)--exposure-in-4.7years-old(mean-age)_DOWN	NA	2039240	1678	715222	1980681	102106	423604	46238	946234	1505657	1392389	133925	119852	33024	84108	123375	83770	35829	3025755
bsdb:911/3/1_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-2.3years-old-(mean-age--1SD)_vs_Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-4.7years-old-(mean-age)_UP	NA	2152	1678	102106	423604	946234	2039302	133925	265975	119852	2740	1929305	1473205	84108	123375	1301	83770	157	172900	35829
bsdb:911/3/2_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-2.3years-old-(mean-age--1SD)_vs_Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-4.7years-old-(mean-age)_DOWN	NA	574697	189330	1940255	848	1378	1960084	596767
bsdb:911/4/1_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Late-pregnancy-glucocorticoid(Late-preGC)-exposure-in-4.7years-old(mean-age)_UP	NA	574697	189330	1940255	848	1378	1960084	596767
bsdb:911/4/2_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Late-pregnancy-glucocorticoid(Late-preGC)-exposure-in-4.7years-old(mean-age)_DOWN	NA	2152	1678	102106	423604	946234	2039302	133925	265975	119852	2740	1929305	1473205	84108	123375	1301	83770	157	172900	35829
bsdb:911/5/1_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-2.3years-old(mean-age--1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_UP	NA	653683	109326	574697	715222	872	423604	46238	1407607	28050	248744	1649471	375288	838	1929305	970	399320	35829
bsdb:911/5/2_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-2.3years-old(mean-age--1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_DOWN	NA	194	189330	209	2767887	906	84108	157
bsdb:911/6/1_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_UP	NA	194	423604	209	906	84108	157	35829
bsdb:911/6/2_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_DOWN	NA	653683	109326	574697	715222	872	189330	46238	1407607	28050	2767887	248744	1649471	375288	838	1929305	970	399320
bsdb:911/7/1_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-2.3-years-old-(mean-age--1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_UP	NA	419014	194	216851	1378	117563	2767887	1981028	459786	1960084	1506577	172900
bsdb:911/7/2_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-2.3-years-old-(mean-age--1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_DOWN	NA	713	416916	653683	1980681	872	46238	1407607	28050	248744	119852	2729669	1508657	1301	83770	35829	3025755
bsdb:911/8/1_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-7.1-years-old-(mean-age-+1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_UP	NA	1980681	872	46238	1407607	28050	1981028	248744	459786	119852	83770	172900	3025755
bsdb:911/8/2_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-7.1-years-old-(mean-age-+1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_DOWN	NA	713	416916	419014	653683	194	216851	1378	117563	2767887	2729669	1960084	1508657	1301	1506577	35829
bsdb:912/1/1_Diet:Test-diet_vs_Reference-diet_UP	NA	2093
bsdb:912/1/2_Diet:Test-diet_vs_Reference-diet_DOWN	NA	1578	1357	1243
bsdb:912/2/1_Diet:January-Test-diet_vs_January-Reference-diet_UP	NA	1578	1243	1357	1257	46255	1386	129337	1485	657	2745	848	623282
bsdb:912/2/2_Diet:January-Test-diet_vs_January-Reference-diet_DOWN	NA	160795
bsdb:912/3/1_Diet:Fishes-fed-with-test-diet-in-April_vs_Fishes-fed-with-test-diet-in-January_UP	NA	657
bsdb:912/4/1_Diet:Fishes-fed-with-test-diet-in-September_vs_Fishes-fed-with-test-diet-in-January_UP	NA	2093
bsdb:912/4/2_Diet:Fishes-fed-with-test-diet-in-September_vs_Fishes-fed-with-test-diet-in-January_DOWN	NA	1243	1578	1357
bsdb:912/5/1_Diet:April-Test-diet_vs_April-Reference-diet_UP	NA	848	2745	2093	22	46255	511678
bsdb:912/5/2_Diet:April-Test-diet_vs_April-Reference-diet_DOWN	NA	1578	1243	1357	1257	1386	160795	657	623282	1485
bsdb:912/6/1_Diet:september-Test-diet_vs_september-Reference-diet_UP	NA	160795	657	1578	22	623282
bsdb:912/6/2_Diet:september-Test-diet_vs_september-Reference-diet_DOWN	NA	2745	2093
bsdb:913/1/1_Myopia:L-group----Ok-Lens-group_vs_N-group----Non-wearer-group_UP	NA	41275	469	583	1279	1716	1301	547	1350	572511	1912216
bsdb:913/1/2_Myopia:L-group----Ok-Lens-group_vs_N-group----Non-wearer-group_DOWN	NA	1386
bsdb:914/1/1_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_UP	NA	1301	1263	838	543311	1080709	906	1578	1505657	209	117563	1378	1730	135858	1678	816	207244	1654
bsdb:914/1/2_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_DOWN	NA	191303	1301	1263	475	1080709	1578	1505657	1730	572511	397864
bsdb:914/2/1_Celiac-disease:Celiac-disease-(CeD)_vs_First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_UP	NA	1080709	906	1578	209	1730	135858	572511	239934
bsdb:914/2/2_Celiac-disease:Celiac-disease-(CeD)_vs_First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_DOWN	NA	191303	1301	1263	543311	1080709	1505657	117563	1378	1730	135858	1678	207244	1654
bsdb:914/3/1_Celiac-disease:Celiac-disease-(CeD)_vs_Disease-Control-(DC)_UP	NA	838	1080709	906	1578	209	135858	572511
bsdb:914/3/2_Celiac-disease:Celiac-disease-(CeD)_vs_Disease-Control-(DC)_DOWN	NA	191303	1263	475	1080709	1578	1505657	1730	572511	397864
bsdb:914/4/1_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_UP	NA	1080709
bsdb:914/4/2_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_DOWN	NA	1080709	1578	724	189330	239934
bsdb:914/5/1_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_UP	NA	1080709	1578
bsdb:914/5/2_Celiac-disease:First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_vs_Disease-Control-(DC)_DOWN	NA	1253	1080709	1505657	189330	572511
bsdb:914/6/1_Celiac-disease:Celiac-disease-(CeD)_vs_First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_UP	NA	1080709	1578
bsdb:914/6/2_Celiac-disease:Celiac-disease-(CeD)_vs_First-degree-relatives-(FDRs)-of-celiac-disease-(CeD)-patients_DOWN	NA	838	1080709	1578	189330	239934
bsdb:915/1/1_Breast-carcinoma:premenopausal-breast-cancer-patients-(Pre-BC)_vs_Premenopausal-female-controls-(Pre-C)_UP	NA	816	848	724	40544
bsdb:915/1/2_Breast-carcinoma:premenopausal-breast-cancer-patients-(Pre-BC)_vs_Premenopausal-female-controls-(Pre-C)_DOWN	NA	239934	239759	1678	102106	33042	39948	547	1350	906	52225	846	375288	508215	1301
bsdb:915/2/1_Breast-carcinoma:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Postmenopausal-female-controls-(Post-C)_UP	NA	1654	724	52225	40544
bsdb:915/2/2_Breast-carcinoma:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Postmenopausal-female-controls-(Post-C)_DOWN	NA	239934	239759	35832	84111	846	33024	1263	1301
bsdb:915/3/2_Menopause:Postmenopausal-female-controls-(Post-C)_vs_Premenopausal-female-controls-(Pre-C)_DOWN	NA	216851	1678
bsdb:915/4/1_Menopause:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Premenopausal-breast-cancer-patients-(Pre-BC)_UP	NA	872	191303
bsdb:915/4/2_Menopause:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Premenopausal-breast-cancer-patients-(Pre-BC)_DOWN	NA	1678	119852	35832	447020
bsdb:916/1/2_Vaginitis:Recurrent-vaginitis-(RV)_vs_Healthy-women-(control)_DOWN	NA	1578
bsdb:916/3/1_Vaginal-microbiome-measurement:Community-state-type-(CST)-III_vs_Community-state-type-(CST)-I-and-IV_UP	NA	1578
bsdb:916/4/1_Vaginal-microbiome-measurement:Community-state-type-(CST)-IV_vs_Community-state-type-(CST)-I-and-III_UP	NA	2701
bsdb:917/1/1_Gut-microbiome-measurement:Antiretroviral-therapy-(ART)-Naïve-at-baseline_vs_Healthy-controls-(HC)_DOWN	NA	1485
bsdb:917/2/2_Clinical-treatment:Antiretroviral-therapy-(ART)-naïve-at-baseline-and-after-24-weeks-of-first-line-ART_vs_Healthy-controls-(HC)_DOWN	NA	12967	830	191303	1485
bsdb:917/3/1_Clinical-treatment:Antiretroviral-therapy-(ART)-experienced-at-baseline_vs_Healthy-controls-(HC)_UP	NA	158846	1506553
bsdb:917/3/2_Clinical-treatment:Antiretroviral-therapy-(ART)-experienced-at-baseline_vs_Healthy-controls-(HC)_DOWN	NA	12967	830	191303	1485
bsdb:917/4/1_Clinical-treatment:Antiretroviral-therapy-(ART)-experienced-at-baseline-and-after-24-weeks_vs_Healthy-controls-(HC)_UP	NA	158846	1506553	35832
bsdb:917/4/2_Clinical-treatment:Antiretroviral-therapy-(ART)-experienced-at-baseline-and-after-24-weeks_vs_Healthy-controls-(HC)_DOWN	NA	12967	830	191303	1485
bsdb:918/1/1_Constipation,Parkinson's-disease:Parkinson's-disease-patients-(PD)-before-Fecal-microbiota-transplant-(FMT)_vs_Healthy-Control-group_UP	NA	816
bsdb:918/2/2_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_UP	NA	572511	102106	189330	1501226
bsdb:918/3/1_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_DOWN	NA	816
bsdb:918/3/2_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_UP	NA	572511	216851
bsdb:918/4/1_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_DOWN	NA	816
bsdb:918/4/2_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_UP	NA	572511
bsdb:918/5/2_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_UP	NA	216851
bsdb:922/1/1_Parkinson's-disease:Parkinson’s-disease_vs_Healthy-controls_UP	NA	239934
bsdb:923/1/1_Response-to-exercise:Aerobic-exercise-training-group-(AET)_vs_Sham-group-and-parkison's-disease-(PD)-group_UP	NA	1578	1357	400634	93681	216851	1060
bsdb:923/2/1_Response-to-exercise:parkison's-disease-(PD)-group_vs_Sham-group-and-Aerobic-exercise-training-group-(AET)-group_UP	NA	1937008	1937007	580024
bsdb:923/3/1_Response-to-exercise:Sham-group_vs_Aerobic-exercise-training-group-(AET)-and-parkison's-disease-(PD)-group_DOWN	NA	46913
bsdb:924/1/1_Parkinson's-disease:Parkinson's-disease-(PD)_vs_Healthy-controls-(HC)_UP	NA	544	1350	570	1357	590	620
bsdb:924/1/2_Parkinson's-disease:Parkinson's-disease-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	841
bsdb:924/2/1_Parkinson's-disease:Parkinson's-disease-(excluding-iCOMT-users)_vs_Healthy-controls-(HC)_UP	NA	570	1578
bsdb:925/1/1_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_UP	NA	1350
bsdb:925/1/2_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_DOWN	NA	572511	209	1937007
bsdb:925/2/1_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_UP	NA	53357	400634	33882	1763	1522432	648802	207599	1883	432330
bsdb:925/2/2_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_DOWN	NA	239759	1283313	1472649	209	1501226
bsdb:925/3/1_Treatment:Ropinirole-treatment-group-(R)_vs_Vehicle-group-(VH)_DOWN	NA	239759	580024	209
bsdb:925/4/1_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_UP	NA	174708	1578	459786
bsdb:925/4/2_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_DOWN	NA	31980	239934	239759	816	872	580024	1918540	459786	577310	841
bsdb:925/5/1_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_UP	NA	174708	1678	1937007	1578	459786	1506577
bsdb:925/5/2_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_DOWN	NA	31980	239934	239759	872	580024	459786	577310	28138
bsdb:925/6/1_Treatment:Ropinirole-treatment-group-(R)_vs_Vehicle-group-(VH)_UP	NA	174708	1937007	1578
bsdb:925/6/2_Treatment:Ropinirole-treatment-group-(R)_vs_Vehicle-group-(VH)_DOWN	NA	841
bsdb:927/1/1_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_UP	NA	816
bsdb:927/2/1_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_UP	NA	174708	419014	1380	1678	830	1716	872	1578	2050	838	196081	191303	577309
bsdb:927/3/1_Response-to-transplant:Behcet's-disease-(BD)-feces-treated-group_vs_Healthy-Control-feces-treated-group_UP	NA	239759	1283313	52784	35832	574697	1348911	248038	577309
bsdb:927/3/2_Response-to-transplant:Behcet's-disease-(BD)-feces-treated-group_vs_Healthy-Control-feces-treated-group_DOWN	NA	102106
bsdb:928/1/1_Chronic-granulomatous-disease:Chronic-granulomatous-disease_vs_Healthy-controls_UP	NA	1506553	1769710	3025755	29465
bsdb:928/1/2_Chronic-granulomatous-disease:Chronic-granulomatous-disease_vs_Healthy-controls_DOWN	NA	207244	1485	102106	33042	189330	28050	191303
bsdb:928/2/2_Chronic-granulomatous-disease:Chronic-granulomatous-disease-(CGD)-patients_vs_Healthy-individuals_DOWN	NA	580596
bsdb:928/4/1_Cohort:NIHCC-Cohort-(CGD-without-IBD)_vs_PIDTC-Cohort-(CGD-without-IBD)_DOWN	NA	1350
bsdb:928/4/2_Cohort:NIHCC-Cohort-(CGD-without-IBD)_vs_PIDTC-Cohort-(CGD-without-IBD)_UP	NA	1766253	207244	816	580596	189330	216851	2039302	841	1263	1769710	292632
bsdb:928/5/1_Cohort:NIHCC-Cohort-(CGD-Patients)_vs_PIDTC-Cohort-(CGD-Patients)_DOWN	NA	580596	1301
bsdb:928/5/2_Cohort:NIHCC-Cohort-(CGD-Patients)_vs_PIDTC-Cohort-(CGD-Patients)_UP	NA	1766253	2039302	437755	459786	1769710	292632
bsdb:928/6/1_Age:CGD-patients-above-12-years_vs_CGD-patients-less-than-or-equal-to-12-years_UP	NA	239759	35832	580596	459786	1769710	292632
bsdb:930/1/1_Gut-microbiome-measurement:Low-litter-performance-sows-at-G109_vs_High-litter-performance-sows-at-G109_UP	NA	33024	191303
bsdb:930/1/2_Gut-microbiome-measurement:Low-litter-performance-sows-at-G109_vs_High-litter-performance-sows-at-G109_DOWN	NA	816
bsdb:930/2/2_Gut-microbiome-measurement:Low-litter-performance-sows-at-L21_vs_High-litter-performance-sows-at-L21_DOWN	NA	33042	375288
bsdb:930/3/1_Gut-microbiome-measurement:Day-21-of-lactation-(L21)-of-H-group_vs_Day-109-of-gestation-(G109)-of-H-group_UP	NA	375288	1263	86331
bsdb:930/3/2_Gut-microbiome-measurement:Day-21-of-lactation-(L21)-of-H-group_vs_Day-109-of-gestation-(G109)-of-H-group_DOWN	NA	816	236052	83770
bsdb:930/4/1_Gut-microbiome-measurement:Day-21-of-lactation-(L21)-of-L-group_vs_Day-109-of-gestation-(G109)-of-L-group_DOWN	NA	33024	236052
bsdb:931/1/1_Essential-tremor:Essential-Tremor_vs_Healthy-Control_UP	NA	40323
bsdb:931/1/2_Essential-tremor:Essential-Tremor_vs_Healthy-Control_DOWN	NA	49082	135858	216851	404402	1578	160674
bsdb:931/2/2_Essential-tremor:Essential-Tremor_vs_Parkinson's-Disease_UP	NA	1506553
bsdb:932/1/1_Delivery-method:Elective-Cesarean-Section-(ECS)_vs_Vaginally-Delivered(VD)_UP	NA	1485
bsdb:932/1/2_Delivery-method:Elective-Cesarean-Section-(ECS)_vs_Vaginally-Delivered(VD)_DOWN	NA	39948	2701	375288
bsdb:932/2/1_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-0_vs_Vaginally-Delivered(VD)-at-Day-0_UP	NA	544
bsdb:932/2/2_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-0_vs_Vaginally-Delivered(VD)-at-Day-0_DOWN	NA	2282523
bsdb:932/3/1_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-15_vs_Vaginally-Delivered(VD)-at-Day-15_UP	NA	1485
bsdb:932/3/2_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-15_vs_Vaginally-Delivered(VD)-at-Day-15_DOWN	NA	561	620	906
bsdb:932/4/1_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-30_vs_Vaginally-Delivered(VD)-at-Day-30_UP	NA	568987	1164882
bsdb:932/4/2_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-30_vs_Vaginally-Delivered(VD)-at-Day-30_DOWN	NA	375288	2701
bsdb:932/5/1_Delivery-method:An-experiment-for-group-1-(day-0)-vs.-group-0-(days-15-and-30)_vs_NA_UP	NA	40323	286	2282523
bsdb:932/6/1_Delivery-method:An-experiment-for-group-1-(day-15)-vs.-group-0-(days-0-and-30)_vs_NA_UP	NA	904	1678	1716	547	561	570	1578	909928	590	620	1279
bsdb:932/6/2_Delivery-method:An-experiment-for-group-1-(day-15)-vs.-group-0-(days-0-and-30)_vs_NA_UP	NA	1678	570	561	1578	590	1279	909928	620	1716
bsdb:932/7/1_Delivery-method:An-experiment-for-group-1-(day-30)-vs.-group-0-(days-0-and-15)_vs_NA_UP	NA	572511	544	1485	547	1350	1730	724	1506553	160674	613	1301	29465
bsdb:933/1/1_Cholestasis:Infantile--cholestasis-(IC)_vs_Healthy-Control-(CON)_UP	NA	156973	1506553	1301
bsdb:933/1/2_Cholestasis:Infantile--cholestasis-(IC)_vs_Healthy-Control-(CON)_DOWN	NA	1501226	75	3025755	580880
bsdb:935/1/1_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	239934	816	2172	1508657	1905344	1392389	990721
bsdb:935/1/2_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	216851	724	1573535	1506553	841	84108	40544	29465
bsdb:935/2/1_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Diseased-Controls_UP	NA	447020	239934	239759	207244	191	1485	1407607	2039302	1501226	172900	2023266
bsdb:935/2/2_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Diseased-Controls_DOWN	NA	1654	1380	29521	574697	135858	102106	1348911	1940255	724	1573535	1578	133925	577309	838	146	1301	674963	1506577
bsdb:936/1/1_Vulvovaginitis:Vulvovaginal-symptoms_vs_Non-vulvovaginal-symptoms-(control)_UP	NA	419014	236752	2701	168808
bsdb:937/1/1_Pregnancy:Clinical-pregnancy-(FP)_vs_Non-pregnant-(FN)_DOWN	NA	434	216851	848	204475	724	1578	33024	48463	841	46255
bsdb:937/1/2_Pregnancy:Clinical-pregnancy-(FP)_vs_Non-pregnant-(FN)_UP	NA	1427378	239934	1283313	2086	244127	28196	1380	35832	574697	872	39948	2701	209	482	375288	577309	577310	44013	1827	1263	191303	212791
bsdb:938/4/1_Gut-microbiome-measurement:Rumen-of-Tan-Sheep-(T_R)_vs_Rumen-of-Dorper-sheep-(D_R)_UP	NA	100175	1200657
bsdb:938/5/1_Gut-microbiome-measurement:Duodenum-of-Tan-Sheep-(T_Du)_vs_Duodenum-of-Dorper-sheep-(D_Du)_UP	NA	1200657	1473205
bsdb:938/7/1_Gut-microbiome-measurement:Colon-of-Tan-Sheep-(T_Co)_vs_Colon-of-Dorper-sheep-(D_Co)_UP	NA	172900
bsdb:939/1/1_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome-positive-(IBS+)_vs_Irritable-Bowel-Syndrome-negative-(IBS-)_DOWN	NA	816	838
bsdb:940/1/1_COVID-19:Covid-19-group_vs_Control-group_UP	NA	1827388	1762950	2875642	63255	405928	1963373	673167	4930	292631	36048	1932873
bsdb:940/1/2_COVID-19:Covid-19-group_vs_Control-group_DOWN	NA	308926	1323519	36922	5094	1666919	5159	45340	5402	5206	34372	241727
bsdb:940/2/1_COVID-19:Post-Covid-19-group_vs_Covid-19-group_UP	NA	64644	45132	5475	27314	27316	55193	4830	5533	42658
bsdb:940/2/2_COVID-19:Post-Covid-19-group_vs_Covid-19-group_DOWN	NA	2875642	405928	1827388	673167	1932873	292631	4930	36048	1963373	63255	1762950
bsdb:940/3/1_COVID-19:Post-Covid-19-group_vs_Control-group_UP	NA	64644	45132	5475	27314	27316	55193	4830	5533	42658
bsdb:940/4/1_COVID-19:Covid-19-N-group_vs_Control-group_UP	NA	1827388	5475	405928	45340
bsdb:940/4/2_COVID-19:Covid-19-N-group_vs_Control-group_DOWN	NA	1323519	34372	5206	5498	55193	308926
bsdb:940/5/1_COVID-19:Covid-19-C-group_vs_Control-group_UP	NA	5475	45340	405928
bsdb:940/5/2_COVID-19:Covid-19-C-group_vs_Control-group_DOWN	NA	1323519	5206	308926
bsdb:940/6/1_COVID-19:Covid-19-C-group_vs_Covid-19-N-group_UP	NA	34372
bsdb:941/1/1_Abnormal-sperm-morphology:Asthenozoospermia_vs_Healthy-Control_UP	NA	416916	1283313	191	872	61170	1578	577310	33024
bsdb:942/1/1_Stroke:Cerebral-ischemic-stroke-patients_vs_Healthy-individuals_UP	NA	459786	434	283168	102106	872	442430
bsdb:942/1/2_Stroke:Cerebral-ischemic-stroke-patients_vs_Healthy-individuals_DOWN	NA	191
bsdb:943/1/1_Major-depressive-disorder:Major-depressive-disorder-(MDD)_vs_Healthy-controls-(HC)_UP	NA	447020
bsdb:943/1/2_Major-depressive-disorder:Major-depressive-disorder-(MDD)_vs_Healthy-controls-(HC)_DOWN	NA	841	1485	724	191303
bsdb:943/2/1_Gut-microbiome-measurement:Non-inflammatory-depression_vs_Healthy-controls-(HC)-and-inflammatory-depression-group_UP	NA	216851	724
bsdb:943/3/1_Gut-microbiome-measurement:Inflammatory-depression_vs_Healthy-controls-(HC)-and-non-inflammatory-depression-group_UP	NA	391952	816	41275	134550	810	1154586	505691	1357	204447	469322	240236
bsdb:943/4/1_Gut-microbiome-measurement:Inflammatory-depression_vs_Non-inflammatory-depression_UP	NA	816	724	1357	375288	207599
bsdb:943/4/2_Gut-microbiome-measurement:Inflammatory-depression_vs_Non-inflammatory-depression_DOWN	NA	216851	724
bsdb:943/6/1_Major-depressive-disorder:Inflammatory-and-non-inflammatory-depression_vs_Healthy-control-(HC)_DOWN	NA	841	1485
bsdb:943/7/1_Gut-microbiome-measurement:High-inflammatory-group_vs_Low-inflammatory,-healthy-control-and-blank-groups_UP	NA	174708	191303
bsdb:943/8/1_Gut-microbiome-measurement:Low-inflammatory-group_vs_High-inflammatory,-healthy-control-and-blank-groups_UP	NA	265
bsdb:943/9/1_Gut-microbiome-measurement:High-inflammatory,-low-inflammatory-and-blank-groups_vs_Healthy-control-(HC)-group_DOWN	NA	816	620
bsdb:943/10/1_Gut-microbiome-measurement:Blank-group_vs_High-inflammatory,-low-inflammatory-and-healthy-control-groups_UP	NA	872
bsdb:943/11/1_Gut-microbiome-measurement:High-inflammatory-group_vs_Clostridium-butyricum-(CB)-and-normal-saline-(NS)-groups_UP	NA	872
bsdb:943/12/1_Gut-microbiome-measurement:Clostridium-butyricum-(CB)_vs_High-inflammatory-and-normal-saline-(NS)-groups_UP	NA	816	620	574697
bsdb:944/1/2_Parkinson's-disease:Parkinson's-disease-group_vs_Healthy-control-(control-matched--CM)_DOWN	NA	1350	1357
bsdb:945/1/1_Cognitive-impairment:Mild-Cognitive-Impairment_vs_Cognitive-Normal_UP	NA	33042	33024
bsdb:945/1/2_Cognitive-impairment:Mild-Cognitive-Impairment_vs_Cognitive-Normal_DOWN	NA	39948
bsdb:945/2/1_Cognitive-impairment:Post-modified-Mediterranean-ketogenic-diet-(MMKD)-in-MCI_vs_Post-American-heart-association-diet-(AHAD)-in-MCI_DOWN	NA	1678
bsdb:945/3/1_Cognitive-impairment:Post-modified-Mediterranean-ketogenic-diet-(MMKD)-in-CN-and-MCI_vs_Post-American-heart-association-diet-(AHAD)-in-CN-and-MCI_DOWN	NA	1678
bsdb:945/4/1_Cognitive-impairment:Post-modified-Mediterranean-ketogenic-diet-(MMKD)-in-CN-and-MCI_vs_Pre-modified-Mediterranean-ketogenic-diet-(MMKD)-in-CN-and-MCI_UP	NA	1357
bsdb:945/4/2_Cognitive-impairment:Post-modified-Mediterranean-ketogenic-diet-(MMKD)-in-CN-and-MCI_vs_Pre-modified-Mediterranean-ketogenic-diet-(MMKD)-in-CN-and-MCI_DOWN	NA	1678
bsdb:946/1/2_Parkinson's-disease:PD:-individuals-with-Parkinson's-disease_vs_HC:-household-controls_DOWN	NA	841
bsdb:946/2/1_Parkinson's-disease:PD:-Individuals-with-Parkinson's-disease_vs_PC:-healthy-population-controls-without-Parkinson's-Disease_UP	NA	1432051	1905344
bsdb:946/2/2_Parkinson's-disease:PD:-Individuals-with-Parkinson's-disease_vs_PC:-healthy-population-controls-without-Parkinson's-Disease_DOWN	NA	216851	830
bsdb:947/2/1_Social-deprivation:Socially-Isolated-SIc-(15-week-socially-isolated-group)_vs_Normal-Control-NCc-(15-week-normal-control-group)_UP	NA	447020	239934	207244	816	1357	248038	13687	40544
bsdb:947/2/2_Social-deprivation:Socially-Isolated-SIc-(15-week-socially-isolated-group)_vs_Normal-Control-NCc-(15-week-normal-control-group)_DOWN	NA	1578	28253	407	283168
bsdb:948/1/1_Disease-staging:Deteriorated-Group-at-year-0_vs_Stable-Group-at-year-0_DOWN	NA	1678
bsdb:948/2/1_Timepoint:Parkinson's-disease-patients-at-year-2_vs_Parkinson's-disease-patients-at-year-0_DOWN	NA	1678	1380	838	1350
bsdb:948/4/1_Timepoint:Stable-group-at-year-2_vs_Stable-group-at-year-0_DOWN	NA	1380	1678	1350
bsdb:949/8/1_Gut-microbiome-measurement:Ascaris-suum-(Females)_vs_Ascaris-summ-(Males)_UP	NA	1485	1505652	838
bsdb:949/8/2_Gut-microbiome-measurement:Ascaris-suum-(Females)_vs_Ascaris-summ-(Males)_DOWN	NA	1283313	39948	832	838	841	1263	292632	1485
bsdb:949/9/1_Gut-microbiome-measurement:Parasite-(Ascaris-suum)-Microbiome_vs_Host-(Ascaris-suum-infected-Pigs)-Microbiome_UP	NA	1766253	1283313	653683	28050	1578	838	286	841	1263	1301	1485
bsdb:949/9/2_Gut-microbiome-measurement:Parasite-(Ascaris-suum)-Microbiome_vs_Host-(Ascaris-suum-infected-Pigs)-Microbiome_DOWN	NA	1505660	1678	1578	906	2740	838	1302778	1485
bsdb:950/1/1_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_UP	NA	838
bsdb:950/1/2_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_DOWN	NA	135858	39948	123375
bsdb:950/2/1_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_UP	NA	838
bsdb:950/2/2_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	102106	2082587	3025755
bsdb:950/3/1_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_UP	NA	838
bsdb:950/4/1_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_UP	NA	838	586
bsdb:950/4/2_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	572511	1481960	1279
bsdb:950/5/1_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_UP	NA	838	586	40544	906
bsdb:950/5/2_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	572511	1481960	1506577	1266	580596	1407607	469	1386	1279	264995
bsdb:950/6/1_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_UP	NA	838	48736	1918540	1386	38501	490567	204447
bsdb:950/6/2_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_DOWN	NA	123375	135858	1506577	2082587	1774107	1392389
bsdb:950/7/1_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_UP	NA	838
bsdb:950/7/2_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	102106	3025755	2082587
bsdb:951/1/1_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_UP	NA	43996	212742	543311	1257	157
bsdb:951/1/2_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_DOWN	NA	1283313	47670
bsdb:951/2/1_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_UP	NA	1016	237
bsdb:951/2/2_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_DOWN	NA	1654	2717	47670	1743	286	32207
bsdb:952/1/1_Clinical-treatment:Parkinson's-disease-(PD)-patients-treated-with-both-levodopa-and-Entacapone-(PD_LE)_vs_Parkinson's-disease-(PD)-patients-treated-with-levodopa-only-(PD_L)_UP	NA	1678	1730
bsdb:952/1/2_Clinical-treatment:Parkinson's-disease-(PD)-patients-treated-with-both-levodopa-and-Entacapone-(PD_LE)_vs_Parkinson's-disease-(PD)-patients-treated-with-levodopa-only-(PD_L)_DOWN	NA	572511	189330	216851	1505657	1578	1769710
bsdb:953/1/1_Upper-digestive-tract-disease:Saliva-samples_vs_Esophagus-samples_UP	NA	482	838
bsdb:953/1/2_Upper-digestive-tract-disease:Saliva-samples_vs_Esophagus-samples_DOWN	NA	1301	724
bsdb:953/2/1_Upper-digestive-tract-disease:Saliva-samples_vs_Cardia-biopsy-samples_UP	NA	482	838
bsdb:953/2/2_Upper-digestive-tract-disease:Saliva-samples_vs_Cardia-biopsy-samples_DOWN	NA	46255
bsdb:953/3/1_Upper-digestive-tract-disease:Saliva-samples_vs_Non-cardia-biopsy-samples_UP	NA	482	838
bsdb:953/3/2_Upper-digestive-tract-disease:Saliva-samples_vs_Non-cardia-biopsy-samples_DOWN	NA	209
bsdb:953/4/1_Upper-digestive-tract-disease:Saliva-samples_vs_Gastric-juice-sample_UP	NA	482	838
bsdb:953/4/2_Upper-digestive-tract-disease:Saliva-samples_vs_Gastric-juice-sample_DOWN	NA	286
bsdb:953/5/1_Upper-digestive-tract-disease:Saliva-samples_vs_Fecal-samples_UP	NA	482	838
bsdb:953/5/2_Upper-digestive-tract-disease:Saliva-samples_vs_Fecal-samples_DOWN	NA	216851	841	572511
bsdb:953/6/1_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Cardia-biopsy-samples_UP	NA	1301	724
bsdb:953/6/2_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Cardia-biopsy-samples_DOWN	NA	46255
bsdb:953/7/1_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Non-cardia-biopsy-samples_UP	NA	1301	724
bsdb:953/7/2_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Non-cardia-biopsy-samples_DOWN	NA	209
bsdb:953/8/1_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Gastric-juice-samples_UP	NA	1301	724
bsdb:953/8/2_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Gastric-juice-samples_DOWN	NA	286
bsdb:953/9/1_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Fecal-samples_UP	NA	1301	724
bsdb:953/9/2_Upper-digestive-tract-disease:Esophageal-swab-samples_vs_Fecal-samples_DOWN	NA	216851	841	572511
bsdb:953/10/1_Upper-digestive-tract-disease:Cardia-biopsy-samples_vs_Non-cardia-biopsy-samples_UP	NA	46255
bsdb:953/10/2_Upper-digestive-tract-disease:Cardia-biopsy-samples_vs_Non-cardia-biopsy-samples_DOWN	NA	209
bsdb:953/11/1_Upper-digestive-tract-disease:Cardia-biopsy-samples_vs_Gastric-juice-samples_UP	NA	46255
bsdb:953/11/2_Upper-digestive-tract-disease:Cardia-biopsy-samples_vs_Gastric-juice-samples_DOWN	NA	286
bsdb:953/12/1_Upper-digestive-tract-disease:Cardia-biopsy-samples_vs_Fecal-samples_UP	NA	46255
bsdb:953/12/2_Upper-digestive-tract-disease:Cardia-biopsy-samples_vs_Fecal-samples_DOWN	NA	216851	841	572511
bsdb:953/13/1_Upper-digestive-tract-disease:Non-cardia-biopsy-samples_vs_Gastric-juice-samples_UP	NA	209
bsdb:953/13/2_Upper-digestive-tract-disease:Non-cardia-biopsy-samples_vs_Gastric-juice-samples_DOWN	NA	286
bsdb:953/14/1_Upper-digestive-tract-disease:Non-cardia-biopsy-samples_vs_Fecal-samples_UP	NA	209
bsdb:953/14/2_Upper-digestive-tract-disease:Non-cardia-biopsy-samples_vs_Fecal-samples_DOWN	NA	216851	841	572511
bsdb:953/15/1_Upper-digestive-tract-disease:Gastric-juice-samples_vs_Fecal-samples_UP	NA	286
bsdb:953/15/2_Upper-digestive-tract-disease:Gastric-juice-samples_vs_Fecal-samples_DOWN	NA	216851	841	572511
bsdb:954/1/1_Parkinson's-disease:MPTP-treated-mice_vs_Control-mice_UP	NA	1716	283168	1827	28138	1678
bsdb:954/1/2_Parkinson's-disease:MPTP-treated-mice_vs_Control-mice_DOWN	NA	447020	574697	375288	838	577309
bsdb:955/1/1_Parkinson's-disease:Parkinson's-Disease-(PD)-Patients_vs_Healthy-controls_UP	NA	1357	149698	48736
bsdb:956/1/1_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_UP	NA	222	100883	1573534	848	1506553	1960084	1266	1279
bsdb:956/1/2_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_DOWN	NA	1766253	507	580596	102106	33042	39948	189330	216851	52225	2039302	1263
bsdb:956/2/1_Schizophrenia:Schizophrenia-patients-with-prominent-positive-symptoms-(SCH-P)_vs_Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_UP	NA	41275	1266
bsdb:956/2/2_Schizophrenia:Schizophrenia-patients-with-prominent-positive-symptoms-(SCH-P)_vs_Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_DOWN	NA	1582879
bsdb:957/1/1_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_UP	NA	906	52225	419014	1016	1578	86331	133925	113286	196081	84108
bsdb:957/1/2_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	46123	47670	459786	13687
bsdb:957/2/1_Parkinson's-disease-symptom-measurement:Patients-with-severe-Parkinson's-disease-(severe-PD)_vs_Patients-with-mild-Parkinson's-disease--(mild-PD)_UP	NA	906	1678	1016	724	1578	133925	113286	196081
bsdb:957/2/2_Parkinson's-disease-symptom-measurement:Patients-with-severe-Parkinson's-disease-(severe-PD)_vs_Patients-with-mild-Parkinson's-disease--(mild-PD)_DOWN	NA	47670
bsdb:957/3/1_Parkinson's-disease-symptom-measurement:Patients-with-severe-Parkinson's-disease-(severe-PD)_vs_Patients-with-mild-Parkinson's-disease--(mild-PD)_UP	NA	1678	698776	33042	561	570	1578	133925	583
bsdb:957/3/2_Parkinson's-disease-symptom-measurement:Patients-with-severe-Parkinson's-disease-(severe-PD)_vs_Patients-with-mild-Parkinson's-disease--(mild-PD)_DOWN	NA	207244	2039240	572511	1730	28050
bsdb:957/4/1_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_UP	NA	239759	1678	102106	561	1649459	1578	86331	283168	459786	375288	44748
bsdb:957/4/2_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	1766253	33042	1350	724	838	841	1263
bsdb:958/1/1_Lung-transplantation:Lung-transplant-event-free-group-(EF)_vs_No-lung-transplant-group-(NT)_UP	NA	1386	1350	570	1263	1301	3025755
bsdb:958/1/2_Lung-transplantation:Lung-transplant-event-free-group-(EF)_vs_No-lung-transplant-group-(NT)_DOWN	NA	1766253	816	2383	216851	838
bsdb:958/2/1_Lung-transplantation:Lung-transplant-chronic-rejection-group-(CR)_vs_No-lung-transplant-group-(NT)_UP	NA	1386	1350	2759736	1301
bsdb:958/2/2_Lung-transplantation:Lung-transplant-chronic-rejection-group-(CR)_vs_No-lung-transplant-group-(NT)_DOWN	NA	816	2383	216851	838
bsdb:959/1/1_Essential-thrombocythemia:Essential-thrombocythemia-(ET)_vs_Healthy-Controls_UP	NA	29465
bsdb:959/1/2_Essential-thrombocythemia:Essential-thrombocythemia-(ET)_vs_Healthy-Controls_DOWN	NA	1766253	216851
bsdb:959/2/1_Essential-thrombocythemia:Janus-kinase-2-(JAK2V617F)-positive_vs_Healthy-Controls_UP	NA	191303	29465
bsdb:959/2/2_Essential-thrombocythemia:Janus-kinase-2-(JAK2V617F)-positive_vs_Healthy-Controls_DOWN	NA	1766253	216851
bsdb:959/3/1_Essential-thrombocythemia:Janus-kinase-2-(JAK2V617F)-negative_vs_Healthy-Controls_UP	NA	292632
bsdb:959/3/2_Essential-thrombocythemia:Janus-kinase-2-(JAK2V617F)-negative_vs_Healthy-Controls_DOWN	NA	1766253	216851
bsdb:959/4/1_Essential-thrombocythemia:Janus-kinase-2-(JAK2V617F)-positive_vs_Janus-kinase-2-(JAK2V617F)-negative_UP	NA	1678
bsdb:960/1/1_Curcumin:CUR-L_vs_MPTP_UP	NA	447020	239759	1283313	2086	2039240	1506553	2518497
bsdb:960/1/2_Curcumin:CUR-L_vs_MPTP_DOWN	NA	239934	1331051	1730	1392389
bsdb:960/2/1_Curcumin:CUR-M_vs_MPTP_UP	NA	580024	2518497	286
bsdb:960/2/2_Curcumin:CUR-M_vs_MPTP_DOWN	NA	1427378	1730
bsdb:960/3/1_Curcumin:CUR-H_vs_MPTP_UP	NA	174708	580024	1392389	2518497	286
bsdb:960/3/2_Curcumin:CUR-H_vs_MPTP_DOWN	NA	1730	61170	1331051
bsdb:961/1/1_Parkinson's-disease:MPTP-(untreated-PD-mice)_vs_Control-(CON-groups)_UP	NA	816	1283313	375288
bsdb:961/1/2_Parkinson's-disease:MPTP-(untreated-PD-mice)_vs_Control-(CON-groups)_DOWN	NA	1331051	283168	2129
bsdb:961/2/1_Clinical-treatment:MPTP-(untreated-PD-mice)_vs_FGF21-+-MPTP-mice-(mice-treated-with-Fibroblast-growth-factor-21-(FGF21))_UP	NA	1279
bsdb:961/2/2_Clinical-treatment:MPTP-(untreated-PD-mice)_vs_FGF21-+-MPTP-mice-(mice-treated-with-Fibroblast-growth-factor-21-(FGF21))_DOWN	NA	1331051
bsdb:962/1/1_Antimicrobial-agent:Antibiotic-(Ab)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_UP	NA	906
bsdb:962/1/2_Antimicrobial-agent:Antibiotic-(Ab)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_DOWN	NA	561
bsdb:962/2/2_Antimicrobial-agent:Therapeutic-Zinc-oxide-(Zn)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_DOWN	NA	561
bsdb:962/3/2_Antimicrobial-agent:Therapeutic-Zinc-oxide-(Zn)-global-data-set_vs_Antibiotics-(AB)-global-data-set_DOWN	NA	906
bsdb:962/7/1_Abnormal-sample:Diarrhoea_7dpw-CT(no-medication)-group_vs_Faecal_7dpw-CT(no-medication)-group_UP	NA	561
bsdb:962/7/2_Abnormal-sample:Diarrhoea_7dpw-CT(no-medication)-group_vs_Faecal_7dpw-CT(no-medication)-group_DOWN	NA	239934
bsdb:962/11/1_Abnormal-sample:Diarrhoea_14pw-CT(no-medication)-group_vs_Faecal_14dpw-CT(no-medication)-group_DOWN	NA	561	906
bsdb:963/8/1_Breast-cancer:Breast-cancer-patients_vs_Healthy-volunteers_UP	NA	35832	186532	906	52225	459786	239759
bsdb:963/8/2_Breast-cancer:Breast-cancer-patients_vs_Healthy-volunteers_DOWN	NA	84111	2172
bsdb:963/18/1_Breast-cancer:Breast-cancer-mice_vs_Heathy-mice_UP	NA	189330
bsdb:963/18/2_Breast-cancer:Breast-cancer-mice_vs_Heathy-mice_DOWN	NA	459786	133925
bsdb:964/1/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-0_vs_Healthy-control-at-Zeitgeber-(ZT)-0_UP	NA	848
bsdb:964/1/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-0_vs_Healthy-control-at-Zeitgeber-(ZT)-0_DOWN	NA	32067
bsdb:964/2/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-6_vs_Healthy-control-at-Zeitgeber-(ZT)-6_UP	NA	848
bsdb:964/3/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-12_vs_Healthy-control-at-Zeitgeber-(ZT)-12_UP	NA	848
bsdb:964/3/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-12_vs_Healthy-control-at-Zeitgeber-(ZT)-12_DOWN	NA	32067
bsdb:964/4/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-18_vs_Healthy-control-at-Zeitgeber-(ZT)-18_UP	NA	848
bsdb:964/4/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-18_vs_Healthy-control-at-Zeitgeber-(ZT)-18_DOWN	NA	32067
bsdb:964/5/1_Polycystic-ovary-syndrome:PCOS-Patients_vs_Healthy-controls_DOWN	NA	572511	1301
bsdb:965/1/1_COVID-19:COVID-19-patients_vs_healthy-controls_UP	NA	233189	1386	32008	1016	1350	1378	397456	724	32067	475	482	838	32207	1279	1301	29465
bsdb:965/1/2_COVID-19:COVID-19-patients_vs_healthy-controls_DOWN	NA	1766253	239934	239759	816	1678	572511	216851	1918511	33024	1263	292632
bsdb:965/2/1_COVID-19:COVID-19-patients_vs_NO-COVID-19-(Patients-with-diagnosis-different-from-COVID-19)_UP	NA	39948
bsdb:965/2/2_COVID-19:COVID-19-patients_vs_NO-COVID-19-(Patients-with-diagnosis-different-from-COVID-19)_DOWN	NA	1283313	848	47670	265	13687	286
bsdb:966/1/1_Parkinson's-disease:Parkinson's-diease-(PD)-patients_vs_Household-Control_DOWN	NA	580596	1407607
bsdb:966/5/1_Parkinson's-disease:Parkinson's-diease-patients-at-6-months_vs_Household-Control_DOWN	NA	1766253	580596	1730	216851	1407607	1263
bsdb:966/6/1_Parkinson's-disease:Parkinson's-diease-patients-at-12-months_vs_Household-Control_DOWN	NA	207244
bsdb:966/7/1_Parkinson's-disease:DBS(deep-brain-stimulation)_vs_Pre-DAT(device-assisted-therapy)_UP	NA	838
bsdb:966/8/1_Parkinson's-disease:DBS(deep-brain-stimulation)_vs_Pre-DAT(device-assisted-therapy)_UP	NA	1386	544	1573536	2172	581	838	157	29465
bsdb:966/8/2_Parkinson's-disease:DBS(deep-brain-stimulation)_vs_Pre-DAT(device-assisted-therapy)_DOWN	NA	258514	244127	946234	241189	404402
bsdb:966/9/1_Parkinson's-disease:LCIG(Levodopa-Carbidopa-Intestinal-Gel)_vs_Pre-DAT(device-assisted-therapy)-PD-patients_UP	NA	841
bsdb:966/9/2_Parkinson's-disease:LCIG(Levodopa-Carbidopa-Intestinal-Gel)_vs_Pre-DAT(device-assisted-therapy)-PD-patients_DOWN	NA	258514	84111	644652	241189	61170
bsdb:966/10/1_Parkinson's-disease:LCIG(Levodopa-Carbidopa-Intestinal-Gel)_vs_Pre-DAT(device-assisted-therapy)-PD-patients_UP	NA	1386	838
bsdb:967/1/1_Parkinson's-disease:Parkinson's-Disease-(PD)-patients_vs_Healthy_UP	NA	447020	239934
bsdb:967/1/2_Parkinson's-disease:Parkinson's-Disease-(PD)-patients_vs_Healthy_DOWN	NA	577309	33024	838	1301	135858	561
bsdb:968/1/1_Alzheimer's-disease:Alzheimer's-group_vs_Healthy-senior-group_UP	NA	239934	1921511	508459	1716	1795363	1730	237	1804994	359407	354354	846	1004302	52972	838	929509	106633	1847386
bsdb:968/1/2_Alzheimer's-disease:Alzheimer's-group_vs_Healthy-senior-group_DOWN	NA	1678	359336	724	2767842	2767885	2767886	2039302	1227	28100	841	1506577	29465
bsdb:968/2/1_Alzheimer's-disease:Alzheimer's-disease-group_vs_Healthy-senior-group_UP	NA	1283313	816	1678	39948	1263	40544
bsdb:968/2/2_Alzheimer's-disease:Alzheimer's-disease-group_vs_Healthy-senior-group_DOWN	NA	816	1730	216851	724	2767886	2039302	1506577	29465
bsdb:969/1/1_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	475	40222	36739	80865	48736	37817	469
bsdb:969/1/2_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_DOWN	NA	37914	32008	93681	1637	2985502	1386	1041	629	114627	1578	28050	29548	570	43994	158851	73029	290731	168934	665874	635	191303	173479	44675	281915
bsdb:969/2/1_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	469	37817
bsdb:969/3/1_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	80865	36739
bsdb:969/3/2_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_DOWN	NA	1386	572511	32008	281915	561	44675	1578	175304	665874	76831	119852	48736	93681	168694	2985502
bsdb:969/4/1_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	469
bsdb:969/5/1_Parkinson's-disease:SpPD-(Spousal-household-Parkinson's-Disease)_vs_SpHC-(Spousal-household-Healthy-Control)_UP	NA	535	475
bsdb:969/5/2_Parkinson's-disease:SpPD-(Spousal-household-Parkinson's-Disease)_vs_SpHC-(Spousal-household-Healthy-Control)_DOWN	NA	57495	1279	28261
bsdb:970/1/1_Alzheimer's-disease-biomarker-measurement:Endogenous-melatonin-reduction-(EMR)-mice_vs_Wild-type-(WT)-mice_UP	NA	2749267	1331051	580024	1578	1742992	100175	1508657
bsdb:971/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	162289
bsdb:971/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	216851	1407607
bsdb:971/2/1_Parkinson's-disease:Female-Parkinson's-disease-Patients_vs_Male-Parkinson's-disease-Patients_UP	NA	162289
bsdb:971/2/2_Parkinson's-disease:Female-Parkinson's-disease-Patients_vs_Male-Parkinson's-disease-Patients_DOWN	NA	216851
bsdb:971/3/1_Parkinson's-disease:Parkinson's-Disease-Patients-with-elevated-Calprotectin-levels_vs_Calprotectin-Negative-Controls_UP	NA	150022	162289
bsdb:971/3/2_Parkinson's-disease:Parkinson's-Disease-Patients-with-elevated-Calprotectin-levels_vs_Calprotectin-Negative-Controls_DOWN	NA	216851	1407607
bsdb:971/4/1_Parkinson's-disease:Parkinson's-Disease-Patients-with-normal-Calprotectin-levels_vs_Calprotectin-positive-Parkinson's-Disease-Patients_UP	NA	216851
bsdb:971/4/2_Parkinson's-disease:Parkinson's-Disease-Patients-with-normal-Calprotectin-levels_vs_Calprotectin-positive-Parkinson's-Disease-Patients_DOWN	NA	1301
bsdb:971/5/1_Parkinson's-disease:Female-Healthy-Controls_vs_Male-Healthy-Controls_UP	NA	1678
bsdb:971/7/1_Parkinson's-disease:Normal-Calprotectin-levels-Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	162289
bsdb:971/8/1_Parkinson's-disease:Parkinson's-Disease-Patients-treated-with-L-dopa_vs_Healthy-Controls_UP	NA	150022	162289
bsdb:971/8/2_Parkinson's-disease:Parkinson's-Disease-Patients-treated-with-L-dopa_vs_Healthy-Controls_DOWN	NA	216851
bsdb:971/11/1_Parkinson's-disease:Parkinson's-disease-Patients-treated-with-entacapone_vs_Healthy-Controls_UP	NA	165779	1678	1350	162289	1769710
bsdb:971/11/2_Parkinson's-disease:Parkinson's-disease-Patients-treated-with-entacapone_vs_Healthy-Controls_DOWN	NA	216851
bsdb:971/12/1_Parkinson's-disease:Parkinson's-disease-Patients-with-HR-Phenotype_vs_Healthy-Controls_UP	NA	162289
bsdb:971/12/2_Parkinson's-disease:Parkinson's-disease-Patients-with-HR-Phenotype_vs_Healthy-Controls_DOWN	NA	216851
bsdb:971/14/1_Parkinson's-disease:Parkinson's-disease-Patients-with-HY-Stage-of-1-to-2.5_vs_Healthy-Controls_UP	NA	216851	162289
bsdb:971/15/1_Parkinson's-disease:Parkinson's-disease-Patients-with-HY-Stage-of-3-to-4_vs_Healthy-Controls_UP	NA	162289	216851
bsdb:972/3/1_Alzheimer's-disease:Alzheimer’s-disease-(4-weeks-after-surgery)_vs_Sham-operated-group_UP	NA	447020	239934	28138
bsdb:972/3/2_Alzheimer's-disease:Alzheimer’s-disease-(4-weeks-after-surgery)_vs_Sham-operated-group_DOWN	NA	1283313	1508657	1301
bsdb:972/6/1_Alzheimer's-disease:Alzheimer’s-disease-(4-weeks-after-surgery)_vs_Control-group_UP	NA	447020	239934	28138
bsdb:972/6/2_Alzheimer's-disease:Alzheimer’s-disease-(4-weeks-after-surgery)_vs_Control-group_DOWN	NA	1283313	1508657	1301
bsdb:973/1/2_Parkinson's-disease:People-with-Parkinson's-Disease-(PWP)_vs_Healthy-Controls_DOWN	NA	2048137	1980681	1505657	2163168	841
bsdb:975/1/2_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_DOWN	NA	102106	841	1407607	572511	216851
bsdb:976/1/1_Response-to-antiviral-drug:Intestinal-samples-of-HIV-Positive-Patients_vs_Intestinal-samples-of-Healthy-Control_UP	NA	239934	102106	1730	848	906	52225	86331	1257	33024	838	83770	2172
bsdb:976/1/2_Response-to-antiviral-drug:Intestinal-samples-of-HIV-Positive-Patients_vs_Intestinal-samples-of-Healthy-Control_DOWN	NA	572511	1485	1263
bsdb:976/2/1_Response-to-antiviral-drug:Colon-wash-samples-of-HIV-Positive-Patients_vs_Colon-wash-samples-of-Healthy-Control_UP	NA	83770	416916
bsdb:976/3/1_Response-to-antiviral-drug:Colon-brush-samples-of-HIV-Positive-Patients_vs_Colon-brush-samples-of-Healthy-Control_UP	NA	906	84108
bsdb:976/4/1_Response-to-antiviral-drug:Terminal-ileum-wash-samples-of-HIV-Positive-Patients_vs_Terminal-ileum-wash-samples-of-Healthy-Control_UP	NA	838	86331	52225	416916
bsdb:977/1/1_COVID-19:COVID-19-patients_vs_local-controls_UP	NA	1654	1283313	1380	906	838	123375	13687	29465
bsdb:977/1/2_COVID-19:COVID-19-patients_vs_local-controls_DOWN	NA	713	194195	816	1678	572511	1016	43996	216851	44259	150022	1378	724	1357	47670	1847725	1840214	86331	482	265975	1263	195950	157
bsdb:977/2/1_Abnormality-of-the-respiratory-system:Non-Covid-19-Patients_vs_local-controls_UP	NA	1654	1380	29393	2759736	1578	2767887	2742598	906	838	508215	29465
bsdb:977/2/2_Abnormality-of-the-respiratory-system:Non-Covid-19-Patients_vs_local-controls_DOWN	NA	713	194195	2060094	1386	59735	1678	572511	1331051	43996	1350	216851	1378	724	47670	1847725	1840214	482	265975	1257	1263	1279	1213720	157
bsdb:977/3/1_COVID-19:Covid-19-patients_vs_non-Covid-19-patients_UP	NA	1283313	59735	194	1331051	43996	1350	117563	724	1847725	475	1257	123375
bsdb:977/3/2_COVID-19:Covid-19-patients_vs_non-Covid-19-patients_DOWN	NA	156454	2759736	1578	2767887	2742598	86331	508215
bsdb:977/4/2_Pneumonia:Covid-19-with-Pneumonia_vs_Covid-19-with-no-Pneumonia_DOWN	NA	475	162289
bsdb:977/5/1_Viral-load:viral-load-(>7.5)_vs_viral-load-(≤7.5)_UP	NA	2147	816	836
bsdb:977/5/2_Viral-load:viral-load-(>7.5)_vs_viral-load-(≤7.5)_DOWN	NA	1350	1378	286
bsdb:977/6/1_COVID-19:Hospitalized-patients_vs_local-controls_UP	NA	1654	1283313	1380	82202	2767887	2742598	906	838	123375	29465
bsdb:977/6/2_COVID-19:Hospitalized-patients_vs_local-controls_DOWN	NA	713	194195	2060094	1386	816	1678	572511	43996	216851	150022	1378	724	47670	1847725	1840214	482	265975	1263	1279	1213720	195950	157
bsdb:978/1/1_Digestive-System-Carcinoma:Responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Non-responders-to-anti–PD-1/PD-L1-immunotherapy_UP	NA	39948	28050	375288
bsdb:978/1/2_Digestive-System-Carcinoma:Responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Non-responders-to-anti–PD-1/PD-L1-immunotherapy_DOWN	NA	816	135858	1649459
bsdb:978/2/1_Colorectal-cancer:Responders-(colorectal-cancer---CRC)_vs_Non-responders-(colorectal-cancer---CRC)_UP	NA	816	39948	946234	1506553	28050	375288
bsdb:978/2/2_Colorectal-cancer:Responders-(colorectal-cancer---CRC)_vs_Non-responders-(colorectal-cancer---CRC)_DOWN	NA	816	1678	1506553	283168	459786	375288	292632
bsdb:978/3/1_Esophageal-carcinoma:Responders-(esophageal-carcinoma)_vs_Non-responders-(esophageal-carcinoma)_UP	NA	816	39948	577309	577310	33024
bsdb:978/3/2_Esophageal-carcinoma:Responders-(esophageal-carcinoma)_vs_Non-responders-(esophageal-carcinoma)_DOWN	NA	816	1485	1649459	28050	1578	248744
bsdb:978/4/1_Gastric-cancer:Responders-(gastric-cancer)_vs_Non-responders-(gastric-cancer)_UP	NA	1678	28050	816	1766253
bsdb:978/4/2_Gastric-cancer:Responders-(gastric-cancer)_vs_Non-responders-(gastric-cancer)_DOWN	NA	1766253	816	1678	574697	158846
bsdb:978/5/1_Digestive-System-Carcinoma:Non-responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Responders-to-anti–PD-1/PD-L1-immunotherapy_UP	NA	629
bsdb:978/5/2_Digestive-System-Carcinoma:Non-responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Responders-to-anti–PD-1/PD-L1-immunotherapy_DOWN	NA	117563
bsdb:979/1/1_Parkinson's-disease:Male-Parkinson’s-disease-(PD_M)-patients_vs_Female-Parkinson’s-disease-(PD_F)-patients_UP	NA	239934	1502180	1470353	448125	46466	82980	83766	291988
bsdb:979/1/2_Parkinson's-disease:Male-Parkinson’s-disease-(PD_M)-patients_vs_Female-Parkinson’s-disease-(PD_F)-patients_DOWN	NA	33042	561	348581	1263
bsdb:980/1/1_Non-alcoholic-fatty-liver-disease:Non-alcoholic-fatty-liver-disease-(NAFLD)_vs_Healthy-controls_UP	NA	580596	946234	570	1506553	1578	1506577
bsdb:980/1/2_Non-alcoholic-fatty-liver-disease:Non-alcoholic-fatty-liver-disease-(NAFLD)_vs_Healthy-controls_DOWN	NA	207244	397864	283	33042	39948	216851	1407607	724	158846	906	2172	577309	1481960	838	1508657	1263	1301
bsdb:980/2/1_Non-alcoholic-steatohepatitis:NASH-(Non-alcoholic-steatohepatitis)-patients_vs_NAFL-(Non-alcoholic-fatty-liver)-patients_UP	NA	841
bsdb:980/2/2_Non-alcoholic-steatohepatitis:NASH-(Non-alcoholic-steatohepatitis)-patients_vs_NAFL-(Non-alcoholic-fatty-liver)-patients_DOWN	NA	239759
bsdb:981/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	1678	574697	946234
bsdb:981/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	1766253	580596	1407607
bsdb:982/1/1_Prion-disease:Prion-infected-mice-(R)_vs_Healthy-Control-(C)_UP	NA	209	1578
bsdb:982/1/2_Prion-disease:Prion-infected-mice-(R)_vs_Healthy-Control-(C)_DOWN	NA	1283313	1331051
bsdb:983/1/1_Colorectal-adenoma:Adenoma_vs_Non-adenoma_UP	NA	848
bsdb:984/1/1_Parkinson's-disease:Parkinson's-Disease_vs_Healthy-Controls_UP	NA	165779	216851	150022	162289	1769710
bsdb:987/1/1_Cesarean-section:Cesarean-section-scar-diverticulum-(CSD)_vs_Control_UP	NA	816	1350	2701	838	48736	13687	1301
bsdb:987/1/2_Cesarean-section:Cesarean-section-scar-diverticulum-(CSD)_vs_Control_DOWN	NA	1729679	1578
bsdb:989/1/2_Colitis:DSS-+-BAC-Group-(Day-7)_vs_DSS-Group-(Day-7)_DOWN	NA	1017280
bsdb:990/1/1_Colorectal-cancer:Living-bacteria-group-(LB)_vs_Tumor-control-group-(CK)_UP	NA	33042	547	561	1578	119852	838	841	191303
bsdb:990/1/2_Colorectal-cancer:Living-bacteria-group-(LB)_vs_Tumor-control-group-(CK)_DOWN	NA	574697	13687
bsdb:990/2/1_Colorectal-cancer:Inactivated-bacteria-group-(IB)_vs_Tumor-control-group-(CK)_UP	NA	33042
bsdb:990/2/2_Colorectal-cancer:Inactivated-bacteria-group-(IB)_vs_Tumor-control-group-(CK)_DOWN	NA	816	838
bsdb:990/3/2_Colorectal-cancer:Living-bacteria-group_vs_Inactivated-bacteria-group_UP	NA	561	1578
bsdb:991/1/1_Disease-staging:Melanoma-surface-of-pigs-with-Melanoma-progression_vs_Melanoma-surface-of-pigs-with-with-melanoma-regression_UP	NA	1654	816	194	44259	848	13075	31983	543311	162289	1257	836	1069494
bsdb:991/1/2_Disease-staging:Melanoma-surface-of-pigs-with-Melanoma-progression_vs_Melanoma-surface-of-pigs-with-with-melanoma-regression_DOWN	NA	137460	292480	572511	43668	872	37914	1350	66831	216851	89092	1470540	227979	1578	1269	90243	497	1501226	841	1505652	191303	46255
bsdb:991/2/1_Disease-staging:Melanoma-tissue-of-pigs-with-Melanoma-progression_vs_Melanoma-tissue-of-pigs-with-with-melanoma-regression_UP	NA	1716	848	31983	543311	162289	1257	836	508215	1069494
bsdb:991/2/2_Disease-staging:Melanoma-tissue-of-pigs-with-Melanoma-progression_vs_Melanoma-tissue-of-pigs-with-with-melanoma-regression_DOWN	NA	469	713	1386	1678	572511	49082	102106	1912216	189330	547	1350	216851	1578	68287	407	40323
bsdb:991/3/1_Cutaneous-melanoma:melanoma-surface-from-black-pigs_vs_healthy-skin_UP	NA	469	137460	292480	572511	43668	1696	1716	37914	1350	66831	216851	89092	1470540	227979	57493	1649	1578	149698	90243	286	497	1501226	841	13687	1505652	191303	46255
bsdb:991/3/2_Cutaneous-melanoma:melanoma-surface-from-black-pigs_vs_healthy-skin_DOWN	NA	848	31983	475	162289	1257	1279	1301
bsdb:991/4/1_Cutaneous-melanoma:melanoma-tissue-from-black-pigs_vs_healthy-skin_UP	NA	469	137460	82373	292480	572511	43668	1696	37914	1350	66831	216851	237	96492	89092	53457	1470540	227979	57493	1649	1578	149698	1269	475	90243	286	497	1501226	841	32207	13687	1505652	191303	46255
bsdb:991/4/2_Cutaneous-melanoma:melanoma-tissue-from-black-pigs_vs_healthy-skin_DOWN	NA	848	1279	1069494	1257	162289	543311	1678	816	1912216
bsdb:991/5/1_Cutaneous-melanoma:Melanoma-progression_vs_controls-without-melanoma-and-melanoma-regression_UP	NA	816	44259	848	31983	283168
bsdb:991/7/1_Cutaneous-melanoma:Melanoma-progression-and-regression_vs_Controls-without-melanoma_DOWN	NA	1283313	82373	216851	248744	265975
bsdb:991/8/1_Breed:Homogenous-breed-MeLiM-piglets_vs_Crossbreed-between-MeLiM-and-white-piglets_UP	NA	816	810	102106	848	1506553	83614	75984	745	162289	286	1501226	1279	1069494
bsdb:991/8/2_Breed:Homogenous-breed-MeLiM-piglets_vs_Crossbreed-between-MeLiM-and-white-piglets_DOWN	NA	1766253	1283313	82373	1678	572511	580596	39948	216851	1578	52225	459786	33024	841	177971	292632
bsdb:993/1/2_Gut-microbiome-measurement:12-months_vs_3-months_DOWN	NA	816
bsdb:994/1/1_Colorectal-adenoma:Adenoma-patients-(cases)_vs_Adenoma-free-(controls)_UP	NA	12916	469	501783	357	239934	92793	146936	73029	80865	209	1578	1357	1243	248744	165695	40323	83770	191303	46255
bsdb:995/1/1_Parkinson's-disease:MPTP-Group_vs_Control-Group_UP	NA	1729679	1892380	375288	577310
bsdb:995/1/2_Parkinson's-disease:MPTP-Group_vs_Control-Group_DOWN	NA	2749267
bsdb:995/3/1_Parkinson's-disease:MPTP-+-Acu-Group_vs_Control-Group_UP	NA	239759	1506553	2304693	1348611
bsdb:995/3/2_Parkinson's-disease:MPTP-+-Acu-Group_vs_Control-Group_DOWN	NA	2749846
bsdb:995/5/1_Parkinson's-disease:MPTP-group_vs_Control-group_UP	NA	1647175	1678	872	1729679	1918511	1892380	61170	248744	577309	577310	33024	1081	1263	44748	3025755	191303
bsdb:995/5/2_Parkinson's-disease:MPTP-group_vs_Control-group_DOWN	NA	1918385	244127	574697	36853	189330	1918454	342658	3028852	459786	1200657
bsdb:995/6/1_Parkinson's-disease:MPTP+Acu-group_vs_Control-group_UP	NA	816	2304693	1348611	213484
bsdb:995/6/2_Parkinson's-disease:MPTP+Acu-group_vs_Control-group_DOWN	NA	2749267
bsdb:995/7/1_Parkinson's-disease:MPTP+Acu-group_vs_MPTP-group_UP	NA	1427378	1918385	239759	274470	2086	653683	574697	990721	36853	946234	1918454	342658	2163168	1506553	3028852	459786	1017280
bsdb:995/7/2_Parkinson's-disease:MPTP+Acu-group_vs_MPTP-group_DOWN	NA	1647175	816	1678	872	1918511	61170	248744	375288	577310	33024	1081	44748	3025755	191303
bsdb:996/1/1_Irritable-bowel-syndrome:IBS-D-patients-(Duodenal-mucosa-samples)_vs_Healthy-controls-(Duodenal-mucosa-samples)_UP	NA	1386	2747	528	1357	1269	1743	407	33882	44249	1716	80865	41275	1763
bsdb:996/1/2_Irritable-bowel-syndrome:IBS-D-patients-(Duodenal-mucosa-samples)_vs_Healthy-controls-(Duodenal-mucosa-samples)_DOWN	NA	469	222
bsdb:996/2/1_Irritable-bowel-syndrome:IBS-D-patients-(Duodenal-lumen-samples)_vs_Healthy-controls-(Duodenal-lumen-samples)_UP	NA	118747	32067	29465	32207
bsdb:996/2/2_Irritable-bowel-syndrome:IBS-D-patients-(Duodenal-lumen-samples)_vs_Healthy-controls-(Duodenal-lumen-samples)_DOWN	NA	836	13687	165695	237
bsdb:996/3/1_Irritable-bowel-syndrome:IBS-D-patients-(Rectal-mucosa-samples)_vs_Healthy-controls-(Rectal-mucosa-samples)_UP	NA	816	212791	270
bsdb:996/3/2_Irritable-bowel-syndrome:IBS-D-patients-(Rectal-mucosa-samples)_vs_Healthy-controls-(Rectal-mucosa-samples)_DOWN	NA	838	265	119852
bsdb:996/4/1_Irritable-bowel-syndrome:IBS-D-patients-(Rectal-lumen-samples)_vs_Healthy-controls-(Rectal-lumen-samples)_UP	NA	375288
bsdb:996/4/2_Irritable-bowel-syndrome:IBS-D-patients-(Rectal-lumen-samples)_vs_Healthy-controls-(Rectal-lumen-samples)_DOWN	NA	216851	1298
bsdb:997/1/1_Gut-microbiome-measurement:Mild-cognitive-impairment-(MCI)-and-Alzheimer’s-disease-(AD)_vs_Healthy-group_DOWN	NA	239759	816	375288	909656	1263
bsdb:997/2/1_Alzheimer's-disease:Alzheimer’s-disease-(AD)_vs_Healthy-group-and-mild-cognitive-impairment-(MCI)_UP	NA	561
bsdb:997/3/1_Cognitive-impairment:Mild-Cognitive-Impairment-(MCI)_vs_Healthy-group-and-Alzheimer's-Disease-(AD)_UP	NA	572511	102106	216851	28050	1301	3025755
bsdb:998/1/1_Parkinson's-disease:PD-patients_vs_Controls_UP	NA	904	264995	244127	194	544	100883	51514	1730	150022	162290	2745	2172	1080709	86331	1253	162289	583	1263	2753	191303	184869
bsdb:998/1/2_Parkinson's-disease:PD-patients_vs_Controls_DOWN	NA	207244	816	572511	189330	216851	28050	33024	838	841	40544
bsdb:998/2/1_Parkinson's-disease:PD-patients_vs_Controls_DOWN	NA	572511	189330	65551	57494
bsdb:998/3/1_Parkinson's-disease:PD-patients_vs_Controls_UP	NA	413496	1839	118	33886	29526
bsdb:998/3/2_Parkinson's-disease:PD-patients_vs_Controls_DOWN	NA	816	572511	308865	1041	150022	2745	1847	28895
bsdb:999/1/1_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_UP	NA	1427378	1375	2086	580596	189330	1729679	946234	1892380	100175	1508657	1263	1506577
bsdb:999/1/2_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_DOWN	NA	447020	239759	1678	43668	1696	830	1470353	1350	66831	227979	1578	248744	2895461	577310	1279	1301	191303	225447
bsdb:999/2/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_UP	NA	239934	174708	1937008	100175	1506577
bsdb:999/2/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_DOWN	NA	1427378	447020	239759	1678	572511	43668	1696	580596	830	189330	1432051	1350	66831	227979	1506553	1578	248744	2895461	375288	577310	841	1279	1301	191303	225447
bsdb:999/3/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Ferrous-sulfate-(FS)-treated-pups-(PD-15)_UP	NA	174708	1470353	1937008	1301
bsdb:999/3/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Ferrous-sulfate-(FS)-treated-pups-(PD-15)_DOWN	NA	1427378	1375	239759	816	1678	572511	580596	189330	1432051	724	1892380	1506553	375288	841
bsdb:999/4/1_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-(YA)-rats_UP	NA	1427378	580024	1940255	375288	32207
bsdb:999/4/2_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-(YA)-rats_DOWN	NA	469	1350	1578	1279	1301	191303	2895461	3028852
bsdb:999/5/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-rats_UP	NA	43668	1696	715222	459786	100175	32207	1506577	225447
bsdb:999/5/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-rats_DOWN	NA	1427378	31980	469	447020	239759	207244	244127	816	1678	572511	189330	580024	1392389	1506553	1578	375288	577310	841	191303	580596	2895461
bsdb:999/6/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_UP	NA	52784	264995	1386	43668	1696	715222	1331051	1470353	37914	1350	66831	1729679	724	596767	437755	100175	1769710	1279	225447
bsdb:999/6/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_DOWN	NA	1427378	31980	447020	239759	207244	816	1678	572511	580596	189330	580024	1392389	1506553	2895461	375288	577310	841
bsdb:1000/1/2_Parkinson's-disease:Rapid-eye-movement-sleep-behavior-disorder-(iRBD)-patients_vs_Controls_DOWN	NA	239934	216851	841
bsdb:1001/1/1_Parkinson's-disease:Parkinson's-disease-patients-with-Akinetic-Rigid---AR_vs_Parkinson's-disease-patients-with-Tremor-Dominant----TD_UP	NA	190972	613	561
bsdb:1001/1/2_Parkinson's-disease:Parkinson's-disease-patients-with-Akinetic-Rigid---AR_vs_Parkinson's-disease-patients-with-Tremor-Dominant----TD_DOWN	NA	216851	572511	33042	28050	69894	1378	1696
bsdb:1001/2/1_Parkinson's-disease:Parkinson's-disease-patients-with-Diskinetic---D_vs_Parkinson's-disease-patients-with-Tremor-Dominant---TD_UP	NA	613	1578	561
bsdb:1001/2/2_Parkinson's-disease:Parkinson's-disease-patients-with-Diskinetic---D_vs_Parkinson's-disease-patients-with-Tremor-Dominant---TD_DOWN	NA	216851	572511	33042	28050	190972	69894	258514	1696	1378
bsdb:1001/3/1_Parkinson's-disease:Parkinson's-disease-patients-with-Akinetic-Rigid---AR_vs_Parkinson's-disease-patients-with-Diskinetic---D_DOWN	NA	1578
bsdb:1002/1/1_Colorectal-cancer:Colorectal-Tumor-Samples_vs_Patient-Matched-Normal-Colon-Tissue-Samples_UP	NA	848	586
bsdb:1003/1/1_Gonorrhea:men-who-have-sex-with-men-using-Biotène_vs_men-who-have-sex-with-men-using-Listerine_DOWN	NA	32067	1301	34104
bsdb:1003/2/1_Gonorrhea:gonorrhea-detected-by-NAAT-at-baseline_vs_did-not-have-gonorrhea-detected_DOWN	NA	59735	848	724	1257
bsdb:1003/3/1_Gonorrhea:men-sex-with-men-who-are-smokers_vs_men-sex-with-men-who-are-non-smokers_UP	NA	157	1434006
bsdb:1003/3/2_Gonorrhea:men-sex-with-men-who-are-smokers_vs_men-sex-with-men-who-are-non-smokers_DOWN	NA	47670
bsdb:1003/4/1_Gonorrhea:men-who-have-sex-with-men-using-listerine_vs_men-who-have-sex-with-men-using-Biotène_DOWN	NA	482
bsdb:1004/1/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-1_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-1_UP	NA	40544	1573535	135858	1473205	2082587	572511	292632	158846	216851
bsdb:1004/1/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-1_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-1_DOWN	NA	1654
bsdb:1004/2/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_UP	NA	1350	117563	1279
bsdb:1004/2/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_DOWN	NA	133925	838
bsdb:1004/3/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_UP	NA	117563
bsdb:1004/3/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_DOWN	NA	29465	133925	1473205	838
bsdb:1005/1/1_Microbiome-measurement:Vagina_vs_Oral-(saliva)_UP	NA	1350
bsdb:1005/1/2_Microbiome-measurement:Vagina_vs_Oral-(saliva)_DOWN	NA	1378	1301	1716	1578	407	374	1857532
bsdb:1005/2/1_Vaginal-microbiome-measurement:Vaginal-metestrus-samples_vs_Vaginal-estrus-samples_UP	NA	149698	1578
bsdb:1005/2/2_Vaginal-microbiome-measurement:Vaginal-metestrus-samples_vs_Vaginal-estrus-samples_DOWN	NA	1857532
bsdb:1006/1/1_Parkinson's-disease:PD-patients-with--wearing-off_vs_PD-patients-with-dyskinesia_UP	NA	1578
bsdb:1006/1/2_Parkinson's-disease:PD-patients-with--wearing-off_vs_PD-patients-with-dyskinesia_DOWN	NA	572511
bsdb:1007/1/1_Inflammatory-bowel-disease:Ulcerative-colitis-(UC)_vs_Healthy-controls-(HC)_UP	NA	904	816	216851	375288	577310	459786
bsdb:1007/1/2_Inflammatory-bowel-disease:Ulcerative-colitis-(UC)_vs_Healthy-controls-(HC)_DOWN	NA	239759	33042	846	816	459786	207244	216851	40544
bsdb:1007/2/1_Inflammatory-bowel-disease:Crohn’s-disease-(CD)_vs_Healthy-controls-(HC)_UP	NA	189330	292632	561	459786	816	904
bsdb:1007/2/2_Inflammatory-bowel-disease:Crohn’s-disease-(CD)_vs_Healthy-controls-(HC)_DOWN	NA	239759	33042	846	816	459786	207244	216851	40544
bsdb:1007/3/1_Inflammatory-bowel-disease:Ulcerative-colitis-(UC)_vs_Crohn's-disease-(CD)_UP	NA	375288	216851	577310
bsdb:1007/3/2_Inflammatory-bowel-disease:Ulcerative-colitis-(UC)_vs_Crohn's-disease-(CD)_DOWN	NA	189330	292632	561
bsdb:1007/4/1_Smoking-behavior:Smokers-(Yes)_vs_Non-Smokers-(No)_UP	NA	816	216851	40544
bsdb:1007/4/2_Smoking-behavior:Smokers-(Yes)_vs_Non-Smokers-(No)_DOWN	NA	207244	816	35832	216851	577310	544
bsdb:1007/5/1_Smoking-behavior:Ex-smokers-(Ex)_vs_Non-Smokers-(No)_UP	NA	816	577310	216851
bsdb:1007/5/2_Smoking-behavior:Ex-smokers-(Ex)_vs_Non-Smokers-(No)_DOWN	NA	207244	35832	216851	40544	544
bsdb:1007/6/1_Smoking-behavior:Smokers-(Yes)_vs_Ex-smokers-(Ex)_UP	NA	35832	216851	816	40544
bsdb:1007/6/2_Smoking-behavior:Smokers-(Yes)_vs_Ex-smokers-(Ex)_DOWN	NA	207244	816	577310	544
bsdb:1008/1/1_Light:Dim-light-at-night-(dLAN)---Control-group_vs_Normal-light‐dark-cycle-(LD)---Control-group_UP	NA	577309	1578
bsdb:1008/1/2_Light:Dim-light-at-night-(dLAN)---Control-group_vs_Normal-light‐dark-cycle-(LD)---Control-group_DOWN	NA	28138	283168
bsdb:1008/3/1_Light:Dim-light-at-night-(dLAN)---DTA-group_vs_Normal-light‐dark-cycle-(LD)---DTA-group_UP	NA	174708	239934
bsdb:1009/1/1_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_UP	NA	239934	848	570	29465
bsdb:1009/1/2_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_DOWN	NA	216851	1505657	1578	158846	52225	292632	40544
bsdb:1009/2/1_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_DOWN	NA	1678	216851	1501226
bsdb:1009/2/2_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_UP	NA	572511	848	570
bsdb:1009/3/1_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_UP	NA	547	561	570
bsdb:1009/3/2_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_DOWN	NA	572511	580596	189330	80865
bsdb:1009/4/1_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_UP	NA	642
bsdb:1009/4/2_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_DOWN	NA	216851
bsdb:1010/1/1_Environmental-exposure-measurement:Ferrous-bisglycinate-group_vs_Placebo-group_UP	NA	46255
bsdb:1010/1/2_Environmental-exposure-measurement:Ferrous-bisglycinate-group_vs_Placebo-group_DOWN	NA	1350
bsdb:1010/2/1_Environmental-exposure-measurement:Ferrous-sulfate-group_vs_Placebo-Group_UP	NA	1350	46255
bsdb:1011/1/1_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_UP	NA	106589	270
bsdb:1011/1/2_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_DOWN	NA	469	13687
bsdb:1011/2/1_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_UP	NA	239759	838
bsdb:1011/2/2_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_DOWN	NA	836
bsdb:1011/3/1_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_UP	NA	239759	207244	118747	102106	33042	872	46913	189330	332102	848	204475	47420	140625	119852	577309	543311	1257	33024	838	43676	83618	638847	1068	1263	292632	1129
bsdb:1011/3/2_Metastatic-colorectal-cancer:Liver-metastasis-(LM)_vs_No-liver-metastasis-(NLM)_DOWN	NA	836
bsdb:1015/1/1_Pituitary-Gland-Adenoma:Patients-with-pituitary-adenomas-(PA)_vs_Healthy-controls_UP	NA	1654	2801844	830	2717	1716	2767353	86331	265975	1257	836	508215	2529408	177971	195950
bsdb:1015/1/2_Pituitary-Gland-Adenoma:Patients-with-pituitary-adenomas-(PA)_vs_Healthy-controls_DOWN	NA	416916	1283313	816	59735	194	1715793	82202	39948	848	724	570	906	482	1926672	620	71	29465
bsdb:1016/1/3_Treatment:Post-treatment-(6-months-later)_vs_Pre-treatment-(baseline)_UP	NA	1578	1301	838	32207	286	196081
bsdb:1016/1/4_Treatment:Post-treatment-(6-months-later)_vs_Pre-treatment-(baseline)_DOWN	NA	1716	32067	1016	265975	838	1654	906	836	848	482
bsdb:1016/2/1_Response-to-surgery:Post-surgery_vs_Pre-surgery_UP	NA	286
bsdb:1016/2/2_Response-to-surgery:Post-surgery_vs_Pre-surgery_DOWN	NA	32067	29465
bsdb:1016/3/3_Microbiome-measurement:Post-chemoradiotherapy_vs_Pre-chemoradiotherapy_UP	NA	1578	196081	286	32207	1301	838
bsdb:1016/3/4_Microbiome-measurement:Post-chemoradiotherapy_vs_Pre-chemoradiotherapy_DOWN	NA	1213720	1016	1164882	194	265975	1380	32067	1654	836	838	906	482
bsdb:1016/4/1_Response-to-combination-chemotherapy:Non-Responders-at-baseline_vs_Responders-at-baseline_UP	NA	156454	838	1301
bsdb:1016/4/2_Response-to-combination-chemotherapy:Non-Responders-at-baseline_vs_Responders-at-baseline_DOWN	NA	46123	1654	1716	47670	32067	482	838	29465
bsdb:1016/5/1_Response-to-combination-chemotherapy:Non-Responders-at-6-months_vs_Responders-at-6-months_DOWN	NA	1654	1380	1378	32207	1301	29465
bsdb:1018/1/1_Strongylocentrotus-purpuratus:Diseased-sea-urchins_vs_Healthy-sea-urchins_UP	NA	358023	1122284
bsdb:1018/2/1_Microbiome-measurement:Lesion-body-wall-samples-(LBW)_vs_Lesion-surface-samples-(LS)_UP	NA	1076727
bsdb:1018/2/2_Microbiome-measurement:Lesion-body-wall-samples-(LBW)_vs_Lesion-surface-samples-(LS)_DOWN	NA	1541822	2433
bsdb:1018/3/1_Microbiome-measurement:Diseased-coelomic-fluid-(DCF)-and-lesion-body-wall-(LBW)_vs_Healthy-coelomic-fluid-(HCF)_DOWN	NA	33882	1696
bsdb:1018/4/1_Microbiome-measurement:Lesion-body-wall-(LBW)_vs_Healthy-coelomic-fluid-(HCF)-and-diseased-coelomic-fluid-(DCF)_UP	NA	1076727	662	1122284	358023
bsdb:1018/5/1_Microbiome-measurement:Diseased-coelomic-fluid-(DCF)_vs_Healthy-coelomic-fluid-(HCF)-and-lesion-body-wall-(LBW)_UP	NA	53246	1541822
bsdb:1019/1/2_Sex-design:female_vs_male_DOWN	NA	168470	432330
bsdb:1019/2/1_Infectious-meningitis:NH:-infected-individuals_vs_H:-uninfected-individuals_UP	NA	375288
bsdb:1019/2/2_Infectious-meningitis:NH:-infected-individuals_vs_H:-uninfected-individuals_DOWN	NA	239934	283168
bsdb:1020/1/1_Esophageal-squamous-cell-carcinoma:EIESC_oral---Early-stage-intramucosal-esophageal-squamous-carcinoma._vs_NC_oral---No-carcinoma._UP	NA	32067	543311	836	638847
bsdb:1020/1/2_Esophageal-squamous-cell-carcinoma:EIESC_oral---Early-stage-intramucosal-esophageal-squamous-carcinoma._vs_NC_oral---No-carcinoma._DOWN	NA	194	1485	68
bsdb:1021/1/1_Smoking-behaviour-measurement:Early-infants-(3-months)-with-maternal-history-of--'YES'-'smoking_vs_Early-infants-(3-months)-with-maternal-history-of--'NO'-'smoking_UP	NA	1870884	946234	1506553	906	40544
bsdb:1021/1/2_Smoking-behaviour-measurement:Early-infants-(3-months)-with-maternal-history-of--'YES'-'smoking_vs_Early-infants-(3-months)-with-maternal-history-of--'NO'-'smoking_DOWN	NA	572511	724	32207
bsdb:1021/2/1_Smoking-behaviour-measurement:Late-infants-(12months)-with-maternal-history-of--'YES'-'smoking_vs_Late-infants-(12months)-with-maternal-history-of--'NO'-'smoking_UP	NA	35832	580596	1980681	946234	40544
bsdb:1021/2/2_Smoking-behaviour-measurement:Late-infants-(12months)-with-maternal-history-of--'YES'-'smoking_vs_Late-infants-(12months)-with-maternal-history-of--'NO'-'smoking_DOWN	NA	724	28050	29465
bsdb:1023/1/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	1766253	2039240	572511	1350	909656	2719313
bsdb:1023/1/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	1918385	1987009	1678	580596	990721	1980681	100883	33042	1716	872	2005359	724	1926667	2163168	1763508	1981028	86331	2039302	283168	459786	846	836	191303
bsdb:1023/2/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	111142	1283313	1380	194	37914	59734	253238	1730	2701	53357	32257	1847725	68	906	16	116071	86331	909928	1210119	162289	838	59195	114248
bsdb:1023/2/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	1653174	397864	1912216	39948	398041	140625	265	48736	841	13687	338	2093335
bsdb:1023/3/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	1696	561367
bsdb:1023/3/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	1375	2569097	207244	38501	574697	33042	2719313	2745	1926667	2039302	475	346096	60919	292632	338	1485	78526	404
bsdb:1023/4/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	46123	133925	1279
bsdb:1023/4/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	43996	44259	265975
bsdb:1024/1/1_Alzheimer's-disease:Alzheimer's-disease_vs_Healthy-controls_UP	NA	244127	33042	838	1266	292632
bsdb:1024/1/2_Alzheimer's-disease:Alzheimer's-disease_vs_Healthy-controls_DOWN	NA	816	572511	1298	946234	1506553	84108	1213720	662	1263
bsdb:1025/1/1_Alcohol-consumption-measurement:Low-to-Moderate-drinking_vs_Non-Drinking_UP	NA	100883	46205	180162	1485	1501226
bsdb:1025/1/2_Alcohol-consumption-measurement:Low-to-Moderate-drinking_vs_Non-Drinking_DOWN	NA	40323	724	72763
bsdb:1026/1/1_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(< 8-days)_vs_SARS-CoV-2-uninfected-PLWH-(< 8-days)_UP	NA	84111	239759	816
bsdb:1026/1/2_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(< 8-days)_vs_SARS-CoV-2-uninfected-PLWH-(< 8-days)_DOWN	NA	1766253	580596	189330	1407607	906	52225
bsdb:1026/2/1_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(8–14-days)_vs_SARS-CoV-2-uninfected-PLWH-(8–14-days)_UP	NA	1164882	162289	86331	1472649	1716	816
bsdb:1026/2/2_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(8–14-days)_vs_SARS-CoV-2-uninfected-PLWH-(8–14-days)_DOWN	NA	906	904	1506553	1766253	207244
bsdb:1026/3/1_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(>1-M)_vs_SARS-CoV-2-uninfected-PLWH-(>1-M)_UP	NA	1331051	204037
bsdb:1026/3/2_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(>1-M)_vs_SARS-CoV-2-uninfected-PLWH-(>1-M)_DOWN	NA	1766253	1407607	841
bsdb:1026/4/1_Illness-severity-status:Moderately/severely-ill-SARS-CoV-2-infected-PLWH-(8–14-days)_vs_Mildly-ill-SARS-CoV-2-infected-PLWH-(8–14-days)_UP	NA	244127
bsdb:1026/4/2_Illness-severity-status:Moderately/severely-ill-SARS-CoV-2-infected-PLWH-(8–14-days)_vs_Mildly-ill-SARS-CoV-2-infected-PLWH-(8–14-days)_DOWN	NA	1283313	102106	572511	189330
bsdb:1027/1/1_Colorectal-carcinoma:Colorectal-cancer-(CRC)_vs_Healthy_UP	NA	469	1654	642	416916	239934	419014	156454	92793	1663	374	41275	574697	990721	1716	538	547	1350	33986	1434006	1378	117563	570	1506553	1578	158846	52225	86331	581	133925	375288	543311	1257	1743	113286	48736	160674	1827	196081	970	84108	123375	13687	1301
bsdb:1027/1/2_Colorectal-carcinoma:Colorectal-cancer-(CRC)_vs_Healthy_DOWN	NA	816	216851	1766253	292632	1263	33024	207244	580596	841	1407607	189330	33042	239759	2039302	577310	724	168808	1980693	1506577	28050	459786	35832	946234	1980681	1573534	3028852
bsdb:1027/2/1_Leukopenia:Hypoleukocytes_vs_Normal-leukocytes_UP	NA	180162	1279384	117563
bsdb:1027/2/2_Leukopenia:Hypoleukocytes_vs_Normal-leukocytes_DOWN	NA	990721	100883	1472762	1582879	848	570	158846	459786	2729669	1849822	33024	1506577
bsdb:1028/1/1_Menopause:Postmenopausal-women-group_vs_Premenopausal-women-group_UP	NA	1283313	724	482
bsdb:1028/1/2_Menopause:Postmenopausal-women-group_vs_Premenopausal-women-group_DOWN	NA	482
bsdb:1028/2/1_Microbiome-measurement:Poor-oral-health-group_vs_Adequate-oral-health-group_UP	NA	482
bsdb:1028/2/2_Microbiome-measurement:Poor-oral-health-group_vs_Adequate-oral-health-group_DOWN	NA	1283313	32067	482	724	195950
bsdb:1028/3/1_Viral-load:High-SARS-CoV-2-viral-load-group_vs_Moderate-SARS-CoV-2-viral-load-group_UP	NA	1283313	724	32067	482
bsdb:1029/1/1_Vaginal-microbiome-measurement:Bacterial-Vaginosis-(BV)-Infected-Women_vs_Normal-Healthy-Women-&-High‑risk-human-papillomavirus(HR-HPV)-Infected-Women-(HPV)_UP	NA	838
bsdb:1029/3/1_Vaginal-microbiome-measurement:Bacterial-vaginosis-(BV)-infected-women-&-High‑risk-human-papillomavirus-(HR-HPV)-(HPV)-infected-Women_vs_Normal-Healthy-Women_DOWN	NA	1578
bsdb:1032/1/1_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_UP	NA	816	1301	29465	3025755
bsdb:1032/1/2_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_DOWN	NA	1501226	35832
bsdb:1032/2/1_Hepatitis-virus-related-hepatocellular-carcinoma:non-hepatitis-B-,-non-hepatitis-C-related-Hepatocellular-carcinoma_vs_viral-related-Hepatocellular-carcinoma_UP	NA	816	1301	375288	3025755
bsdb:1032/2/2_Hepatitis-virus-related-hepatocellular-carcinoma:non-hepatitis-B-,-non-hepatitis-C-related-Hepatocellular-carcinoma_vs_viral-related-Hepatocellular-carcinoma_DOWN	NA	216851	1766253	838	33042	292632	1573535
bsdb:1032/3/1_Hepatitis-virus-related-hepatocellular-carcinoma:non-hepatitis-B-,-non-hepatitis-C-related-Hepatocellular-carcinoma_vs_viral-related-Hepatocellular-carcinoma_UP	NA	117563
bsdb:1033/1/1_Papillary-thyroid-carcinoma:PTC-patients-with-advanced-lesions-(T3_4)_vs_PTC-patients-with-mild-lesions-(T1_2)_UP	NA	1301	117563	724
bsdb:1033/1/2_Papillary-thyroid-carcinoma:PTC-patients-with-advanced-lesions-(T3_4)_vs_PTC-patients-with-mild-lesions-(T1_2)_DOWN	NA	286	1827	13687
bsdb:1033/3/1_Papillary-thyroid-carcinoma:Patients-with-PTC-at-clinical-stage-T3_vs_Patients-with-PTC-at-clinical-stage-T1_DOWN	NA	286	1827	13687
bsdb:1033/4/1_Papillary-thyroid-carcinoma:Patients-with-PTC-at-clinical-stage-T4_vs_Patients-with-PTC-at-clinical-stage-T1_DOWN	NA	286
bsdb:1033/5/1_Papillary-thyroid-carcinoma:Patients-with-PTC-at-clinical-stage-T3_vs_Patients-with-PTC-at-clinical-stage-T2_DOWN	NA	286	13687
bsdb:1033/6/1_Papillary-thyroid-carcinoma:Patients-with-PTC-at-clinical-stage-T4_vs_Patients-with-PTC-at-clinical-stage-T2_DOWN	NA	286
bsdb:1033/8/1_Papillary-thyroid-carcinoma:Female-Patients-with-PTC-(G2)_vs_Male-Patients-with-PTC-(G1)_UP	NA	1827	48736	59732	32008	1827195	1822464
bsdb:1033/9/1_Hormone:Thyroid-Stimulating-Hormone-(TSH)_vs_NA_DOWN	NA	2747	838
bsdb:1033/10/1_Hormone:Triiodothyronine-(T3)_vs_NA_DOWN	NA	117563
bsdb:1033/11/1_Hormone:Thyroxine-(T4)_vs_NA_DOWN	NA	570
bsdb:1033/12/1_Hormone:Free-Triiodothyronine-(FT3)_vs_NA_UP	NA	157
bsdb:1033/13/1_Hormone:Free-Thyroxine-(FT4)_vs_NA_UP	NA	482
bsdb:1033/13/2_Hormone:Free-Thyroxine-(FT4)_vs_NA_DOWN	NA	570
bsdb:1033/14/1_Antibody:Anti-thyroid-stimulating-receptors-(Anti-TSHR)_vs_NA_DOWN	NA	570	32008	1827195	1822464
bsdb:1033/15/1_Antibody:Anti-thyroid-peroxidase-(Anti-TPO)_vs_NA_DOWN	NA	1678	970	838	1301	543311	239934	816	724
bsdb:1033/16/1_Antibody:Anti-thyroglobulin-(Anti-TG)_vs_NA_UP	NA	13687	1827	48736	41275
bsdb:1033/16/2_Antibody:Anti-thyroglobulin-(Anti-TG)_vs_NA_DOWN	NA	165779	239934
bsdb:1033/17/1_Hormone:Triiodothyronine-(T3)_vs_NA_DOWN	NA	117563
bsdb:1033/18/1_Hormone:Free-Triiodothyronine-(FT3)_vs_NA_DOWN	NA	117563
bsdb:1033/20/1_Antibody:Anti-thyroid-stimulating-receptors-(Anti-TSHR)_vs_NA_UP	NA	32067
bsdb:1033/21/1_Antibody:Anti-thyroid-peroxidase-(Anti-TPO)_vs_NA_UP	NA	1678	724
bsdb:1034/1/1_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_UP	NA	1375	1380	1485	39948	2701	1378	906	543311	838
bsdb:1034/1/2_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_DOWN	NA	32008	80865	963	1578	1007	504481
bsdb:1034/2/1_Birth-measurement:Leukocyte-high-(grades-III-IV)_vs_Leukocyte-low-(grades-I-II)_UP	NA	32008	80865	1578	162289
bsdb:1034/2/2_Birth-measurement:Leukocyte-high-(grades-III-IV)_vs_Leukocyte-low-(grades-I-II)_DOWN	NA	165779	1301	40544
bsdb:1035/1/1_Urinary-schistosomiasis:Infection-Only_vs_Healthy-Control_UP	NA	469	1375	59732	66831	570	286	22	1279
bsdb:1035/1/2_Urinary-schistosomiasis:Infection-Only_vs_Healthy-Control_DOWN	NA	469	635	547	551	2701	568	131079	13159	29487	497	46255	1279
bsdb:1035/2/1_Urinary-schistosomiasis:Advanced_vs_Healthy-Control_UP	NA	816	227979	838	848	29465	1375	117563	66831	1696	162289	75	1578	1279	469
bsdb:1035/2/2_Urinary-schistosomiasis:Advanced_vs_Healthy-Control_DOWN	NA	547	635	46255	551	29487	568	286	1279	469
bsdb:1035/3/1_Urinary-schistosomiasis:Infected_vs_Non-Infected_UP	NA	469	1375	816	1696	59732	1350	66831	848	117563	227979	1578	1357	33969	162289	838	1279	29465
bsdb:1035/3/2_Urinary-schistosomiasis:Infected_vs_Non-Infected_DOWN	NA	469	1386	59732	635	212791	547	551	2701	568	29580	131079	13159	29487	497	1279	46255
bsdb:1035/4/1_Urinary-schistosomiasis:Advanced_vs_Pathology-only_UP	NA	469	1375	816	1696	283	66831	848	117563	227979	1578	162289	838	28453	29465	343873	1013	232523
bsdb:1035/4/2_Urinary-schistosomiasis:Advanced_vs_Pathology-only_DOWN	NA	469	1386	59732	635	212791	568	29580	286	1279	551	29487
bsdb:1035/5/1_Urinary-schistosomiasis:Advanced_vs_Infection-Only_UP	NA	816	838	227979	497	848	29465	117563	66831	1696	162289	75	2701	28453	343873	131079	1013	1578	13159	469	1279
bsdb:1035/5/2_Urinary-schistosomiasis:Advanced_vs_Infection-Only_DOWN	NA	59732	469	1279	286
bsdb:1035/6/1_Urinary-schistosomiasis:Infection-Only_vs_Pathology-Only_UP	NA	1375	283	1350	59732	469
bsdb:1035/6/2_Urinary-schistosomiasis:Infection-Only_vs_Pathology-Only_DOWN	NA	547	635	551	29487	75	1279	212791	59732	1386	29580	497	469
bsdb:1035/7/1_Urinary-schistosomiasis:Infected_vs_Non-Infected_DOWN	NA	165779	1257	158851	46255	626
bsdb:1035/7/2_Urinary-schistosomiasis:Infected_vs_Non-Infected_UP	NA	28453	40323
bsdb:1036/1/1_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_UP	NA	1357	35832	33042	283	283168	580024	33024	42255	1432051	2129	149698	209879
bsdb:1036/1/2_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_DOWN	NA	133925	1386	239934	1283313
bsdb:1037/1/1_Chronic-constipation:Constipated-women_vs_Healthy-women_UP	NA	816	1407607	375288	544
bsdb:1037/1/2_Chronic-constipation:Constipated-women_vs_Healthy-women_DOWN	NA	570	841
bsdb:1038/1/1_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	165779	1380	118747	194	39948	236752	1686313	848	1378	2050	437755	543311	2740	162289	1257	836	838	123375	1213720
bsdb:1038/1/2_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	469	31988	1912216	1578	286	67575	1279
bsdb:1038/2/1_Response-to-radiation:Postmenopausal-Pre-treatment-group_vs_Postmenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	28263	848	437755	2740	162289	836	1213720
bsdb:1038/2/2_Response-to-radiation:Postmenopausal-Pre-treatment-group_vs_Postmenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	2701	1378	1649463	68287
bsdb:1038/3/1_Response-to-radiation:Premenopausal-Post-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	165779	194	1716	39948	150022	162289	1257	838	1301
bsdb:1038/3/2_Response-to-radiation:Premenopausal-Post-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	31988	1678	234	117563	274591	219181	375288	1330546
bsdb:1038/4/1_Response-to-radiation:Postmenopausal-Post-treatment-group_vs_Postmenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	75	238749	836	1645	13687
bsdb:1038/4/2_Response-to-radiation:Postmenopausal-Post-treatment-group_vs_Postmenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	2701	1649463	68287
bsdb:1038/5/1_Response-to-radiation:Post-treatment-group_vs_Pre-treatment-group_UP	NA	469	572511	75	501783	1716	106589	1912216	238749	150022	1357	149698	1918540	482	84567	286	48736	1645	67575	93681	13687	1279	1301
bsdb:1038/5/2_Response-to-radiation:Post-treatment-group_vs_Pre-treatment-group_DOWN	NA	118747	848	133925	2740	836	838	123375	1213720
bsdb:1038/6/1_Response-to-radiation:3-months-post-treatment-group-(follow-up-samples)_vs_Pre-treatment-group_UP	NA	150022
bsdb:1038/6/2_Response-to-radiation:3-months-post-treatment-group-(follow-up-samples)_vs_Pre-treatment-group_DOWN	NA	123375
bsdb:1039/1/1_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_UP	NA	816	33024	848	830	1506553	3025755	239759	35832	946234	283168	397864	459786	1432051	1980693
bsdb:1039/1/2_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_DOWN	NA	265975	1470353	423604	970	157	39948	216851	838
bsdb:1039/3/1_Diet:Frozen-food-samples-from-urban-Xhosa-households_vs_Frozen-food-samples-from-rural-Xhosa-households_DOWN	NA	1356488	46255
bsdb:1039/4/1_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_UP	NA	469	1375	222991	92793	102106	82800	1522056	150022	227979	265	838	162291	497	1263	141948	82802	83770	662
bsdb:1039/4/2_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_DOWN	NA	402649	1386	1357	400634	86795	165696	528	162289	613	13687	85043	46255
bsdb:1040/1/1_COVID-19:RPs-(Recovered-Patients)_vs_HCs-(Healthy-Controls)_UP	NA	28196	36922	44249	5094	270	46255	43994	265975	1213720	118747	29465	848	168808	69278	34019	528	57739	475
bsdb:1040/1/2_COVID-19:RPs-(Recovered-Patients)_vs_HCs-(Healthy-Controls)_DOWN	NA	5475	2801844	1283313	838	308865	59734	2737	407	68287	374	953	1381133	47670	48736	416916	662
bsdb:1041/1/1_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_UP	NA	41275
bsdb:1041/1/2_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_DOWN	NA	482	528	508215	29465
bsdb:1041/2/1_Oral-cavity-carcinoma:Precancer_vs_Adjacent-normal-tissue-(AT)_DOWN	NA	1654	816	1016	1716	32067	482	119852	84567	1257	836	157
bsdb:1041/5/1_Oral-cavity-carcinoma:Cancer_vs_Precancer_UP	NA	836	838	286	157	32067	1016	119852
bsdb:1041/5/2_Oral-cavity-carcinoma:Cancer_vs_Precancer_DOWN	NA	28263	543311	508215
bsdb:1041/6/1_Oral-cavity-carcinoma:Late-Stage-Cancer_vs_Early-Stage-Cancer_UP	NA	84567
bsdb:1041/6/2_Oral-cavity-carcinoma:Late-Stage-Cancer_vs_Early-Stage-Cancer_DOWN	NA	32067
bsdb:1042/1/1_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_UP	NA	28453	400634	1301	42255
bsdb:1042/1/2_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_DOWN	NA	32
bsdb:1043/1/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-at-baseline-(A0)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	838
bsdb:1043/1/2_Human-immunodeficiency-virus:Acute-HIV-infected-participants-at-baseline-(A0)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	32067	1578	32207	47670	195950	1716	191303	841	1501226	816	82202	459786	475	43996
bsdb:1043/2/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-at-baseline-(B0)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	1301
bsdb:1043/2/2_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-at-baseline-(B0)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	1654	1578	32207	47670	195950	1716	191303	841	1501226	816	82202	459786	475	1213720	43996	265975
bsdb:1043/3/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-(A12)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	374	724
bsdb:1043/3/2_Human-immunodeficiency-virus:Acute-HIV-infected-participants-(A12)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	1578	1654	47670	32207
bsdb:1043/4/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-(B12)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	374
bsdb:1043/4/2_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-(B12)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	1578	1654	713
bsdb:1043/5/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-on-Antiretroviral-Therapy-(A12)_vs_Acute-HIV-infected-participants-at-baseline-(A0)_UP	NA	374
bsdb:1043/6/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-on-Antiretroviral-Therapy(B12)_vs_Chronic-HIV-infected-participants-at-baseline-(B0)_UP	NA	374
bsdb:1043/6/2_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-on-Antiretroviral-Therapy(B12)_vs_Chronic-HIV-infected-participants-at-baseline-(B0)_DOWN	NA	29465
bsdb:1043/7/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-at-baseline-(B0)_vs_Acute-HIV-infected-participants-at-baseline-(A0)_DOWN	NA	265975
bsdb:1043/8/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-on-Antiretroviral-Therapy(B12)_vs_Acute-HIV-infected-participants-on-Antiretroviral-Therapy(A12)_UP	NA	194
bsdb:1043/9/1_Human-immunodeficiency-virus:CD4+-T-cells-<-200-cells/mm3_vs_Uninfected-Controls_DOWN	NA	724	1654	32207
bsdb:1043/10/2_Human-immunodeficiency-virus:CD4+-T-cells->-200-cells/mm3_vs_Uninfected-Controls_DOWN	NA	1654	32207
bsdb:1043/11/1_Human-immunodeficiency-virus:CD4+-T-cells->-200-cells/mm3_vs_CD4+-T-cells-<-200-cells/mm3_UP	NA	724	1654	32207
bsdb:1044/2/1_Lung-transplantation:Recipients-with-rejection_vs_Clinically-stable-(or-event-free)-recipients_UP	NA	32207	46123	482	1654	32067
bsdb:1044/3/1_Lung-transplantation:Recipients-with-rejection_vs_Recipients-with-infection_UP	NA	46123	1654	32067	482	508215
bsdb:1045/1/1_Gut-microbiome-measurement:Workers-after-entry-into-an-underground-tunnel-(Exposed-status-(ES))_vs_Workers-before-entry-into-an-underground-tunnel-(Baseline-status-(BS))_UP	NA	1678	55968	1501226	1485
bsdb:1045/1/2_Gut-microbiome-measurement:Workers-after-entry-into-an-underground-tunnel-(Exposed-status-(ES))_vs_Workers-before-entry-into-an-underground-tunnel-(Baseline-status-(BS))_DOWN	NA	216851	841
bsdb:1046/1/1_Aging:PLWH-on-ART_vs_PLWOH_UP	NA	1283313	135858
bsdb:1046/1/2_Aging:PLWH-on-ART_vs_PLWOH_DOWN	NA	239759	816	216851
bsdb:1046/2/1_Aging:PLWH-on-ART_vs_PLWOH_UP	NA	1283313	135858
bsdb:1046/2/2_Aging:PLWH-on-ART_vs_PLWOH_DOWN	NA	239759	816	292632
bsdb:1046/3/1_Aging:PLWH-on-ART_vs_PLWOH_UP	NA	135858
bsdb:1046/4/1_Aging:Samples-PLWH-on-ART_vs_Samples-of-PLWOH_UP	NA	1766253	207244	572511	135858	102106	1407607	1573535	1501226	1301
bsdb:1046/4/2_Aging:Samples-PLWH-on-ART_vs_Samples-of-PLWOH_DOWN	NA	239759	1283313	816	848	1506553	375288	40544
bsdb:1046/5/1_Aging:Samples-of-PLWH-on-ART_vs_Samples-of-PLWOH_UP	NA	1766253	207244	572511	135858	102106	189330	1407607	1573535	1501226
bsdb:1046/5/2_Aging:Samples-of-PLWH-on-ART_vs_Samples-of-PLWOH_DOWN	NA	239759	1283313	816	848	1506553	375288	40544
bsdb:1047/1/1_Major-depressive-disorder:CUMS-group_vs_Control-group_UP	NA	570	816
bsdb:1047/1/2_Major-depressive-disorder:CUMS-group_vs_Control-group_DOWN	NA	1279
bsdb:1047/2/1_Major-depressive-disorder:CUMS + XYS-group_vs_Control-group_UP	NA	1578
bsdb:1047/2/2_Major-depressive-disorder:CUMS + XYS-group_vs_Control-group_DOWN	NA	1279
bsdb:1047/3/1_Major-depressive-disorder:CUMS + FLX-group_vs_Control-group_UP	NA	174708
bsdb:1047/3/2_Major-depressive-disorder:CUMS + FLX-group_vs_Control-group_DOWN	NA	1279
bsdb:1047/4/1_Major-depressive-disorder:CUMS + XYS-group_vs_CUMS-group_UP	NA	1578
bsdb:1047/4/2_Major-depressive-disorder:CUMS + XYS-group_vs_CUMS-group_DOWN	NA	570	816
bsdb:1047/5/1_Major-depressive-disorder:CUMS + FLX-group_vs_CUMS-group_UP	NA	174708
bsdb:1047/5/2_Major-depressive-disorder:CUMS + FLX-group_vs_CUMS-group_DOWN	NA	570	816
bsdb:1047/6/1_Major-depressive-disorder:CUMS + FLX-group_vs_CUMS-+-XYS-group_UP	NA	174708
bsdb:1047/6/2_Major-depressive-disorder:CUMS + FLX-group_vs_CUMS-+-XYS-group_DOWN	NA	1578
bsdb:1047/7/1_Major-depressive-disorder:CUMS_vs_Control-group_UP	NA	838
bsdb:1047/7/2_Major-depressive-disorder:CUMS_vs_Control-group_DOWN	NA	216851
bsdb:1047/8/1_Major-depressive-disorder:Control-+-FMT(CUMS)-group_vs_Control-group_UP	NA	174708	375288	838
bsdb:1047/9/1_Major-depressive-disorder:CUMS-+-FMT(XYS)-group_vs_Control-group_UP	NA	1578	239934
bsdb:1047/10/1_Major-depressive-disorder:CUMS-+-FMT(XYS)-group_vs_CUMS-group_UP	NA	838
bsdb:1047/10/2_Major-depressive-disorder:CUMS-+-FMT(XYS)-group_vs_CUMS-group_DOWN	NA	49082	39948	1263
bsdb:1048/33/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	838	33024
bsdb:1048/33/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/34/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	838	33024
bsdb:1048/34/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/35/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	838	33024
bsdb:1048/35/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/36/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	838	33024
bsdb:1048/36/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/37/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	838	33024
bsdb:1048/37/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/38/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	838	33024
bsdb:1048/38/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/39/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	838	157
bsdb:1048/39/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	216851	33024	841
bsdb:1048/40/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_UP	NA	216851	33024
bsdb:1048/40/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-0-hour_DOWN	NA	838	157	841
bsdb:1048/41/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	157	216851
bsdb:1048/41/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838	33024	841
bsdb:1048/42/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	33024	841	157	216851
bsdb:1048/42/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/43/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	33024
bsdb:1048/43/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838	157	216851	841
bsdb:1048/44/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	157	216851	841
bsdb:1048/44/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838	33024
bsdb:1048/45/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/45/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/46/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	157	216851	841
bsdb:1048/46/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838	33024
bsdb:1048/47/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_UP	NA	157	216851
bsdb:1048/47/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/48/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_UP	NA	216851	841
bsdb:1048/48/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_DOWN	NA	838	157	33024
bsdb:1048/49/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_UP	NA	157	216851	841
bsdb:1048/49/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_DOWN	NA	838	33024
bsdb:1048/50/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_UP	NA	157	216851	841
bsdb:1048/50/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_DOWN	NA	838	33024
bsdb:1048/51/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_UP	NA	216851	841
bsdb:1048/51/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_DOWN	NA	838	157	33024
bsdb:1048/52/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/52/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/53/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/53/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/54/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_UP	NA	157
bsdb:1048/54/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_DOWN	NA	838	33024	216851	841
bsdb:1048/55/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_UP	NA	157	216851	841
bsdb:1048/55/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_DOWN	NA	838	33024
bsdb:1048/56/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/56/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/57/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/57/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/58/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/58/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/62/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_UP	NA	157	216851
bsdb:1048/62/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_DOWN	NA	838	33024	841
bsdb:1048/64/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_UP	NA	216851	33024	841
bsdb:1048/64/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_DOWN	NA	838	157
bsdb:1048/65/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/65/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_DOWN	NA	838
bsdb:1048/66/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_UP	NA	157	33024	216851	841
bsdb:1048/66/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(-20°C)_DOWN	NA	838
bsdb:1048/67/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(5°C)_UP	NA	157	216851	841
bsdb:1048/67/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(5°C)_DOWN	NA	838	33024
bsdb:1048/68/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(5°C)_UP	NA	157	216851	33024	841
bsdb:1048/68/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(5°C)_DOWN	NA	838
bsdb:1048/69/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(5°C)_UP	NA	216851	33024	841
bsdb:1048/69/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(5°C)_DOWN	NA	838	157
bsdb:1048/70/1_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(5°C)_UP	NA	157	216851
bsdb:1048/70/2_Microbiome:Unspiked-pig-feces(P1)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(5°C)_DOWN	NA	838	33024	841
bsdb:1048/71/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(5°C)_UP	NA	157	216851
bsdb:1048/71/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-64-hours-(5°C)_DOWN	NA	838	33024	841
bsdb:1048/72/1_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(22°C)_UP	NA	157	216851
bsdb:1048/72/2_Microbiome:Unspiked-pig-feces(P1)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P1)-at-16-hours-(22°C)_DOWN	NA	838	33024	841
bsdb:1048/109/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	33024	838	841
bsdb:1048/109/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	216851	157
bsdb:1048/110/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	838
bsdb:1048/110/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	216851	33024	841	157
bsdb:1048/111/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	838	33024	841
bsdb:1048/111/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	157	216851
bsdb:1048/112/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	838	33024
bsdb:1048/112/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	157	216851	841
bsdb:1048/113/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	216851	33024	841
bsdb:1048/113/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	838	157
bsdb:1048/114/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	216851	33024	841
bsdb:1048/114/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	838	157
bsdb:1048/115/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	216851	33024	841
bsdb:1048/115/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	838	157
bsdb:1048/116/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_UP	NA	216851	33024	841
bsdb:1048/116/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-0-hour_DOWN	NA	838	157
bsdb:1048/117/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(80°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	216851
bsdb:1048/117/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(80°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	838	157	33024	841
bsdb:1048/118/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	838	33024
bsdb:1048/118/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	157	216851	841
bsdb:1048/119/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	838	33024
bsdb:1048/119/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	157	216851	841
bsdb:1048/120/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/120/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/121/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/121/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/122/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/122/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/123/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/123/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-80°C)_DOWN	NA	838
bsdb:1048/124/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_UP	NA	838	157	33024	841
bsdb:1048/124/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_DOWN	NA	216851
bsdb:1048/125/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_UP	NA	838	157	33024
bsdb:1048/125/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_DOWN	NA	216851	841
bsdb:1048/126/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/126/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/127/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_UP	NA	216851	33024	841	157
bsdb:1048/127/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/128/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_UP	NA	157	216851	33024	841
bsdb:1048/128/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/129/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_UP	NA	216851	33024	157	841
bsdb:1048/129/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/130/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_UP	NA	33024
bsdb:1048/130/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_DOWN	NA	838	157	216851	841
bsdb:1048/131/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/131/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/132/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/132/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/133/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/133/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/134/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/134/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(-20°C)_DOWN	NA	838
bsdb:1048/135/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_UP	NA	157	216851	841
bsdb:1048/135/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_DOWN	NA	838	33024
bsdb:1048/136/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/136/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_DOWN	NA	838
bsdb:1048/137/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_UP	NA	216851	157	841	33024
bsdb:1048/137/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_DOWN	NA	838
bsdb:1048/138/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_UP	NA	157	216851	33024	841
bsdb:1048/138/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(-20°C)_DOWN	NA	838
bsdb:1048/139/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(5°C)_UP	NA	216851	33024	841
bsdb:1048/139/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(5°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(5°C)_DOWN	NA	838	157
bsdb:1048/140/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(5°C)_UP	NA	216851	33024	841
bsdb:1048/140/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(5°C)_DOWN	NA	838	157
bsdb:1048/141/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(5°C)_UP	NA	216851	33024	841
bsdb:1048/141/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(5°C)_DOWN	NA	838	157
bsdb:1048/142/1_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(5°C)_UP	NA	838	157
bsdb:1048/142/2_Microbiome:Unspiked-pig-feces(P2)-at-16-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(5°C)_DOWN	NA	216851	33024	841
bsdb:1048/143/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(5°C)_UP	NA	157	33024
bsdb:1048/143/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-64-hours-(5°C)_DOWN	NA	838	216851	841
bsdb:1048/144/1_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(22°C)_UP	NA	157	33024	841
bsdb:1048/144/2_Microbiome:Unspiked-pig-feces(P2)-at-64-hours-(22°C)_vs_Unspiked-pig-feces(P2)-at-16-hours-(22°C)_DOWN	NA	216851	838
bsdb:1048/145/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	28196	838	642
bsdb:1048/145/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	469	375288
bsdb:1048/146/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	28196	642
bsdb:1048/146/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	469	375288	838
bsdb:1048/147/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	28196	642
bsdb:1048/147/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	469	375288	838
bsdb:1048/148/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	28196	642	838
bsdb:1048/148/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	375288	469
bsdb:1048/149/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	28196	838	642
bsdb:1048/149/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	469	375288
bsdb:1048/150/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	375288	838	642
bsdb:1048/150/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	28196	469
bsdb:1048/151/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	375288	838	642
bsdb:1048/151/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	28196	469
bsdb:1048/152/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_UP	NA	838	642
bsdb:1048/152/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-0-hours_DOWN	NA	28196	469	375288
bsdb:1048/153/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	642
bsdb:1048/153/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	469	375288	838
bsdb:1048/154/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	469
bsdb:1048/154/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	375288	838	642
bsdb:1048/155/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	838
bsdb:1048/155/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	469	375288	642
bsdb:1048/156/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	375288	838
bsdb:1048/156/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	469	642
bsdb:1048/157/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	375288
bsdb:1048/157/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	469	838	642
bsdb:1048/158/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	469	375288	838
bsdb:1048/158/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	642
bsdb:1048/159/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_UP	NA	838	642
bsdb:1048/159/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(22°C)_vs_Unspiked-sewage-samples-(S1)-at-16-hours-(-80°C)_DOWN	NA	28196	469	375288
bsdb:1048/160/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_UP	NA	28196	469	375288	642
bsdb:1048/160/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_DOWN	NA	838
bsdb:1048/161/1_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_UP	NA	28196	469	375288	838
bsdb:1048/161/2_Microbiome:Unspiked-sewage-samples-(S1)-at-64-hours-(-20°C)_vs_Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_DOWN	NA	642
bsdb:1048/162/1_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_UP	NA	28196	469	375288	838
bsdb:1048/162/2_Microbiome:Unspiked-sewage-samples-(S1)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S1)-at-64-hours-(-80°C)_DOWN	NA	642
bsdb:1048/207/1_Microbiome:Unspiked-sewage-samples-(S2)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S2)-at-64-hours-(-20°C)_UP	NA	375288
bsdb:1048/207/2_Microbiome:Unspiked-sewage-samples-(S2)-at-16-hours-(5°C)_vs_Unspiked-sewage-samples-(S2)-at-64-hours-(-20°C)_DOWN	NA	28196	469	838	642
bsdb:1049/1/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	1663	1716	281915
bsdb:1049/2/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	1663	1386	1298	286	204447
bsdb:1049/2/2_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	1716	1912216	407	1839	265	125216	295418	13687	1279	1301
bsdb:1049/3/1_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_UP	NA	89966
bsdb:1049/3/2_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_DOWN	NA	434	848
bsdb:1049/4/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	469	281915	1649317
bsdb:1049/4/2_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_DOWN	NA	434	1016	86795	158846
bsdb:1049/5/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	1716	1912216	1298	848	86795	1839	219181	265	286	295418	332248
bsdb:1049/5/2_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	398041	89966	407	482	836	204447	13687	1279
bsdb:1049/6/1_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_UP	NA	1663	38501	2767323	1016	1912216	848	1378	1839	42255	107	1301
bsdb:1049/6/2_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_DOWN	NA	204447	1279
bsdb:1049/7/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	572511	47670	836	1742993	42255	204447
bsdb:1049/7/2_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_DOWN	NA	469	334107	407	33882	745	34072
bsdb:1049/8/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	1016	547	44259	848	186650	745	1279
bsdb:1049/8/2_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	434	1654	59735	1912216	1298	47670	407	29404	482	1839	219181	836	295418	2529408	1301	332248
bsdb:1049/9/1_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_UP	NA	836	508215
bsdb:1049/9/2_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_DOWN	NA	89966	86795	1279
bsdb:1049/10/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	1654	501783	475
bsdb:1049/10/2_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_DOWN	NA	47670	149698	836	125216	1279	191303
bsdb:1049/11/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	38501	572511	1298	398041	583	295418	1279
bsdb:1049/11/2_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	1663	816	1912216	41275	2005355	237	47670	407	29404	186650	53460	1839	836	204447	13687
bsdb:1049/12/1_Atopic-eczema:cADpre-dogs_vs_Healthy_UP	NA	848
bsdb:1049/12/2_Atopic-eczema:cADpre-dogs_vs_Healthy_DOWN	NA	2749267	207244	572511	946234	836	1279	1485
bsdb:1049/13/1_Atopic-eczema:cADpost-dogs_vs_cADpre_UP	NA	2749267	816	572511	2005355	946234	1505652	3025755	1485
bsdb:1049/13/2_Atopic-eczema:cADpost-dogs_vs_cADpre_DOWN	NA	2039240	2719313	848	836	583	1501226	841	1279
bsdb:1049/14/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	2039240	2005355	1716
bsdb:1049/14/2_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_DOWN	NA	1485	191303
bsdb:1050/1/1_Taxonomic-microbiome-measurement:Esophagus_vs_Oral-cavity_UP	NA	469	713	174708	572511	374	59732	33042	212791	407	165696	528	119852	20	1743	286	48736	1007	504481	165695	13687	1279	40323	1301
bsdb:1050/1/2_Taxonomic-microbiome-measurement:Esophagus_vs_Oral-cavity_DOWN	NA	1654	2717	482	346096	970
bsdb:1051/1/1_Lung-cancer:Lung-cancer-(L-group)_vs_Benign-pulmonary-diseases-(N-group)_UP	NA	816
bsdb:1051/1/2_Lung-cancer:Lung-cancer-(L-group)_vs_Benign-pulmonary-diseases-(N-group)_DOWN	NA	572511	2747	33042	1407607	1649	1164882	1743	292632
bsdb:1052/1/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-control-(NC)_UP	NA	1766253	1283313	1380	508459	33042	216851	543311	286	123375
bsdb:1052/1/2_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-control-(NC)_DOWN	NA	3025755	1506577
bsdb:1053/1/1_Nephrolithiasis:KB-group---Bladder-urine-from-kidney-stone-patients._vs_HB-group---Bladder-urine-from-healthy-controls._UP	NA	838	216851	231454	34037	2740	165697	31988	44249	375288	283168
bsdb:1053/1/2_Nephrolithiasis:KB-group---Bladder-urine-from-kidney-stone-patients._vs_HB-group---Bladder-urine-from-healthy-controls._DOWN	NA	469	848
bsdb:1053/2/1_Nephrolithiasis:KP-group---Renal-pelvis-urine-from-kidney-stone-patients._vs_KB-group---Bladder-urine-from-kidney-stone-patients._UP	NA	848	469
bsdb:1053/2/2_Nephrolithiasis:KP-group---Renal-pelvis-urine-from-kidney-stone-patients._vs_KB-group---Bladder-urine-from-kidney-stone-patients._DOWN	NA	150247
bsdb:1054/1/1_Streptococcal-infection:GBS-culture-positive-pregnant-women_vs_GBS-culture-negative-pregnant-women_DOWN	NA	1578
bsdb:1054/1/2_Streptococcal-infection:GBS-culture-positive-pregnant-women_vs_GBS-culture-negative-pregnant-women_UP	NA	194	1716	2701	1257	1279	1301	2129
bsdb:1055/1/1_Pregnancy:Amniotic-fluid-derived-extracellular-vesicles-(AM-EVs)_vs_Amniotic-fluid-(AM)_UP	NA	239759	1283313	816	374	1298	57495	29393	1378	117563	1847725	482	162289	836	838	1279	1301	29465
bsdb:1055/2/1_Pregnancy:Maternal-feces-(FE)_vs_Amniotic-fluid-(AM)_UP	NA	374	57495	216851	1279
bsdb:1055/5/1_Pregnancy:Feces-derived-extracellular-vesicles-(FE-EV)_vs_Amniotic-fluid-derived-extracellular-vesicles-(AM-EV)_UP	NA	816	150022	848
bsdb:1055/6/1_Pregnancy:Feces-derived-extracellular-vesicles-(FE-EV)_vs_Maternal-feces-(FE)_UP	NA	239759	1283313	165779	816	397864	572511	1980681	1298	29393	171412	1582879	216851	150022	1378	117563	1847725	1269	482	543311	162289	836	1279	1301	292632	29465
bsdb:1056/1/1_Microbiome-measurement:RNAlater---Day-4_vs_RNAlater---Day-0_UP	NA	102106
bsdb:1056/2/1_Microbiome-measurement:Fecal-occult-blood-test-[FOBT]-cards---Day-0_vs_RNAlater---Day-0_UP	NA	1678	102106	84111	580024	1473205	1578	1357	1301	1485	86331	207244	572511	189330	1407607	248744	1505657	1501226	1505652	580596	216851	1980693	1263	292632	1573535	123375	906	52225
bsdb:1056/2/2_Microbiome-measurement:Fecal-occult-blood-test-[FOBT]-cards---Day-0_vs_RNAlater---Day-0_DOWN	NA	816	397864	574697	283168	1283313	239759	375288	830	28050	1470353	459786	2152	172900	35832	872	83770	577310	40544
bsdb:1056/3/1_Microbiome-measurement:Scope-mouthwash---Day-4_vs_Scope-mouthwash---Day-0_UP	NA	1678	1301	2740	123375	47670	286
bsdb:1056/3/2_Microbiome-measurement:Scope-mouthwash---Day-4_vs_Scope-mouthwash---Day-0_DOWN	NA	32207	836	1283313	1378	482	416916	724
bsdb:1056/4/1_Microbiome-measurement:Scope-mouthwash_vs_OMNIgene-ORAL-kit_UP	NA	46123	419014	194	1016	1378	129337	1578	47670	909656	286	196081	970
bsdb:1056/4/2_Microbiome-measurement:Scope-mouthwash_vs_OMNIgene-ORAL-kit_DOWN	NA	32207	1283313	43996	1164882	265975	123375	848	482	713	416916	724
bsdb:1057/1/1_Lifestyle-measurement:Female-subjects-situated-in-Soweto_vs_Female-subjects-situated-in-Bushbuckridge_UP	NA	258514
bsdb:1057/1/2_Lifestyle-measurement:Female-subjects-situated-in-Soweto_vs_Female-subjects-situated-in-Bushbuckridge_DOWN	NA	239759	2086	216851	946234	577310	838	1263	40544	213484
bsdb:1057/2/1_Lifestyle-measurement:Lean-female-subjects-in-Soweto_vs_Lean-female-subjects-in-Bushbuckridge_UP	NA	1678	135858	33024	841	1263	40544	838	816
bsdb:1057/2/2_Lifestyle-measurement:Lean-female-subjects-in-Soweto_vs_Lean-female-subjects-in-Bushbuckridge_DOWN	NA	816	39948
bsdb:1057/3/1_Lifestyle-measurement:Obese-female-subjects-in-Soweto_vs_Obese-female-subjects-in-Bushbuckridge_DOWN	NA	1263
bsdb:1057/4/1_Lifestyle-measurement:Obese-female-subjects-in-both-cohorts_vs_Lean-female-subjects-in-both-cohorts_UP	NA	1392389	838
bsdb:1057/5/1_Lifestyle-measurement:Obese-female-subjects-in-Bushbuckridge_vs_Lean-female-subjects-in-Bushbuckridge_UP	NA	258514	239934	135858	375288	33024	838	40544	213484
bsdb:1057/6/1_Lifestyle-measurement:Obese-female-subjects-in-Soweto_vs_Lean-female-subjects-in-Soweto_UP	NA	561	724	1392389	375288	838	44748
bsdb:1057/6/2_Lifestyle-measurement:Obese-female-subjects-in-Soweto_vs_Lean-female-subjects-in-Soweto_DOWN	NA	375288
bsdb:1058/1/1_Coronary-artery-disease:Patient-with-coronary-artery-disease_vs_Healthy-controls_UP	NA	1980681	102106	1573534	2767881	1980693	162289	123375	40544
bsdb:1058/1/2_Coronary-artery-disease:Patient-with-coronary-artery-disease_vs_Healthy-controls_DOWN	NA	572511	1730	1407607	2039302
bsdb:1060/1/1_Population:Kwepe_vs_Kuvale_UP	NA	118747	177971	158876
bsdb:1060/2/1_Population:Himba_vs_Kuvale_UP	NA	1578	2801844
bsdb:1060/2/2_Population:Himba_vs_Kuvale_DOWN	NA	158483	590
bsdb:1060/3/1_Population:Tjimba_vs_Kuvale_UP	NA	638847
bsdb:1060/3/2_Population:Tjimba_vs_Kuvale_DOWN	NA	158483	568
bsdb:1060/4/2_Population:Kwisi_vs_Kuvale_DOWN	NA	158483
bsdb:1060/5/1_Population:Twa_vs_Kuvale_UP	NA	544	1279384	547	561	836	286	590	613	158876	44259
bsdb:1060/5/2_Population:Twa_vs_Kuvale_DOWN	NA	577309	848	836
bsdb:1060/6/1_Population:Tshwa_vs_Kuvale_UP	NA	43996	544	1279384	547	1350	561	44259	568	43994	1913599	590	158876
bsdb:1060/6/2_Population:Tshwa_vs_Kuvale_DOWN	NA	1164882	577309	836	71
bsdb:1060/7/1_Population:!Xun_vs_Kuvale_UP	NA	1279384	1913599	1743	177971
bsdb:1060/7/2_Population:!Xun_vs_Kuvale_DOWN	NA	46123	1386	1870884	1350
bsdb:1060/8/1_Population:Himba_vs_Kwepe_DOWN	NA	158483	590	158876
bsdb:1060/8/2_Population:Himba_vs_Kwepe_UP	NA	1578	2801844
bsdb:1060/9/2_Population:Tjimba_vs_Kwepe_DOWN	NA	568	118747	158483	158876
bsdb:1060/10/2_Population:Kwisi_vs_Kwepe_DOWN	NA	1654	158876	158483
bsdb:1060/11/1_Population:Twa_vs_Kwepe_UP	NA	544	547	286	561
bsdb:1060/12/1_Population:Tshwa_vs_Kwepe_UP	NA	544	547	561	590
bsdb:1060/12/2_Population:Tshwa_vs_Kwepe_DOWN	NA	1654	906
bsdb:1060/14/1_Population:Tjimba_vs_Himba_UP	NA	590
bsdb:1060/14/2_Population:Tjimba_vs_Himba_DOWN	NA	568
bsdb:1060/15/1_Population:Kwisi_vs_Himba_UP	NA	590
bsdb:1060/15/2_Population:Kwisi_vs_Himba_DOWN	NA	1578
bsdb:1060/16/1_Population:Twa_vs_Himba_UP	NA	590	158483	547	158876	544	561	568	194	613	970
bsdb:1060/16/2_Population:Twa_vs_Himba_DOWN	NA	577309
bsdb:1060/17/1_Population:Tshwa_vs_Himba_UP	NA	590	158483	547	544	158876	568	561
bsdb:1060/17/2_Population:Tshwa_vs_Himba_DOWN	NA	1578	2801844
bsdb:1060/18/1_Population:!Xun_vs_Himba_UP	NA	590	194
bsdb:1060/18/2_Population:!Xun_vs_Himba_DOWN	NA	46123	1386	1870884	1350	2801844
bsdb:1060/19/2_Population:Tshwa_vs_Twa_DOWN	NA	71	1654
bsdb:1060/20/1_Population:!Xun_vs_Twa_DOWN	NA	158483	544	1870884	547	1350	561	286	508215	590	613	158876
bsdb:1060/21/1_Population:!Xun_vs_Tshwa_UP	NA	71	1743
bsdb:1060/21/2_Population:!Xun_vs_Tshwa_DOWN	NA	613	1378	47670	1350	544	547	561	590	158876	158483	1870884
bsdb:1060/22/1_Population:Kwisi_vs_Tjimba_UP	NA	568
bsdb:1060/22/2_Population:Kwisi_vs_Tjimba_UP	NA	638847
bsdb:1060/23/1_Population:Twa_vs_Tjimba_UP	NA	568	158483	547	158876	561	544
bsdb:1060/24/1_Population:Tshwa_vs_Tjimba_UP	NA	568	547	158483	544	158876	561	590
bsdb:1060/25/1_Population:!Xun_vs_Tjimba_UP	NA	568	1743
bsdb:1060/26/1_Population:Twa_vs_Kwisi_UP	NA	158483	547	158876	544
bsdb:1060/27/1_Population:Tshwa_vs_Kwisi_UP	NA	158483	547	544
bsdb:1060/27/2_Population:Tshwa_vs_Kwisi_DOWN	NA	71	475
bsdb:1060/28/1_Population:!Xun_vs_Kwisi_UP	NA	1743
bsdb:1060/28/2_Population:!Xun_vs_Kwisi_DOWN	NA	46123	1386	1870884	1350	561
bsdb:1060/29/1_Socioeconomic-status:Foragers_vs_Pastoralists_UP	NA	1279384
bsdb:1060/29/2_Socioeconomic-status:Foragers_vs_Pastoralists_DOWN	NA	46123	1386	1870884	1350	508215
bsdb:1060/30/1_Socioeconomic-status:Peripatetics_vs_Pastoralists_UP	NA	544	570	561	590	568	547	286	1279384	1013	583
bsdb:1060/30/2_Socioeconomic-status:Peripatetics_vs_Pastoralists_DOWN	NA	123375	1164882	1578	577309
bsdb:1060/31/1_Socioeconomic-status:Foragers_vs_Peripatetics_UP	NA	1743
bsdb:1060/31/2_Socioeconomic-status:Foragers_vs_Peripatetics_DOWN	NA	46123	1386	544	1870884	1350	561	570	47670	32207	590
bsdb:1061/1/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-(CN)-and-amnestic-mild-cognitive-impairment-(aMCI)_UP	NA	838	29465	848	286	1033	156454	2282523	2767358	906	374	2767353	1213720	469322
bsdb:1061/2/1_Alzheimer's-disease:Amnestic-mild-cognitive-impairment-(aMCI)_vs_Cognitively-normal-(CN)-and-Alzheimer’s-Disease-(AD)_UP	NA	482	32207	48736	75
bsdb:1061/3/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)-and-Amnestic-mild-cognitive-impairment-(aMCI)_vs_Cognitively-normal-(CN)_DOWN	NA	561	724	1827	2801844	59735	1913599	43996	2755140
bsdb:1062/2/1_Gut-microbiome-measurement:Yes---antibiotics_vs_No---antibiotics_DOWN	NA	543311	46255
bsdb:1063/1/1_Oral-lichen-planus:Oral-lichen-planus-(both-erosive-and-non-erosive-)_vs_Healthy-Control_UP	NA	361177	1663	906	2050	265975
bsdb:1063/1/2_Oral-lichen-planus:Oral-lichen-planus-(both-erosive-and-non-erosive-)_vs_Healthy-Control_DOWN	NA	46123	2147	416916	816	538	1582879	332102	32067	482	504481	1054211	195950
bsdb:1063/4/1_Oral-lichen-planus:OLP-patients-with-erosive-lesions-(E)_vs_Healthy-control_UP	NA	265975
bsdb:1063/4/2_Oral-lichen-planus:OLP-patients-with-erosive-lesions-(E)_vs_Healthy-control_DOWN	NA	46123	724	482
bsdb:1063/5/1_Oral-lichen-planus:OLP-patients-without-erosive-lesions-(NE)_vs_Healthy-control_UP	NA	724	482	265975
bsdb:1063/5/2_Oral-lichen-planus:OLP-patients-without-erosive-lesions-(NE)_vs_Healthy-control_DOWN	NA	46123
bsdb:1063/7/1_Oral-lichen-planus:OLP-patients-with-erosive-lesions-(E)_vs_OLP-patients-without-erosive-lesions-(NE)_UP	NA	46123
bsdb:1063/7/2_Oral-lichen-planus:OLP-patients-with-erosive-lesions-(E)_vs_OLP-patients-without-erosive-lesions-(NE)_DOWN	NA	724	482	265975
bsdb:1064/1/1_Response-to-irinotecan:Colon-cancer-and-Irinotecan-treated-patients_vs_Healthy-individuals_DOWN	NA	1678	204475	1263	33024	872
bsdb:1064/2/1_Response-to-irinotecan:Irinotecan-treated-patients_vs_Healthy-individuals-and-colon-cancer-(CRC)-patients_UP	NA	1578	580596	29465
bsdb:1064/3/1_Response-to-irinotecan:Colon-cancer-patients_vs_Healthy-individuals-and-Irinotecan-treated-patients_UP	NA	39948
bsdb:1065/1/1_Breast-cancer:pre-menopausal-breast-cancer-(BC)-patients_vs_pre-menopausal-controls_UP	NA	1924093	1678	204475	1905344
bsdb:1065/2/1_Breast-cancer:post-menopausal-BC-patients_vs_post-menopausal-controls_UP	NA	2048137	1892380
bsdb:1065/2/2_Breast-cancer:post-menopausal-BC-patients_vs_post-menopausal-controls_DOWN	NA	1348911	189330	375288
bsdb:1066/1/1_Polycystic-ovary-syndrome:Polycystic-ovary-syndrome-(PCOS)-patients_vs_Healthy-Controls_UP	NA	5352	4930
bsdb:1066/1/2_Polycystic-ovary-syndrome:Polycystic-ovary-syndrome-(PCOS)-patients_vs_Healthy-Controls_DOWN	NA	5052
bsdb:1067/1/1_Acquired-primary-ovarian-failure:Primary-ovarian-failure-(POF)_vs_Healthy-controls_UP	NA	838	2701	1678	168808	836	816	39948	29465	194	162289	165779	1301	31983	586	1716	577310	1485	613	28196	182709	59732	1654	150022	404402	572511	83614	33976	2742	83770	1161127	2745	904	1378	909928	204475	32207	90243	1350	28263	1283313
bsdb:1067/1/2_Acquired-primary-ovarian-failure:Primary-ovarian-failure-(POF)_vs_Healthy-controls_DOWN	NA	1578	41275	543311	841	528	1380
bsdb:1070/4/1_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_UP	NA	4910	113604	5340
bsdb:1070/4/2_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_DOWN	NA	5260	5529	410829	1047167	148303
bsdb:1070/5/1_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_UP	NA	1915381	229219	148959
bsdb:1070/5/2_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_DOWN	NA	5021	37840	766733	4948	4943
bsdb:1070/6/1_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_UP	NA	5206	5455	4815	4948	460517
bsdb:1070/6/2_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_DOWN	NA	80635
bsdb:1071/1/1_Psoriasis:Psoriasis_vs_Healthy-Control-(HC)_UP	NA	216851	204475	158846	638847	2753
bsdb:1071/1/2_Psoriasis:Psoriasis_vs_Healthy-Control-(HC)_DOWN	NA	848	816
bsdb:1071/2/1_Gut-microbiome-measurement:Psoriasis-Vulgaris-(PV)_vs_Pustular-Psoriasis-(PP)_DOWN	NA	118966	216851
bsdb:1072/1/1_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_UP	NA	189330	1506577	86331	123375	1501226	1485	2740	2172	248744	1573535	572511	1506553
bsdb:1072/1/2_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_DOWN	NA	1508657	1350	53335	629	1578	1263	1301	1766253	841	239759	292632	46255	207244
bsdb:1072/2/1_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV+-MASLD-_UP	NA	189330	1506577	86331	123375	1501226	1485	2740	2172	248744	1573535	572511	1506553
bsdb:1072/2/2_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV+-MASLD-_DOWN	NA	904	1283313	82373	2152	135858	102106	906	52225	375288	577309	33024	836	838	83770	40544	39948	816
bsdb:1072/3/1_Non-alcoholic-fatty-liver-disease:HIV--MASLD+_vs_HIV+-MASLD-_UP	NA	1508657	1350	53335	629	1578	1263	1301	1766253	841	239759	207244	292632	46255
bsdb:1072/3/2_Non-alcoholic-fatty-liver-disease:HIV--MASLD+_vs_HIV+-MASLD-_DOWN	NA	904	1283313	82373	2152	135858	102106	906	52225	375288	577309	33024	836	838	83770	40544	39948	816
bsdb:1073/1/1_Bacterial-disease:Diseased-sea-urchins_vs_Healthy-sea-urchins_UP	NA	1617805	365032	28228	393277	76008	437504	1579315	574899	45247	1649465	449810	1779141	2321187	1122284	156993	265488	1827484	2433
bsdb:1073/1/2_Bacterial-disease:Diseased-sea-urchins_vs_Healthy-sea-urchins_DOWN	NA	261825	93171	1068873	893	109168	46913	1471399	444459	1217416	2038635	188905	1434035	83612	265488	1827484	1147735	22	237444
bsdb:1073/2/1_Bacterial-disease:Recovered-sea-urchins_vs_Healthy-sea-urchins_UP	NA	1635133	1920241	776	40413	872	1084558	518755	361050	1518149	662
bsdb:1073/2/2_Bacterial-disease:Recovered-sea-urchins_vs_Healthy-sea-urchins_DOWN	NA	93171	109168	46913	1471399	1579315	574899	2038635	188905	1649465	1434035	2433	1147735	22	237444
bsdb:1073/3/1_Bacterial-disease:Diseased-sea-urchins_vs_Recovered-sea-urchins_UP	NA	1617805	365032	28228	393277	76008	437504	1579315	574899	45247	1649465	449810	1779141	2321187	1122284	156993	265488	1827484	2433
bsdb:1073/3/2_Bacterial-disease:Diseased-sea-urchins_vs_Recovered-sea-urchins_DOWN	NA	1635133	1920241	776	872	1084558	518755	361050	1518149	662
bsdb:1073/4/1_Bacterial-disease:Sea-water-from-diseased-sea-urchins-aquarium_vs_Sea-water-from-healthy-sea-urchins-aquarium_UP	NA	28228	45247	358023
bsdb:1073/4/2_Bacterial-disease:Sea-water-from-diseased-sea-urchins-aquarium_vs_Sea-water-from-healthy-sea-urchins-aquarium_DOWN	NA	109168	1434035	53246	67572	1827484	662
bsdb:1073/5/1_Bacterial-disease:Sea-water-from-recovered-sea-urchins-aquarium_vs_Sea-water-from-healthy-sea-urchins-aquarium_UP	NA	67572
bsdb:1073/5/2_Bacterial-disease:Sea-water-from-recovered-sea-urchins-aquarium_vs_Sea-water-from-healthy-sea-urchins-aquarium_DOWN	NA	662	28228	45247	109168	53246	1827484	358023	1434035
bsdb:1073/6/1_Bacterial-disease:Diseased-sea-urchins_vs_Recovered-sea-urchins_UP	NA	28228	551	45247	358023	662	332102	53945	28196	265487	52959
bsdb:1073/6/2_Bacterial-disease:Diseased-sea-urchins_vs_Recovered-sea-urchins_DOWN	NA	204286	109168	202746	226	67572	361050	262	288021	361177	776	904708	1007082	518755	286104	150830
bsdb:1073/7/1_Bacterial-disease:Sea-water-diseased-sea-urchins-aquarium_vs_Sea-water-from-recovered-sea-urchins-aquarium_UP	NA	662	28228	45247	358023
bsdb:1073/7/2_Bacterial-disease:Sea-water-diseased-sea-urchins-aquarium_vs_Sea-water-from-recovered-sea-urchins-aquarium_DOWN	NA	109168	1434035	53246	67572	1827484
bsdb:1073/8/1_Bacterial-disease:Recovered-sea-urchins_vs_Healthy-sea-urchins_UP	NA	226	204286	109168	67572	202746	361050	262	288021	361177	776	904708	872	518755	286104	150830
bsdb:1073/8/2_Bacterial-disease:Recovered-sea-urchins_vs_Healthy-sea-urchins_DOWN	NA	28228	1434025	208215	53246	662	118	67572	22	314318	1207070	2742	245186	146	1264044	50056	1618113	60136	1471399	35798	379070	1763	83612
bsdb:1074/2/1_Response-to-antiviral-drug:Follow-up-at-week-72-(FUw72)--SVR_vs_Baseline---SVR_UP	NA	572511	1678	292632	189330	158846	102106	1407607	33042	207244	906	1573535	1301
bsdb:1074/2/2_Response-to-antiviral-drug:Follow-up-at-week-72-(FUw72)--SVR_vs_Baseline---SVR_DOWN	NA	816	1506553	40544	28050
bsdb:1074/7/1_Response-to-antiviral-drug:Patients-with-HCV/HIV-coinfection-at-FUw72_vs_Patients-with-HCV/HIV-coinfection-at-baseline_UP	NA	572511	1766253	1678	158846	102106	189330	33042
bsdb:1074/7/2_Response-to-antiviral-drug:Patients-with-HCV/HIV-coinfection-at-FUw72_vs_Patients-with-HCV/HIV-coinfection-at-baseline_DOWN	NA	816	838
bsdb:1074/11/1_Response-to-antiviral-drug:patients-with-HCV-monoinfection-at-FUw72_vs_patients-with-HCV-monoinfection-at-baseline_UP	NA	1678	572511	102106	189330	1407607	292632
bsdb:1074/11/2_Response-to-antiviral-drug:patients-with-HCV-monoinfection-at-FUw72_vs_patients-with-HCV-monoinfection-at-baseline_DOWN	NA	816	1506553
bsdb:1074/12/1_Response-to-antiviral-drug:patients-with-HCV-monoinfection-at-baseline_vs_healthy-control_DOWN	NA	1485	102106	28050	375288	1501226	292632
bsdb:1074/13/1_Response-to-antiviral-drug:patients-with-HCV/HIV-coinfection-at-baseline_vs_Healthy-controls_UP	NA	1283313	135858
bsdb:1074/13/2_Response-to-antiviral-drug:patients-with-HCV/HIV-coinfection-at-baseline_vs_Healthy-controls_DOWN	NA	572511	102106	239759	292632	1407607	28050	33042	1485
bsdb:1074/14/1_Response-to-antiviral-drug:patients-with-HCV/HIV-coinfection-at-baseline_vs_patients-with-HCV-monoinfection-at-baseline_UP	NA	1283313	83770
bsdb:1074/14/2_Response-to-antiviral-drug:patients-with-HCV/HIV-coinfection-at-baseline_vs_patients-with-HCV-monoinfection-at-baseline_DOWN	NA	572511	1678	1407607
bsdb:1075/1/2_Puberty:Pubertal_vs_Non-pubertal_DOWN	NA	724	100883
bsdb:1076/1/1_Allergic-rhinitis:Allergic-rhinitis-(AR)_vs_healthy-controls-(HC)_UP	NA	80865	150022	570	838	1279	662
bsdb:1076/1/2_Allergic-rhinitis:Allergic-rhinitis-(AR)_vs_healthy-controls-(HC)_DOWN	NA	93681
bsdb:1077/1/1_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_UP	NA	2086	816	51514	1578	248038	375288
bsdb:1077/1/2_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_DOWN	NA	174708	1678
bsdb:1077/2/1_Gut-microbiome-measurement:TAC-CH-group_vs_TAC-group_UP	NA	207244	244127	1485	119852	191303
bsdb:1077/2/2_Gut-microbiome-measurement:TAC-CH-group_vs_TAC-group_DOWN	NA	447020	49082	189330	1279
bsdb:1077/3/2_Gut-microbiome-measurement:JAX-CH-group_vs_TAC-CH-group_DOWN	NA	816
bsdb:1077/4/1_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_UP	NA	816	51514	1578	248038	375288
bsdb:1077/4/2_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_DOWN	NA	447020	174708	1678	119852	1263
bsdb:1077/5/1_Gut-microbiome-measurement:TAC-CH-group_vs_TAC-group_UP	NA	33042
bsdb:1077/5/2_Gut-microbiome-measurement:TAC-CH-group_vs_TAC-group_DOWN	NA	189330
bsdb:1077/7/1_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_UP	NA	816	51514	248038	375288
bsdb:1077/7/2_Gut-microbiome-measurement:JAX-CH-group_vs_JAX-group_DOWN	NA	174708	1678	1279
bsdb:1077/8/1_Gut-microbiome-measurement:TAC-CH-group_vs_TAC-group_UP	NA	191303
bsdb:1077/10/1_Gut-microbiome-measurement:JAX-CH-fecal-pellets-group_vs_JAX-CH-colon-group_UP	NA	447020	239934	207244	1678	1578	191303
bsdb:1077/10/2_Gut-microbiome-measurement:JAX-CH-fecal-pellets-group_vs_JAX-CH-colon-group_DOWN	NA	2086	244127	33042	51514	1350	248038	119852	1263
bsdb:1077/11/1_Gut-microbiome-measurement:TAC-CH-fecal-pellets-group_vs_TAC-CH-colon-group_UP	NA	447020	239934	816	1678	1578	375288
bsdb:1077/11/2_Gut-microbiome-measurement:TAC-CH-fecal-pellets-group_vs_TAC-CH-colon-group_DOWN	NA	248038	2086	119852	1263	33042
bsdb:1077/12/1_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_UP	NA	239934	1485	447020	1578
bsdb:1077/12/2_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_DOWN	NA	375288	816	248038
bsdb:1077/15/1_Gut-microbiome-measurement:F1-mJAX-group_vs_F1-mTAC-group_UP	NA	239934
bsdb:1077/16/1_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_UP	NA	239934	1485	2086	1678	469
bsdb:1077/16/2_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_DOWN	NA	375288	816	248038	51514	189330
bsdb:1077/19/1_Gut-microbiome-measurement:F1-mJAX-group_vs_F1-mTAC-group_UP	NA	239934
bsdb:1077/19/2_Gut-microbiome-measurement:F1-mJAX-group_vs_F1-mTAC-group_DOWN	NA	51514
bsdb:1077/20/1_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_UP	NA	239934	1485	447020	2086
bsdb:1077/20/2_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_DOWN	NA	375288	816	248038	51514
bsdb:1077/23/1_Gut-microbiome-measurement:F1-mJAX-group_vs_F1-mTAC-group_UP	NA	239934
bsdb:1079/1/1_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_UP	NA	836	838	1301
bsdb:1079/1/2_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_DOWN	NA	838
bsdb:1079/2/1_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-1_UP	NA	1654	1380	117563	32257	1164882	906	86331	838	1301	29465
bsdb:1079/2/2_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-1_DOWN	NA	838
bsdb:1079/3/1_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-2_UP	NA	1654	1380	117563	32257	1164882	906	86331	838	29465
bsdb:1079/3/2_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-2_DOWN	NA	836	838	1301
bsdb:1079/4/2_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_DOWN	NA	1016	724	508215	117563
bsdb:1079/5/1_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-1_UP	NA	29465
bsdb:1079/5/2_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-1_DOWN	NA	1016	724	32207	117563
bsdb:1079/6/1_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-2_UP	NA	29465
bsdb:1079/7/1_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)_vs_Normal-(Normal-esophagus)_UP	NA	186831	44259	194
bsdb:1079/7/2_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)_vs_Normal-(Normal-esophagus)_DOWN	NA	1578
bsdb:1079/8/1_Gastroesophageal-reflux-disease:Gastroesophageal-reflux-disease-GERD(within-subjects-classified-as-PPI-NO)_vs_Normal_UP	NA	508215	838	1301	44259	186831	29465	32067	194	2717
bsdb:1079/8/2_Gastroesophageal-reflux-disease:Gastroesophageal-reflux-disease-GERD(within-subjects-classified-as-PPI-NO)_vs_Normal_DOWN	NA	84108	838	1578	1301	265975	82202	906	29465
bsdb:1079/9/1_Barrett's-esophagus:Barrett’s-Esophagus-(BE)_vs_Normal_UP	NA	32067	1016
bsdb:1079/10/1_Barrett's-esophagus:Barrett’s-Esophagus-(BE)_vs_Gastroesophageal-reflux-disease-(GERD)_UP	NA	1016
bsdb:1079/10/2_Barrett's-esophagus:Barrett’s-Esophagus-(BE)_vs_Gastroesophageal-reflux-disease-(GERD)_DOWN	NA	1283313
bsdb:1079/11/1_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_Gastroesophageal-reflux-disease-(GERD)_UP	NA	838	1200657
bsdb:1079/11/2_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_Gastroesophageal-reflux-disease-(GERD)_DOWN	NA	838	186831
bsdb:1079/12/1_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_Normal_UP	NA	838
bsdb:1079/14/2_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)within-subjects-classified-as-PPI-NO_vs_Normal-(Normal-esophagus)_DOWN	NA	906
bsdb:1079/15/1_Barrett's-esophagus:Barrett’s-Esophagus-(BE)_vs_Normal_UP	NA	1378
bsdb:1079/16/1_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_Normal_UP	NA	46123	156454	32008	893	1279384	209
bsdb:1079/17/1_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_GERD(Gastroesophageal-reflux-disease)_UP	NA	46123	1279384	209	32257
bsdb:1079/18/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-1)_vs_Normal-(Cluster-1)_UP	NA	1301	29465
bsdb:1079/18/2_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-1)_vs_Normal-(Cluster-1)_DOWN	NA	1578
bsdb:1079/19/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-2)_vs_Normal-(Cluster-2)_UP	NA	1716	838	265975	44259	123375	970	29465	28219	482
bsdb:1079/19/2_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-2)_vs_Normal-(Cluster-2)_DOWN	NA	838
bsdb:1079/20/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-3)_vs_Normal-(Cluster-3)_UP	NA	838	1016
bsdb:1079/21/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-1)_vs_Normal-(Cluster-1)_UP	NA	1283313	1730
bsdb:1079/21/2_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-1)_vs_Normal-(Cluster-1)_DOWN	NA	1283313
bsdb:1079/22/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-2)_vs_Normal-(Cluster-2)_UP	NA	32067	508215
bsdb:1079/23/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-3)_vs_Normal-(Cluster-3)_UP	NA	1378	724	482
bsdb:1079/23/2_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-3)_vs_Normal-(Cluster-3)_DOWN	NA	1380	838
bsdb:1079/24/2_Esophageal-adenocarcinoma:Subjects-with-normal-esophagus-on-PPI-Yes_vs_Subjects-with-normal-esophagus-on-PPI-No_DOWN	NA	1257
bsdb:1079/25/1_Esophageal-adenocarcinoma:Subjects-with-GERD-on-PPI-Yes_vs_Subjects-with-GERD-on-PPI-No_UP	NA	32207	1283313	1213720	906	29465
bsdb:1080/1/1_Lower-respiratory-tract-disease:Chronic-Otitis-Media-With-Effusion-(COME)-with-asthma-or-bronchiolitis_vs_Chronic-Otitis-Media-With-Effusion-(COME)-without-asthma-or-bronchiolitis_UP	NA	724	1279	475
bsdb:1081/1/1_Taxonomic-microbiome-measurement:Highly-attractive-group_vs_Poorly-attractive-group_UP	NA	73778	13687	1279
bsdb:1081/1/2_Taxonomic-microbiome-measurement:Highly-attractive-group_vs_Poorly-attractive-group_DOWN	NA	41275	1716	665874
bsdb:1082/1/2_Polycystic-ovary-syndrome:polycystic-ovary-syndrome-(PCOS)-like-mice_vs_Controls_DOWN	NA	816	375288	1647175
bsdb:1083/1/1_Age:B-Group-(B25.2)_vs_B-Group-(B15.2)_UP	NA	1234
bsdb:1083/5/2_Age:B-Group-(B45.4)_vs_B-Group-(B15.4)_DOWN	NA	233189
bsdb:1084/1/1_Recalcitrant-atopic-dermatitis:mild-atopic-dermatitis-(AD)_vs_healthy-controls_UP	NA	1763
bsdb:1085/1/1_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_UP	NA	1678	1716	1301
bsdb:1085/1/2_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_DOWN	NA	1279	1350	570	1485
bsdb:1085/2/1_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_UP	NA	1654	1678	1350	32207	1301
bsdb:1085/2/2_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_DOWN	NA	816	1485	150022	1378	570
bsdb:1086/1/1_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-(CTRL-S)_UP	NA	194	724	1164882	29465
bsdb:1086/1/2_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-(CTRL-S)_DOWN	NA	1654	2801844	2717	43996	1434006	133925	2740	1257	1213720
bsdb:1086/2/1_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Controls-(CTRL-SP)_UP	NA	1654	1434006
bsdb:1086/2/2_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Controls-(CTRL-SP)_DOWN	NA	416916	1016	1378	32067	1257
bsdb:1086/3/1_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-Adults-(CTRL-S)_UP	NA	194	1016	32257
bsdb:1086/3/2_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-Adults-(CTRL-S)_DOWN	NA	1654	2801844	43996	1434006	2740	1213720
bsdb:1086/4/1_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Control-Adults-(CTRL-SP)_UP	NA	1654	1434006	32257
bsdb:1086/4/2_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Control-Adults-(CTRL-SP)_DOWN	NA	1378	1257	1213720
bsdb:1086/5/1_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-Children-(CTRL-S)_UP	NA	724	1164882	265975
bsdb:1086/5/2_Phenylketonuria:Phenylketonuria-(PKU-S)_vs_Control-Children-(CTRL-S)_DOWN	NA	1654	2801844	1434006	133925	2740	1213720	195950
bsdb:1086/6/1_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Control-Children-(CTRL-SP)_UP	NA	1654	1380	1434006	32257	133925	265975	970	1213720
bsdb:1086/6/2_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Control-Children-(CTRL-SP)_DOWN	NA	416916	1016	1378	32067	1257
bsdb:1086/7/1_Phenylketonuria:Ch-CTRL-unrel-(unrelated-control-children)_vs_Ch-CTRL-rel-(Healthy-siblings-of-PKU-patients)_UP	NA	724	1164882	265975
bsdb:1086/7/2_Phenylketonuria:Ch-CTRL-unrel-(unrelated-control-children)_vs_Ch-CTRL-rel-(Healthy-siblings-of-PKU-patients)_DOWN	NA	1434006	2801844	1654	1380	47670	1257
bsdb:1086/8/1_Phenylketonuria:Ch-PKU-(PKU-children)_vs_Ch-CTRL-rel-(Healthy-siblings-of-PKU-patients)_UP	NA	1016	1257	2740	32067	1164882	836	416916
bsdb:1086/8/2_Phenylketonuria:Ch-PKU-(PKU-children)_vs_Ch-CTRL-rel-(Healthy-siblings-of-PKU-patients)_DOWN	NA	133925	970	1380	1654	1434006
bsdb:1086/9/1_Phenylketonuria:Control-(CTRL-SP)_vs_Control-(CTRL-S)_UP	NA	29465	1301	1213720	1257	724	1378	1380	1283313	482	836	265975	838
bsdb:1086/9/2_Phenylketonuria:Control-(CTRL-SP)_vs_Control-(CTRL-S)_DOWN	NA	416916	2801844	194	1016	2717	1716	848	32257	32067	133925	970	195950
bsdb:1086/10/1_Phenylketonuria:Control-Adults-(CTRL-SP)_vs_Control-Adults-(CTRL-S)_UP	NA	29465	1301	1213720	1257	724	1378	1380	1283313	482	836	265975	838
bsdb:1086/10/2_Phenylketonuria:Control-Adults-(CTRL-SP)_vs_Control-Adults-(CTRL-S)_DOWN	NA	416916	2801844	194	1016	2717	1716	848	32257	133925	970	195950
bsdb:1086/11/1_Phenylketonuria:Control-Children-(CTRL-Ch-SP)_vs_Control-Children-(CTRL-Ch-S)_UP	NA	838	265975	836	482	1283313	1380	1378	724	1257	1213720	1301	29465
bsdb:1086/11/2_Phenylketonuria:Control-Children-(CTRL-Ch-SP)_vs_Control-Children-(CTRL-Ch-S)_DOWN	NA	1016	848	1716	32257	2801844	2717	133925	195950	194	1434006
bsdb:1086/12/1_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Phenylketonuria-(PKU-S)_UP	NA	1283313	1380	1378	724	1164882	482	265975	1257	836	838	508215	1213720	1301	29465
bsdb:1086/12/2_Phenylketonuria:Phenylketonuria-(PKU-SP)_vs_Phenylketonuria-(PKU-S)_DOWN	NA	1654	416916	2801844	194	1016	2717	1716	1434006	848	32257	47670	133925	2740	970	195950
bsdb:1086/13/1_Phenylketonuria:Phenylketonuria-Adults-(PKU-SP)_vs_Phenylketonuria-Adults-(PKU-S)_UP	NA	838	508215	1164882	1283313	1380	1378	724	1213720	1301	29465
bsdb:1086/13/2_Phenylketonuria:Phenylketonuria-Adults-(PKU-SP)_vs_Phenylketonuria-Adults-(PKU-S)_DOWN	NA	194	2740	133925	2717	1654	970	2801844	1434006	1716	848	1016
bsdb:1086/14/1_Phenylketonuria:Phenylketonuria-Ch-(PKU-SP)_vs_Phenylketonuria-Ch-(PKU-S)_UP	NA	1283313	1380	1378	724	1164882	482	1257	836	838	1301	29465
bsdb:1086/14/2_Phenylketonuria:Phenylketonuria-Ch-(PKU-SP)_vs_Phenylketonuria-Ch-(PKU-S)_DOWN	NA	194	195950	2740	133925	2717	1654	970	32257	1434006	1716	848	1016	2801844
bsdb:1088/1/1_Schizophrenia:SCZF:-patients-with-schizophrenia_vs_HCF:-healthy-controls-(no-psychiatric-diagnosis-of-schizophrenia)_UP	NA	1654	1663	102106	106589	1730	88	13159	354349	286	113286	620
bsdb:1088/1/2_Schizophrenia:SCZF:-patients-with-schizophrenia_vs_HCF:-healthy-controls-(no-psychiatric-diagnosis-of-schizophrenia)_DOWN	NA	447020	239759	92793	816	33042	1350	216851	724	1159323	119852	375288	838	46205	1263
bsdb:1088/2/1_Schizophrenia:SCZ:-schizophrenia-fecal-microbiota-recipient-mice_vs_HC:-healthy-control-fecal-microbiota-recipient-mice_UP	NA	1716	209	283168	577309	1508657
bsdb:1088/2/2_Schizophrenia:SCZ:-schizophrenia-fecal-microbiota-recipient-mice_vs_HC:-healthy-control-fecal-microbiota-recipient-mice_DOWN	NA	239759	816	990721	1578	375288	1505663
bsdb:1089/1/1_Treatment:Schizophrenia-patients-after-treatment-(AT)_vs_Schizophrenia-patients-before-treatment-(BT)_UP	NA	580596	216851	119852	838	841	458032
bsdb:1089/1/2_Treatment:Schizophrenia-patients-after-treatment-(AT)_vs_Schizophrenia-patients-before-treatment-(BT)_DOWN	NA	32207
bsdb:1090/1/1_Metabolic-syndrome:Schizophrenia-patients-without-MetS_vs_Schizophrenia-patients-with-MetS_UP	NA	239934	135858	1485	1730	1266	191303	1218
bsdb:1090/1/2_Metabolic-syndrome:Schizophrenia-patients-without-MetS_vs_Schizophrenia-patients-with-MetS_DOWN	NA	816	32008	1485	39948	1578	158846	375288	40544
bsdb:1091/1/1_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_UP	NA	33042	848	724	1578	459786	375288	33024	40544	29465
bsdb:1091/1/2_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_DOWN	NA	469	447020	1678	102106	1350	1730	581	286
bsdb:1091/2/1_Chronic-gastritis,Gastric-cancer:Early-stage-gastric-cancer_vs_Other-sub-groups-(NIM,-IM-and-late-stage-gastric-cancer))_UP	NA	1350	283168	33024	29465
bsdb:1091/3/1_Chronic-gastritis,Gastric-cancer:Late-stage-gastric-cancer_vs_Other-sub-groups-(NIM,-IM-and-early-stage-gastric-cancer)_UP	NA	375288	459786	848	40544
bsdb:1091/4/1_Chronic-gastritis,Gastric-cancer:Intestinal-metaplasia_vs_Other-sub-groups-(NIM,-early-stage-gastric-cancer-and-late-stage-gastric-cancer))_UP	NA	447020	207244	1730
bsdb:1091/5/1_Chronic-gastritis,Gastric-cancer:Non-intestinal-metaplasia_vs_Other-sub-groups-(IM,-early-stage-gastric-cancer-and-late-stage-gastric-cancer))_UP	NA	469	158846	286
bsdb:1092/1/1_Cognitive-decline-measurement:Probiotic-group_vs_Placebo-group_UP	NA	838
bsdb:1092/1/2_Cognitive-decline-measurement:Probiotic-group_vs_Placebo-group_UP	NA	816	577310	838	1980693
bsdb:1093/1/1_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	816	1380	848	906	29465	239934
bsdb:1093/1/2_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	816	33024	397864	572511	33042	39948	1407607	570	407	1301
bsdb:1094/1/1_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_UP	NA	904	119977	244127	118747	135858	1485	102106	33870	1716	872	547	1378	1578	52225	86331	583	1266	970	83770	28033	179
bsdb:1094/1/2_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_DOWN	NA	239934	580596	508459	189330	216851	1357	906	482	638847	29465
bsdb:1094/2/1_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_UP	NA	239759	1485	2742598	2895461	158846	906	33024	1263	970
bsdb:1094/2/2_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_DOWN	NA	816	572511	33042	1730	1573535	28050	841	2944152
bsdb:1095/1/1_Metabolite:HF+DI-(High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_HF+Veh-(High-fat-and-Vehicle-treated-mice)_UP	NA	174708	1283313	191	83770
bsdb:1095/1/2_Metabolite:HF+DI-(High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_HF+Veh-(High-fat-and-Vehicle-treated-mice)_DOWN	NA	1392389	1506553	83618	1508657	332162
bsdb:1095/2/1_Metabolite:FMT-HF+DI-(Fecal-microbiome-transplantation-High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_FMT-HF+Veh-(Fecal-microbiome-transplantation-High-fat-and-Vehicle-treated-mice)_UP	NA	872	580024	2093	841	1506577
bsdb:1095/2/2_Metabolite:FMT-HF+DI-(Fecal-microbiome-transplantation-High-fat-and-Dimethyl-Itaconate-treated-mice)_vs_FMT-HF+Veh-(Fecal-microbiome-transplantation-High-fat-and-Vehicle-treated-mice)_DOWN	NA	354349	1937007	1937008
bsdb:1096/1/1_Gut-microbiome-measurement:Infants_vs_Mothers_UP	NA	258514	447020	239759	244127	109326	397864	572511	580596	1348911	33042	39948	216851	1407607	204475	644652	61170	1392389	86331	459786	841	1263
bsdb:1096/1/2_Gut-microbiome-measurement:Infants_vs_Mothers_DOWN	NA	1654	1380	1678	84111	547	1350	150022	1378	117563	570	1578	68287	32207	13687	1279	29465
bsdb:1096/2/1_Gut-microbiome-measurement:Infants_vs_Grandmothers_UP	NA	258514	447020	1647175	239759	397864	35832	572511	580596	1348911	33042	216851	1573536	1407607	204475	61170	1392389	2172	133925	459786	33024	1501226	841	1263	44748	191303
bsdb:1096/2/2_Gut-microbiome-measurement:Infants_vs_Grandmothers_DOWN	NA	1654	1380	1678	547	150022	1378	117563	724	570	68287	13687	1279	29465
bsdb:1096/3/1_Gut-microbiome-measurement:Infants_vs_Mothers_UP	NA	1918385	447020	2048137	239759	1924093	2039240	244127	553372	397864	1929297	580596	2316203	990721	33042	39948	1472649	189330	2591381	1730	2211178	216851	2005359	1918454	1407607	204475	644652	61170	2764317	28050	1763508	420345	2172004	2895461	3028852	86331	283168	459786	119852	44249	1926677	841	1263	292632	338
bsdb:1096/3/2_Gut-microbiome-measurement:Infants_vs_Mothers_DOWN	NA	1678	1350	561	2701	570	1578	620	29465
bsdb:1096/4/1_Gut-microbiome-measurement:Infants_vs_Grandmothers_UP	NA	1918385	447020	239759	2569097	1924093	2039240	1935176	553372	35832	580596	33042	189330	2591381	1730	2211178	216851	2005359	1918454	1407607	204475	1892380	61170	1506553	28050	1763508	2172004	2895461	86331	283168	459786	44249	33024	1017280	1501226	1263	36086	338
bsdb:1096/4/2_Gut-microbiome-measurement:Infants_vs_Grandmothers_DOWN	NA	1678	561	2701	570	1578	620	1506577	29465
bsdb:1096/5/1_Gut-microbiome-measurement:Infants_vs_Mothers-and-Grandmothers_UP	NA	1678	1578
bsdb:1096/6/1_Gut-microbiome-measurement:Mothers_vs_Infants-and-Grandmothers_UP	NA	572511	39948	61170	40544
bsdb:1096/7/1_Gut-microbiome-measurement:Grandmothers_vs_Infants-and-Mothers_UP	NA	258514	239934	35832	33870	1433996	133925	1427376	33024
bsdb:1099/1/1_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Baseline-(S0)_vs_Healthy-controls-(C)_UP	NA	1506553
bsdb:1099/1/2_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Baseline-(S0)_vs_Healthy-controls-(C)_UP	NA	1506553
bsdb:1099/2/1_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Week-6-(S1)_vs_Healthy-controls-(C)_DOWN	NA	1501226
bsdb:1099/3/1_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Week-12-(S2)_vs_Healthy-controls-(C)_DOWN	NA	1501226
bsdb:1099/4/1_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Week-24-(S3)_vs_Healthy-controls-(C)_DOWN	NA	1501226
bsdb:1099/6/1_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Week-24-(S3)_vs_Schizophrenia-(SCH)-patients-at-Baseline-(S0)_UP	NA	28050	40544	239759	31980
bsdb:1099/6/2_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Week-24-(S3)_vs_Schizophrenia-(SCH)-patients-at-Baseline-(S0)_DOWN	NA	1506553
bsdb:1100/1/1_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_UP	NA	816	158846	838
bsdb:1100/1/2_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_DOWN	NA	1432051
bsdb:1102/2/1_Alzheimer's-disease:APP/PS1_vs_Wild-type-(WT)_UP	NA	239934	174708	1283313	1678	3025755
bsdb:1102/4/1_Alzheimer's-disease:APP/PS1_vs_Wild-type-(WT)_UP	NA	239934	572511	1506577	191303
bsdb:1102/5/1_Alzheimer's-disease:APP/PS1_vs_Wild-type-(WT)_UP	NA	239934	872
bsdb:1102/5/2_Alzheimer's-disease:APP/PS1_vs_Wild-type-(WT)_DOWN	NA	292480	239759
bsdb:1103/1/1_Dry-eye-syndrome:Mild-Dry-Eye_vs_control_UP	NA	1663	748770	57494	13687	1569
bsdb:1103/1/2_Dry-eye-syndrome:Mild-Dry-Eye_vs_control_DOWN	NA	1578	1716	212791	528	1743
bsdb:1103/2/1_Dry-eye-syndrome:Moderate-to-severe-dry-eye_vs_control_UP	NA	174708	28209	106589	270	449972
bsdb:1103/2/2_Dry-eye-syndrome:Moderate-to-severe-dry-eye_vs_control_DOWN	NA	1578	212791	528	1716	1743
bsdb:1103/3/1_Dry-eye-syndrome:Moderate-to-severe-dry-eye_vs_mild-dry-eye_UP	NA	174708	449972	28209	270
bsdb:1103/3/2_Dry-eye-syndrome:Moderate-to-severe-dry-eye_vs_mild-dry-eye_DOWN	NA	1663	748770	57494	13687	1569
bsdb:1104/1/1_Gut-microbiome-measurement:Paternal-Gut-Microbiome-Depleted-Mice_vs_Male-Mice-with-Normal-Gut-Microbiome_DOWN	NA	816	1578	1485
bsdb:1104/1/2_Gut-microbiome-measurement:Paternal-Gut-Microbiome-Depleted-Mice_vs_Male-Mice-with-Normal-Gut-Microbiome_UP	NA	816	1578
bsdb:1105/3/1_Physical-activity:Professional-football-players-after-intensive-training_vs_Professional-football-players-before-intensive-training_UP	NA	1301
bsdb:1105/3/2_Physical-activity:Professional-football-players-after-intensive-training_vs_Professional-football-players-before-intensive-training_DOWN	NA	397864
bsdb:1105/4/1_Physical-activity:Professional-football-players-after-intensive-training_vs_Professional-football-players-before-intensive-training_UP	NA	46123	416916	1016	2717	1716	39948	47670	543311	32207	195950
bsdb:1105/4/2_Physical-activity:Professional-football-players-after-intensive-training_vs_Professional-football-players-before-intensive-training_DOWN	NA	117563	265975	838
bsdb:1106/1/1_Breastfeeding-duration:Non_Exclusive-Breast-Feeding-(Non-EBF)_vs_Exclusive-Breast-Feeding-(EBF)_UP	NA	1678	1350
bsdb:1106/1/2_Breastfeeding-duration:Non_Exclusive-Breast-Feeding-(Non-EBF)_vs_Exclusive-Breast-Feeding-(EBF)_DOWN	NA	572511	135858	102106	1578	838	1263
bsdb:1106/2/1_Breastfeeding-duration:Reduced-exclusivity-of-beast-feeding-to-none-breastfeeding_vs_Increasing-Exclusive-Breast-Feeding-(EBF)_UP	NA	239934	572511	33042	1730
bsdb:1106/2/2_Breastfeeding-duration:Reduced-exclusivity-of-beast-feeding-to-none-breastfeeding_vs_Increasing-Exclusive-Breast-Feeding-(EBF)_DOWN	NA	724	1279
bsdb:1106/3/1_Breastfeeding-duration:Non-Exclusive-Breastfeeding-(Non-EBF),-Vaginally-Born-and-C-section-Born_vs_Exclusively-Breastfeeding-(EBF),-Vaginally-Born-and-C-section-Born_UP	NA	816	1485	33042	1730	906
bsdb:1106/4/1_Breastfeeding-duration:Non-Exclusive-Breastfeeding-(Non-EBF)_vs_Exclusive-Breastfeeding-(EBF)_UP	NA	816	1485	906	29465	1730
bsdb:1106/5/1_Breastfeeding-duration:Reduced-exclusivity-of-beast-feeding-to-none-breastfeeding_vs_Increasing-Exclusive-Breast-Feeding-(EBF)_UP	NA	904	1730	816	416916	1357	572511
bsdb:1106/5/3_Breastfeeding-duration:Reduced-exclusivity-of-beast-feeding-to-none-breastfeeding_vs_Increasing-Exclusive-Breast-Feeding-(EBF)_DOWN	NA	244127	33024	583	1279
bsdb:1106/6/1_Breastfeeding-duration:Non-Exclusive-Breastfeeding-(Non-EBF)_vs_Exclusive-BreastFeeding-(EBF)_UP	NA	904	816	1485	33042	1730	906	29465
bsdb:1106/7/1_Breastfeeding-duration:Reduced-exclusivity-of-beast-feeding-to-none-breastfeeding_vs_Increasing-Exclusive-Breast-Feeding-(EBF)_UP	NA	816	1485	1730	906
bsdb:1108/1/1_HIV-infection,Abnormal-inflammatory-response:HIV-infected_vs_HIV-uninfected_UP	NA	84108	102106
bsdb:1108/1/2_HIV-infection,Abnormal-inflammatory-response:HIV-infected_vs_HIV-uninfected_DOWN	NA	1501226
bsdb:1111/1/1_Relapsing-remitting-multiple-sclerosis:Caucasian-Americans-(CA)_vs_Healthy-Controls_UP	NA	1485	239934
bsdb:1111/2/1_Relapsing-remitting-multiple-sclerosis:Hispanic-Americans-(HA)_vs_Healthy-Controls_UP	NA	572511	1485	189330	61170	447020
bsdb:1111/2/2_Relapsing-remitting-multiple-sclerosis:Hispanic-Americans-(HA)_vs_Healthy-Controls_DOWN	NA	39948	28050	838	84108
bsdb:1111/3/1_Relapsing-remitting-multiple-sclerosis:African-Americans-(AA)_vs_Healthy-Controls_UP	NA	447020	580596	1485
bsdb:1114/1/1_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_UP	NA	191303	142587
bsdb:1114/1/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	253238	906	838	32207	292632	29465
bsdb:1114/2/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	102106	189330	1743	22	292632
bsdb:1115/1/1_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_UP	NA	830	1716
bsdb:1115/1/2_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_DOWN	NA	580596	1407607
bsdb:1115/2/1_Ischemic-stroke:Patients-with-stroke-associated-Pnuemonia(SAP)_vs_Patients-without-stroke-associated-Pnuemonia(non-SAP)_UP	NA	816	580596	574697	33042	1407607
bsdb:1117/1/1_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_UP	NA	1654	978	279	2985502
bsdb:1117/1/2_Gestational-diabetes:Gestational-diabetes-mellitus-(GDM)_vs_Healthy-controls_DOWN	NA	1375	212791	216851	963	497	93681
bsdb:1118/1/1_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_UP	NA	46123	547	848	1506553	906	1827	1301	29465
bsdb:1118/1/2_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	239759	207244	816	397864	1678	216851	1407607	119852	577309	577310	841	292632	172900
bsdb:1118/2/1_HIV-infection:immunological-non-responders-(INR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_UP	NA	848	906	292632	577310	1283313
bsdb:1118/2/6_HIV-infection:immunological-non-responders-(INR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	239759	207244	397864	1678	572511	189330	216851	1407607	724	577309	841
bsdb:1118/3/1_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_immunological-non-responders-(INR)-HIV-infected-individual_UP	NA	123375	1472649	572511
bsdb:1118/3/2_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_immunological-non-responders-(INR)-HIV-infected-individual_DOWN	NA	207244	1283313	1730
bsdb:1124/1/1_Vaginal-microbiome-measurement:Main-group---CG,-Caucasian-German-women_vs_Combination-of-groups---AA,-AC,-AI-and-AK-women_UP	NA	1378
bsdb:1124/2/1_Vaginal-microbiome-measurement:AK,-African-Kenyan-women_vs_Combination-of-groups---AA,-AC,-AI-and-CG-women_UP	NA	836
bsdb:1124/3/1_Vaginal-microbiome-measurement:AI,-Asian-Indonesian-women_vs_Combination-of-groups---AA,-AC,-AK-and-CG-women_UP	NA	1279	165779	1257	1582879
bsdb:1124/4/1_Vaginal-microbiome-measurement:AC,-Afro-Caribbean-women_vs_Combination-of-groups---AA,-AI,-AK-and-CG-women_DOWN	NA	838	162289
bsdb:1125/1/2_Glucose-metabolism-measurement:African-citizens_vs_Han-Chinese-citizens_DOWN	NA	816
bsdb:1130/1/1_Diarrhea:Diarrhea_vs_healthy-controls_UP	NA	1301
bsdb:1130/1/2_Diarrhea:Diarrhea_vs_healthy-controls_DOWN	NA	1578	52225
bsdb:1130/2/1_Diarrhea:Acute-Diarrhea_vs_Healthy-Controls_UP	NA	1678	194	1301
bsdb:1130/2/2_Diarrhea:Acute-Diarrhea_vs_Healthy-Controls_DOWN	NA	1578	52225
bsdb:1130/3/1_Diarrhea:Prolonged-or-Persistent-Diarrhea_vs_Healthy-Controls_UP	NA	194	1301
bsdb:1130/3/2_Diarrhea:Prolonged-or-Persistent-Diarrhea_vs_Healthy-Controls_DOWN	NA	816	52225
bsdb:1130/4/1_Diarrhea:Prolonged-or-Persistent-Diarrhea_vs_Acute-Diarrhea_UP	NA	1578
bsdb:1132/1/1_Type-II-diabetes-mellitus:T2DM-individuals-(subjects-with-Type-2-Diabetes)_vs_Non-T2DM-controls-(healthy-individuals)_UP	NA	33024	904
bsdb:1132/1/2_Type-II-diabetes-mellitus:T2DM-individuals-(subjects-with-Type-2-Diabetes)_vs_Non-T2DM-controls-(healthy-individuals)_DOWN	NA	237557	55193	5206
bsdb:1139/1/2_Gut-microbiome-measurement:Prebiotic-group_vs_Placebo-group_DOWN	NA	1924093
bsdb:1139/3/1_Fructose,Gut-microbiome-measurement:Prebiotic_vs_Placebo_UP	NA	1678
bsdb:1141/1/1_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_UP	NA	1331051	248744
bsdb:1141/1/2_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_DOWN	NA	1506577
bsdb:1142/1/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Control_UP	NA	1678	39948	308865	44259	1378	1578	543311	2171988
bsdb:1142/2/1_Hypertrophy:Adenotonsillar-hypertrophy-(ATH)_vs_Control_UP	NA	2767353
bsdb:1142/5/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Adenotonsillar-hypertrophy-(ATH)_UP	NA	1378	543311	1678	39948	44259	2171988	1578	308865
bsdb:1142/5/2_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Adenotonsillar-hypertrophy-(ATH)_DOWN	NA	2767353
bsdb:1142/6/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Adenoid-hypertrophy-(AH)_UP	NA	1378	543311	1678	39948	44259	2171988	1578	308865
bsdb:1144/1/1_Autism-spectrum-disorder:Children-with-Autism-Spectrum-Disorder-(ASD)_vs_Healthy-children_UP	NA	216851	838	292632	1263	1766253
bsdb:1144/1/2_Autism-spectrum-disorder:Children-with-Autism-Spectrum-Disorder-(ASD)_vs_Healthy-children_DOWN	NA	1678	1730
bsdb:1151/1/1_Lactose-intolerance:Participants-with-Lactose-Intolerance_vs_Healthy-Controls_UP	NA	572511	1485	102106	283	39948	724	906	157
bsdb:1151/1/2_Lactose-intolerance:Participants-with-Lactose-Intolerance_vs_Healthy-Controls_DOWN	NA	239759	830	872	1730	838	1263	83770
bsdb:1151/2/1_Lactose-intolerance:Participants-with-Lactose-Intolerance_vs_Healthy-Control_UP	NA	547	561	28050	1243	590	620	570	375288
bsdb:1151/2/2_Lactose-intolerance:Participants-with-Lactose-Intolerance_vs_Healthy-Control_DOWN	NA	216851
bsdb:1152/1/1_HIV-infection:Chronic-HIV-infected-cases_vs_HIV-uninfected-controls_UP	NA	397864
bsdb:1156/1/1_Age,Erythrocyte-indices,Growth-protocol,Hemoglobin-A2-measurement,Abnormal-result-of-function-studies:Exposed_vs_Unexposed_UP	NA	838
bsdb:1156/1/2_Age,Erythrocyte-indices,Growth-protocol,Hemoglobin-A2-measurement,Abnormal-result-of-function-studies:Exposed_vs_Unexposed_UP	NA	838
bsdb:1157/1/1_Stroke:Stroke-Associated-Pneumonia-(SAP)-Training-cohort_vs_Non-Stroke-Associated-Pneumonia-(non-SAP)-Training-cohort_UP	NA	35832	1350	551	375288
bsdb:1157/1/2_Stroke:Stroke-Associated-Pneumonia-(SAP)-Training-cohort_vs_Non-Stroke-Associated-Pneumonia-(non-SAP)-Training-cohort_DOWN	NA	841
bsdb:1157/2/1_Stroke:Stroke-Associated-Pneumonia-(SAP)-Validation-cohort_vs_Non-Stroke-Associated-Pneumonia-(non-SAP)-Validation-cohort_UP	NA	872	547	1578
bsdb:1157/2/2_Stroke:Stroke-Associated-Pneumonia-(SAP)-Validation-cohort_vs_Non-Stroke-Associated-Pneumonia-(non-SAP)-Validation-cohort_DOWN	NA	816	724	40544	841	28050	33042
bsdb:1157/3/1_Stroke:Stroke-Associated-Pneumonia-(SAP)-subgroup-in-the-training-cohort_vs_Non-Stroke-Associated-Pneumonia-(non-SAP)-subgroup-in-the-training-cohort_UP	NA	83770	551	1350
bsdb:1157/3/2_Stroke:Stroke-Associated-Pneumonia-(SAP)-subgroup-in-the-training-cohort_vs_Non-Stroke-Associated-Pneumonia-(non-SAP)-subgroup-in-the-training-cohort_DOWN	NA	216851	51514	841
bsdb:1158/1/1_Sleep-duration:Short-Sleepers_vs_Normal-Sleepers_UP	NA	39948	816
bsdb:1158/1/2_Sleep-duration:Short-Sleepers_vs_Normal-Sleepers_DOWN	NA	838
bsdb:1158/2/1_Sleep-duration:Long-Sleepers_vs_Normal-Sleepers_UP	NA	39948	838	119852	135858
bsdb:1158/3/1_Sleep-duration:Long-Sleepers_vs_Short-sleepers_UP	NA	119852	135858
bsdb:1158/3/2_Sleep-duration:Long-Sleepers_vs_Short-sleepers_DOWN	NA	816
bsdb:1161/1/1_Schistosomiasis:Schistosomiasis-positive_vs_Schistosomiasis-negative_UP	NA	469	1283313	872	39948	724	906	133925	2740	838
bsdb:1161/1/2_Schistosomiasis:Schistosomiasis-positive_vs_Schistosomiasis-negative_DOWN	NA	375288	292632	1485
bsdb:1162/2/1_Viral-encephalitis:Encephalitis-(ENC)_vs_healthy-controls-(CON)_UP	NA	239934	119852	375288
bsdb:1162/2/2_Viral-encephalitis:Encephalitis-(ENC)_vs_healthy-controls-(CON)_DOWN	NA	216851	838	1263	40544
bsdb:1165/1/1_Gut-microbiome-measurement:Potamochoerus-porcus-housed-in-Bioparco,-located-in-Rome,-Italy_vs_Potamochoerus-porcus-housed-in-Parco-Natura-Viva,-located-in-Bussolengo,-Verona,-Italy_UP	NA	1283313	40544
bsdb:1166/1/1_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-who-are-breast-fed_vs_Infants-who-are-not-breast-fed_UP	NA	1678	1301
bsdb:1166/2/1_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-with-diarrhea_vs_Infants-without-diarrhea_UP	NA	1485	620	570
bsdb:1166/2/2_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-with-diarrhea_vs_Infants-without-diarrhea_DOWN	NA	816
bsdb:1168/1/1_HIV-infection:HIV--infected-Pregnant-women_vs_HIV-uninfected-Pregnant-women_UP	NA	1654	83770
bsdb:1168/1/2_HIV-infection:HIV--infected-Pregnant-women_vs_HIV-uninfected-Pregnant-women_DOWN	NA	816	1678	1485	216851	119852	375288	1263	157	191303
bsdb:1168/2/1_Birth-weight:Infants-with-Low-birthweight-<2500g_vs_Infants-with-High-birthweight->2500g_UP	NA	157
bsdb:1168/3/1_Viral-load:HIV-virally-un-suppressed-pregnant-women_vs_HIV-virally-suppressed-pregnant-women_UP	NA	838	577309
bsdb:1168/3/2_Viral-load:HIV-virally-un-suppressed-pregnant-women_vs_HIV-virally-suppressed-pregnant-women_DOWN	NA	1485
bsdb:1169/1/1_Gestational-diabetes:gestational-diabetes-mellitus-(GDM)-pregnancy_vs_Normoglycaemic--pregnancy_UP	NA	1654	102106	872	117563	1243	86331	508215
bsdb:1169/1/2_Gestational-diabetes:gestational-diabetes-mellitus-(GDM)-pregnancy_vs_Normoglycaemic--pregnancy_DOWN	NA	653683	35829	248744
bsdb:1169/2/1_Gestational-diabetes:Previous-GDM-pregnancy_vs_Previous-normoglycaemic--pregnancy_UP	NA	102106	56112	568	404402	133925
bsdb:1169/2/2_Gestational-diabetes:Previous-GDM-pregnancy_vs_Previous-normoglycaemic--pregnancy_DOWN	NA	1263	848
